2012 Final Program

Created by Jacques Mugica June 13-16*, 2012 Nice Acropolis • French Riviera Fin a l P r o gr am 18th World Congress in Cardiac Electrophysiology & C a r d i a c Te c h n i q u e s *Exhibits : June 13-15 Painting by Françoise PersillonCardiostim 2012 Exhi bits Guide to www.cardiostim.com In collaboration with

FacultyAbi-Samra F. M. - USA Ernst S. - GBR Labrousse L. - FRA Ricci R. - ITAAdragao P. - PRT Exner D. - CAN Lakatta E. - USA Ritter P. - FRAAl Fayyad M. - KSA Fast V. - USA Lambiase P. - GBR Ronaszéki A. - HUNAlboni P. - ITA Fedorov V. - USA Lazarus A. - FRA Rozkovec A. - GBRAl-Fagih A. - SAU Fischer W. - DEU Lazzara R. - USA Ruffy R. - USAAliot E. - FRA Fishman G. I. - USA Le Heuzey J.Y. - FRA Sacher F. - FRAAlonso C. - FRA Flammang D. - FRA Leclercq J. F. - FRA Sadoul N. - FRAAmmirati F. - ITA Francis D. - GBR Leclercq C. - FRA Saksena S. - USAAntzelevitch C. - USA Franz M. R. - USA Leenhardt A. - FRA Sanders P. - AUSAuricchio A. - CHE Furniss S. - GBR Lemke B. - DEU Santini M. - ITABadhwar N. - USA Gaita F. - ITA Lenarczyk R. - POL Santomauro M. - ITABelott P. H. - USA Garrigue S. - FRA Lévy S. - FRA Saoudi N. - MCOBenditt D. G. - USA Gillis A. M. - CAN Lewalter T. - DEUBerenfeld O. - USA Gilmour Jr R. - USA Linde C. M. - SWE Savelieva I. - GBRBerul C. - USA Goette A. - DEU Linker N. J. - GBR Saxon L. A. - USABiffi M. - ITA Gold M. - USA Locati E. - ITA Schalij M. - NLDBinner L. - DEU Goldberger J. - USA Lubinski A. - POL Scheinman M. M. - USABlanc J. J. - FRA Gorenek B. - TUR Lunati M. - ITA Schotten U. - DEUBlomstrom-Lundqvist C. - SWE Gras D. - FRA Mabo P. - FRA Schumacher B. - DEUBogun F. - USA Grunnet M. - DNK Maier L. S. - DEU Schwartz P.J. - ITABongiorni M. G. - ITA Guiraudon G. M. - CAN Maltret A. - FRA Shah D. - CHEBordachar P. - FRA Guirgis M. - FRA Marchlinski F. E. - USA Shen W.K. - USABorggrefe M. - DEU Gulizia G. - ITA Marrouche N. F. - USA Shivkumar K. - USABoriani G. - ITA Haigney M. - USA Mazgalev T. N. - USA Silverman N. - USABotto G. - ITA Haïssaguerre M. - FRA McVenes R. - USA Simantirakis E. N. - GRCBoveda S. - FRA Hammill S. C. - USA Michaud G. F. - USA Singh J. - USABoyden P. A. - USA Hatala R. - SVK Mont L. - ESP Skanes A. - USABreithardt G. - DEU Hayes D. - USA Morgan J. M. - GBR Sloman G. - AUSBrignole M. - ITA Heidbüchel H. - BEL Moss A. J. - USA Soejima K. - JPNBrugada P. - BEL Helland J. R. - USA Mounsey J. P. - USA Sperzel J. - DEUButter C. - DEU Hindricks G. - DEU Munger T. T. - USA Squarcia U. - ITACalkins H. - USA Hocini M. - FRA Murgatroyd F. D. - GBR Steinberg J. - USACallans D. - USA Hoffmann E. - DEU Naccarelli G. V. - USA Stern S. - ISRCamm A. J. - GBR Hohnloser S. - DEU Nakazato Y. - JPNCannom D. S. - USA Hombach V. - DEU Napolitano C. - ITA Sulke N. - GBRCappato R. - ITA Hornberger L. K. - CAN Narayan S. M. - USA Sutton R. - MCOCapucci A. - ITA Huikuri H. - FIN Neuzil P. - CZE Svendsen J. H. - DNKCazeau S. - FRA Israel C. W. - DEU Nielsen J. C. - DNK Taborski M. - POLChauvin M. - FRA Jackman W.M. - USA O’Neill M. - GBR Thambo J. B. - FRACheng J. - USA Jaeggi E. - CAN Opthof T. - NLD Thibault B. - CANChierchia J.B. - ITA Jaïs P. - FRA Oseroff O. - ARG Tristani-Firouzi M. - USAChirife R. - ARG Jalife J. - USA Oto A. - TUR Tseng G. N. - USAClémenty J. - FRA Jauvert G. - FRA Ovsyshcher E. - ISR Turitto G. - USAClemmensen P. M. - DNK Jazra C. - LBN Oyarzun R. - CHL van Gelder I. C. - NLDCohen I. S. - USA Jordaens L. - NLD Padeletti L. - ITA Vardas P. E. - GRCCrijns H. J. - NLD Kaab S. - DEU Page R. L. - USA Varma N. - USACuneo B. - USA Kacet S. - FRA Panfilov A. V. - NLD Veltman C. - DEUCurnis A. - ITA Kalman J. M. - AUS Pappone C. - ITA Verrier R. L. - USADanchin N. - FRA Kautzner J. - CZE Parry S. W. - GBR Vlietstra R. E. - USADaubert J. C. - FRA Kay N. - USA Piotrowicz R. - POL Vohra J. K. - AUSDavies W. - GBR Kennergren C. - SWE Poelzing S. - USA Vos M. - NLDDavy J. M. - FRA Kenny R. A. - IRL Ponikowski P. - POL Vrints C. - BELDe Chillou C. - FRA Khoury M. - LBN Poole J. E. - USA Waldo A. L. - USADe Roy L. - BEL Kirchhof P. - DEU Pratt C. M. - USA Wellens H. J. - NLDDefaye P. - FRA Kleber A. - CHE Prakash S. - AUS Wilkoff B. L. - USADeisenhofer I. - DEU Klein G. J. - CAN Prinzen F. W. - NLDDelnoy P. P. - NLD Klein H. - USA Priori S. G. - ITA Wissner E. - DEUDerval N. - FRA Klingenheben T. - DEU Probst V. - FRA Wolpert C. - DEUDickstein K. - NOR Klug D. - FRA Pruvot E. - CHE Wranicz J. K. - POLDiener H. C. - DEU Knecht S. - BEL Prystowsky E. N. - USA Yamada K. - USADubner S. - ARG Kottkamp H. - CHE Rasmussen L. H. - DNK Zareba W. - USAEhrlich J. - DEU Krieger D. - DNK Raviele A. - ITA Zaza A. - ITAEllenbogen K. - USA Kuck K. H. - DEU Reddy V. Y. - USA Zeppenfeld K. - NLDEl-Sherif N. - USA Kusumoto F. - USA Reynolds D. W. - USA Zipes D.P. - USAEpstein L. - USA La Rovere M. T. - ITA Rhode K. - GBR Zupan I. - SVN - 1 - www.cardiostim.com

ContentsContents P. 4 P. 5 Hotel Directory General Information P. 7 Opening Ceremony P. 8 Acknowledgments P. 9 Editorial P.10-11 Acropolis Floor Plan P. 13 Press Partners P. 15 Scientific Contents P. 21 Wednesday, June 13 P. 57 Thursday, June 14 P. 105 Friday, June 15 Advertisers P. 153 Saturday, June 16 Air France (p.12) Biosense (p.2) Cardiostim 2014 (cover page 3) EHRA (p.14) Elsevier (cover page 4) EP Data (p.24 & 152) Innovation (p.60 & 108) Medtronic (p.6) P. 161 Chairman & Author Index Sorin (cover page 2) P. 181 Exhibiting Company Index The right to use the information contained in this publication is P. 182 Exhibits Floor Plan contractually restricted to the pur-chaser for his or her personal needs. Therefore, the purchaser shall P. 184 Exhibiting Company refrain from entering into any form of sale, marketing or transfer to Presentation third parties in relation to the said information. Improper usage of this publication may result in legal P. 195 Future events proceedings against the perpetra- tors. The publisher and the Car- diostim organization disclaim any liability for errors or omissions that may come to light, despite the care taken in the production of this catalogue. - 3 - www.cardiostim.com

Hotel DirectoryALL SEASONS CITEA IBIS GARE MERCURE PROMENADE PEROUSE8, rue Emmanuel Philibert 42, boulevard Risso 14, avenue Thiers DES ANGLAIS 11, quai Rauba Capeu06000 Nice 06300 Nice 06000 Nice 2, rue Halevy 06300 NiceTel : +33 (0)4 92 00 59 00 Tel : +33 (0)4 92 27 82 00 06000 Nice Tel : +33 (0)4 93 62 34 63Fax : +33 (0)4 92 00 59 09 IBIS PALAIS DES Tel : +33 (0)4 93 82 30 88 Fax : +33 (0)4 93 62 59 41 DE FLORE BEST WESTERN CONGRES Fax : +33 (0)4 93 82 18 20 www.hroy.comwww.nicebeaurivage.com 2, rue Maccarani 38, rue Barberis www.mercure.comAPOGIA 06000 Nice RADISSON26, rue Smolett 06300 Nice Tel : +33 (0)4 92 14 40 20 MERCURE SOPHIA 223, promenade des06300 Nice Tel : +33 (0)4 92 00 21 21 Fax : +33 (0)4 92 14 40 21 ANTIPOLIS AnglaisTel : +33 (0)4 93 89 18 88 Fax : +33 (0)4 92 00 21 22 560, rue Albert Caquot www.hotel-flore-nice.com 06200 NiceFax : +33 (0)4 93 89 16 06 www.ibishotel.com 06560 Valbonne Tel : +33 (0)4 93 37 17 17www.apogia-hotel-nice.com ELLINGTON Tel : +33 (0)4 92 96 04 04 Fax : +33 (0)4 93 71 21 71 25, boulevard Dubouchage IMPERIAL www.mercure.com www.radissonsas.comGRAND HOTEL ASTON 06000 Nice 8, boulevard Carabacel12, avenue Felix Faure Tel : +33 (0)4 92 47 79 79 06000 Nice MERIDIEN REGENCE06000 Nice Fax : +33 (0)4 92 47 79 80 Tel : +33 (0)4 93 62 21 40 1, promenade des Anglais 21, rue MassenaTel : +33 (0)4 92 17 53 00 www.ellington-nice.com 06046 Nice 06000 NiceFax : +33 (0)4 92 17 53 65a LEPANTE Tel : +33 (0)4 97 03 44 44 Tel : +33 (0)4 93 87 75 08www.hotels-aston.com GRAND HOTEL 6, rue de Lepante www.lemeridiennice.com www.hotelregence.com DE FLORENCE 06000 NiceBEAU RIVAGE 3, rue Paul Deroulede Tel : +33 (0)4 93 62 20 55 MEURICE RELAIS ACROPOLIS24, rue St François de Paule 06000 Nice www.hotellepante.com 14, avenue de Suède 20, boulevard Risso06300 Nice Tel : +33 (0)4 93 88 46 87 06000 Nice 06000 NiceTel : +33 (0)4 92 47 82 82 Fax : +33 (0)4 93 88 43 65 MAS D’ARTIGNY Tel : +33 (0)4 97 03 05 20 Tel : +33 (0)4 92 00 14 50Fax : +33 (0)4 92 47 82 83 www.hotel-florence-nice. Chemin des Salettes Fax : +33 (0)4 97 03 05 21 Fax : +33 (0)4 92 00 14 51www.nicebeaurivage.com com 06570 Saint Paul www.hotel-le-meurice.com www.hotel-relais-acropo- Tel : +33 (0)4 93 32 84 54 NEGRESCO lis.comBOREAL FOUR POINTS9, rue Paul Deroulede www.mas-artigny.com 37, promenade des Anglais 59, promenade des Anglais SPLENDID06000 Nice 06000 Nice 06000 Nice 50, boulevard Victor Hugo MARRIOTT CAP D’AILTel : +33 (0)4 93 82 36 36 Tel : +33 (0)4 93 97 90 90 Tel : +33 (0)4 93 16 64 00 06000 Nice Port de Cap d’Ailwww.hotelboreal.fr Fax : +33 (0)4 93 44 50 40 www.hotel-negresco-nice. 06320 Cap d’Ail Tel : +33 (0)4 93 16 41 00 www.fourpoints.com com Tel : +33 (0)4 92 10 67 67 Fax : +33 (0)4 93 87 02 46BOSCOLO EXEDRA www.mariotthotel.com NICE RIVIERA www.splendid-nice .com12, boulevard Victor Hugo GOUNOD06300 Nice 45, rue Pastorelli 3, rue Gounod SPORTMEN MALMAISON 06000 NiceTel : +33 (0)4 97 03 89 89 06000 Nice 4, rue BarberisFax : +33 (0)4 93 88 68 60 48, boulevard Victor Hugo Tel : +33 (0)4 93 92 69 60 Tel : +33 (0)4 93 16 41 00 06300 Nicewww.boscolohotels.com 06000 Nice Fax : +33 (0)4 93 92 69 22 www.gounod-nice.com Tel : +33 (0)4 93 89 27 18 Tel : +33 (0)4 93 87 62 56 www.hotel-nice-rivoli.com Fax : +33 (0)4 93 89 09 97BOSCOLO PARK GARDEN BEACH Fax : +33 (0)4 93 16 17 99 NOVOTEL ARENAS www.hotel-sportmen.com6, avenue de Suède 17, boulevard Edouard www.lamalmaison.com06000 Nice 455, promenade des Baudouin TERRASSES D’EZETel : +33 (0)4 97 03 19 00 MASSENA Anglais 06160 Antibes 1138, route de la TurbieFax : +33 (0)4 93 03 19 01 58, rue Gioffredo 06299 Nice Tel : +33 (0)4 92 93 57 57 06360 Eze Tel : +33 (0)4 93 21 22 50www.boscolohotels.com www.juanlespinshotel.fr 06000 Nice Tel : +33 (0)4 92 41 55 55 Tel : +33 (0)4 92 47 88 88 NOVOTEL Fax : +33 (0)4 92 41 55 10BOSCOLO PLAZA H33 Fax : +33 (0)4 92 47 88 89 8-10, parvis de L’Europe www.terrasse-eze.com12, avenue de Verdun 33, rue Pastorelli www.hotel-massena-nice. 06300 Nice06000 Nice 06000 Nice UNIVERS com Tel : +33 (0)4 93 13 09 04Tel : +33 (0)4 93 16 75 75 Tel : +33 (0)4 93 62 18 82 2, rue de la LibertéFax : +33 (0)4 93 88 61 11 www.h33-hotel-nice.com MEDICIS NOVOTEL 06000 Nicewww.boscolohotels.com 58, rue Herold SOPHIA ANTIPOLIS Tel : +33 (0)4 97 03 06 06 HI PARK 290, rue Fedor Dostoievski www.hotelunivers-nice.comBW Madrid 22, boulevard du Général 06000 Nice Sophia Antipolis3, rue de Belgique Louis Delfino Tel : +33 (0)4 93 88 96 73 VERDUN Tel : +33 (0)9 52 65 06 3406000 Nice 06300 Nice www.hotel-medicis.com 49, rue de l’Hotel des www.bdeskemasophiaan-Tel : +33 (0)4 93 88 85 18 Tel : +33 (0)4 92 00 92 10 tipolis.com Postes MERCURE NICE CENTREwww.bestwestern- www.hipark-residences. 06000 Nicehotel-madrid.com NOTRE-DAME PALAIS DE com Tel : +33 (0)4 93 62 24 10 28, avenue Notre-Dame LA MEDITERRANEE www.hotel-verdun.comBW NEW YORK HOLIDAY INN NICE 06000 Nice 11, promenade des Anglais44, avenue du Maréchal 20, boulevard Victor Hugo Tel : +33 (0)4 93 13 36 36 06000 Nice VILLA RIVOLIFoch 06000 Nice Fax : +33 (0)4 93 62 61 69 Tel : +33 (0)4 92 14 77 00 10, rue de Rivoli06000 Nice Tel : +33 (0)4 97 03 22 22 www.mercure.com Fax : +33 (0)4 92 14 77 14 06300 NiceTel : +33 (0)4 93 85 14 31 Fax : +33 (0)4 97 03 22 23 www.lepalaisdelamediter- Tel : +33 (0)4 93 88 80 25www.hotel-newyork- www.hnice.com MERCURE GRIMALDI ranee.com Fax : +33 (0)4 93 88 96 28nice.com 6, rue Grimaldi www.villa-rivoli.com HOLIDAY INN PARK INN 06000 NiceBW RIVIERA ST LAURENT 179, boulevard René VILLA LA TOUR Tel : +33 (0)4 93 87 70 0727, avenue Thiers 167, promenade des Flots Cassin 4, rue de la Tour Fax : +33 (0)4 93 16 17 8006000 Nice Bleus 06200 Nice 06300 NiceTel : +33 (0)6 61 50 35 63 www.mercure.com 06700 Saint Laurent du Var Tel : +33 (0)4 93 18 34 00 Tel : +33 (0)4 93 80 08 15www.hotel-riviera-nice.com Tel : +33 (0)4 93 14 80 00 MERCURE NICE MARCHE Fax : +33 (0)4 93 71 40 63 www.villa-la-tour.com Fax : +33 (0)4 93 07 21 24 AUX FLEURS www.rezirparkinn.comCAMPANILE www.holidayinn.com WEST END58, boulevard Risso 91, quai des Etats-Unis PETIT PALAIS 31, promenade des Anglais06300 Nice IBIS NOTRE DAME 06000 Nice 17, avenue Emile Bieckert 06000 NiceTel : +33 (0)4 93 26 20 60 41, rue Lamartine Tel : +33 (0)4 93 85 74 19 06000 Nice Tel : +33 (0)4 92 14 44 00www.hotel-campanile- 06000 Nice Fax : +33 (0)4 93 13 90 94 Tel : +33 (0)4 93 62 19 11 Fax : +33 (0)4 93 88 85 07nice.fr Tel : +33 (0)4 93 62 14 43 www.mercure.com www.petitpalaisnice.com www.hotel-westend.com www.cardiostim.com -4-

General InformationScientific Sessions Luggage CheckDelegates have access to all sessions taking place Located in Agora 0, on the right hand side afterduring the Congress days they registered for. the main entrance.Please check the session schedule and floor plan Opening hours:page 10-11 June 13, 14, 15: 8.00 a.m. - 6.30 p.m. June 16: 8.30 a.m. - 1.00 p.m.Poster presentationsPoster presentations and poster workshops will Message Boardtake place on Level 3 (Agora III and Les Muses). Located in Agora, level 1, next to the Registration Desk.Exhibits Shuttle Bus ServiceDelegates have access to the Technical Exhibits A complimentary shuttle bus service will belocated on level 2 (Rhodes and Agora II). provided between most participating hotelsExhibit hours: and Acropolis Convention Centre. Please checkJune 13, 14, 15: 9.00 a.m. - 6.00 p.m. schedule posted in hotel lobbies and near theSee exhibits floor plan pages ** registration desk.Preview Room Opening Ceremony on June 13The preview room is located on level 2 Room 2.7. The Opening Ceremony will be held on WednesdayPresenters are expected to check-in prior to their June 13, 2012 from 12.45 p.m. to 1.30 p.m. in thepresentation time, do allow enough time before the Athena Room.beginning of the sessions. Speakers may go to thePreview room to preview and approve their Innovation Award Ceremony onpresentations on computers configured with the June 15adapted hardware and software. Professional The Innovation Award Ceremony will be held onaudiovisual consultants will be available for assistance. Friday June 15 from 12:30 p.m. to 13:15 p.m. inBars - Restaurants Room 3.5 Calliope - level 3 Les Muses«La Brasserie des Muses» is open on level 3 and Convention Rate Ticketsproposes different lunch boxes. Several bars andrestaurants are open in Acropolis Convention Don’t forget!Centre, on level 2 and 3. - If you have flown by plane (Air France or otherNumerous other restaurants are located in the companies), keep your badge. It may be requestedimmediate surroundings of Acropolis. when you check in for the return flight.Coffee Breaks Meet the expertsCoffee breaks will be served in the morning Don’t miss the opportunity to exchange with an expertand in the afternoon at each level of Acropolis during the lunch at «La Brasserie des Muses» - level 3!Convention Centre. Program at the registration desk and «La Brasserie des Muses»Hotel Reservations,Sightseeing ToursPlease contact Mathez Travel Agency on theregistration desk in Agora 1, level 1 General organization of Cardiostim: Scientific Organization: Exhibits: REED EXPOSITIONS FRANCE / CARDIOSTIM Created by Jacques Mugica CARDIOSTIM 2012 52-54, quai de Dion-Bouton 92806 Puteaux Cedex - France Tel.: +33 (0)1 47 56 24 56 Fax: +33 (0)1 47 56 24 55 Tel.: +33 (0)1 47 56 21 18 Fax: +33 (0)1 47 56 24 66 E-mail: cardiostim@wanadoo.fr E-mail: monique.gauthier@reedexpo.fr - 5 - www.cardiostim.com

Opening CeremonyWednesday June 13 After the first two morning sessionsOPENING CEREMONY Room 2, Athena Level 2 - Rhodes From 12:45 to 13:30 - 7 - www.cardiostim.com

AcknowledgementsPhilippe Ritter (Bordeaux, FRA)Pierre Bordachar, Stéphane Garrigue, Sylvain Reuter, Frédéric Sacher (Bordeaux, FRA)Mark O’Neill (London, GBR), Vincent Probst (Nantes, FRA)David Hayes (Rochester, USA) J.Claude Daubert (Rennes, FRA)Douglas Zipes (Indianapolis, USA) J.Jacques Blanc (Brest, FRA)European Heart Rhythm Association (EHRA) President: Angelo Auricchio - Lugano, CHE Europace 2013 Program Committee Chairman: Andreas Goette - Magdeburg, DEU Vice-President: John M. Morgan - Southampton, GBRIn collaboration with: European Heart Rhythm Association (EHRA) European Society of CardiologyUnder the auspices of • Société Française de Cardiologie • European Society of Cardiology • Heart Rhythm Society (HRS) • World Society of Arrhythmias WSA/ICPES • International Society for Holter and Noninvasive Electrocardiology (ISHNE) • roupe Français d’Electrophysiologie et de Stimulation Cardiaque de la Société Française G de Cardiologie • Sociedad Asociación Civil Argentina de Estimulación Cardiaca (SADEC) • Japanese Heart Rhythm Society (JHRS) • Asia-Pacific Society of Cardiology • Brazilian Society of Cardiology • Latin-American Society of Pacing and Electrophysiology (SOLAECE) • Artificial Cardiac Electrostimulation Department of the Brazilian Cardiac Surgery Group (DECA) • Associazione Italiana di Aritmologia e Cardiostimolazione (A.I.A.C.) • Mediterranean Society of Pacing and Electrophysiology (MESPE) • he RETAC Group (Reunion of European countries for the Treatment of Arrhythmias in T Cardiology/Réseau Européen pour le Traitement des Arythmies Cardiaques)The Organizing Committee wishes to express its appreciation to all ExhibitingCompaniesParticular thanks are expressed to companies which made it possible to organize sessions:• BIOTRONIK • MEDTRONIC• BOSTON SCIENTIFIC • ST. JUDE MEDICAL• CAMERON HEALTH • SORIN Group CRM• CARDIOINSIGHT TECHNOLOGIES • SPECTRANETICS www.cardiostim.com -8-

EditorialDear Colleagues,Welcome to Cardiostim 2012!As the Chairman of Cardiostim, and considering programs of the previous editions, I do think thatthis program is the best ever! The 200 scientific sessions do reflect the present status of ourspecialty, and feature the techniques that will be in our hands in the near future.This program is the result of the participation of colleagues who actively worked for the preparationof this 2012 Congress. The collaboration of Andreas Goette and his team from EHRA has beenparticularly fruitful, with their participation in the difficult task of the abstracts selection, and theextension of the EHRA program to 31 sessions. I must thank all friends from the United States who sustainably worked for Cardiostim for yearsto provide the highest standard programs and gather the best speakers coming from all over theworld. • Doug Zipes for Basic Electrophysiology; • Mel Scheinman for Invasive Electrophysiology and Ablation Techniques; • Jerry Naccarelli for Treatments in Atrial Fibrillation; • Wojciech Zareba for Non-Invasive Electrophysiology; • Nabil El Sherif for Sudden Cardiac Death Management; • Albert Waldo for Trials; • David Hayes and David Cannom for Devices; • Win Shen and Ron Vlietstra for Geriatric CardiologyThese facts are the expression of what Cardiostim is: an international platform where attendeescan exchange with the best experts in the field.Despite the international financial crisis, the main industry partners went on supporting Cardiostimas they traditionally did in the past, trusting our work and the team. Once again, I have to thankall exhibitors and all industry sponsors for their long lasting commitment to Cardiostim.Last but not least, a special thank to Pierre Bordachar and Frédéric Sacher who have been helpfuland constructive all along the preparation of this edition, to Jocelyne Toulouse for her unconditionalsupport and fantastic work and to the REED team without whom nothing could happen!Thank you all for attending. You’ll find everything you need: education, technological advances,state of the art sessions, science... in a studious and relaxed working atmosphere.Thank you all for attendingEnjoy Cardiostim 2012!Philippe RitterCardiostim Chairman - 9 - www.cardiostim.com

Acropolis Floor Plans 34x22_Mise en page 1 15/05/12 16:56 Page122_Mise en page 1 15/05/12 16:56 Page1 Agora 3: Poster Area LES MUSES: Rooms 3.1 to 3.5/ Agora 3: Poster Area Area Leisure LES MUSES: Rooms 3.1 to 3.5/Post Leisure Area WIFI WIFI Poster Area Poster Area COFFEE BREAK LEVEL 3 COFFEE BREAK Poster A LEVEL 3 POLYMNIE POLYMNIE A POLYMNIE POLYMNIE B Poster Area A B CLIO THALIE ERAT Poster Area CLIO 3.1 THALIE 3.2ERATO 3.3 U Poster Area 3.1 3.2 3.3 Agora 2: Exhibits RHODES: Preview Room/Risso, Ga Agora 2: Exhibits RHODES: Preview Room/Risso, Gallien TechVillage ROOM PREVIEW 2.8 ROOM PREVIEWROOM 2.7 TechVillage ROO 2.8 ROOM 2.7 A11 A15 A25 A11 A15 A25 A01 A29 A29 TO A01 A31 TO LEVEL 1 A31 A43 A41 B23 LEVEL 2 A43 C2 B23 B22 A38 A41 LEVEL 2 C25 A36 A40 A42 B22 A38 A36 A34 A40 A42 C23 C22 A34 C16 A02 B19 HERMES 2.1 A02 A28 MAIAB19 B16 A16 A26 HERMES 2.1 A28 MAIA 2.2 B16 A22 A16 A26 2.2 C12 A22 PRESS CENTER PRESS B5 SCIENTIFIC CENTER SECRETARIAT C05 SCIENTIFIC B5 SECRETARIAT Agora 1: Registration Area Agora 1: Registration Area BADGE READER & HOUSING MÉDITERRANÉE: RO BADGE READER & HOUSING MÉDITERRANÉE: ROOMS REGISTRATION LEVEL 1 REGISTRATION LEVEL 1 TO LEVEL 2 TO LEVEL 2 CERTIFICATE OF ATTENDANCE CERTIFICATE ROOM 1.1 ROOM 1 OF ATTENDANCE ROOM 1.1 ROOM 1.2 BAG BAG PICK-UP PICK-UP TOURISM OFFICE TOURISM OFFICE www.cardiostim.com - 10 -

Acropolis Floor PlanMUSES: Rooms 3.1 to 3.5/Poster Area/Brasserie/Terracems 3.1 to 3.5/Poster Area/Brasserie/Terrace La Brasserie La Brasserie Des Muses Des Muses COFFEE BREAK TERRACE/ Poster AreaOFFEE BREAK TERRACE/ La Brasserie POLYMNIE Poster Area Des Muses B La Brasserie Des Muses CLIO THALIE ERATO URANIE CALLIOPE 3.1 3.2 3.3 3.4 3.5 THALIE ERATO URANIE CALLIOPE 3.2 3.3 3.4 3.5Preview Room/Risso, Gallieni Rooms 2.1 to 2.9 and Exhibitsom/Risso, Gallieni Rooms 2.1 to 2.9 and Exhibits ROOM PREVIEW ROOM TechVillage ROOM 2.6 2.5 ROOM 2.4 RISSO A 2.8 ROOM 2.7 ROOM ROOM PREVIEW ROOM 2.6 ROOM 2.4 RISSO A 2.8 ROOM 2.7 2.5 TO LEVEL 1 TO LEVEL 1 A43 A41 B23 C25 C24 D24 E23 F23 Rooms38B23 B22 C24 D24 E23 F23 D23 E24 ATHENA 2.3 Rooms Exhibits A40 A42 C25 B22 D23 C23 C22 E24 E22 F21 ATHENA 2.3 F22 C23 C22 C16 F21 F22 E22 D13 D14 E16 F17 Exhibits C16 B19 D13 D14 E16 F17 E14 F16 Offices Offices ES 2.1 F16 F12 MAIA B16 E14 D11 E9 E11 F11 B19 C12 2.2 B16 C12 D11 D12 E9 E11 F11 F12D12 D09 Services Services PRESS COFFEE BREAK D09 CENTER C05COFFEE BREAK SCIENTIFIC SECRETARIAT C05 B5 D05 RHODES RHODES 1 2 RISSO B Poster Area B5 D05 RHODES RHODES 1 2 RISSO B Poster Area Elevator Elevator Escalator SM Escalator SM Information Information Toilets MÉDITERRANÉE: ROOMS 1.1 to 1.6 (access by Rhodes) ToiletsRRANÉE: ROOMS 1.1 to 1.6 (access by Rhodes) Restaurant Restaurant TO LEVEL 2 Bar TO LEVEL 2 Bar Coffee break Coffee break Cyber Café Cyber Café ROOM 1.4 ROOM 1.1 ROOM 1.2 ROOM 1.3 ROOM 1.4 Wifi ROOM 1.1 ROOM 1.2 ROOM 1.3 Wifi ROOM 1.5 IRIS 1.6 Disabled access ROOM 1.5 IRIS 1.6 Disabled access COFFEE Cloakroom COFFEE BREAK Cloakroom BREAK Leisure Area Leisure Area - 11 - www.cardiostim.com

PartnersSpecial thanks to all the publishers, journals and societies that participatedin the promotion of Cardiostim 2012.Press partners www.cardiacrhythmnews.com www.ipej.org www.ihe-online.com www.karger.ch www.neonatologytoday.net www.cardiologyjournal.org www.oxfordjournals.org www.congenitalcardiologytoday.com www.crc.springer.de www.e-coretvasa.cz www.theheart.org www.elsevier.com www.touchcardiology.com www.hospimedica.com www.onlinelibrary.wiley.comSocieties partners Croatia Society of Cardiology Polish Cardiac Society www.kardio.cr www.ptkardio.pl Danish Society of Cardiology Portuguese Society of Cardiology www.cardio.dk www.spc.pt/spc/ Society of Cardiology German Cardiac Society of the Russian Federation www.dgk.com www.cardiosite.ru - 13 - www.cardiostim.com

Scientific Contents To get your certificate, come to the EHRA/ESC booth #D12 in the exhibition. «The event EHRA Sessions at CARDIOSTIM 2012 is accredited by the European Board for Accreditation in Cardiology (EBAC) for 21 hours of External CME credits. Each participant should claim only those hours of credit that have actually been spent in the educationalactivity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).»EHRA Session name (Session number/Page number)Wednesday June 13 • ontemporary Considerations Based on Technological C• RT in the 21st Century. What Do We Have Now? C Developments in Cardiac Pacing (151/101) Status Quo and Quo Vadis? (2/25) • ranslational Approaches in Atrial Fibrillation (152/101) T• acemaker Therapy in Year 2012 (7/26) P Friday June 15• ew Insights in Basics of Arrhythmias (11/27) N • he Complex Pacemaker Implantation (171/114) T• on Channelopathies (12/27) I • mproving Outcomes in the Catheter Ablation of Atrial I• RT: Reading the Guidelines (22/30) C Fibrillation (172/115)• urkinje Fibers and Ventricular Arrhythmias (31/35) P • ontinuous Monitoring in Atrial Fibrillation C Management. New Science or New Truth? (191/128)• hat a Device Specialist Needs to Know about Heart W Failure (32/35) • omplications Related to Atrial Fibrillation Catheter C Ablation (192/129)• ew EHRA Documents (42/38) N • anagement of Patients with Defibrillator Shocks: M• udden Cardiac Death in the Young (51/42) S State-of-the Art (211/136)• CD Therapy in Year 2012 (62/50) I • dvances in Robotic and 3D Mapping Technologies for A• tate-of-the Art on Ventricular Tachycardia Ablation S Atrial Fibrillation Ablation (212/136) (71/54) • iagnostic Evaluation of Syncope in Special Patient DThursday June 14 Groups (228/147) • rrhythmias in Women: State of the Evidence (231/149) A• troke Prevention in Atrial Fibrillation - State-of-the Art S and New Concepts (82/61) • ew Energies and Technologies to treat Atrial Fibrillation N (232/149)• reventing Sudden Cardiac Death with RF Ablation P (91/66) Saturday June 16• ighlights from Europace 2011: Interventional EP and H • ebates and Controversies in the Antithrombotic D Medical Therapy/Highlights from Europace 2011: Device Management of Atrial Fibrillation (251/155) Therapy (111/80) • ertification: Fighting against Inequality in Health Care C• RT Implantation and Follow-Up: EHRA-HRS Consensus C Across Borders (252/155) Statement (122/83) • ntiarrhythmic Drugs for Atrial Fibrillation (271/157) A• he Challenges of the Asymptomatic Patient in T • urse-Led Interventions for Patients with Arrhythmias N Hereditary Syndromes (142/96) (272/158) How to use this Final Program In the Index, preceding each name, are numbers like: 41/2, 121/3, 56/45, etc. The first number indicates the session number: 41/2 = session #41. The second number shows the position of the presentation in that session: 41/2 = second presentation in session #41; if a poster session, 56/45 indicates the 45th poster of session #56. The same numbers are used in the Index, the main text of the Final Program, and the EUROPACE Abstract Book (EUROPACE supplement) for the oral and poster sessions. - 15 - www.cardiostim.com

Scientific ContentsSession name (Session number/Page number)BASIC ELECTROPHYSIOLOGY • anagement of Arrhythmias in the Elderly in the Asian M Pacific Region (168/113)• ardiac Stem Cells and Gene Therapy (1/25) C • mproving Outcomes in the Catheter Ablation of Atrial I• ew Insights in Basics of Arrhythmias (11/27) N Fibrillation (172/115)• trial Fibrillation: Dealing with Complexity (15/29) A • ontinuous Monitoring in Atrial Fibrillation C• ew Imaging Techniques (21/30) N Management. New Science or New Truth? (191/128)• yocyte-Fibroblast Interactions in Normal and Diseased M • omplications Related to Atrial Fibrillation Catheter C Myocardium (41/37) Ablation (192/129)• ardiac Ion Channels and Macromolecular Complexes C • dvances in Robotic and 3D Mapping Technologies for A in Health and Disease (61/50) Atrial Fibrillation Ablation (212/136)• ontribution of Genetics to Understanding Mechanisms C • ew Energies and Technologies to treat Atrial N and Risk (81/61) Fibrillation (232/149)• oes Genetic Testing for Sudden Death Help in Clinical D Practice? (101/75) ABLATION TECHNIQUES & CRT• omputational Electrophysiology: Novel Tools to C • apid Mapping and CRT Optimization with Noninvasive R Improve Clinical Understanding (109/79) 3D Electrocardiography: A New Era! (85/63)• he Intercalated Disc and Arrhythmogenic T Cardiomyopathy (121/82) ACUTE CARDIAC CARE• art I: Repolarization Alternans – Translating P Fundamental Observations to Clinical Practice for Atrial • rrhythmias in Primary PCI (28/33) A and Ventricular Arrhythmias (129/86) • rrhythmias in Acute Cardiac Care Setting (83/62) A• nderstanding Atrial Fibrillation (141/96) U• echanistically-Guided Therapies for Human Cardiac M ABLATION Fibrillation - Part II - Atrial Arrhythmias (149/100) • lternate Techniques for AF Ablation (203/132) A• ranslational Approaches in Atrial Fibrillation T • trial Imaging Techniques to Guide AF Therapy and A (152/101) Ablation (183/124)• ole of CamkII In Arrhythmias (161/109) R • omplications of Catheter Ablation (229/148) C• echanistically-Guided Approaches to Human Cardiac M • ontact Force and Outcome of AF Ablation (204/132) C Fibrillation -Part III – Ventricular Arrhythmias (169/113) • picardial or Endocardial Approach to the Treatment of E• ole of The Autonomic Nervous System in R VT (163/110) Arrhythmogenesis (181/123) • onitoring and Outcome after AF Ablation (223/145) M• mall Conductance Calcium-Activated Potassium S • ew Signal Processing in Alation of Atrial Fibrillation N Channels (SK) and Cardiac Arrhythmias (201/131) (225/146)• ole of miRNAs in Arrhythmia Syndromes (221/144) R • utcome After VT Ablation (63/51) OABLATION TECHNIQUES BASIC ELECTROPHYSIOLOGY &• merging Leaders in Electrophysiology: Case E ABLATION TECHNIQUES Presentation and Discussion (65/52) • urkinje Fibers and Ventricular Arrhythmias (31/35) P• tate-of-the Art on Ventricular Tachycardia Ablation S (71/54) INVASIVE EP• ulmonary Vein Isolation: The Cornerstone of Atrial P Fibrillation Ablation (126/85) • asic Mechanisms of Arrhythmias (224/145) B• he 2012 HRS / EHRA / ECAS Consensus Document T • apping of Complex Arrhythmias: A New Look at Old M on Catheter and Surgical Ablation of Atrial Fibrillation Diseases (205/133) (162/109) • urgical Treatment of AF (23/31) S www.cardiostim.com - 16 -

Scientific ContentsSession name (Session number/Page number)PACING HEART FAILURE• onventional Pacing: Clinical Indications and C • eart Failure and Cardiac Imaging: Special H Programming (64/51) Considerations and Relevant Issues in the Elderly (148/90)CRT ICD THERAPY• RT in the 21st Century. What Do We Have Now? C Status Quo and Quo Vadis? (2/25) • CD Therapy in Year 2012 (62/50) I • hallenges of ICD Therapy - Part I: Functioning and C• election of CRT Patients: Guidelines and Beyond (10/26) S Choice of the Device (94/67)• RT: Reading the Guidelines (22/30) C • he Subcutaneous Lead (105/77) T• an Response to CRT Be Better Predicted by… C • hallenges of ICD Therapy - Part II: Programming the C (30/34) Device (114/81)• hat a Device Specialist Needs to Know about Heart W • hallenges of ICD Therapy - Part III: Management of C Failure (32/34) Electrical Storms and Inappropriate Shocks (134/89)• uring Implantation, Can CRT Be Optimized During D • hallenges of ICD Therapy - Part IV: Difficult Decisions C Implant by….. (50/42) (154/102)• uestions in Optimizing Benefits of CRT (53/43) Q • CD Therapy Saves Lives: Do You Care? (166/112) I• echniques for LV Lead Placement (70/54) T • ubcutaneous ICDs: a Path to a Technological S Revolution (174/116)• tate of the Art HF Management: From Implant to S Long-Term Follow-Up (86/63) • anagement of Patients with Defibrillator Shocks: M State-of-the Art (211/136)• ase#2: 54 Y/O Female with no Cardiac Risk Factors C • ppropriate or Inappropriate ICD Therapy (Interactive A Presents With Chf, Lvef=25%, And Lbbb (92/66) Session) (233/150)• ow to Increase CRT Response? (106/77) H • a Consultation en Live : fonctionnement des L• ole of Different Providers to Assure CRT Success R défibrillateurs automatiques implantables à partir des (110/79) programmateurs (d’une marque à l’autre) (234/150)• RT Implantation and Follow-Up: EHRA-HRS Consensus C Statement (122/83) ICD THERAPY & ABLATION TECHNIQUES• our Opinion - CRT Issues - Part I (130/87) Y • roubleshootings (253/156) T• dvances in CRT: Automatic CRT Optimization for A • ightmares (273/158) N Improved Patient Response (146/98)• our Opinion - CRT Issues - Part II (150/100) Y IMAGING TECHNIQUES• our Opinion - CRT Issues - Part III (170/114) Y • nnovations in Intracardiac Echocardiography: Novel I• RT Issues, Part IV: Opinions Regarding Techniques for C Applications and Evidence Based Evaluation (89/65) LV Lead Placement (190/128)• ollow-Up of CRT Patients (210/135) F INVASIVE ELECTROPHYSIOLOGY• mmediate and Long-Term Optimization of CRT I • aising the Bar: Improving Navigation and Safety with R (206/133) Innovations in the EP Lab (25/32)• ew Means of LV Stimulation to Increase the Response N to CRT (43/38) INVASIVE ELECTROPHYSIOLOGY• esponse To CRT (226/146) R & ABLATION TECHNIQUESFETAL CARDIOLOGY • trial Fibrillation Ablation I (35/37) A • trial Fibrillation Ablation II (55/44) A• asic Understanding of Fetal Rhythm (103/76) B • trial Fibrillation Ablation III (75/56) A• etal Arrhythmias - Part I (123/83) F • trial Flutter Ablation (95/68) A - 17 - www.cardiostim.com

Scientific ContentsSession name (Session number/Page number)• aroxysmal Supraventricular Tachycardia Ablation I P ICDs (115/82)• aroxysmal Supraventricular Tachycardia Ablation II P • ew Means of ICD Programming and Indications N (135/89) (44/39)• nteractive Session (155/103) I NON INVASIVE ELECTROPHYSIOLOGY• entricular Tachycardia Ablation I (175/116) V• entricular Tachycardia Ablation II (195/130) V • trial Fibrillation I (87/64) A• entricular Tachycardia Ablation III - Debates V • trial Fibrillation II (107/78) A (215/138) • trial Fibrillation III (127/85) A• entricular Tachycardia Ablation IV (235/151) V • trial Fibrillation IV (147/99) A• he Challenging Case - Part I (255/157) T • ebates and Controversies in the Antithrombotic D• he Challenging Case - Part II (275/159) T Management of Atrial Fibrillation (251/155) • ntiarrhythmic Drugs for Atrial Fibrillation (271/157) ALEAD EXTRACTION • ardiac Arrhythmias / Other Topics (13/28) C• ead Management (52/43) L • trial Fibrillation (17/29) A• ied Patient Infection (90/65) C • rugada Syndrome (33/36) B• erforming Lead Extraction (131/87) P • hallenging ECG Diagnosis (73/55) C• ead Extraction: State of the Art (164/111) L • rugada Syndrome, Long QT Syndrome, Early B Repolarization (97/74)• aser Lead Extraction: Moving to the Next Level L • isk Stratification of Sudden and Total Mortality in R (165/111) Specific Groups (133/88)LEADS • onsensus on Remote Monitoring of Cardiac Implanted C Device (153/102)• hat Are Engineers doing to improve Cardiac Lead W • ardiac Arrhythmias, Holter (177/123) C Function & Reliability? (47/40)• hat Are Physicians learning that Needs Improvement W PACING in Cardiac Leads? (67/53) • acemaker Therapy in Year 2012 (7/26) PMISCELLANEOUS • hould We Implant those Patients? (27/33) S • udden Cardiac Death in the Young (51/42) S• ew EHRA Documents (42/38) N • ontemporary Considerations Based on Technological C• rrhythmia in ME: From Incidence to Solution A Developments in Cardiac Pacing (151/101) (66/52) • he Complex Pacemaker Implantation (171/114) T• ighlights from Europace 2011: Interventional EP and H • ew Advances in Treatment of Pacemaker Patients N Medical Therapy/Highlights from Europace 2011: Device (185/125) Therapy (111/80) • a Consultation en Live : fonctionnement des L• ew Advances for Patients with Atrial Fibrillation N stimulateurs cardiaques et tout ce que vous avez (125/84) oublié ! (254/156)• urrent Concerns in Japan (187/126) C • a Consultation en Live : démarche diagnostique et L• P: What’s Hot, What’s Not, What’s Tough (209/135) E thérapeutique chez le patient stimulé et symptomatique (douleur thoracique, dyspnee, palpitations, malaise,• rrhythmias in Women: State of the Evidence A syncope) (274/159) (231/149)• ertification: Fighting against Inequality in Health Care C PACING & CRT Across Borders (252/155)• urse-Led Interventions for Patients with Arrhythmias N • rt of Timing (Part I) (29/34) A (272/158) • rt of Timing (Part II) (49/41) A www.cardiostim.com - 18 -

Scientific ContentsSession name (Session number/Page number)PACING & ICD THERAPY • pproaches to Atrial Fibrillation and Stroke Prevention: A New Techniques, New Technology, New Anticoagulants• acemaker and ICD: When So We Say Yes and When P and New Drugs for the Elderly (108/78) Do We Say No? (128/86) • AA* Closure for Stroke Prevention: What Every L• verything and MRI: Is It for Everybody? (145/98) E Electrophysiologist Should Know (186/126)• our Opinion (194/130) Y SUDDEN CARDIAC DEATH• port Practice in Pacemaker and ICD Patients S (207/134) • on Channelopathies (12/27) I • VH and Sudden Death: From Classification to LPACING AND ICD Management (48/41)• ow to Identify Responders/NonResponders to CRT? H • ase#1: 65 Y/O Male, H/O Aswmi; S/P Cabgx3, C (230/148) 5 Weeks Ago; Lvef=38%, Presents with a Recent Syncopal Episode (72/55)PALPITATIONS • pdate on Methods in the Risk Stratification of SCD U (93/67)• anagement of Patients with Palpitations (202/131) M • ase#3: 29 Y/O Male Collapsed and Spontaneously CPEDIATRIC CARDIOLOGY Recovered During Running Ny Marathon, ECG= LVH Pattern, 2-D Echo= Suggestive of Hypertrophic• ittfalls and Pearls… (84/62) P Cardiomyopathy (112/80)• ot Topic in Pediatric Pacing (104/76) H • arly Repolarization (113/81) E• hannelopathy in Pediatrics: Case Report, EKG C • ase#4: 45 Y/O Male Presents with One Syncopal C (124/84) Episode, Normal 2-D Echo. ECG=Prominent Early Repolarization Wave in Inferior Surface Leads• entricular Arryhthmias and Sudden Death in V (132/88) Congenital Heart Disease: Challenges and Creative Solutions (144/97) • he Challenges of the Asymptomatic Patient in T Hereditary Syndromes (142/96)DEVICES • herapeutic Options in Brugada Syndrome (167/112) T • T Variability and Dynamics (173/115) Q• emote Monitoring - Magnetic Resonance Imaging R (184/125) • nsolved Issues in Brugada Syndrome (189/127) U• hort High Impact Presentations (68/53) S • arly Repolarization: Benign versus Dangerous? E (193/129)ICDs • pdate on Inherited Arrhythmia Disorders: Don’T Miss U the Diagnosis (Case-Based Presentation) (213/137)• ensing and ICDs (24/31) S • udden Death in Hospital and out-of-Hospital: News S Automatic External Defibrillation on-Line (227/147)SLEEP APNEA SUDDEN CARDIAC DEATH &• he Role of Cardiologists in Sleep Apnea Management T (46/40) ABLATION TECHNIQUES • reventing Sudden Cardiac Death with RF Ablation PSTROKE (91/66)• iagnosing AF: Can We Prevent Strokes Caused by AF? D SYNCOPE (26/32)• reating AF: How to Effectively Reduce Stroke Risk? T • ainting and Falls: How Can We Maintain the Upright F (45/39) Position as We Get Older? (88/64)• troke Prevention in Atrial Fibrillation - State-of-the Art S • aso Vagal Syncope: There Are New Data! (102/75) V and New Concepts (82/61) • nderstanding Syncope (188/127) U - 19 - www.cardiostim.com

Scientific ContentsSession name (Session number/Page number)• linical Cases Session (208/134) C • La Consultation en Live: Fonctionnement des• iagnostic Evaluation of Syncope in Special Patient D Défibrillateurs Automatiques Implantables à partir des Groups (228/147) Programmateurs (d’une marque à l’autre) (214/137) • La Consultation en Live: fonctionnement desTRIALS défibrillateurs automatiques implantables à partir des programmateurs (d’une marque à l’autre) (234/150)• he New Oral Anticoagulants (OACs) for Stroke T • La Consultation en Live: fonctionnement des Prevention in AF - Part 1 (14/28) stimulateurs cardiaques et tout ce que vous avez oublié!• linical Trials in AF - Influence on Guidelines - C (254/156) Discussion and Perspective (54/44) • La Consultation en Live: démarche diagnostique et• F Ablation Trials (74/56) A thérapeutique chez le patient stimulé et symptomatique (douleur thoracique, dyspnee, palpitations, malaise,STIMUPRAT syncope) (274/159)• Les Thérapies Hybrides: Prothèse Implantable+Ablation + Médicaments + ... du Cabinet à la Salled’Electrophysiologie (182/124) www.cardiostim.com - 20 -

Scientific Contents Wednesday June 13 Wednesday June 13 Sessions 1 to 75 page 25 to 56 Created by Jacques Mugica - 21 - www.cardiostim.com

Wednesday June 13 Medtronic Room 2.9 Gallieni Level Visit the TechVillage and discuss with experts . The Next Generation Cryo Technology . The Next Generation Phased RF Technology . The Next Generation Cardiac Monitors . Medtronic - Leading in Leads Opening Hours: Wednesday June 13 to Friday June 15 From 9:00 to 17:00 Please contact your Medtronic representative to register in advance or directly at the welcome desk! www.cardiostim.com - 22 -

Wednesday June 13Welcome to Cardiostim 2012 Wednesday June 13You just passed the registration, and time has come to choose your itineraryfor the day.At 9:00 this morning, there are 9 rooms running, whereas 15 are active from 11:00 am. • asic Electrophysiology - Room 2.1 B • HRA program - Rooms 1.3, 2.3, 3.1 & 3.2 E • ead technology - Room 1.3 L • ession on lead extraction - Room 3.2 S • RT program - Rooms 1.5 & 1.6 C • on-Invasive Electrophysiology - Room 3.3 N • rials - Room 3.4 T • blation Techniques - Room 3.5 A • cute Cardiac Care - Room 1.4 A • ral abstract sessions - Rooms 1.4, 2.4 & 2.6 OIndustry symposia will be the followingAt 11:00 am: • aint Jude Medical, room 1.1: Innovation in EP – Adding New Values: Clinical Approaches S and the Lab of the Future. • Medtronic, room 1.2: Diagnosing AF: Can We Prevent Strokes Caused by AF?At 2:00 pm: • edtronic, room 1.1: Treating AF: How to Effectively Reduce Stroke Risk? M • orin, room 1.2: The Role of Cardiologists in Sleep Apnea Management. SAt 4:00 pm: • edtronic, room 1.1: Emerging Leaders in Electrophysiology: Case Presentation and M Discussion. • aint Jude Medical, room 1.2: MEA S i Don’t forget to visit the Poster area in Agora 3, level 3 this afternoon! Please think about switching off your cell phone. If your phone rings during sessions, it really disturbs the speakers, thank you for them. Preview Room 2.7 is at level 2, Gallieni level. Scientific Secretariat is at level 2, close to room 2.1 Hermès. - 23 - www.cardiostim.com

Wednesday June 13 BASIC ELECTROPHYSIOLOGY CRT Chairman: D. Zipes - Indianapolis, USA European Heart Rhythm Association «FORTY YEARS OF GROUND-BREAKING CONCEPTS IN (EHRA) Program Wednesday June 13 CARDIAC ELECTROPHYSIOLOGY» Organized by EUROPACE Program Committee Chairman: A. Goette - Magdeburg, DEU 09:00-10:30 09:00-10:30 Room 2.1 / Hermes - Level 2 / Rhodes Room 2.3 / Athena - Level 2 / RhodesSESSION 1 SESSION 2CARDIAC STEM CELLS AND GENE THERAPY CRT IN THE 21ST CENTURY. WHAT DO WECo-Chair: HAVE NOW? STATUS QUO AND QUO VADIS?Cohen I.S. - Stony Brook, USA / Fast V. - Birmingham, USA Co-Chair: Boriani G. - Bologna, ITA / Kuck K.H. - Hamburg, DEU09:00 n Making Hearts RegeneratePedrazzini T. - Lausanne, CHE 1/1 09:00 n CRT in Ischemic Heart Failure Patients: From Cell Function to Clinical Outcome09:20 n Cardiac Differentiation of Human Keratinocytes Auricchio A. - Lugano, CHE 2/1Derived from Plucked Hair FolliclesBinah O. - Haifa, ISR 1/2 09:20 n CRT in Patients with Atrial Fibrillation Vardas P. - Heraklion, GRC 2/209:40 nInduced Pluripotent Stem Cells from Patientswith Inherited Arrhythmias 09:40 n Two Years with New Guidelines. Do We HaveJanuary C. - Madison, USA 1/3 Unresolved Questions? Dickstein K. - Stavanger, NOR 2/310:00 n What Are the Clinical Implications?Rosen M. - New York, USA 1/4 10:00 n CRT in Narrow QRS Ponikowski P. - Wroclaw, POL 2/410:20 n General Discussion n Break / Visit of Exhibits n Break / Visit of Exhibits nnn nnn Do not miss the OPENING CEREMONY Do not miss the OPENING CEREMONY 12:45 to 13:45 (Room 2.3 / Athena - Level 2) 12:45 to 13:45 (Room 2.3 / Athena - Level 2) - 25 - www.cardiostim.com

Wednesday June 13Created by Jacques Mugica PACING CRT European Heart Rhythm Association Course Directors: D. Hayes - Rochester, USA/ (EHRA) Program P. Ritter- Bordeaux, FRA/ D.S. Cannom - Los Angeles, USA/ J. Singh - Boston, USA/ F. Abi-Samra - New Orleans, USA Organized by EUROPACE Program Committee Chairman: A. Goette - Magdeburg, DEU 09:00-10:30 09:00-10:30 Room 1.3 - Level 1 / Méditerranée Room 1.6 / Iris - Level 1 / Méditerranée SESSION 7 SESSION 10 PACEMAKER THERAPY IN YEAR 2012 SELECTION OF CRT PATIENTS: GUIDELINES Co-Chair: AND BEYOND Simantirakis E.N. - Heraklion, GRC / Oyarzun R. - Santiago, CHL Co-Chair: Mabo P. - Rennes, FRA / Kottkamp H. - Zurich, CHE 09:00 n How Important Is Minimization of RV Pacing? Israel C. - Bielefeld, DEU 7/1 09:00 n CRT Guidelines: Interpretation and Differences of ESC & American Guidelines 09:20 n MR Safe Pacemakers Gillis A. - Calgary, CAN 10/1 Davy J. - Montpellier, FRA 7/2 09:15 n Patient with QRS between 120 and 150 ms: Are 09:40 n Where in the RV Should Ventricular Pacing Be They Candidates for CRT? Applied? Holmeister J. - Zurich, CHE 10/2 Butter C. - Bernau, DEU 7/3 09:30 n Should CRT Be Implemented during or after 10:00 Should AAI Pacing Be Considered Obsolete? n Cardiac Surgery in Patients with Low LVEF? Nielsen J. - Aarhus, DNK 7/4 Goscinska-Bis K. - Katovice, POL 10/3 n Break / Visit of Exhibits 09:45 n Should CRT Be Routinely Used in patients with Spontaneous Complete Heart Block and after AVN Ablation? Gutleben K. - Bad Oeynhausen, DEU 10/4 nnn Do not miss the OPENING CEREMONY 10:00 n Should Patients with RBBB Be Implanted with a CRT Device? 12:45 to 13:45 (Room 2.3 / Athena - Level 2) Botto G. - Como, ITA 10/5 n Break / Visit of Exhibits nnn Do not miss the OPENING CEREMONY 12:45 to 13:45 (Room 2.3 / Athena - Level 2) www.cardiostim.com - 26 -

Wednesday June 13 BASIC ELECTROPHYSIOLOGY SUDDEN CARDIAC DEATH European Heart Rhythm Association European Heart Rhythm Association (EHRA) Program (EHRA) Program Wednesday June 13 Organized by EUROPACE Program Committee Chairman: Organized by EUROPACE Program Committee Chairman: A. Goette - Magdeburg, DEU A. Goette - Magdeburg, DEU 09:00-10:30 09:00-10:30 Room 3.1 / Clio - Level 3 / Les Muses Room 3.2 / Thalie - Level 3 / Les MusesSESSION 11 SESSION 12NEW INSIGHTS IN BASICS OF ARRHYTHMIAS ION CHANNELOPATHIESCo-Chair: Co-Chair:Crijns H.J. - Maastricht, NLD / Savelieva I. - London, GBR Jalife J. - Ann Arbor, USA / Kaab S. - Munich, DEU09:00 n Calcium Handling and Arrhythmias: A Link to 09:00 n Long QT Syndrome - Types and TherapiesBe Targeted Priori S. - Pavia, ITA 12/1Zaza A. - Milan, ITA 11/1 09:20 n Brugada Syndrome - Place of Ion Channel09:20 n «Nodes» in the Arrhythmia Pathogenetic Antiarrhythmic DrugsNetwork Wolpert C. - Ludwigsburg, DEU 12/2Schotten U. - Maastricht, NLD 11/2 09:40 n J Wave Syndromes09:40 Mitochondrial Dysfunction and Arrhythmias n Antzelevitch C. - Utica, USA 12/3O’Rourke B. - Baltimore, USA 11/3 10:00 n Idiopathic Ventricular Fibrillation - Does It10:00 nClinical Evidence and Possible Therapy of These Exist?Arrhythmias Wilde A. - Amsterdam Zuidoost, NLD 12/4van Gelder I. - Groningen, NLD 11/4 n Break / Visit of Exhibits n Break / Visit of Exhibits nnn nnn Do not miss the OPENING CEREMONY Do not miss the OPENING CEREMONY 12:45 to 13:45 (Room 2.3 / Athena - Level 2) 12:45 to 13:45 (Room 2.3 / Athena - Level 2) - 27 - www.cardiostim.com

Wednesday June 13Created by Jacques Mugica NONINVASIVE TRIALS ELECTROCARDIOLOGY The 8 Biennial Meeting on Clinical th ADVANCES IN NONINVASIVE Trials in Cardiac Arrhythmias ELECTROCARDIOLOGY (ISHNE) Chairmen: Waldo A.L. - Cleveland, USA, Camm A.J. - London, GBR, Prartt C. - Houston, USA Chairmen: W. Zareba, USA, S. Dubner, ARG, A.J. Moss, USA 09:00-10:30 09:00-10:30 Room 3.3 / Erato - Level 3 / Les Muses Room 3.4 / Uranie - Level 3 / Les Muses SESSION 13 SESSION 14 CARDIAC ARRHYTHMIAS / OTHER TOPICS THE NEW ORAL ANTICOAGULANTS (OACs) Co-Chair: FOR STROKE PREVENTION IN AF - Part 1 Zareba W. - Rochester, USA / Piotrowicz R. - Warsaw, POL Chair: Waldo A.L. - Cleveland, USA 09:00 n Tachycardia Detection Performance of Implantable Loop Recorders 09:00 n ROCKET AF - Rivaroxaban for the Treatment of Stadler R., Wyszynski R., Volosin K., Kirchhof P. - Moundsview, Atrial Fibrillation USA 13/1 Breithardt G. - Münster, DEU 14/1 09:15 n Ecg Quality of Dry, Non-Adhesive Electrodes 09:30 n Rivaroxaban in DVT and ACS Trials - An OAC for for Arrhythmia Monitoring All Seasons? Szymkiewicz S., Wan C. - Pittsburgh, USA 13/2 Verheught F. - Nijmegen, NLD 14/2 09:30 n Atrial Natriuretic Peptide and Brain Natriuretic 10:00 n Dabigatran AF Sub-Studies Peptide Levels Are Elevated in Lone Atrial Fibrillation Hohnloser S. - Frankfurt, DEU 14/3 Calvo N., Ramos P., Coll-Vinent B., Hevia S., Berruezo A., Sitges M., Brugada J., Mont L. - Barcelona, ESP 13/3 n Break / Visit of Exhibits 09:45 n Conversion of Persistent Atrial Fibrillation and Flutter with New Class III Antiarrhythmic Agent Niferidile Yuricheva Y., Maykov E., Sokolov S., Mironov N., Golitsyn S., nnn Rosenshtraukh L., Chazov E. - Moscow, RUS 13/4 Do not miss the OPENING CEREMONY 10:00 Usefulness of Positioning the Left Ventricular n 12:45 to 13:45 (Room 2.3 / Athena - Level 2) Lead in the Area with Maximal Electrical Delay: Hemodynamic, Mapping and Clinical Assessment. Ploux S., Lumens J., Strom M., Denis A., Derval N., Zemmoura A., Ritter P., De Guillebon M., Ramanathan C., Clementy J., Haïssaguerre M., Bordachar P. - Pessac, FRA 13/5 10:15 n T-Wave Variability for Prediction of Arrhythmias in Resinchronization Therapy Zizek D., Cvijic M., Tasic J., Zupan I. - Ljubljana, SVN 13/6 n Break / Visit of Exhibits nnn Do not miss the OPENING CEREMONY 12:45 to 13:45 (Room 2.3 / Athena - Level 2) www.cardiostim.com - 28 -

Wednesday June 13 BASIC ELECTROPHYSIOLOGY NONINVASIVE From Mechanism to Process. ELECTROCARDIOLOGY Paradigm Shift? ADVANCES IN NONINVASIVE Wednesday June 13 organized by Guiraudon G. - London, CAN ELECTROCARDIOLOGY (ISHNE) Philippe Coumel Session Chairmen: W. Zareba, USA, S. Dubner, ARG, A.J. Moss, USA The author’s presence is required to present their poster from 10:30 to 11:00 Posters must remain on display from 9:30 to 12:00 09:00-10:30 10:30-11:00 Room 3.5 / Calliope - Level 3 / Les Muses Poster Area Les Muses - Level 3 / Les MusesSESSION 15 SESSION 17PWATRIAL FIBRILLATION: DEALING WITH ATRIAL FIBRILLATIONCOMPLEXITY Co-Chair:Co-Chair: Haigney M. - Bethesda, USA / Wranicz J.K. - Lodz, POLGuiraudon G.M. - London , CAN / Klein G.J. - London, CAN 10:30 n Screening for Asymptomatic Atrial Fibrillation09:00 n Intrinsic Autonomic Cardiac Nervous System: in Primary Care with Handheld EcgNew Physiology or Deregulation? Does Neuroablation Hendrikx T., Rosenqvist M., Sandström H. - Umeå, SWE17PW/1Have Predictable Long-Term Effects?Cardinal R. - Montréal, CAN 15/1 10:30 n Prevalence of Risk Factors for Atrial Fibrillation and Stroke among 1,210 Patients with Sleep Disordered09:30 n Understanding the Complexity of the Substrate Breathing.of Human AF Valenza M., Healey J., Muñoz T., Valenza G., Fitzpatrick M.,Allessie M. - Maastricht, NLD 15/2 Hopman W., Baranchuk A. - Granada, ESP 17PW/210:00 n When Complexity Beats Ablation? Alterative 10:30 n Reduction of Hospitalizations with Patients’Interventions to Restore Chronotropic Function, and Stroke Self-Acquired ECG Recording and Analysing SystemPrevention Van Langenhove G., Schwagten B., Bonaventura K.,Guiraudon G. - London , CAN 15/3 Riemenscheider M., Brand F. - Antwerpen, BEL 17PW/3 n Break / Visit of Exhibits 10:30 n Chads2 Score Predicts Atrial Fibrillation after Coronary Artery Bypass Nazeri A., Elayda M., Lee V., Wilson J., Massumi A., Razavi M. - Houston, USA 17PW/4 nnn 10:30 n New-Onset Atrail Fibrillation in the Elderly Who Do not miss the OPENING CEREMONY Received Health Screening Tests: Incidence and Risk Factors 12:45 to 13:45 (Room 2.3 / Athena - Level 2) Byeon K., Kim E., Lee S., Park S., Huh J., Sung J., Kim J., On Y. - Seoul, KOR 17PW/5 10:30 n The Prognostic Value of Resting Heart Rate in Patients with Atrial Fibrillation/atrial Flutter – an Analysis of the Active Trials Chin A., Ng J., Connolly S. - Burlington, CAN 17PW/6 n Break / Visit of Exhibits nnn Do not miss the OPENING CEREMONY 12:45 to 13:45 (Room 2.3 / Athena - Level 2) - 29 - www.cardiostim.com

Wednesday June 13Created by Jacques Mugica BASIC ELECTROPHYSIOLOGY CRT Chairman: D. Zipes – Indianapolis, USA European Heart Rhythm Association «FORTY YEARS OF GROUND-BREAKING CONCEPTS IN (EHRA) Program CARDIAC ELECTROPHYSIOLOGY» Organized by EUROPACE Program Committee Chairman: A. Goette - Magdeburg, DEU 11:00-12:30 11:00-12:30 Room 2.1 / Hermes - Level 2 / Rhodes Room 2.3 / Athena - Level 2 / Rhodes SESSION 21 SESSION 22 NEW IMAGING TECHNIQUES CRT: READING THE GUIDELINES Co-Chair: Co-Chair: Kalman J.M. - Parkville, AUS / Mazgalev T.N. - Cleveland, USA Auricchio A. - Lugano, CHE / Kirchhof P. - Münster, DEU 11:00 n Electrocardiographic Imaging to Understand 11:00 n CRT in Mild Heart Failure Arrhythmia Mechanisms Linde C. - Stockholm, SWE 22/1 Rudy Y. - St. Louis, USA 21/1 11:20 n CRT in Atrial Fibrillation 11:20 Simulations to Predict Sites of VT Ablation n Sutton R. - Monaco, MCO 22/2 Trayanova N. - Baltimore, USA 21/2 11:40 n CRT in Patients with Conventional Pacemaker 11:40 n MRI for Risk Prediction of Arrhythmogenic Indications Areas Burri H. - Geneva, CHE 22/3 Halperin H. - Baltimore, USA 21/3 12:00 n CRT in Clinical Practice: The European CRT 12:00 What Are the Clinical Implications? n Survey Borggrefe M. - Mannheim, DEU 21/4 Dickstein K. - Stavanger, NOR 22/4 12:20 n General Discussion n Lunch n Lunch nnn nnn Do not miss the OPENING CEREMONY 12:45 to 13:45 (Room 2.3 / Athena - Level 2) Do not miss the OPENING CEREMONY 12:45 to 13:45 (Room 2.3 / Athena - Level 2) www.cardiostim.com - 30 -

Wednesday June 13 INVASIVE EP ICDs Wednesday June 13 11:00-12:30 11:00-12:30 Room 2.4 - Level 2 / Gallieni Room 2.6 - Level 2 / GallieniSESSION 23 SESSION 24SURGICAL TREATMENT OF AF SENSING AND ICDsCo-Chair: Chair:Hatala R. - Bratislava, SVK / Guiraudon G.M. - London, CAN Clémenty J. - Bordeaux, FRA11:00 n Staged Hybrid Surgical-Ep Ablation for 11:00 n Performance of an ICD Algorithm to DetectPersistent Atrial Fibrillation Lead Failure Noise and Prevent Inappropriate TherapyMuneretto C., Bisleri G., Bontempi L., Curnis A. - Brescia, ITA 23/1 Beau S., Greer S., Ellis C., Keeney J., Asopa S. - Little Rock, USA 24/111:15 n Acute Rate of Transmural Lesions Induced bythe Epicor System ® during Peri-Operative Left Atrial 11:15 n Multipole Analysis of Heart Rate Variability asAblation for Atrial Fibrillation a Predictor of Imminent Ventricular Arrhythmias in ICDMaury P., Bennadji A., Marcheix B., Cron C., Duparc A., Mondoly Patients.P., Rollin A., Cardin C., Delay M., Glock Y. - Toulouse, FRA 23/2 Rozen G., Kobo B., Feldman S., Levitan J., Sapunar M., Luria D., Eldar M., Glikson M. - Tel Hashomer, ISR 24/211:30 n Bipolar Radiofrequency Surgical Maze-AblationEffectively Treats Atrial Fibrillation but Decreases Left 11:30 n Programming of Antitachycardia PacingAtrial Contraction Reduces the Overall Shock Delivery for Ventricular as WellCompier M., Braun J., Delgado V., Zeppenfeld K., Klautz R., as Supraventricular Tachyarrhythmias in ICD Patients -Schalij M., Trines S. - Leiden, NLD 23/3 Results of the Atponfastvt - Substudy Schwab J., Bollinger C., Wiegand U., Bodden C., Birkenhauer F.,11:45 n Benefit of Ablation of First Diagnosed Atrial Veltmann C. - Bonn, DEU 24/3Fibrillation in Patients Submitted to Coronary ArteryBypass Grafting 11:45 n VF Detection Utilizing the Lead Bending SensorPokushalov E., Romanov A., Chernyavskiy A., Karaskov A. - Brusich S., Ferek-Petric B., Tomasic D., Cubranic Z. - Rijeka, HRVNovosibirsk, RUS 23/4 24/412:00 n Atrial Tachycardia 3d-Mapping and Ablation 12:00 n Prediction of Exercise Stress Test Outcome Usingafter Cardiac Transplantation Intracardiac Electrogram Available in the Analyst® ICDMouhoub Y., Marrakchi S., Varnous S., Fernandez F., Sperzel J., Geller C., Nölker G., Schauerte P., Brachmann J.,Waintraub X., Gandjbakhch E., Frank R., Pavie A., Kleemann T., Carlson M., Gill J., Farazi T., Wuensch D., Hamm C.Hidden-Lucet F., Duthoit G. - Paris, FRA 23/5 - Bad Nauheim, DEU 24/512:15 n Worldwide Survey on the Safety of Atrial 12:15 n International Experience with a SubcutaneousFibrillation Ablation Using the Hansen Robotic System ICD; Preliminary Results of the Effortless S-ICD Registry.Di Biase L., Bai R., Valderrabbano M., Lorgat F., Mlcochova H., Lambiase P., Theuns D., Neuzil P., Sholten M., Barr C., Knops R.,Tilz R., Meyerfeldt U., Hranitzky P., Wazni O., Kanagaratnam P., Murgatroyd F., Johansen J., Boersma L. - London, GBR 24/6Doshi R., Gibson D., Pisapia A., Mohanty P., Saliba W., OuyangF., Kautzner J., Gallinghouse G., Natale A. - Austin, USA 23/6 n Lunch n Lunch nnn nnn Do not miss the OPENING CEREMONY Do not miss the OPENING CEREMONY 12:45 to 13:45 (Room 2.3 / Athena - Level 2) 12:45 to 13:45 (Room 2.3 / Athena - Level 2) - 31 - www.cardiostim.com

Wednesday June 13Created by Jacques Mugica INVASIVE ELECTROPHYSIOLOGY STROKE 11:00-12:30 11:00-12:30 Room 1.1 - Level 1 / Méditerranée Room 1.2 - Level 1 / Méditerranée SESSION 25 SESSION 26 RAISING THE BAR: IMPROVING NAVIGATION DIAGNOSING AF: CAN WE PREVENT AND SAFETY WITH INNOVATIONS IN THE EP STROKES CAUSED BY AF? LAB Co-Chair: Chair: Krieger D. - Kopenhagen, DNK / Hohnloser S. - Frankfurt, DEU Pappone C. - Milan, ITA 11:00 n More Intensive Monitoring Leads to More AF 11:00 Challenges in the EP Lab: Radiation Exposure n Detection and Visualization Wachter R. - Göttingen, SWE 26/1 Kautzner J. - Prague, CZE 25/1 11:20 n AF Burden Is a Determinant Risk Factor for 11:10 Advancements in Technology with 3D n Stroke Cardiovascular Navigation System: MediGuide Boriani G. - Bologna, ITA 26/2 Piorkowski C. - Leipzig, DEU 25/2 11:40 n Cryptogenic Stroke: Why Move Beyond the 11:35 n Recorded Live Case from Cotignola: MediGuide Guidelines? with Velocity Integration Cotter P. - Cambridge, GBR 26/3 Pappone C. - Milan, ITA 25/3 12:00 n Screening High Risk Patients for AF through 12:05 Is Closing the Left Atrial Appendage: A Viable n Continuous Monitoring Alternative for Stroke Prevention in AF Patients? Heinzel F. - Graz, AUT 26/4 Davies W. - London, GBR 25/4 n Lunch n Lunch Session made possible thanks to an educational grant from Session made possible thanks to an educational grant from MEDTRONIC ST JUDE MEDICAL nnn nnn Do not miss the OPENING CEREMONY Do not miss the OPENING CEREMONY 12:45 to 13:45 (Room 2.3 / Athena - Level 2) 12:45 to 13:45 (Room 2.3 / Athena - Level 2) www.cardiostim.com - 32 -

Wednesday June 13 PACING ACUTE CARDIAC CARE Course Directors: D. Hayes - Rochester, USA/ in cooperation with the WG on Acute P. Ritter- Bordeaux, FRA/ D.S. Cannom - Los Angeles, USA/ Cardiac Care of the ESC J. Singh - Boston, USA/ F. Abi-Samra - New Orleans, USA Wednesday June 13 Chairmen: Vrints C. - Edegem, BEL/Gorenek B. - Eskisehir, TUR 11:00-12:30 11:00-12:30 Room 1.3 - Level 1 / Méditerranée Room 1.4 - Level 1 / MéditerranéeSESSION 27 SESSION 28SHOULD WE IMPLANT THOSE PATIENTS? ARRHYTHMIAS IN PRIMARY PCICo-Chair: Co-Chair:Sulke N. - Eastbourne, GBR / Ruffy R. - Salt Lake City, USA Clemmensen P.M. - Copenhagen, DNK / Gorenek B. - Eskisehir, TUR11:00 n Conduction Disorders after TAVI 11:00 n Incidence and Prognostic ImpactLeroux L. - Bordeaux, FRA 27/1 Lettino M. - Rome, ITA 28/111:20 n Nocturnal Bradycardia with and without Sleep 11:20 n How to Prevent and Manage ReperfusionApnea ArrhythmiasNielsen J. - Aarhus, DNK 27/2 Gorenek B. - Eskisehir, TUR 28/211:40 n Drug-Induced Bradycardia 11:40 n New Onset Atrial FibrillationAdragao P. - Lisbon, PRT 27/3 Manolis A. - Athens, GRC 28/312:00 n Myotonic Dystrophy (Steinert Disease) 12:00 n Coronary Intervention during VF /VT or AsystoleLazarus A. - St Cloud, FRA 27/4 Clemmensen P. - Copenhagen, DNK 28/4 n Lunch n Lunch nnn nnn Do not miss the OPENING CEREMONY Do not miss the OPENING CEREMONY 12:45 to 13:45 (Room 2.3 / Athena - Level 2) 12:45 to 13:45 (Room 2.3 / Athena - Level 2) - 33 - www.cardiostim.com

Wednesday June 13Created by Jacques Mugica PACING & CRT CRT Course Directors: D. Hayes - Rochester, USA/ Course Directors: D. Hayes - Rochester, USA/ P. Ritter- Bordeaux, FRA/ D.S. Cannom - Los Angeles, USA/ P. Ritter- Bordeaux, FRA/ D.S. Cannom - Los Angeles, USA/ J. Singh - Boston, USA/ F. Abi-Samra - New Orleans, USA J. Singh - Boston, USA/ F. Abi-Samra - New Orleans, USA 11:00-12:30 11:00-12:30 Room 1.5 - Level 1 / Méditerranée Room 1.6 / Iris - Level 1 / Méditerranée SESSION 29 SESSION 30 ART OF TIMING (PART I) CAN RESPONSE TO CRT BE BETTER Co-Chair: PREDICTED BY… Ronaszéki A. - Budapest, HUN / Chirife R. - Buenos Aires, ARG Co-Chair: Butter C. - Bernau, DEU / Defaye P. - Grenoble, FRA 11:00 n The Concept of Optimal AV Delay Ronaszéki A. - Budapest, HUN 29/1 11:00 n Scar Zone Location and Transmurality? Mela T. - Boston, USA 30/1 11:20 Impact of Inter- and Intra-Atrial Conduction n Delays on Optimal AV Interval 11:20 n Limited Regional Delayed Contraction in Saksena S. - Warren, USA 29/2 Recommended Candidates? Spragg D. - USA 30/2 11:40 What Can We Learn from Computer n Simulations of AV- and VV-Delay Optimization? 11:40 n Assessment of Segmental Contractile Reserve? Lumens J. - Maastricht, NLD 29/3 Gasparini M. - Rozzano (MI), ITA 30/3 12:00 n Effect of Heart Rate and Exercise on Optimal 12:00 n Presence of Co-Morbidities (RV Dysfunction, AV Interval Renal Failure, Ageing, Diabetes etc..)? Israel C. - Bielefeld, DEU 29/4 Van Bommel R. - Leiden, NLD 30/4 n Lunch n Lunch nnn nnn Do not miss the OPENING CEREMONY Do not miss the OPENING CEREMONY 12:45 to 13:45 (Room 2.3 / Athena - Level 2) 12:45 to 13:45 (Room 2.3 / Athena - Level 2) www.cardiostim.com - 34 -

Wednesday June 13 BASIC ELECTROPHYSIOLOGY & CRT ABLATION TECHNIQUES European Heart Rhythm Association European Heart Rhythm Association (EHRA) Program Wednesday June 13 (EHRA) Program Organized by EUROPACE Program Committee Chairman: A. Goette - Magdeburg, DEU Organized by EUROPACE Program Committee Chairman: A. Goette - Magdeburg, DEU 11:00-12:30 11:00-12:30 Room 3.1 / Clio - Level 3 / Les Muses Room 3.2 - Level 3 / Les MusesSESSION 31 SESSION 32PURKINJE FIBERS AND VENTRICULAR WHAT A DEVICE SPECIALIST NEEDS TOARRHYTHMIAS KNOW ABOUT HEART FAILURECo-Chair: Co-Chair:Kuck K.H. - Hamburg, DEU / Leclercq J.F. - Paris, FRA Daubert J.C. - Rennes, FRA / Ponikowski P. - Wroclaw, POL11:00 n Arrhythmia of Purkinje Fibers: Specificity of 11:00 n Pacing in Heart Failure: What Happens on theCellular Mechanisms Cellular Level?Ehrlich J. - Frankfurt, DEU 31/1 Vanderheyden M. - Aalst, BEL 32/111:20 n Effect of Antiarrhythmic Drugs on the Purkinje 11:20 n Optimal Medical Treatment in Heart FailureNetwork: Electrophysiological and Pharmacological Aspects Cowie M. - London, GBR 32/2Vos M. - Utrecht, NLD 31/2 11:40 n The Device Patient with End Stage Heart Failure11:40 n Ablation of Polymorphic VT in Patients with Fruhwald F. - Graz, AUT 32/3Structural Heart DiseasePiorkowski C. - Leipzig, DEU 31/3 12:00 n Role of Implantable Sensors in Heart Failure Management12:00 n Idiopathic VF Originating from the Purkinje Braunschweig F. - Stockholm, SWE 32/4Network: Ablation Targets and Long-Term Follow-UpKnecht S. - Bruxelles, BEL 31/4 n Lunch n Lunch nnn nnn Do not miss the OPENING CEREMONY 12:45 to 13:45 (Room 2.3 / Athena - Level 2) Do not miss the OPENING CEREMONY 12:45 to 13:45 (Room 2.3 / Athena - Level 2) - 35 - www.cardiostim.com

Wednesday June 13Created by Jacques Mugica NONINVASIVE TRIALS ELECTROCARDIOLOGY The 8 Biennial Meeting on Clinical Trials th ADVANCES IN NONINVASIVE in Cardiac Arrhythmias ELECTROCARDIOLOGY (ISHNE) Chairmen: Waldo A.L. – Cleveland, USA, Camm A.J. – London, GBR, Prartt C. – Houston, USA Chairmen: W. Zareba, USA, S. Dubner, ARG, A.J. Moss, USA 11:00-12:30 11:00-12:30 Room 3.3 / Erato - Level 3 / Les Muses Room 3.4 / Uranie - Level 3 / Les Muses SESSION 33 SESSION 34 BRUGADA SYNDROME THE NEW ORAL ANTICOAGULANTS Co-Chair: (OACS) FOR STROKE PREVENTION IN AF - Brugada P. - Aalst, BEL / Dubner S. - Buenos Aires, ARG Part 2 Chair: 11:00 n Short-Term Effect of Hydroquinidine on Camm A.J. - London, GBR Ventricular Repolarization in the Brugada Syndrome Patients: Results of the Quidam Study 11:00 n ARISTOTLE (Apixaban vs Warfarin) Probst V., Sacher F., Mansourati J., Maury P., Babuty D., Defaye Wallentin L. - Uppsala, SWE 34/1 P., Hermida J., Davy J., Chevalier P., Deharo J., Leenhardt A., Sadoul N., Klug D., Fouchard S., Le Marec H. - Nantes, FRA 33/1 11:30 n AVERROES (Apixaban vs Aspirin) – Implications for Aspirin as Thromboprophylaxis for Stroke Prevention 11:15 n Prevalence and Prognosis Role of Various in AF Conduction Disturbances in Patients with Brugada Syndrome Waldo A. - Cleveland, USA 34/2 Maury P., Rollin A., Probst V., Sacher F., Pasquié J., Raczka F., Gouraud J., Vervueren P., Bongard V., Duparc A., Mondoly P., Cardin C., Delay M., Davy J., Hocini M., Jaïs P., Haïssaguerre M. - 12:00 n Anticoagulation in AF - Which Agent? Toulouse, FRA 33/2 Which Patient? Weitz J. - Hamilton, CAN 34/3 11:30 Validation of an Increased Tpeak-Tend Interval n n Lunch in a Large Series of Brugada Syndrome Patients as a Highly and Independently ECG Parameter Related to Symptoms and Cardiac Events. Rollin A., Maury P., Sacher F., Probst V., Pasquié J., Raczka F., Gouraud J., Vervueren P., Bongard V., Duparc A., Mondoly P., Cardin C., Delay M., Davy J., Hocini M., Jaïs P., Haïssaguerre M. - nnn Toulouse, FRA 33/3 Do not miss the OPENING CEREMONY 11:45 Non-Invasive Identification of Brugada n Syndrome Patients without a Type I Ecg 12:45 to 13:45 (Room 2.3 / Athena - Level 2) Fonseca-Guzman A., Climent A., Millet J., Berne P., Ramos R., Brugada J., Brugada R., Guillem M. - Valencia, ESP 33/4 12:00 n Prevalence and Prognosis Role of Type 1 ST Elevation in Limb ECG Leads in Patients with Brugada Syndrome. Rollin A., Maury P., Sacher F., Probst V., Raczka F., Pasquié J., Gouraud J., Vervueren P., Bongard V., Duparc A., Mondoly P., Cardin C., Delay M., Davy J., Hocini M., Jaïs P., Haïssaguerre M. - Toulouse, FRA 33/5 12:15 n Sudden Cardiac Death in the Post Acute ST Elevation Myocardial Infarction Population – Longitudinal Follow up Data from a Single Center in India Rao H., Sastry B., Korabathina R., Raju P. - Hyderabad, IND 33/6 n Lunch www.cardiostim.com - 36 -

Wednesday June 13 INVASIVE ELECTROPHYSIOLOGY BASIC ELECTROPHYSIOLOGY & ABLATION TECHNIQUES Chairman: D. Zipes – Indianapolis, USA WORLD CONGRESS ON CATHETER ABLATION «FORTY YEARS OF GROUND-BREAKING CONCEPTS IN Wednesday June 13 Chairmen: M. Scheinman - San Fransciso, USA, CARDIAC ELECTROPHYSIOLOGY» M. O’Neill - London, GBR - V. Probst- Nantes, FRA - F. Sacher - Bordeaux-Pessac, FRA 11:00-12:30 14:00-15:30 Room 3.5 / Calliope - Level 3 / Les Muses Room 2.1 / Hermes - Level 2 / RhodesSESSION 35 SESSION 41ATRIAL FIBRILLATION ABLATION I MYOCYTE-FIBROBLAST INTERACTIONS INCo-Chair: NORMAL AND DISEASED MYOCARDIUMNarayan S.M. - San Diego, USA / Marrouche N.F. - Salt Lake Co-Chair:City, USA Kleber A. - Bern, CHE / Vos M. - Utrecht, NLD11:00 n Mechanisms of Atrial Fibrillation. Implication 14:00 n Myocyte Fibroblast Interactionfor Ablation Strategies Kohl P. - London, GBR 41/1Nattel S. - Montreal, CAN 35/1 14:20 n Myofibroblasts as Arrhythmia Triggers11:20 n Real Time Mapping to Guide Atrial Fibrillation Rohr S. - Bern, CHE 41/2AblationNarayan S.- San Diego, USA 35/2 14:40 n Electromechanical Consequences of Adult Cardiomyocyte Myofibroblast Interactions11:40 n “MR Imaging:” Does It Have a Role in Atrial Jalife J. - Ann Arbor, USA 41/3Fibrillation Ablation?Marrouche N. - Salt Lake City, USA 35/3 15:00 n What Are the Clinical Implications? Duffy H. - Boston, USA 41/412:00 n Atrial Fibrillation Ablation for Patients withLong Standing Persistent Atrial Fibrillation 15:20 n General DiscussionSanders P. - Adelaide, AUS 35/4 n Break / Visit of Exhibits n Lunch nnn Do not miss the OPENING CEREMONY 12:45 to 13:45 (Room 2.3 / Athena - Level 2) - 37 - www.cardiostim.com

Wednesday June 13Created by Jacques Mugica MISCELLANEOUS CRT European Heart Rhythm Association (EHRA) Program Organized by EUROPACE Program Committee Chairman: A. Goette - Magdeburg, DEU 14:00-15:30 14:00-15:30 Room 2.3 / Athena - Level 2 / Rhodes Room 2.4 - Level 2 / Gallieni SESSION 42 SESSION 43 NEW EHRA DOCUMENTS NEW MEANS OF LV STIMULATION TO Chair: INCREASE THE RESPONSE TO CRT Raviele A. - Venice, ITA Co-Chair: Singh J. - Boston, USA / Bordachar P. - Bordeaux, FRA 14:00 n Palpitations 14:00 n Superiority of Multisite Versus Monosite Left Raviele A. - Venice, ITA 42/1 Ventricular Pacing for Cardiac Resynchronization Therapy in a Chronic Left Bundle Branch Block Model 14:20 n Bleeding Risk Ploux S., Strik M., Van Hunnik A., Van Middendorp L., Lip G. - Birmingham, GBR 42/2 Kuiper M., Prinzen F. - Bordeaux - Pessac, FRA 43/1 14:40 n ‘ICD for Life’ Initiative--Fighting against Sudden 14:10 n Feasibility and Safety of Triple-Site Crt: Insights Cardiac Death in Emerging Economies. from the Randomized Trial Merkely B. - Budapest, HUN 42/3 Lenarczyk R., Kowalski O., Sredniawa B., Pruszkowska-Skrzep P., Mazurek M., Jedrzejczyk-Patej E., Wozniak A., Kalarus Z., For The 15:00 n Genetic Testing Triple-Site Versus Standard Resynchronizat - Zabrze, POL 43/2 Priori S. - Pavia, ITA 42/4 14:20 n Dual LV Pacing in Very Dilated Cardiomyopathy: n Break / Visit of Exhibits an Haemodynamic Study Duparc A., Mondoly P., Cardin C., Rolin A., Rezaei M., Noblemaire R., Thompson E., Ritter P., Maury P., Delay M. - Toulouse, FRA 43/3 14:30 n Intraoperative Measurements of LV Dp/dt in CRT Patients with Two Left Ventricular Leads (dual Lv) Present Significant Improvement in Comparison to Conventional CRT with a Single Left Ventricular Lead. Kranig W., Grove R., Wolff E., Imnadze G., Vahlkamp K., Kowalski M., Thale J. - Bad Rothenfelde, DEU 43/4 14:40 n Crt with Multisite LV Pacing Improves Acute Mechanical Dyssynchrony and Hemodynamics in HF Patients Rinaldi C., Kranig W., Leclercq C., Kacet S., Betts T., Bordachar P., Gutleben K., Keel A., Ryu K., Farazi T., Simon M., Naqvi T. - London, GBR 43/5 14:50 n Hemodynamic Evaluation of Alternative Left Ventricular Endocardial Pacing Sites in Clinical Nonreponders to Cardiac Resynchronization Therapy Van Gelder B., Houthuizen P., Bracke F. - Eindhoven, NLD 43/6 15:00 n Acute Human Feasibilty and a Safety of a Novel Superior-Access Atrial Transseptal Left Ventricular Endocardial Lead Implant: Preliminary Results of Alternate Site Cardiac Resynchronization (alsync) Study Jais P. - Bordeaux, FRA 43/7 n Break / Visit of Exhibits www.cardiostim.com - 38 -

Wednesday June 13 ICDs STROKE Wednesday June 13 14:00-15:30 14:00-15:30 Room 2.6 - Level 2 / Gallieni Room 1.1 - Level 1 / MéditerranéeSESSION 44 SESSION 45NEW MEANS OF ICD PROGRAMMING AND TREATING AF: HOW TO EFFECTIVELYINDICATIONS REDUCE STROKE RISK?Co-Chair: Co-Chair:Lunati M. - Milan, ITA / Sadoul N. - Nancy, FRA Kirchhof P. - Münster, DEU / Diener H.C. - Duisburg, DEU14:00 n Depression Is Associated with a 2-Fold 14:00 n Stroke Prevention from the Cardiologist‘sIndependent Risk of Mortality in ICD Patients PerspectivePedersen S., Erdman R., Jordaens L., Theuns D. - Tilburg, NLD Camm A. - London, GBR 45/1 44/1 14:15 n What We Need to Know about Strokes Caused14:15 n Prognostic Value of Programmed Ventricular by AFStimulation in Dilated Cardiomyopathy Patients with an Thijs V. - Leuven, BEL 45/2Implantable Cardioverter Defibrillator.Tsiachris D., Gatzoulis K., Vouliotis A., Arsenos P., Archontakis 14:30 n New Drugs for Stroke PreventionS., Dilaveris P., Sideris S., Karystinos G., Gialernios T., Kallikazaros Huber K. - Vienna, AUT 45/3I., Stefanadis C. - Athens, GRC 44/2 14:45 n Early PVI as a Treatment Option after Stroke14:30 nProgramming ICDs to Prolong Time to First Caused by AFShock: Primary Results from the Provide Study Tondo C. - Milan, ITA 45/4Saeed M., Styperek R., Khan A., Hanna I., Alonso J., Robotis D.,Neason C., Saberi L. - Houston, USA 44/3 15:00 n Future Strategies for Device Therapy in AF Management14:45 n Non-Compaction Cardiomyopathy. Risk Hill M. - Minneapolis, USA 45/5Stratification for Prophylactic Indication of ImplantableCardiac Defibrillators. n Break / Visit of ExhibitsGalizio N., Palazzo A., Robles F., Albano F., Carnero G., Gargano A.,Martinenghi N., Vallejos X., Gonzalez J. - Caba, ARG 44/4 Session made possible thanks to an educational grant from MEDTRONIC15:00 n Effects of Stem Cell Transplantation on SuddenDeath in Dilated CardiomyopathyVrtovec B., Poglajen G., Sever M., Lezaic L., Domanovic D.,Cernelc P., Haddad F. - Ljubljana, SVN 44/515:15 n Decreasing the Number of Unnecessary ICDImplantations ThreefoldKrinski V., Guberman S., Sacher F., Couderc J., Luther S.,Hasenfuss G., Haïssaguerre M. - Goettingen, DEU 44/6 n Break / Visit of Exhibits - 39 - www.cardiostim.com

Wednesday June 13Created by Jacques Mugica SLEEP APNEA LEADS PACING & ICD LEADS Chair: J. Helland - Sylmar, USA 14:00-15:30 14:00-15:30 Room 1.2 - Level 1 / Méditerranée Room 1.3 - Level 1 / Méditerranée SESSION 46 SESSION 47 THE ROLE OF CARDIOLOGISTS IN SLEEP WHAT ARE ENGINEERS DOING TO IMPROVE APNEA MANAGEMENT CARDIAC LEAD FUNCTION & RELIABILITY? Co-Chair: Co-Chair: Hayes D. - Rochester, USA / Garrigue S. - Bordeaux, FRA McVenes R. - Mounds View, USA / Ricci R. - Rome, ITA 14:00 n Why Should Cardiologists Now Be Alert to 14:00 n What New Standardized Testing of Leads Will Sleep Apnea? Be Implemented by Manufacturers: An AAMI CRMD Manisty C. - London, GBR 46/1 Cooke D. - St-Paul, USA 47/1 14:20 n Prevalence and Mechanisms of Sleep Apnea 14:15 n What Does a Physician Extractor Need to Know Syndrome about the Design of Cardiac Leads? Skowasch D. - Bonn, DEU 46/2 Marshall M. - Mounds View, USA 47/2 14:40 n Contribution of Pacemaker Sensors to Provide 14:30 n Clinical Safety & Reliability Performance Update Apnea/Hypopnea Index of DF4 Connector Systems Defaye P. - Grenoble, FRA 46/3 Helland J. - Sylmar, USA 47/3 15:00 n How Can Cardiologists Better Manage Sleep 14:45 n How Does the Implant Technique & Location Apnea Patients? Affect the Forces & Stresses Applied to Implanted Leads? Bordier P. - Pessac Cedex, FRA 46/4 Binner L. - Ulm, DEU 47/4 15:20 n Round Table Discussion 15:00 n What Have Engineers Learned from Analyzing Force Loading and Use Conditions on Implanted Leads? n Break / Visit of Exhibits Baxter W. - Santa Ana, USA 47/5 Session made possible thanks to an educational grant from n Break / Visit of Exhibits SORIN GROUP www.cardiostim.com - 40 -

Wednesday June 13 SUDDEN CARDIAC DEATH PACING & CRT Cardiopace Course Directors: D. Hayes - Rochester, USA/ P. Ritter- Bordeaux, FRA/ D.S. Cannom - Los Angeles, USA/ organized by Jazra C. - Beirut, LBN J. Singh - Boston, USA/ F. Abi-Samra - New Orleans, USA Wednesday June 13 14:00-15:30 14:00-15:30 Room 1.4 - Level 1 / Méditerranée Room 1.5 - Level 1 / MéditerranéeSESSION 48 SESSION 49LVH AND SUDDEN DEATH: FROM ART OF TIMING (PART II)CLASSIFICATION TO MANAGEMENT Co-Chair:Co-Chair: Ronaszéki A. - Budapest, HUN / Chirife R. - Buenos Aires, ARGAl Fayyad M. - Riyad, SAU / Khoury M. - Beirut, LBN 14:00 n Different Methods for Hemodynamic14:00 Echo versus ECG Classification of LVH n OptimizationChammas E. - Beirut, LBN 48/1 Gold M. - Charleston, USA 49/114:20 n Mechanism of Arrhythmia in Patients with LVH 14:20 n How Efficient Are the Automatic Features ofOto A. - Ankara, TUR 48/2 Implantable Devices? Lunati M. - Milan, ITA 49/214:40 n Risk Assessment: What Do the Guidelines Tell Us?Veltmann C. - Hannover, DEU 48/3 14:40 n Round Table: AVD and V-V Interval Optimization in CRT: How Is This Best Accomplished?15:00 n Hypertension and LVH: Determinants of Risk Singh J. - Boston, USA 49/3Jazra C. - Beyrouth, LBN 48/4 Gold M. - Charleston, USA 49/4 Lunati M. - Milan, ITA 49/5 n Break / Visit of Exhibits Ritter P. - Bordeaux, FRA 49/6 Abi-Samra F. - New Orleans, USA 49/7 n Break / Visit of Exhibits - 41 - www.cardiostim.com

Wednesday June 13Created by Jacques Mugica CRT SUDDEN CARDIAC DEATH Course Directors: D. Hayes - Rochester, USA/ European Heart Rhythm Association P. Ritter- Bordeaux, FRA/ D.S. Cannom - Los Angeles, USA/ (EHRA) Program J. Singh - Boston, USA/ F. Abi-Samra - New Orleans, USA Organized by EUROPACE Program Committee Chairman: A. Goette - Magdeburg, DEU 14:00-15:30 14:00-15:30 Room 1.6 / Iris - Level 1 / Méditerranée Room 3.1 / Clio - Level 3 / Les Muses SESSION 50 SESSION 51 DURING IMPLANTATION, CAN CRT BE SUDDEN CARDIAC DEATH IN THE YOUNG OPTIMIZED during implant BY… Co-Chair: Co-Chair: Heidbüchel H. - Leuven, BEL / Morgan J.M. - Southampton, GBR Francis D. - London, GBR / Ellenbogen K. - Richmond, USA 14:00 n Autopsy Rate and Cause of Death in the Young: 14:20 Change in QRS Width and/or Morphology? n A National Study from Denmark Daubert J. - Rennes, FRA 50/1 Winkel B. - Copenhagen, DNK 51/1 14:00 n Localization of Time-Delayed Activated Areas 14:20 n Brugada Syndrome: Not as Dangerous as First and Scar Zones? Assumed? Rinaldi A. - London, GBR 50/2 Borggrefe M. - Mannheim, DEU 51/2 14:40 n Real-Time Echo Assessment? 14:40 n How Should We Make a Work-Up in Young Van Bommel R. - Leiden, NLD 50/3 Cardiac Arrest Survivors? Braunschweig F. - Stockholm, SWE 51/3 15:00 n Measurement of Hemodynamic Parameters? Whinnett Z. - London, GBR 50/4 15:00 n Coronary Abnormalities and Sudden Cardiac Death n Break / Visit of Exhibits Ho S. - London, GBR 51/4 n Break / Visit of Exhibits www.cardiostim.com - 42 -

Wednesday June 13 LEAD EXTRACTION CRT LEAD MANAGEMENT ADVANCES IN NONINVASIVE Organized by C. Kennergren – Göteborg, SWE ELECTROCARDIOLOGY (ISHNE) Wednesday June 13 Chairmen: W. Zareba, USA, S. Dubner, ARG, A.J. Moss, USA 14:00-15:30 14:00-15:30 Room 3.2 / Thalic - Level 3 / Les Muses Room 3.3 / Erato - Level 3 / Les MusesSESSION 52 SESSION 53LEAD MANAGEMENT QUESTIONS IN OPTIMIZING BENEFITSCo-Chair: OF CRTEpstein L. - Boston, USA / Bongiorni M.G. - Pisa, ITA Co-Chair: Moss A.J. - Rochester, USA / Haigney M. - Bethesda, USA14:00 n What Leads Should/Should Not Be RemovedAccording to EHRA and HRS Recommendations? 14:00 n CRT in RBBB Patients – Should We Abandon It?Deharo J. - Marseille, FRA 52/1 Zareba W. - Rochester, USA 53/114:20 n What Are the Present Results of Lead Extraction 14:20 n How Important Is the CRT Lead Location?in High, Medium and Low Volume Centers? Klein H. - Rochester, USA 53/2Pelargonio G. - Rome, ITA 52/2 14:40 n Optimizing AV and VV Interval in CRT Patients –14:40 n Management of Superfluous Leads; Should All Is It Needed?Superfluous Leads Be Extracted? Schuger C. - Detroit, USA 53/3Butter C. - Bernau, DEU 52/3 15:00 n CRT in Atrial Fibrillation Patients– Who and15:00 nManagement of Recalled Leads; What Leads in How?Which Patients Should and Should Not Be Extracted? Steinberg J. - New York, USA 53/4Birgersdotter Green U. - San Diego, USA 52/4 n Break / Visit of Exhibits n Break / Visit of Exhibits - 43 - www.cardiostim.com

Wednesday June 13Created by Jacques Mugica TRIALS INVASIVE ELECTROPHYSIOLOGY & The 8 Biennial Meeting on Clinical th ABLATION TECHNIQUES Trials in Cardiac Arrhythmias WORLD CONGRESS ON CATHETER ABLATION Chairmen: Waldo A.L. – Cleveland, USA, Chairmen: M. Scheinman - San Fransciso, USA, Camm A.J. – London, GBR, Prartt C. – Houston, USA M. O’Neill - London, GBR - V. Probst- Nantes, FRA - F. Sacher - Bordeaux-Pessac, FRA 14:00-15:30 14:00-15:30 Room 3.4 / Uranie - Level 3 / Les Muses Room 3.5 / Calliope - Level 3 / Les Muses SESSION 54 SESSION 55 CLINICAL TRIALS IN AF - INFLUENCE ATRIAL FIBRILLATION ABLATION II ON GUIDELINES - DISCUSSION AND Co-Chair: PERSPECTIVE Michaud G.F. - Boston, USA / Hindricks G. - Leipzig, DEU Chair: 14:00 n Newer Left Atrial Appendage Occlusion and Page R.L. - Seattle, USA Ligation Devices for Stroke Prevention: Should They Be Part of an Atrial Fibrillation Procedure? 14:00 n Ventricular Rate Control [Really RATE II in Lee R. - San Francisco, USA 55/1 perspective] van Gelder I. - Groningen, NLD 54/1 14:20 n Epicardial Ablation of Atrial Fibrillation Michaud G.F. - Boston, USA 55/2 14:30 Rhythm Control [includes prior Rate vs Rhythm n trials and dronedarone story] 14:40 n Catheter Ablation of Atrial Fibrillation Using a Saksena S. - Warren, USA 54/2 Non-Fluoroscopic Sensor Navigation Device Hindricks G. - Leipzig, DEU 55/3 15:00 n Devices (BiV pacemakers, ICDs, etc.) Daubert J.C. - Rennes, FRA 54/3 15:00 n Contact Monitoring and New Ablation Toys Wright M. - London, GBR 55/4 n Break / Visit of Exhibits n Break / Visit of Exhibits www.cardiostim.com - 44 -

Wednesday June 13 NON INVASIVE EP, CARDIAC PACING osters must remain on display from 14:00 to 17:30, but during the break your presence is required beside your poster P Wednesday June 13 14:00-17:30 Poster Area - Level 3 / Agora 3SESSION 56PNON INVASIVE EP, CARDIAC PACING n Head-Up Tilt Testing (hutt): Age and Gender Differences - 5 Years Experience at Fortis Escorts Heart Institute n Influence of Atrial Fibrillation into Singhal R., Jaswal A., Saxena A. - Delhi, IND 56P/8Cardiovascular Risk in Patients with Permanent CardiacPacing n Ventricular Arrhythmia Risk in Patients withMlynarska A., Mlynarski R., Pilat E., Wilczek J. - Katowice, POL Left Ventricular Hypertrophy: More than Just Wall 56P/1 Thickness Measurement. Dijkman B., Cramer M., Verkooijen H., Velthuis B. - n Long-Term Fish Oil Supplementation Attenuates Utrecht, NLD 56P/9Age-Related Increase in Atrial Tachyarrhythmia Burden inPatients >= 60 Yrs n Initial Experience with Remote Monitoring ofKumar S., Sutherland F., Stevenson I., Sparks P. - Implantable Loop RecordersMelbourne, AUS 56P/2 Fazal I., Bhardwaj R., Tynan M., Plummer C., Mccomb J. - Newcastle Upon Tyne, GBR 56P/10 n Abnormal Power Increase in Fractal Analysis ofHeart Rate Variability Is a Strong Predictor of Sleep Apnea n Chronic Atrioventricular Conduction DiseaseSyndrome after Acute EhrlichiosisFujimoto M., Ikeda T., Tsuchida M., Kiyama M., Okeie K., Uyguanco E., Walburg J. - Dix Hills, USA 56P/11Yamamoto M. - Takaoka, JPN 56P/3 n Invasive Assessment of Atrioventricular n Role of Autonomic Disbalance in Nonrheumatic Conduction Changes Following Transcatheter Aortic ValveAtrial Fibrillation Implantation with Self-Expandable or Balloon-ExpandableBarauskiene V., Martinkute E., Rumbinaite E. - Kaunas, LTU Prosthesis 56P/4 Rollin A., Dumonteil N., Mondoly P., Marcheix B., Duparc A., Boudou N., Lhermusier T., Tchetche D., Delay M., Maury P., n Development of Ventricular Tachycardias in Carrie D. - Toulouse, FRA 56P/12Patients with Repaired Congenital Heart DefectsRamdjan T., Theuns D., Delacretaz E., Yaksh A., Haitsma D., n Conduction Abnormalities and PacemakerSzili-Torok T., Witsenburg M., Jordaens L., Bogers A., De Groot Indications in Transcatheter Aortic Valve Implantation andN. - Rotterdam, NLD 56P/5 Their Long Term Follow Up. Single Center Experience. Aversa E., Cepeda S., Albornoz M., Muratore C., Payaslian n Mean Heart Rate and Rate Irregularity Versus M., Menendez C., Mazzetti H., Tentori M. - Buenos Aires, ARGData from Short-Term ECGs 56P/13Chudzik M., Cygankiewicz I., Klimczak A., Lewek J., Wranicz J.- Lodz, POL 56P/6 n HV Measurement in Intention to Treat: Variability and Implication n Left Atrial Appendage Morphology and Risk of Gourraud J., Evain S., Rendu E., Gras D., Daubert J., Dupuis J.,Stroke in Patients with AF: Is There a Link? Results from a Tassin A., Burban M., Cebron J., Leclercq C., Solnon A.,Multicenter Study Probst V., Mabo P., Lande G. - Nantes, FRA 56P/14Di Biase L., Santangeli P., Anselmino M., Mohanty P., SalvettiI., Gili S., Horton R., Sanchez J., Bai R., Mohanty S., Pump A.,Gallinghouse G., Burkhardt J., Cesarani F., Scaglione M., Gaita F.,Natale A. - Austin, USA 56P/7 - 45 - www.cardiostim.com

Wednesday June 13Created by Jacques Mugica NON INVASIVE EP, CARDIAC PACING osters must remain on display from 14:00 to 17:30, but during the break your presence is required beside your poster P 14:00-17:30 Poster Area - Level 3 / Agora 3 n Forces on Cardiac Implantable Electronic n The Clinical Implications of High Right Devices during Remote Magnetic Navigation Ventricular Pacing Burden in Pacemaker Patients Jilek C., Badran H., Stracke B., Semmler V., Lennerz C., Richards M., Faulknier B., Karlsson A., Mahmood I., Barnett C., Reents T., Ammar S., Fichtner S., Hessling G., Deisenhofer I., Thakur R. - Toledo, USA 56P/23 Kolb C. - München, DEU 56P/15 n Chads2 Score Predicts New Onset of AF in Multi Slice Computer Tomography in Patients n Pacemaker Patients - Results from Longitudinal Follow-Up with Cardiac Pacemakers: Do Endocardial Leads Limit in the Bradycare Trial Applicability of the Tool? Richards M., Barnett C., Faulknier B., Gustafsson J., Jarverud K., Burazor I., Perisic Z., Todorovic L., Burazor M., Lazovic M., Thakur R. - Toledo, USA 56P/24 Radovanovic Z., Bosnjakovic P., Ilic D., Kostic T., Cvetkovic P. - Nis, SRB 56P/16 n Pacemaker’s Patients Perception of Daily Life Activities and Medical Follow-Up: a French Survey n Incidence and Predictors of Pericardial Effusion Amara W., Cheggour S., Taieb J., Salih H., Ben Youssef I., after Permanent Heart Rhythm Device Implantation: Sagnol P., Gully C., Rabah N., Milhem A., Bonny A., Bru P. - Prospective Evaluation of 968 Consecutive Patients Montfermeil, FRA 56P/25 Ohlow M., Lauer B., Brunelli M., Geller J. - Bad Berka, DEU 56P/17 n Risk Factors for the Development of a Stenosis or Total Occlusion of Subclavian Vein or Superior Vena n Expression of Genes after Right Ventricular Cava in Patients Undergoing Pacemaker or Defibrillator Apical Pacing Implantations: Analysis of 362 Upper Limb Venograms Simantirakis E., Kontaraki I., Arkolaki E., Chrysostomakis S., Grove R., Kranig W., Wolff E., Imnadze G., Ziaukas V., Nyktari E., Patrianakos A., Vardas P. - Heraklion, GRC 56P/18 Warnecke H., Thale J. - Bad Rothenfelde, DEU 56P/26 n Pacemaker Implantation Influence in n High Prevalence of Amyloid Deposition in Unfavorable Way on Sexuality and Sexual Behaviors of Subcutaneous Fat Tissue in Patients with Bradyarrhythmia Women - Partners of Patients after Cardiac Pacemaker Omi W., Ikeda K., Hanaoka R., Takatori O., Saeki T., Kasashima Implantation S., Kawashima A., Sakagami S. - Kanazawa, JPN 56P/27 Mlynarska A., Mlynarski R., Sosnowski M., Wilczek J. - Katowice, POL 56P/19 n The Impact of Device Settings on Predicted Longevity of Dual Chamber Pacemakers: Data from a Large n Is Chronotropic Incompetance Overestimated? Unselected Bradycardia Registry Lessons from the Appropriate Study Benkemoun H., Sacrez J., Lagrange P., Amiel A., Prakash A., Giudici M., Chawla M., Paul D., Grantham T. - Davenport, USA Himmrich E., Aime E., Mairesse G., Guenon C., Sbragia P. - 56P/20 Perpignan, FRA 56P/28 n Rhythm Recovery in Patients with Permanent n Safer Nearly Eliminates Unnecessary Right Pacemaker after Cardiac Surgery Ventricular Pacing Regardless of Pacemaker Implant Ribeiro V., M Garcia R., Frutuoso C., Melao F., Araujo C., Indications Pinho P., Maciel M. - Porto, PRT 56P/21 Jauvert G., Hoffmann E., Dupuis J., Molon G., El Allaf D., Prades E., Davy J. - Paris, FRA 56P/29 n AF Diagnosed by Pacemakers & Defibrillators - Are We Paying Attention? Meldrum N., Jones M., Betts T. - Oxford, GBR 56P/22 www.cardiostim.com - 46 -

Wednesday June 13 NON INVASIVE EP, CARDIAC PACING osters must remain on display from 14:00 to 17:30, but during the break your presence is required beside your poster P Wednesday June 13 14:00-17:30 Poster Area - Level 3 / Agora 3 n Distribution of Intrinsic Atrio-Ventricular (av) n Lv Dyssynchrony Induction by Right VentricularDelay in a Broad Pacemaker Population with Sinus Node Apical Pacing Is Associated with Long-Term Poor OutcomeDysfunction or AV Block Hoke U., Auger D., Leong D., Ajmone Marsan N., Holman E.,Moreno J., Jauvert G., Hatala R., Butter C., Bode F., Schalij M., Bax J., Delgado V. - Leiden, NLD 56P/37Rodriguez J., Rolando M., Stockburger M. - Madrid, ESP 56P/30 n Left Ventricular Function and Synchrony after nComparison of Cumulative % of Ventricular Long Term His/ Para-His Vs. Right Ventricular Septal Pacing.Pacing between Right Atrial Septal Versus Appendage Kronborg M., Mortensen P., Poulsen S., Gerdes J., Jensen H.,Pacing in DDD Patients with Sinus Node Disease. Nielsen J. - Aarhus N, DNK 56P/38Watabe T., Abe H., Oginosawa Y., Kohno R., Otsuji Y. -Kitakyushu City, JPN 56P/31 n Comparison of Left Ventricular Function Using Equilibrium Radionuclide Angiography in Patients n Atrio-Ventricular Optimization in Patients with Paced from the Right Ventricular Outflow Tract and RightDDD Pacemaker with Lead in Rvot Ventricular Apex – a One-Year Follow up Study.Klimczak A., Chudzik M., Zielinska M., Lewek J., Wranicz J. - Sharma G., Singh H., Salahuddin S., Patel C., Roy A., Naik N.,Lodz, POL 56P/32 Juneja R., Bahl V. - New Delhi, IND 56P/39 n Ventricular Capture Surveillance Driven by the n The Fluoroscopic Left Anterior View PoorlyTvi Sensor Predicts Septal Position in Right Ventricular Outflow TractPizzimenti G., Lisi M., Doria G., Barbetta A., Di Gregorio F., Pacing - Validation with Cardiac CT AngiographyVasquez L., Lisi F., Felis S., Tempio D., Virgilio A., Calvi V. - Sharma G., Salahuddin S., Jagia P., Sharma S., Bahl V. -Milazzo Me, ITA 56P/33 New Delhi, IND 56P/40 n Proarrhythmic Effects by New Algorithm for n Long Term Safety and Efficacy of RightMinimizing Right Ventricular Pacing in Patients with Ventricular Permanent High Septal Pacing.Cardiac Dysfunction Occhetta E., Quirino G., Magnani A., Bortnik M., Francalacci G.,Hayashi H., Nakazato Y., Sekita G., Komatsu K., Daida H. - Baduena L., Pistelli P., Plebani L., Marino P. - Novara, ITA 56P/41Tokyo, JPN 56P/34 n Parahisian Versus Right Ventricular Apical Reduction of Ventricular Pacing by a Follow-Up n Cardiac Pacing in a Long Term Follow Up.Tool AV Advisor Occhetta E., Baduena L., Nappo R., Cavallino C., Di Ruocco V.,Bulava A., Bodky J., O_mera O., Sep_i M., Hoenen S., Bortnik M., Magnani A., Francalacci G., Plebani L., Marino P. -Lindovská M., Salbach P. - Ceske Budejovice, CZE 56P/35 Novara, ITA 56P/42 n Paced QRS Duration Predicts Long-Term n Comparing the Development of Mitral &Left Ventricular Function in Patients with Permanent Tricuspid Regurgitation between Right Ventricular ApexPacemakers – One-Year Follow-Up Study Using Equilibrium and Right Ventricular Outflow Tract PacingRadionuclide Angiography. Hemayat S., Oraii S., Roshanali F., Sami-Aldoboni A., Shafiee A.Sharma G., Singh S., Salahuddin S., Patel C., Singla S., Roy A., - Tehran, IRN 56P/43Naik N., Juneja R., Bahl V. - New Delhi, IND 56P/36 - 47 - www.cardiostim.com

Wednesday June 13Created by Jacques Mugica NON INVASIVE EP, CARDIAC PACING osters must remain on display from 14:00 to 17:30, but during the break your presence is required beside your poster P 14:00-17:30 Poster Area - Level 3 / Agora 3 n Evaluating Impact of Right Ventricular Apical n Use of a Novel Pacing Lead for Epymiocardial Versus Septal Pacing on Left Ventricular Dyssynchrony and Implantation Function Zambolim C., Costa R., Bueno S., Fiorelli M., Crevellari E., Khaled Nagi H., Atia I., Azab A., Hussein K., Abed N. - Silva K., Martinelli M., Tamaki W. - São Paulo, BRA 56P/52 Cairo, EGY 56P/44 n RF-Induced Change in Capture Thresholds: an The Distinction of Secure Lead Placement n In-Vivo Investigation Toward Inter Ventricular Septum in Patients Undergoing Shehada R., Klionsky L., Scott A., Hoberman K., Dietrich J., Pacemaker Implantation Williamson R., Dianaty A. - Sylmar, USA 56P/53 Suga C., Hirahara T., Sugawara Y., Nakajima J., Wakaba H., Ako J., Momomura S. - Saitama, JPN 56P/45 n MR-Conditional Leads: Heat Dissipation by Blood Flow n Myocardial Perforation in Cardiac Pacing Shehada R., More R., Rahbari S., Williamson R., Dianaty A. - Kirkfeldt R., Johansen J., Nohr E., Moller M., Arnsbo P., Sylmar, USA 56P/54 Nielsen J. - Aarhus N, DNK 56P/46 n MR-Conditional Pacemakers: In-Vitro Long-Term Effect of Steroid Elution on the n Assessment of the Vibrations Hazard to the Patient Electrical Performance of Coronary Sinus Leads for Cardiac Shehada R., More R., Imani R., Zhou W., Dietrich J., Resynchronization Therapy Williamson R., Dianaty A. - Sylmar, USA 56P/55 Landolina M., Gasparini M., Lunati M., Boriani G., Bianchi S., Padeletti L., Santini M., Savastano S., Vincenti A., Varbaro A., n Gradient-Induced Pulse Cancellation in Mri- Visconti G. - Pavia, ITA 56P/47 Conditional Pacing Systems Shehada R., Costandi P., Mouchawar G., Habibi H., Dietrich J., n Long-Term Reduction in Inappropriate Mode Rahbari S., Williamson R., Dianaty A. - Sylmar, USA 56P/56 Switches Utilizing Short-Spaced Bipolar Atrial Lead Design Compared to Conventional Atrial Leads n Effect of Body Type and Position on Tangential Hegwood E., Costeas C., Roelke M. - Newark, USA 56P/48 E-Fields in a 1.5t MRI RF Coil Sison S., Min X., Liu Y., Feng K., Chen J., Nyenhuis J., n Chronic Performance of 20,000 Optim Leads in Mouchawar G., Dietrich J. - Sunnyvale, USA 56P/57 14,000 Patients: Optimum Registry Greenberg S., Hamati F., Styperek R., Alonso J., Bolanos O., n Electrical Performances of a New Family of MRI Keeney J. - Rosyln, USA 56P/49 – Conditional Leads: the Solia® Leads. Belvito C., Bakhtadze N., Michelotti F., Lucca E., Merati F., n Endocardial Pacemakers in Pediatric Filippoli E., Gotti E., Rovai N., Mascioli G. - Bergamo, ITA 56P/58 Populations with Ultra Thin Catheters. Bochoeyer A., Rabinovich R., Arguello J., Rivarola M., n Displacement of Ventricular Pacemaker Lead Trentacoste L., Conejeros W., Grippo M. - Buenos Aires- after Magnetic Resonance Exposure: a Case Report Formosa, ARG 56P/50 Chaib A., Bouzelmat H., Kheyi J., Moustaghfir A. - Rabat, MAR 56P/59 n Programming of Antiarrhythmic Devices before Computed Tomography n Rf Heating Performance of Conditionally MRI Mlynarski R., Mlynarska A., Sosnowski M., Wilczek J. - Safe Systems in Gel Phantoms Katowice, POL 56P/51 Chen J., Liu Y. - Houston, USA 56P/60 www.cardiostim.com - 48 -

Wednesday June 13 NON INVASIVE EP, CARDIAC PACING osters must remain on display from 14:00 to 17:30, but during the break your presence is required beside your poster P Wednesday June 13 14:00-17:30 Poster Area - Level 3 / Agora 3 n Opsite® System for Occlusion of Pace Maker n Transvenous Removal of Pacing andOperative Site and Washing with Povidone Iodine. Results Defibrillating Leads: The Pisa Experience.of an Average 3 Years Monocentric Follow-Up Study. Bongiorni M., Soldati E., Segreti L., Zucchelli G., Di Cori A., Viani S.,Penot J., Lejeune N., Penot M., Jacquot C., Bonet J., Pochet H., Paperini L., De Lucia R., Levorato D., Boem A. - Pisa, ITA 56P/69Arbouin C., Weiss A., Fressonnet R., Jean S. -Saint Georges De Didonne, FRA 56P/61 n When Reimplantation Can Be Safely Deferred after Lead Extraction ?: A Single High Volume Centre Experience n Utility and Safety of Temporary Pacing Using Viani S., Soldati E., Zucchelli G., Di Cori A., Segreti L., PaperiniActive Fixation Leads and an Externally Placed Reusable L., De Lucia R., Bongiorni M. - Pisa, ITA 56P/70Permanent Pacemaker.Kawata H., Phan P., Mulpuru S., Patel J., Pretorius V., Feld G., n Percutaneous Lead Extraction Using theGreen B. - La Jolla, USA 56P/62 Evolution™ System: a Single Centre Experience. Mokrani B., Molin F., O’Hara G., Blier L., Champagne J., Sarrazin J., n Loss of Silicone Tubes during Transvenous Lead Nault I., Zannad N., Bartez O., Phillipon F. - Québec, CAN 56P/71Extraction, Value of EchocardiographyTomaszewski A., Kutarski A., Tomaszewski M., Brzozowski W. n Transvenous Extraction of 1668 Permanently- Lublin, POL 56P/63 Implanted Leads in 968 Pts. Using Mechanical Systems - Effectiveness and Complications Kutarski A., Czajkowski M., Pietura R. - Lublin, POL 56P/72 n Echocardiographic Diagnosis of TricuspidPapillary Muscle Injury after Transvenous Lead ExtractionTomaszewski A., Kutarski A., Tomaszewski M., Brzozowski W. n Cardiac Device Endocarditis with Infected Vegetations: a Single-Center Experience and Consequences- Lublin, POL 56P/64 of Transvenous Extraction Nagashima M., Goya M., Soga Y., Andou K., Makihara Y., n Vacuum Assisted Closure as a Method of An Y., Nobuyoshi M. - Kitakyushu, JPN 56P/73Support of Pacemaker/icd Late Wound Healing.Pilat E., Mlynarski R., Mlynarska A., Wilczek J. - Katowice, POL n The Needles Eye Snare as a Primary Tool for 56P/65 Pacing Lead Extraction Bracke F., Van Gelder B., Dekker L. - Eindhoven, NLD 56P/74 n Lead Extraction – Growing Problem in Childrenwith Endocardial Pacing n Are We Downsizing Pacing/icd Leads in Vain?Bieganowska K., Miszczak-Knecht M., Kaszuba A., Brzezinska- A Venous Occlusion Study of 115 Consecutive PatientsPaszke M., Rekawek J., Birbach M., Lipinski W., Daszkowska- Giudici M., Fortin D., Crowley A., Stevens C., Paul D., Sloane C.,York J., Kutarski A. - Warsaw, POL 56P/66 Babka D., Heacock A., Lorenz T., Cousins L., Vanwhy K., Foreman B. - Davenport, USA 56P/75 n The Benefits of Nuclear Imaging Techniques inSupporting the Controversial Diagnosis of Cardiovascular n Transvenous Removal of Malfunctioning ICDImplantable Electronic Devices Infections Leads: Results and Complications in the Pisa Experience.Golzio P., Vinci M., Pelissero E., Fanelli A., Gaita F. - Segreti L., Soldati E., Di Cori A., Zucchelli G., Viani S., Paperini L.,Torino, ITA 56P/67 De Lucia R., Levorato D., Boem A., Bongiorni M. - Pisa, ITA 56P/76 n Initial Experience in Transvenous Lead n Lead Extraction with Cook Evolution System:Extraction with Evolution Mechanical Dilator Sheath Two Years ExperienceMazzone P., Ciconte G., Marzi A., Paglino G., Bellini B., González Villegas E., Razzo O., Ramirez Valdiris U., Sartor L., SánchezPetracca F., Vergara P., Gulletta S., Della Bella P. - Milan, ITA Caravaca R., Mesa García J., Silvestre García J. - Madrid, ESP 56P/77 56P/68 n End - 49 - www.cardiostim.com

Wednesday June 13Created by Jacques Mugica BASIC ELECTROPHYSIOLOGY ICD THERAPY Chairman: D. Zipes - Indianapolis, USA European Heart Rhythm Association «FORTY YEARS OF GROUND-BREAKING CONCEPTS IN (EHRA) Program CARDIAC ELECTROPHYSIOLOGY» Organized by EUROPACE Program Committee Chairman: A. Goette - Magdeburg, DEU 16:00-17:30 16:00-17:30 Room 2.1 / Hermes - Level 2 / Rhodes Room 2.3 / Athena - Level 2 / Rhodes SESSION 61 SESSION 62 CARDIAC ION CHANNELS AND ICD THERAPY IN YEAR 2012 MACROMOLECULAR COMPLEXES IN Co-Chair: HEALTH AND DISEASE Garrigue S. - Bordeaux, FRA / Svendsen J.H. - Copenhagen, DNK Co-Chair: 16:00 n Defibrillation Testing during Implant: To Do or Fishman G.I. - New York, USA / Fedorov V. - St.Louis, USA Not to Do? Bänsch D. - Rostock, DEU 62/1 16:00 n Macromolecular Complexes and the Control of Cardiac Ion Channel Expression and Distribution 16:20 n How to Reduce Inappropriate Shock Therapy Abriel H. - Bern, CHE 61/1 Wolpert C. - Ludwigsburg, DEU 62/2 16:20 n Intercalated Disc as a Macromolecular Complex 16:40 n Reliability of Implantable Devices and Leads - Niche and Its Role in ARVC Are They Good Enough? Delmar M. - New York, USA 61/2 Steinhaus D. - Minneapolis, USA 62/3 16:40 n MAGUK Proteins Are Important in Ion Channel 17:00 n How Should We Program Tachy Parameters in Diseases ICDs? Jalife J. - Ann Arbor, USA 61/3 Zupan I. - Ljubljana, SVN 62/4 17:00 n What Are the Clinical Implications? n End Coronel R. - Amsterdam, NLD 61/4 17:20 n General Discussion n End www.cardiostim.com - 50 -

Wednesday June 13 ABLATION PACING Wednesday June 13 16:00-17:30 16:00-17:30 Room 2.4 - Level 2 / Gallieni Room 2.6 - Level 2 / GallieniSESSION 63 SESSION 64OUTCOME AFTER VT ABLATION CONVENTIONAL PACING: CLINICALCo-Chair: INDICATIONS AND PROGRAMMINGWissner E. - Hamburg, DEU / Shivkumar K. - Los Angeles, USA Co-Chair: Fischer W. - Peissenberg, DEU / Sutton R. - Monaco, MCO16:00 n Outcomes of Ventricular Tachycardia Ablationin Patients with Non-Ischemic Cardiomyopathy and 16:00 n System Upgrade in Patients with a Single LeadAnalysis of Procedural Failure Atrial (aair) PacemakerPiers S., Leong D., Van Huls Van Taxis C., Tayyebi M., Trines S., Kirkfeldt R., Andersen H., Nielsen J., On Behalf Of The DanpaceDelgado V., Schalij M., Zeppenfeld K. - Leiden, NLD 63/1 Investigators - Aarhus N, DNK 64/116:15 n Catheter Ablation of Ventricular Tachycardias 16:15 n Prognostic Value of Prolonged HV Interval inUsing Remote Magnetic Navigation: A Consecutive Case- AV Block: the Evocav StudyControl Study Gourraud J., Gras D., Mabo P., Dupuis J., Tassin A., Burban M.,Akca F., Schwagten B., Bauernfeind T., Dabiri Abkenari L., Probst V., Leclercq C., Solnon A., Cebron J., Daubert J.,Haitsma D., Van Belle Y., De Groot N., Jordaens L., Szili-Torok T. - Lande G. - Nantes, FRA 64/2Rotterdam, NLD 63/2 16:30 n Efficacy of Permanent Pacing with Closed Loop16:30 Comparison of Late Potentials Ablation Versus n Stimulation in Patients with Neurocardiogenic SyncopeScar Encircling for Ventricular Tachycardia Ablation Prakash A., Thirukkonda P., Moen D., Khare V., Parikh N.,Vergara P., Petracca F., Bellini B., Trevisi N., Bisceglia C., Baratto F., Eklund J. - Cedar Grove, USA 64/3Mazzone P., Maccabelli G., Della Bella P. - Milano, ITA 63/3 16:45 n Hemodynamic Effects of Atrio-Ventricular Delay16:45 nScar Dechanneling in Ischemic Cardiomyopathy Programming Assessed by Three Noninvasive Indices ofFernández-Armenta J., Berruezo A., Mont L., Andreu D., Cardiac PerformanceTrucco E., Evertz R., Matas M., Tolosana J., Arbelo E., Brugada J. - Chirife R., Ruiz A., Gayet E., Muratore C., Mazzetti H.,Barcelona, ESP 63/4 Sambelashvili A., Pelegrino A., Tentori C. - Buenos Aires, ARG 64/417:00 n Displacement of the Target Ablation Site andVentricles during Premature Ventricular Contractions: 17:00 n Pacemaker Lead Perforation: ClinicalRelevance for Ventricular Tachycardia Ablation. Presentation and Risk ProfileAndreu D., Berruezo A., Fernández-Armenta J., Herczku C., Stockburger M., Lembcke A., Schulze C., Baumann G.,Borràs R., Ortiz J., Mont L., Brugada J. - Barcelona, ESP 63/5 Melzer C. - Berlin, DEU 64/517:15 n Primary Prevention of Sudden Death in 17:15 n Epicardial Ganglionated Plexus Stimulationa Nonischemic Dilated Cardiomyopathy Population. Decreases Post-Operative Inflammatory Response inReappraisal of the Role of Programmed Ventricular HumansStimulation. Rossi P., Ricci A., De Paulis R., Papi E., Pavaci H., Porcelli D.,Vouliotis A., Gatzoulis K., Tsiachris D., Archontakis S., Monari G., Maselli D., Bellisario A., Turani F., Nardella S.,Gialernios T., Karystinos G., Dilaveris P., Sideris S., Kallikazaros I., Azzolini P., Piccirillo G., Quaglione R., Valsecchi S., Bianchi S. -Stefanadis C. - Athens, GRC 63/6 Rome, ITA 64/6 n End n End - 51 - www.cardiostim.com

Wednesday June 13Created by Jacques Mugica ABLATION TECHNIQUES MISCELLANEOUS 16:00-17:30 16:00-17:30 Room 1.1 - Level 1 / Méditerranée Room 1.2 - Level 1 / Méditerranée SESSION 65 SESSION 66 EMERGING LEADERS IN ARRHYTHMIA IN ME: FROM INCIDENCE TO ELECTROPHYSIOLOGY: CASE SOLUTION PRESENTATION AND DISCUSSION Co-Chair: Co-Chair: Al-Fagih A. - SAU / Curnis A. - Brescia, ITA Prystowsky E.N. - Indianapolis, USA / Schalij M. - Leiden, NLD 16:00 n The Evolving Landscape of Electrophysiology Faculty n Services: Challenges and Opportunities Schalij M. - Leiden, NLD 65/1 Alsheikh-Ali A. - Abu Dhabi, SAU 66/1 Priori S. - Pavia, ITA 65/2 Borggrefe M. - Mannheim, DEU 65/3 16:20 n Pacemaker Evolution: From Standard VVI to MRI Compatible 16:00 n Case report 1 Khoury M. - Beirut, LBN 66/2 Bianchi S. - Roma, ITA 65/4 16:40 n What’s New in CRT: The Other Two Electrodes 16:20 Case report 2n Sweidan R. - Jeddah, SAU 66/3 Thomas D. - Heidelberg, DEU 65/5 17:00 n Afib Ablation: Usage of Different Technology 16:40 Case report 3 n for Complex Arrhythmia Duparc A. - Toulouse, FRA 65/6 Aslan O. - Izmir, TUR 66/4 17:00 n Case report 4 n End Brown B. - Manchester, GBR 65/7 Session made possible thanks to an educational grant from n End ST JUDE MEDICAL Session made possible thanks to an educational grant from MEDTRONIC www.cardiostim.com - 52 -

Wednesday June 13 LEADS DEVICES PACING & ICD LEADS Chair: J. Helland - Sylmar, USA Wednesday June 13 16:00-17:30 16:00-17:30 Room 1.3 - Level 1 / Méditerranée Room 1.4 - Level 1 / MéditerranéeSESSION 67 SESSION 68WHAT ARE PHYSICIANS LEARNING THAT SHORT HIGH IMPACT PRESENTATIONSNEEDS IMPROVEMENT IN CARDIAC LEADS? Co-Chair: Lazarus A. - St Cloud, FRA / Lenarczyk R. - Zabrze, POLCo-Chair:Helland J.R. - Sylmar, USA / Kennergren C. - Göteborg, SWE 16:00 n Breast Cancer and Pacemaker Implantation Mazzetti H., Tentori M. - Buenos Aires, ARG 68/116:00 n Multi-Electrode LV Leads: What Should the 16:10 n Device Acceptance Is Greater in FemaleElectrode Spacing Be and Why? Implantable Cardioverter Defibrillator Recipients withThibault B. - Montréal, CAN 67/1 Submammary Implant Technique Giudici M., Vasquez L., Paul D., Sloane C., Krupa R.,16:15 n When Transvenous LV Leads Won’t Work – EP Meierbachtol C., Conti J., Sears S. - Davenport, USA 68/2Implantation of Cardiac Leads in the Pericardial SpaceJaïs P. - Bordeaux, FRA 67/2 16:20 n Revision Interventions in Pacemaker and ICD Patients in Presence of Severe Stenosis or Occlusion of V. Subclavia and/or V. Cava Superior16:30 n What Improvements Are Needed in Lead Grove R., Kranig W., Wolff E., Imnadze G., Thale J., Ziaukas V.,Design and Materials to Reduce Patient Risk and Increase Warnecke H. - Bad Rothenfelde, DEU 68/3Reliability of Successful Extractions?Schaerf R. - Burbank, USA 67/3 16:30 n RV Septal Pacing Driven by Endocardial Mapping Pastore G., Aggio S., Baracca E., Zanon F., Carraro M., Conte L.,16:45 n What Is the Proper Way to Place the Device & Roncon L. - Rovigo, ITA 68/4Lead in the Pocket and to Anchor Lead Suture Sleeves andWhat Is Needed for the Future? 16:40 n Optimization of Biventricular Pacing Using Vectorcardiography in DogsSkehan J. - Leicester, GBR 67/4 Van Deursen C., Strik M., Rademakers L., Van Hunnik A., Kuiper M., Wecke L., Crijns H., Vernooy K., Prinzen F. - Maastricht, NLD 68/517:00 n What Does a Physician Need to Consider WhenUsing MRI Safe Systems Regarding Lead Abandonment vs 16:50 n Defibrillation Thresholds with Right PectoralExtraction? ICDs: Impact of Waveform TuningBongiorni M. - Pisa, ITA 67/5 Varma N., Schaerf R., Kalbfleisch S., Pimentel R., Cranke G., Oza A. - Cleveland, USA 68/6 n End 17:00 n Defibrillation Thresholds with Mid-Septal Versus Apical Right Ventricular Electrodes Kolb C., Asbach S., Solzbach U., Lemke B., Klein N., Andrikopoulos G., Tzeis A., Semmler V., Lennerz C. - München, DEU 68/7 17:10 n Electrophysiological Similarities in Left Ventricular and Biventricular Pacing Strik M., Van Deursen C., Van Middendorp L., Van Hunnik A., Kuiper M., Auricchio A., Prinzen F. - Maastricht, NLD 68/8 17:20 n A Simple Method to Implant Epicardial Aicd Using Two Separated Coils Hidden-Lucet F., D’Alessandro C., Duthoit G., Himbert C., Pavie A., Komajda M. - Paris, FRA 68/9 n End - 53 - www.cardiostim.com

Wednesday June 13Created by Jacques Mugica CRT ABLATION TECHNIQUES Course Directors: D. Hayes - Rochester, USA/ P. Ritter- Bordeaux, European Heart Rhythm Association FRA/ D.S. Cannom - Los Angeles, USA/ J. Singh - Boston, USA/ F. (EHRA) Program Abi-Samra - New Orleans, USA Organized by EUROPACE Program Committee Chairman: A. Goette - Magdeburg, DEU 16:00-17:30 16:00-17:30 Room 1.6 / Iris - Level 1 / Méditerranée Room 3.1 / Clio - Level 3 / Les Muses SESSION 70 SESSION 71 TECHNIQUES FOR LV LEAD PLACEMENT STATE-OF-THE ART ON VENTRICULAR Co-Chair: TACHYCARDIA ABLATION Gras D. - Nantes, FRA / Belott P.H. - El Cajon, USA Co-Chair: De Chillou C. - Nancy, FRA / Wellens H.J. - Maastricht, NLD 16:00 n Balloon Anchoring Cha Y. - Rochester, USA 70/1 16:00 n Endocardial Catheter Ablation of Monomorphic VT: From Bench to EP Lab 16:20 n Coronary Venoplasty Atie J. - Rio do Janeiro, BRA 71/1 Worley S. - Lancaster, USA 70/2 16:20 n Epicardial Approach: A First Line Therapy? 16:40 Snares n Della Bella P. - Milan, ITA 71/2 Worley S. - Lancaster, USA 70/3 16:40 n New Mapping and Ablation Strategies 17:00 Transeptal n for Catheter Ablation of VT in Patients with Dilated Bordachar P. - Bordeaux, FRA 70/4 Cardiomyopathies Piorkowski C. - Leipzig, DEU 71/3 n End 17:00 n Combined Ablation Endo-Epicardial Approach for VT Ablation Kottkamp H. - Zurich, CHE 71/4 n End www.cardiostim.com - 54 -

Wednesday June 13 SUDDEN CARDIAC DEATH NONINVASIVE INTERNATIONAL SYMPOSIUM ON HIGH ELECTROCARDIOLOGY RESOLUTION ECG AND NONINVASIVE ADVANCES IN NONINVASIVE Wednesday June 13 ELECTROPHYSIOLOGY ELECTROCARDIOLOGY (ISHNE) Organized by Chairmen: W. Zareba, USA, S. Dubner, ARG, A.J. Moss, USA El.Sherif N. - Brooklyn, USA & Turitto G. - New York City, USA Sudden Cardiac Death. From Molecular Biology to Clinical Management, an Unfinished Odyssey 16:00-17:30 16:00-17:30 Room 3.2 - Level 3 / Les Muses Room 3.3 / Erato - Level 3 / Les MusesSESSION 72 SESSION 73CASE#1: 65 y/o male, h/o ASWMI; s/p CHALLENGING ECG DIAGNOSISCABGx3, 5 weeks ago; LVEF=38%, Co-Chair:presents with a recent syncopal Dubner S. - Buenos Aires, ARG / Steinberg J. - New York, USAepisode 16:00 n Presentation and Interpretation of ChallengingCo-Chair: ECG TracingsEl-Sherif N. - Brooklyn, USA Dubner S. - Buenos Aires, ARG 73/1 Steinberg J. - New York, USA 73/211:00 n Post-MI Remodeling; Molecular and Piotrowicz R. - Warsaw, POL 73/3Electrophysiological SubstratesEl-Sherif N. - Brooklyn, USA 72/1 n End11:20 n Are Noninvasive Risk Stratification of Post-MIPatients Still RelevantLa Rovere M. - Pavia, ITA 72/211:40 n How to Risk Stratify SCD in Post-MI Patientswith LVEF>35%Turitto G. - Brooklyn, USA 72/312:00 n Panel consensus: How To Best Manage ThisPatient n End - 55 - www.cardiostim.com

Wednesday June 13Created by Jacques Mugica TRIALS INVASIVE ELECTROPHYSIOLOGY & The 8 Biennial Meeting on Clinical th ABLATION TECHNIQUES Trials in Cardiac Arrhythmias WORLD CONGRESS ON CATHETER ABLATION Chairmen: Waldo A.L. – Cleveland, USA, Chairmen: M. Scheinman - San Fransciso, USA, Camm A.J. – London, GBR, Prartt C. – Houston, USA M. O’Neill - London, GBR - V. Probst- Nantes, FRA - F. Sacher - Bordeaux-Pessac, FRA 16:00-17:30 16:00-17:30 Room 3.4 / Uranie - Level 3 / Les Muses Room 3.5 / Calliope - Level 3 / Les Muses SESSION 74 SESSION 75 AF ABLATION TRIALS ATRIAL FIBRILLATION ABLATION III Co-Chair: Co-Chair: Page R.L. - Seattle, USA Ellenbogen K. - Richmond, USA / O’Neill M. - London, GBR 16:00 n Late Follow-Up – Efficacy and Safety 16:00 n Cryo Balloon Ablation of AF Kuck K. - Hamburg, DEU 74/1 Ellenbogen K. - Richmond, USA 75/1 16:30 n Ongoing Trials (EAST, CASTLE AF, CABANA, 16:20 n Patients Selection for AF Ablation Others) O’Neill M. - London, GBR 75/2 Arruda M. - Case Western, USA 74/2 16:40 n How to Identify Targets and End-Points for 17:00 Ablation in Heart Failure n Atrial Fibrillation Ablation? Jaïs P. - Bordeaux, FRA 74/3 Asirvatham S. - Rochester, USA 75/3 n End 17:00 n Long-Term Outcome for Atrial Fibrillation Ablation Weerasooriya R. - Perth, AUS 75/4 n End www.cardiostim.com - 56 -

Scientific Contents Thursday June 14 Thursday June 14 Sessions 81 to 155 page 61 to 103 Created by Jacques Mugica - 57 - www.cardiostim.com

Thursday June 14 Medtronic Room 2.9 Gallieni Level Visit the TechVillage and discuss with experts . The Next Generation Cryo Technology . The Next Generation Phased RF Technology . The Next Generation Cardiac Monitors . Medtronic - Leading in Leads Opening Hours: Wednesday June 13 to Friday June 15 From 9:00 to 17:00 Please contact your Medtronic representative to register in advance or directly at the welcome desk! www.cardiostim.com - 58 -

Today, the traditional lines of programs go on. Other prepared programs will be helduntil tonight: • etal Cardiology - Room 2.4 F • ediatric Cardiology - Room 2.6 P • CAF, on the management of AF - Room 1.3 A • eriatric Cardiology - Room 1.4 G • ession on ICE, and high-tech topics - Room 1.5 S • ead extraction and CRT - Room 1.6 L • udden Cardiac Death - Room 3.2 S Thursday June 14 • CD therapy - Room 3.4 IIndustry symposia will be the followingAt 9:00 am: • ardioInsight Technologies, room 1.1: Rapid Mapping and CRT Optimization with C Non-Invasive 3D Electrocardiography: A New Era! • aint Jude Medical, room 1.2: State of the Art HF Management: From Implant to S Long-Term Follow-Up.At 11:00 am: • ameron Health, room 1.1: The Subcutaneous ICD. C • edtronic, room 1.2: How to Increase CRT Response? MAt 2:00 pm: • iotronik, room 1.1: New Advances for Patients with Atrial Fibrillation. B • edtronic, room 1.2: Pulmonary Vein Isolation: The Cornerstone of Atrial Fibrillation M Ablation.At 4:00 pm: • aint Jude Medical, room 1.1: Everything and MRI: Is It for Everybody? S • orin, room 1.2: The Importance of CRT Optimization in Daily Life: Addressing the S Changing Patient Need. i Don’t forget to visit the Poster area in Agora 3, level 3! Please think about switching off your cell phone. If your phone rings during sessions, it really disturbs the speakers, thank you for them. Preview Room is at level 2, Gallieni level, close to room 2.4. Scientific Secretariat is at level 2, close to room 2.1 Hermès. - 59 - www.cardiostim.com

Thursday June 14 BASIC ELECTROPHYSIOLOGY STROKE Chairman: D. Zipes – Indianapolis, USA European Heart Rhythm Association «FORTY YEARS OF GROUND-BREAKING CONCEPTS (EHRA) Program IN CARDIAC ELECTROPHYSIOLOGY» Organized by EUROPACE Program Committee Chairman: A. Goette - Magdeburg, DEU 09:00-10:30 09:00-10:30 Thursday June 14 Room 2.1 / Hermes - Level 2 / Rhodes Room 2.3 / Athena - Level 2 / RhodesSESSION 81 SESSION 82CONTRIBUTION OF GENETICS TO STROKE PREVENTION IN ATRIALUNDERSTANDING MECHANISMS AND RISK FIBRILLATION - STATE-OF-THE ART ANDCo-Chair: NEW CONCEPTSSanders P. - Adelaide, AUS / Lazzara R. - Oklahoma City, USA Co-Chair: Camm A.J. - London, GBR / Rasmussen L.H. - Aalborg, DNK09:00 n Experimental Models to Explain InheritedDiseases 09:00 n Basic Science Insights into the ProthromboticAntzelevitch C. - Utica, USA 81/1 State in Atrial Fibrillation De Caterina R. - Chieti, ITA 82/109:20 n Cardiac Pathology to Explain PhenotypeBasso C. - Padova, ITA 81/2 09:20 n Clinical Trial Update - What Do the RELY, ROCKET, ARISTOTLE and AVERROES Trials Tell Us?09:40 n Cellular Electrophysiology to Explain Clinical Lip G. - Birmingham, GBR 82/2PhenotypesNapolitano C. - Pavia, ITA 81/3 09:40 n Does Aspirin Still Have a Role in Atrial Fibrillation?10:00 n What Are the Clinical Implications? Grond M. - Berlin, DEU 82/3Moss A. - Rochester, USA 81/4 10:00 n What Should the New Guideline Revisions on10:20 n General Discussion Stroke Prevention Look Like? Kirchhof P. - Münster, DEU 82/4 n Break / Visit of Exhibits n Break / Visit of Exhibits - 61 - www.cardiostim.com

Thursday June 14Created by Jacques Mugica ACUTE CARDIAC CARE PEDIATRIC CARDIOLOGY in cooperation with the WG on Acute Organized by Thambo J.B. - Bordeaux, FRA, Cardiac Care of the ESC Alice Maltret - Paris, FRA, Paul Khairy - Montreal, CAN, Georgia Brugada - Barcelona, ESP Chairmen: Vrints C. - Edegem, BEL / Gorenek B. - Eskisehir, TUR 09:00-10:30 09:00-10:30 Room 2.4 - Level 2 / Gallieni Room 2.6 - Level 2 / Gallieni SESSION 83 SESSION 84 ARRHYTHMIAS IN ACUTE CARDIAC CARE PITTFALLS AND PEARLS… SETTING Co-Chair: Co-Chair: Maltret A. - Paris, FRA / Derval N. - Bordeaux, FRA Vrints C. - Edegem, BEL / Danchin N. - Paris, FRA 09:00 n WPW and Supraventricular Tachycardia 09:00 n Acute Arrhythmias in Adult Congenital Heart Ernst S. - London, GBR 84/1 Disease Price S. - London, GBR 83/1 09:30 n Arrhythmias and Grown-Ups with Congenital Heart Defect 09:20 n Atrial Fibrillation in Patients with Acute MI; Hebe J. - Bremen, DEU 84/2 Prognostic Impact and Treatment Options Zeymer U. - Ludwigshafen, DEU 83/2 10:00 n Abnormal EKG or Not Derval N. - Bordeaux, FRA 84/3 09:40 Atrial Fibrillation in Acute Heart Failure n Vrints C. - Edegem, BEL 83/3 n Break / Visit of Exhibits 10:00 n Electrical Storm in Patients with ICD Santini M. - Rome, ITA 83/4 n Break / Visit of Exhibits www.cardiostim.com - 62 -

Thursday June 14 ABLATION TECHNIQUES & CRT CRT 09:00-10:30 09:00-10:30 Thursday June 14 Room 1.1 - Level 1 / Méditerranée Room 1.2 - Level 1 / MéditerranéeSESSION 85 SESSION 86RAPID MAPPING AND CRT STATE OF THE ART HF MANAGEMENT: FROMOPTIMIZATION WITH NONINVASIVE 3D IMPLANT TO LONG-TERM FOLLOW-UPELECTROCARDIOGRAPHY: A NEW ERA! Co-Chair:Co-Chair: Thibault B. - Montréal, CAN / Leclercq C. - Rennes, FRAHaïssaguerre M. - Bordeaux, FRA / Singh J. - Boston, USA 09:00 n The Future of CRT Therapy : Addressing09:00 nAccurate Single Beat Mapping and Ablation of Common Pacing Complications and Minimizing FluoroPremature Ventricular Beats ExposureKanagaratnam P. - London, GBR 85/1 Bongiorni M. - Pisa, ITA 86/109:20 n Rapid Mapping of Focal Ventricular 09:20 n Improving CRT Response : Optimizing CRTArrhythmias – A Prospective Multi-Centric Evaluation Pacing and Assessment of Multipoint PacingNeumann T. - Bad Nauheim, DEU 85/2 Gutleben K. - Bad Oeynhausen, DEU 86/209:40 n Electrical Synchrony: A Powerful Tool for 09:40 n Experience with Quadripolar Technology (CaseSelection, Implantation and Optimization of CRT Reports)Ritter P. - Bordeaux, FRA 85/3 Gras D. - Nantes, FRA 86/310:00 n Clinical Validation of Noninvasive 10:00 n Advancement of HF Management : On theElectrocardiographic Mapping of Arrhythmias: A Multi- Cutting EdgeCenter Experience Zaidi A. - Manchester, GBR 86/4Lindsay B. - Cleveland, USA 85/4 n Break / Visit of Exhibits n Break / Visit of Exhibits Session made possible thanks to an educational grant fromSession made possible thanks to an educational grant from ST JUDE MEDICALCARDIOINSIGHT TECHNOLOGIES - 63 - www.cardiostim.com

Thursday June 14Created by Jacques Mugica NON INVASIVE SYNCOPE ELECTROPHYSIOLOGY GERIATRIC CARDIOLOGY THERAPIES FOR ATRIAL FIBRILLATION Organized by Win K. Shen – Rochester, USA, ADVANCES AND CONTROVERSIES Ronald E. Vlietstra – Lakeland, USA IN ATRIAL FIBRILLATION (A.C.A.F) Special Concerns for Your Elderly Patient: A Case-Based Interactive Program Chairmen: G. V. Naccarelli - Hershey, USA, J.J. Blanc - Brest, France, S. Lévy – Marseille, France 09:00-10:30 09:00-10:30 Room 1.3 - Level 1 / Méditerranée Room 1.4 - Level 1 / Méditerranée SESSION 87 SESSION 88 ATRIAL FIBRILLATION I FAINTING AND FALLS: HOW CAN WE Co-Chair: MAINTAIN THE UPRIGHT POSITION AS WE Naccarelli G.V. - Hershey, USA / Boriani G. - Bologna, ITA GET OLDER? Co-Chair: 09:00 n Early Attempts at Rhythm Control Slows Benditt D.G. - Minneapolis, USA / Raviele A. - Venice, ITA Progression of AF Crijns H. - Maastricht, NLD 87/1 09:00 n State of the Art Lecture: Aging and Autonomic Regulation: Physiology and Clinical 09:30 n Has Basic Science Helped Us Develop Better Relevance Pharmacologic and Ablative Therapies for AF Low P. - Rochester, USA 88/1 Allessie M. - Maastricht, NLD 87/2 10:00 n Upstream Therapy of AF – Is It All over but the 09:20 n Case 1: 84 yr W, Diabetic w/ Parkinson’s & recurrent syncope Shouting? Schondorf R. - Montreal, CAN 88/2 Dorian P. - Toronto, CAN 87/3 n Break / Visit of Exhibits 09:40 n Case 2: 88 yr M, dementia, LBBB, 1 year H/O recurrent syncope Unrestricted Educational Support: sanofi aventis Parry S. - Newcastle Upon Tyne, GBR 88/3 10:00 n Case 3: 87 yr M, anemia, EF 30%, palpitations & near syncope x 2 Mc Leod C. - Rochester, USA 88/4 n Break / Visit of Exhibits www.cardiostim.com - 64 -

Thursday June 14 IMAGING TECHNIQUES LEAD EXTRACTION IMAGING SYMPOSIUM ICE LEAD MANAGEMENT Organized by S. Saksena - Warren, USA Organized by C. Kennergren – Göteborg, SWE 09:00-10:30 09:00-10:30 Thursday June 14 Room 1.5 - Level 1 / Méditerranée Room 1.6 - Level 1 / MéditerranéeSESSION 89 SESSION 90INNOVATIONS IN INTRACARDIAC CIED PATIENT INFECTIONECHOCARDIOGRAPHY: NOVEL Co-Chair:APPLICATIONS AND EVIDENCE BASED Wilkoff B.L. - Cleverland, USA / Neuzil P. - Prague, CZEEVALUATION 09:00 n Categories, Incidences, Causes and OutcomesCo-Chair: Bracke F. - Eindhoven, NLD 90/1Saksena S. - Warren, USA / Kusumoto F. - Rochester, USA 09:20 n Diagnosis, Pharmacological Treatment and09:00 n Importance and Limitations of Imaging Timing of ExtractionTechniques in Left Ventricular Lead Placement For Cardiac Burger H. - Bad Nauheim, DEU 90/2ResynchronizationDesai M. - Cleveland, USA 89/1 09:40 n Transvenous Extraction, Surgical Extraction and Local Revision09:15 n Advances in ICE Based Analyses of Left Fischer A. - New York, USA 90/3Ventricular FunctionDi Biase L. - Austin, USA 89/2 10:00 n Timing of Re-Implantation and Treatment of PM Dependent09:30 n ICE Guided CRT: Design and Implications of an Defaye P. - Grenoble, FRA 90/4Evidence Based Approach – The CHOICE StudySaksena S. - Warren, USA 89/3 n Break / Visit of Exhibits09:45 n Left Atrium and Appendage Imaging with ICE:Technologic Advances and Unconventional ApproachesLiu C. - New York, USA 89/410:00 n ICE Guided Cardioversion: Are We Ready forClinical Trials?Jordaens L. - Rotterdam, NLD 89/5 n Break / Visit of Exhibits - 65 - www.cardiostim.com

Thursday June 14Created by Jacques Mugica SUDDEN CARDIAC DEATH & CRT ABLATION TECHNIQUES INTERNATIONAL SYMPOSIUM ON HIGH European Heart Rhythm Association RESOLUTION ECG AND NONINVASIVE (EHRA) Program ELECTROPHYSIOLOGY Organized by EUROPACE Program Committee Chairman: Organized by A. Goette - Magdeburg, DEU El.Sherif N. - Brooklyn, USA & Turitto G. - New York City, USA Sudden Cardiac Death. From Molecular Biology to Clinical Management, an Unfinished Odyssey 09:00-10:30 09:00-10:30 Room 3.1 / Clio - Level 3 / Les Muses Room 3.2 - Level 3 / Les Muses SESSION 91 SESSION 92 PREVENTING SUDDEN CARDIAC DEATH CASE#2: 54 y/o female with no cardiac WITH RF ABLATION risk factors presents with CHF, Co-Chair: LVEF=25%, and LBBB Sacher F. - Bordeaux, FRA / Mont L. - Barcelona, ESP Co-Chair: Turitto G. - Brooklyn, USA 09:00 n Mapping and Ablation of Idiopathic Ventricular Fibrillation 09:00 n Molecular Biology and Pathophysiology of Non- Sacher F. - Bordeaux, FRA 91/1 Ischemic Cardiomyopathy Corrado D. - Padova, ITA 92/1 09:20 n Prevention of VF Episodes in Brugada Syndrome by Catheter Ablation 09:20 n QRS Duration and Configuration. The Need to Merino J. - Madrid, ESP 91/2 Modify Selection Criteria for CRT Zareba W. - Rochester, USA 92/2 09:40 n Combined Endocardial and Epicardial Ablation in Patients with ARVD 09:40 n Does the Controversy of CRT-P vs CRT-D Still Wissner E. - Hamburg, DEU 91/3 Exist? Klein H. - Rochester, USA 92/3 10:00 n Catheter Ablation of Ventricular Electrical Storms 10:00 n Panel consensus: How to Best Manage This Atie J. - Rio do Janeiro, BRA 91/4 Patient n Break / Visit of Exhibits n Break / Visit of Exhibits www.cardiostim.com - 66 -

Thursday June 14 SUDDEN CARDIAC DEATH ICD THERAPY ADVANCES IN NONINVASIVE Course Directors: D. Hayes - Rochester, USA/ ELECTROCARDIOLOGY (ISHNE) P. Ritter- Bordeaux, FRA/ D.S. Cannom - Los Angeles, USA/ J. Singh - Boston, USA/ F. Abi-Samra - New Orleans, USA Chairmen: W. Zareba, USA, S. Dubner, ARG, A.J. Moss, USA 09:00-10:30 09:00-10:30 Thursday June 14 Room 3.3 / Erato - Level 3 / Les Muses Room 3.4 / Uranie - Level 3 / Les MusesSESSION 93 SESSION 94UPDATE ON METHODS IN THE RISK CHALLENGES OF ICD THERAPY - PART I:STRATIFICATION OF SCD FUNCTIONING AND CHOICE OF THE DEVICECo-Chair: Co-Chair:Hombach V. - Ulm, DEU / Oto A. - Ankara, TUR Israel C.W. - Bielefeld, DEU / Delnoy P.P. - Zwolle, NLD09:00 n Heart Rate Recovery – How Useful? 09:00 n Five ICD Manufacturers: Specificities forOto A. - Ankara, TUR 93/1 Detection, Discrimination and Therapies Bordachar P. - Bordeaux, FRA 94/109:20 n Holter-Based T Wave Alternans – How toAnalyze It? 09:30 n The Specific Features of the Different ICDsVerrier R. - Boston, USA 93/2 Available Influence My Choice Ellenbogen K. - Richmond, USA 94/209:40 n Exercise-Induced T Wave Alternans – Is It Hereto Stay? 10:00 n The Specific Features of the Different ICDsKlingenheben T. - Bonn, DEU 93/3 Available Influence My Choice Cannom D. - Los Angeles, USA 94/310:00 n HRV or QTV or Their Combination?La Rovere M. - Pavia, ITA 93/4 n Break / Visit of Exhibits n Break / Visit of Exhibits - 67 - www.cardiostim.com

Thursday June 14Created by Jacques Mugica INVASIVE ELECTROPHYSIOLOGY & NON INVASIVE EP, ICDs ABLATION TECHNIQUES Posters must remain on display from 9:00 to 12:30, WORLD CONGRESS ON CATHETER ABLATION but during the break your presence is required beside your poster Chairmen: M. Scheinman - San Fransciso, USA, M. O’Neill - London, GBR - V. Probst- Nantes, FRA - F. Sacher - Bordeaux-Pessac, FRA 09:00-10:30 09:00-12:30 Room 3.5 / Calliope - Level 3 / Les Muses Poster Area - Level 3 / Agora 3 SESSION 95 SESSION 96P ATRIAL FLUTTER ABLATION NON INVASIVE EP, ICDs Co-Chair: Mounsey J.P. - Chapel Hill, USA / Knecht S. - Brussels, BEL n A Novel Surface Electrocardiogram Based Marker of Ventricular Arrhythmia 09:00 n Unusual forms (Double Loop, Lower Loop and Nicolson W., Mccann G., Brown P., Sandilands A., Stafford P., Intra-Isthmus Reentry) Schlindwein F., Samani N., Ng G. - Leicester, GBR 96P/1 Mounsey J.P. - Chapel Hill, USA 95/1 n Electrocardiographic Pattern of Premature 09:20 Approach to the Ablation of Post Atrial n Ventricular Beats in Patients with Left- and Right-Ventricle Fibrillation Induced Left Atrial Flutter Outflow Tract Arrhythmias Knecht S. - Brussels, BEL 95/2 Szydlo K., Wnuk-Wojnar A., Hoffmann A., Nowak S., Kolasa J., Trusz-Gluza M. - Katowice, POL 96P/2 09:40 n Diagnoses and Ablation of Right Sided Flutter Yagi T. - Sendai, JPN 95/3 n Fragmented QRS Wave Can Be a Useful Predictor of the Idiopathic Ventricular Tachyarrhythmia 10:00 n Interactive Flutter Cases On Y., Park S., Park S., Kim J. - Seoul, KOR 96P/3 Kalman J. - Parkville, AUS 95/4 n Younger People Show More Changes in n Break / Visit of Exhibits Repolarization Wecke L., Andersson E., Nilsson J., Lundahl G., Bergfeldt L. - Stockholm, SWE 96P/4 n Outcome of Patients with Syncope and Early Repolarization Pattern Le Bloa M., Sacher F., Maury P., Gouraud J., Mabo P., Leclercq C., Mansourati J., Babuty D., Hocini M., Laurent G., Lamaison D., Jaïs P., Pasquié J., Furber A., Hermida J., Derval N., Klug D., Denis A., Haïssaguerre M., Probst V. - Pessac, FRA 96P/5 n Electrocardiographic Clues to Differentiate Idiopathic Right Ventricular Outflow Tract Arrhythmia from Arrhythmogenic Right Ventricular Cardiomyopathy Mollazadeh R., Emkanjoo Z., Mohammadi Z., Khalili M. - Tehran, IRN 96P/6 n Comparing Efficacy of Holter ECG and Handheld ECG : the Primarytm Study Hendrikx T., Rosenqvist M., Sandström H., Hörnsten R. - Umeå, SWE 96P/7 www.cardiostim.com - 68 -

Thursday June 14 NON INVASIVE EP, ICDs Posters must remain on display from 9:00 to 12:30, but during the break your presence is required beside your poster 09:00-12:30 Thursday June 14 Poster Area - Level 3 / Agora 3 n Microvolt T-Wave Alternans in the Prediction of n Identification of Atrio-Ventricular RelationshipICD Interventions with Echocardiography - A Useful Tool to DiagnoseSredniawa B., Kowalczyk J., Lenarczyk R., Kowalski O., Tachycardia MechanismCebula S., Musialik-Lydka A., Kalarus Z. - Zabrze, POL 96P/8 Jacobsen P., Modi S., Mccarthy D., Klein G., Gula L., Skanes A., Krahn A., Yee R., Leong-Sit P. - London, GBR 96P/16 n Diagnosis of Syncope: Focus on Anamnesis.Etiological Suspicion Based on Clinical History and the n Prognosis Value of Twave Variability in PatientsDescription of the Episode with Low Ejection Fraction and IcdRuiz G., Chirife R., Tentori M., Aversa E., Muratore C., Beaufort C., Pambrun T., Lequeux B., Christophle-Boulard S.,Grancelli H. - Florida-, ARG 96P/9 Lonlas E., Herpin D., Christiaens L., Degand B. - Poitiers, FRA 96P/17 n Wavelet Analysis of P Wave during SinusRhythm Reveals Specific Conduction Disarrangements in n A Common Variant near Kcnj2 Gene IsPatients with Lone Atrial Fibrillation Associated with T-Peak to T-End IntervalDakos G., Vassilikos V., Mantziari L., Chatzizisis I., Chouvarda I., Marjamaa , Lasse Oikarinen , Kimmo Porthan , Samuli Ripatti,Paraskevaidis S., Theifilogiannakos S., Maglaveras N., Styliadis I. - Gina Peloso , Peter Noseworthy , Matti Viitasalo , MarkkuThessaloniki, GRC 96P/10 S.Nieminen , Lauri Toivonen , Kimmo Kontula , Leena Peltonen , Aki S.Havulinna , Antti Jula , Christopher J.O’donnell , n 1. Nonischemic Ventricular Arrhythmias: Christopher Newton-Cheh , Markus Perola ,Invisible Points of ECG Diagnostic Veikko Salomaa - Helsinki, FIN 96P/18Noskova M. - Moscow, RUS 96P/11 n Time-Frequency Analysis of the QRS Energy nImpact of Pulmonary Vein Isolation on P-Wave Provides Additional Information to QRS Duration forMorphology the Prediction of Response to Cardiac ResynchronizationSekiya K., Masuda M., Inoue K., Kimura R., Toyoshima Y., TherapyDoi A., Sotomi Y., Ueda M., Kobayashi K., Shiraiwa R., Mantziari L., Vassilikos V., Dakos G., Kamperidis V., Chouvarda I.,Iwakura K., Fujii K. - Osaka, JPN 96P/12 Chatzizisis Y., Paraskevaidis S., Karvounis H., Maglaveras N., Styliadis I. - Thessaloniki, GRC 96P/19 n Alteration of Heart Rate Variability afterPulmonary Vein Isolation n Quantification of Intrathoracic Impedence withIshikawa Y., Harada T., Soejima K., Nakajima M., Takagi Y., Heart Failure Functional Capacity and BiomarkersTakano M., Nakano E., Matsuda H., Nishio S., Sakurai T., Gulati S., Maslow A., Sims J. - Fayetteviee, USA 96P/20Miyake F. - Kawasaki City, JPN 96P/13 n Utility of Latitude Symptoms Score in Remote n Physical Activity and Relation to Sudden Cardiac Follow-Up of CRT Patient: First Italian ExperienceArrest Luzi M., Molini S., Brambatti M., Cipolletta L., Flori M.,Wan C., Szymkiewicz S. - Pittsburgh, USA 96P/14 Marchesini M., Matassini M., Schiavon S., Guardian S., Capucci A. - Ancona, ITA 96P/21 n Left Atrial Reservoir Function Predicts StructuralAsymmetrical Remodelling n Requirement of Discontinuation fromFloria M., Ambarus V., Jamart J., Arsenescu Georgescu C. - Amiodarone for Lethal ArrhythmiasIasi, ROM 96P/15 Kohjitani H., Kobori A., Hatani T., Ide Y., Toyota T., Honda S., Nishino T., Kim K., Kitai T., Ehara N., Kinoshita M., Kaji S., Yamamuro A., Tani T., Furukawa Y. - Kobe, JPN 96P/22 - 69 - www.cardiostim.com

Thursday June 14Created by Jacques Mugica NON INVASIVE EP, ICDs Posters must remain on display from 9:00 to 12:30, but during the break your presence is required beside your poster 09:00-12:30 Poster Area - Level 3 / Agora 3 n Heart Rate-Guided Titration of Beta Blockers n Effects of Bisoprolol Doses on Clinical and Does Not Affect Ventricular Repolarization in Heart Failure Instrumental End-Points in Patients Treated with Cardiac Fister M., Vrtovec B., Starc V., Haddad F. - Resynchronization Therapy (CRT) Ljubljana, SVN 96P/23 Lucca E., Belvito C., Bakhtadze N., Michelotti F., Capelli F., Sava G., Cortinovis A., Pennesi M., Mascioli G. - n Ventricular Repolarization Instability in Dilated Bergamo, ITA 96P/30 Cardiomyopathy Is Associated with High Scar/hibernation Ratio n Long-Term Results of Using Ventricular Mikuz U., Poglajen G., Starc V., Hsia H., Haddad F., Vrtovec B. - Reduction as Sole Anti-Arrhythmic Therapy for Ischemic Ljubljana, SVN 96P/24 Cardiomyopathy Gundry S., Ehrman W., Epstein J. - Palm Springs, USA 96P/31 n Ventricular Fibrillation Storm: A Unique Presenting Feature of Mitochondrial Crisis n Association of Ace I/d Polymorphism in Tunisia Mukerji S., Memon S., Koenig M., Meyers D., Memon N., Zarrouk-Mahjoub S., Mehri S., Ouarda F., Hammami M. - Kantharia B. - Houston, USA 96P/25 Monastir, TUN 96P/32 n Chads2 Score Predicts New AF & Ischemic Stroke n Dyssynchrony and Indices of Left Ventricle in in Patients without Preexisting AF Patients with CHF. Siu C., Zuo M., Tse H. - Hong Kong, HKG 96P/26 Trukshina M., Sitnikova M., Shlyakhto E. - St.Petersburg, RUS 96P/33 n Sleep-Disordered Breathing, Atrial Fibrillation and Heart Failure: How Are They Strictly Related? n Features of Neurogenic Vascular Regulation Matassini M., Guerra F., Maffei S., Cipolletta L., Brambatti M., and Orthostatic Tolerance in Patients with Chronic Heart Marchesini M., De Luca S., Pupita G., Capucci A. - Failure with Permanent Atrial Fibrillation Torrette Di Ancona, ITA 96P/27 Mamontov O., Berngardt E., Parmon E., Treshkur T., Shlyakhto E. - Saint-Petersburg, RUS 96P/34 n Right Lateral Decubitus Position Reduces Central Apnea Index in Chronic Heart Failure Patients with n Evolution in the Management of Patients with Permanent Pacemaker Implantation Brugada Syndrome Miyamoto S., Fujita M., Ishimura T., Inoko M., Haruna T., Izumi Loizeau C., Sacher F., Derval N., Jaïs P., Hocini M., Bordachar T., Nakane E., Katoh T., Hirose S., Minamono E., Kimura M., P., Ritter P., Denis A., Zemmoura A., Ploux S., De Guillebon M., Morita Y., Iida J., Saji Y., Ueyama K., Nohara R. - Ramoul K., Aurillac-Lavignolle V., Clémenty J., Haïssaguerre M. - Osaka, JPN 96P/28 Pessac, FRA 96P/35 n QRS and QTC Interval in Prediction of n Implantable Cardioverter/Defibrillator Short- and Long-Term Outcomes of Patients with Acute Interventions in Primary Prevention: Very Long-Term Data Decompensated Heart Failure from an Unselected Single-Center Real World Population Byeon K., On Y., Huh J., Park S., Lee S., Choi J., Jeon E. - Conte G., Galizia C., Altavilla T., Gonzi G., Carboni A., Seoul, KOR 96P/29 Ardissino D., Zardini M. - Parma, ITA 96P/36 n Incidence and Predictors of Phantom Shocks in Prophylactic Implantable Cardioverter Defibrillator Recipients Kraaier K., Starrenburg A., Verheggen R., Van Der Palen J., Scholten M. - Enschede, NLD 96P/37 www.cardiostim.com - 70 -

Thursday June 14 NON INVASIVE EP, ICDs Posters must remain on display from 9:00 to 12:30, but during the break your presence is required beside your poster 09:00-12:30 Thursday June 14 Poster Area - Level 3 / Agora 3 n Fragmented QRS and Mortality Risk in Patients n Electrophysiological Study-Based Prophylacticwith Inducible Ventricular Arrhythmia Implantable Cardioverter-Defibrillator Therapy forHayashi T., Fukamizu S., Matsushita N., Hojo R., Abe T., Asypmptomatic Brugada Syndrome; Long-Term Follow-UpKomiyama K., Tanabe Y., Tejima T., Nishizaki M., Hiraoka M., and Risk Factors of ICD Discharge in Japanese PopulationSakurada H. - Tokyo, JPN 96P/38 Mizobuchi M., Enjoji Y., Ino Y., Yamamoto N., Funatsu A., Kobayashi T., Nakamura S., Ejima E., Matsumura K., Hayashi F., n Implantable Cardioverter Defibrillator Therapy Shibata K. - Kyoto, JPN 96P/45Activation for High Risk Patients with Relatively WellPreserved Left Ventricular Ejection Fraction. Does It Really n Ventricular Tachycardia Acceleration atWork? Anti-Tachycardia Pacing of Implantable CardioverterGatzoulis K., Tsiachris A., Dilaveris P., Vouliotis A., Arsenos P., Defibrillators Is an Independent Predictor of the PoorArchontakis S., Sideris S., Trantalis G., Kartsagoulis E., Outcome in Patients with Chronic Heart Failure.Kallikazaros I., Stefanadis C. - Athens, GRC 96P/39 Kida H., Furukawa Y., Yamada T., Morita T., Tanaka K., Iwasaki Y., Kawasaki M., Fukunami M. - Osaka, JPN 96P/46 n Appropriate ICD-Shocks in Comparison toAntitachycardiac Pacing for Termination of Ventricular n Are Patients with Chagas’ Disease ImplantedArrhythmias in Clinical Practice: Different Prognostic with a Defibrillator and Preserved Ventricular FunctionImpact on Clinical Outcome? Different from Those with Depressed Ventricular Function?Kleemann T., Hochadel M., Strauss M., Skarlos A., Kouraki K., Di Toro D., Muratore C., Malan A., Greco O., Pachon J.,Zahn R. - Ludwigshafen, DEU 96P/40 Escudero J., Tentori M., Maloney J., Baranchuk A. - Buenos Aires, ARG 96P/47 n Repolarization Dynamicity as a Predictor ofAppropriate ICD Interventions in Patients with the Remote n Cost-Effectiveness of Prophylactic ImplantableMyocardial Infarction, Untreated with Amiodarone. Cardioverter Defibrillator Treatment: Data from a LargeSzydlo K., Trusz-Gluza M., Filipecki A., Orszulak W., Clinical RegistryUrbanczyk D., Kwasniewski W., Wita K. - Katowice, POL 96P/41 Thijssen J., Van Den Akker M., Borleffs C., Van Rees J., De Bie M., Van Der Velde E., Van Erven L., Schalij M. - n A Ten Years Experience with Outpatient ICD Leiden, NLD 96P/48and CRT Device ImplantationFeliciano Z., Bersohn M., Noheria A., Han J. - n The Mode of Death in Implantable CardioverterLos Angeles, USA 96P/42 Defibrillator and Cardiac Resynchronization Therapy – Defibrillator Patients: Results from Routine Clinical Practice n Bridging ICD Implantation Reduces Mortality in Thijssen J., Van Rees J., Venlet J., Borleffs C., Hoke U.,Patients Awaiting Heart Transplantation Van Der Velde E., Van Erven L., Schalij M. - Leiden, NLD 96P/49Sedlacek K., Grieco D., Jurkuvenas P., Ho_ková L., Málek I.,Kautzner J. - Prague, CZE 96P/43 n Longterm Prospective Comparison of Patients with and without Known DFT Following ICD Implantation n Regional Evidence-Based Shock Reduction Bokhari F. - Jeddah, SAU 96P/50Programming in ICD PatientsArora V., Fischer A., Sachanandani H., Hoey M., Yang F., n Importance of Shocks and Type D Personality inPeterson B., Nair M. - New Delhi, IND 96P/44 Younger ICD Patients Versteeg H., Tekle F., Pedersen S., Van Der Voort P., Alings M., Van Den Broek K., Denollet J. - Tilburg, NLD 96P/51 - 71 - www.cardiostim.com

Thursday June 14Created by Jacques Mugica NON INVASIVE EP, ICDs Posters must remain on display from 9:00 to 12:30, but during the break your presence is required beside your poster 09:00-12:30 Poster Area - Level 3 / Agora 3 n Procedure- and Device-Related Complications n Mechanical Transvenous Extraction of Are Not Associated with Psychological Morbidity 12 Endocardial Implantable Cardioverter Defibrillator Leads: Months Post ICD Implantation Feasibility, Safety and Determinants of Success in the Pisa Hoogwegt M., Theuns D., Erdman R., Jordaens L., Pedersen S. - Experience Tilburg, NLD 96P/52 Segreti L., Soldati E., Zucchelli G., Di Cori A., De Lucia R., Viani S., Paperini L., Boem A., Levorato D., n Are Shocks in ICD Patients Still to Be Feared Bongiorni M. - Pisa, ITA 96P/61 after Long Eventfree Years? Reiter T., Ritter O., Bauer W. - Wuerzburg, DEU 96P/53 n Chronic Performance of 7FR Durata Leads Greenberg S., Hamati F., Styperek R., Alonso J., Bolanos O., n Risk Stratification at ICD Generator Keeney J. - Rosyln, USA 96P/62 Replacement Matthews I., Bland J., Mccomb J. - n Incidence of Riata Defibrillator Lead Failure Newcastle Upon Tyne, GBR 96P/54 Higher than Previously Reported Fazal I., Shepherd E., Tynan M., Plummer C., Mccomb J. - n Frequent ICD Lead Complication during Heart Newcastle Upon Tyne, GBR 96P/63 Transplantation Abraham P., Caliskan K., Kardos A., Theuns D., Maat A., n Incidence of Externalized Conductors in ICD Balk A., Jordaens L., Szili-Torok T. - Rotterdam, NLD 96P/55 Leads Using PA and Lateral Chest X-Ray Imaging Corbisiero R., Armbruster R. - Browns Mills, USA 96P/64 n Electrode Conductive Surface Area Effect on Defibrillation Energy Requirement n Experience with the Df4 System: Updated Klehn R. - Sylmar, USA 96P/56 Results from the Sj4 Post Approval Study Mirro M., Niebauer M., Styperek R., Jumrussirikul P., n Decreased Incidence of Lead Abrasion and Wong W., Ha K. - Fort Wayne, USA 96P/65 Mechanical Failures with Durata® Leads Hayes D., Freedman R., Kalbfleisch S., Kutalek S., Schaerf R. - n Risk of Inappropriate Shocks Rochester, USA 96P/57 Amine M., Nasir N., Hariharan R., Hessen S., Rubin E., Roberts J. - Houston, USA 96P/66 n Poor Survival of Defibrillator Leads with Small Diameter n Mechanism of R-Wave Amplitude Fluctuation in Johansen J., Joergensen O., Nielsen J., Videbaek R., Haarbo J., ICD Patients; a Potential Cause of T-Wave Oversensing Riahi S., Arnsbo P., Moller M. - Odense, DNK 96P/58 Mizobuchi M., Enjoji Y., Ino Y., Yamamoto N., Ejima E., Hayashi F., Matsumura K., Shibata K., Funatsu A., Kobayashi T., n Analysis of the Riata 1580, 1581 and 1582 Leads Nakamura S. - Kyoto, JPN 96P/67 Jordaens L., Valk S., Dabiri-Abkenari L., Van Malderen S., Berman L., Haitsma D., De Groot N., Szili-Torok T., Theuns D. - n New Options for Remote Monitoring of Cardiac Rotterdam, NLD 96P/59 Resynchronization Therapy Faerestrand S., Vollan G., Lunde T., Kristiansen H. - n Right Ventricular Lead Revision Risks: Bergen, NOR 96P/68 Implications for Advisories / Recalls Gleva M., Mitchell K., Holcomb R., Poole J. - n First Clinical Case of Acute ST–segment St. Louis, USA 96P/60 Deviation Monitoring in an ICD Kloppe A., Mijic D., Bogossian H., Zarse M., Lemke B. - Bochum, DEU 96P/69 www.cardiostim.com - 72 -

Thursday June 14 NON INVASIVE EP, ICDs Posters must remain on display from 9:00 to 12:30, but during the break your presence is required beside your poster 09:00-12:30 Thursday June 14 Poster Area - Level 3 / Agora 3 n Remote Monitoring Follow-Up of ICD/ n Usefulness of Optimized Waveform to ReduceCRT-D Recipients Is Associated with a Very Low Rate of Defibrillation FailuresInappropriate Shocks Copie X., Hermida J., Bizeau O., Degand B., Bolloré G.,Cassagneau R., Jacon P., Pellet N., Vandeneynde C., Defaye P. - Piot O. - Saint Denis, FRA 96P/78La Tronche, FRA 96P/70 n Improved Atrial Arrhythmia Detection in ICDs n Role of Training on ICD Patients Understanding Fischer A., Rhude J. - New York, USA 96P/79and Acceptance Regarding the Remote Control SystemLaurent G., Amara W., Mansourati J., Bizeau O., Garrigue S., n Analysis of a Spatial Projection of TachycardiaHermida J., Couderc P., Popescu E., Guyomar Y., Delarche N., for Arrhythmia Discrimination in ICDsMoini C. - Dijon, FRA 96P/71 Milpied P., Klug D., Aime E., Mansourati J., Anselme F., Euzen M., Sadoul N. - Clamart, FRA 96P/80 n Characteristics of VF Episodes DetectionSettings in ICD Patients Transmitted by a New Remote n From Endocardial Electrograms to SurfaceMonitoring System – First Results of the German Carelink ElectrocardiogramsAnalytics Device Database Lazarus A., Bru P., Burban M., Makdissi A., Carrault G.,Schwab J., Rybak K., Perings C., Balke A., Lauter J. - Duchemin L., Guedon Moreau L. - St Cloud, FRA 96P/81Bonn, DEU 96P/72 n A Novel Representation of Electrograms for nTime Usage for Remote Follow-Up in a Large Capture and Fusion Monitoring in ICDsCohort of ICD-Patients Mabo P., Alonso C., Nagele H., Euzen M., Milpied P.,Petersen H., Jensen M., Svendsen J. - Copenhagen Ø, DNK Ritter P. - Rennes, FRA 96P/82 96P/73 n Unsuccessful Shocks during ICD Testing: n Daily Vs. Periodic Transmissions in ICD Remote Ischemic Versus Nonischemic Heart DiseaseMonitoring: Effects on Adverse Event Detection Rate Bonnes J., Jaspers Focks J., Westra S., Brouwer M.,De Ruvo E., Sciarra L., Rebecchi M., Stirpe F., De Luca L., Smeets J. - Nijmegen, NLD 96P/83Zuccaro L., Sangiovanni L., Fagagnini A., Sforza M., Miniati M.,Gargaro A., Calò L. - Rome, ITA 96P/74 n Pulseless Electrical Activity Post Device Based Defibrillation Testing n New Options for Remote Monitoring of Kanj M., Wazni O., Baranowski B., Saliba W., Callahan T.,Implantable Cardioverter Defibrillators Martin D., Lindsay B., Dresing T., Wilkoff B., Chung M.,Faerestrand S., Vollan G., Lunde T., Kristiansen H. - Tchou P. - Cleveland, USA 96P/84Bergen, NOR 96P/75 n Implantable Cardioverter Defibrillator (icd) n Computerized Cha2ds2vasc Classification in Therapies in Adults with Congenital Heart DiseaseRemote Atrial Fibrillation Alerts: an Ontology-Based Approach According to Congenital Lesion: Are Traditional ICDMabo P., Burgun A., Van Hille P., Zweigenbaum P., Beuscart R., Implant Indications Appropriate?Jacques J., Henry C., Duchemin L., Rosier A. - Kella D., Hoskins M., Langberg J., Book W., Jokhadar M.,Rennes, FRA 96P/76 Sahu A., Lloyd M. - Atlanta, USA 96P/85 n Correlation of Intracardiac Electrogram (iegm)with Surface ECG in Brugada Syndrome PatientsProbst V., Sacher F., Gill J., Medkour F., Derval N., Mabo P.,Le Marec H. - Nantes, FRA 96P/77 - 73 - www.cardiostim.com

Thursday June 14Created by Jacques Mugica NON INVASIVE EP, ICDs NONINVASIVE Posters must remain on display from 9:00 to 12:30, but during ELECTROCARDIOLOGY the break your presence is required beside your poster ADVANCES IN NONINVASIVE ELECTROCARDIOLOGY (ISHNE) Chairmen: W. Zareba, USA, S. Dubner, ARG, A.J. Moss, USA The author’s presence is required to present their poster from 10:30 to 11:00. Posters must remain on display from 9:30 to 12:00 09:00-12:30 10:30-11:00 Poster Area - Level 3 / Agora 3 Poster Area Les Muses - Level 3 / Les Muses SESSION 97PW Intraoperative ICD-Testing: Still Mandatory with n BRUGADA SYNDROME, LONG QT Respect to Cognitive Function? Prull M., Unverricht S., Bittlinsky A., Butz T., Van Bracht M., SYNDROME, EARLY REPOLARIZATION Plehn G., Trappe H. - Herne, DEU 96P/86 Co-Chair: Wranicz J.K. - Lodz, POL / Goldberger J. - Chicago, USA n Intraoperative Testing of the Implantable Cardioverter-Defibrillator- Is It Necessary? 10:30 n Clinical Presentation of Brugada Syndrome Ohlow M., Lauer B., Buchter B., Farah A., Dar Alammouri Y., Patients Included in the Quidam Study Fuhrmann J., Brunelli M., Schreiber M., Tukhiashvili K., Probst V., Sacher F., Mansourati J., Maury P., Babuty D., Hassan A., Geller J. - Bad Berka, DEU 96P/87 Defaye P., Hermida J., Davy J., Chevalier P., Deharo J., Leenhardt A., Sadoul N., Klug D., Fouchard S., Le Marec H. - n The Leader Registry: Defibrillation Testing Nantes, FRA 97PW/1 during ICD Implantation in Real Life Lazarus A., Defaye P., Mouton E., Bizeau 0., Dupuis J., 10:30 n Ventricular Arrhythmia Risk Assessment in Delarche N., Blanc J., Sadoul N. - St Cloud, FRA 96P/88 Patients with Right Ventricular Cardiomyopathy Can Be Improved with Cardiac Magnetic Resonance. n Lunch Dijkman B., Cramer M., Verkooijen H., Velthuis B. - Utrecht, NLD 97PW/2 10:30 n Prevalence, Prognosis and Identification of the Malignant Form of Early Repolarization Pattern in a Population Based Study Rollin A., Maury P., Bongard V., Mondoly P., Delay M., Duparc A., Carrie D., Ferrieres J., Ruidavets J. - Toulouse, FRA 97PW/3 10:30 n Beta-Blocker Therapy Attenuates the Prolongation of the Qtc Interval after Standing in a Single Pedigree with the Lqt2 Mutation C.2494 A>t Muggenthaler M., Raju H., Bastiaenen R., Green A., Jeffery S., Behr E. - London, GBR 97PW/4 10:30 n Early Repolarization and ST-Segment Characteristics in Apparently Healthy Amateur Athletes Ramoul K., Derval N., Roten L., Diallo A., Chevalier M., Pedersen M., Denis A., Sacher F., Hocini M., Jaïs P., Douard H., Haïssaguerre M. - Bordeaux, FRA 97PW/5 10:30 n Cardiac Characteristics and Long-Term Outcome in Andersen-Tawil Syndrome Patients Related to Kcnj2 Mutation Probst V., Delannoy E., Sacher F., Mabo P., Mansourati J., Camous J., Tournant G., Denjoy I. - Nantes, FRA 97PW/6 n Break / Visit of Exhibits www.cardiostim.com - 74 -

Thursday June 14 BASIC ELECTROPHYSIOLOGY SYNCOPE Chairman: D. Zipes – Indianapolis, USA Organized by Blanc J.J. - Brest, FRA «FORTY YEARS OF GROUND-BREAKING CONCEPTS IN CARDIAC ELECTROPHYSIOLOGY» 11:00-12:30 11:00-12:30 Thursday June 14 Room 2.1 / Hermes - Level 2 / Rhodes Room 2.3 / Athena - Level 2 / RhodesSESSION 101 SESSION 102DOES GENETIC TESTING FOR SUDDEN VASO VAGAL SYNCOPE: THERE ARE NEWDEATH HELP IN CLINICAL PRACTICE? DATA!Co-Chair: Co-Chair:Tseng G.N. - Richmond, USA / Priori S.G. - Pavia, ITA Alboni P. - Cento (FE), ITA / Sutton R. - Monaco, MCO11:00 n Long QT Syndrome 11:00 n What Is Vaso Vagal Syncope: Physiopathology,Schwartz P. - Pavia, ITA 101/1 Genetics and Diagnosis? Benditt D. - Minneapolis, USA 102/111:20 n Brugada Syndrome and CPVTBrugada P. - Aalst, BEL 101/2 11:20 n Vaso Vagal Reactions in Animals to Vaso Vagal Syncope in Humans: Identical or Different?11:40 n Hypertrophic Cardiomyopathy Blanc J. - Brest, FRA 102/2Maron B. - Minneapolis, USA 101/3 11:40 n When and How to Treat Vaso Vagal Syncope12:00 nOut of Hospital Cardiac Arrest (except by Pacing)?Chugh S. - Los Angeles, USA 101/4 Ammirati A. - Rome, ITA 102/312:20 n What Are the Clinical Implications? 12:00 n Pacing in Vaso Vagal Syncope: From VPS I toViskin S. - Tel Aviv, ISR 101/5 ISSUE III Brignole M. - Lavagna, ITA 102/4 n Lunch n Lunch - 75 - www.cardiostim.com

Thursday June 14Created by Jacques Mugica FETAL CARDIOLOGY PEDIATRIC CARDIOLOGY Organized by Guirgis M. - Paris FRA Organized by Thambo J.B. - Bordeaux, FRA, Alice Maltret - Paris, FRA, Paul Khairy - Montreal, CAN, Georgia Brugada - Barcelona, ESP 11:00-12:30 11:00-12:30 Room 2.4 - Level 2 / Gallieni Room 2.6 - Level 2 / Gallieni SESSION 103 SESSION 104 BASIC UNDERSTANDING OF FETAL RHYTHM HOT TOPIC IN PEDIATRIC PACING Co-Chair: Co-Chair: Guirgis M. - Paris, FRA / Squarcia U. - Parma, ITA Bordachar P. - Bordeaux, FRA / Prinzen F.W. - Maastricht, NLD 11:00 n Normal Development of Conductive System 11:00 n Pediatric Pacing 30 Years after and Regulation of Fetal Rhythm: Substrate for Fetal Silvetti M. - Milan, ITA 104/1 Arrhythmias Blom N. - Leiden, DEU 103/1 11:30 n Alternative Approaches in Patients with Congenital Heart Disease 11:30 n Classic and New Techniques in Evaluation of Bordachar P. - Bordeaux, FRA 104/2 Fetal Rhythm Cuneo B. - Chicago, USA 103/2 12:00 n Indication and Technical Considerations for Leads Extraction in Patients with Congenital Heart Disease 12:00 n Telemedicine Role in Fetal Cardiology Hidden Lucet F. - Paris, FRA 104/3 Cuneo B. - Chicago, USA 103/3 n Lunch n Lunch www.cardiostim.com - 76 -

Thursday June 14 ICD THERAPY CRT 11:00-12:30 11:00-12:30 Thursday June 14 Room 1.1 - Level 1 / Méditerranée Room 1.2 - Level 1 / MéditerranéeSESSION 105 SESSION 106THE SUBCUTANEOUS LEAD HOW TO INCREASE CRT RESPONSE?Co-Chair: Co-Chair:Wilkoff B.L. - Cleveland, USA / Klein H. - Rochester, USA Gras D. - Nantes, FRA / Curnis A. - Brescia, ITA11:00 n Overview of the S-ICD System 11:00 n Defining CRT ResponseCappato R. - San Donato Milanese (MI), ITA 105/1 Leclercq C. - Rennes, FRA 106/111:20 n Results of the S-ICD System’s IDE Study 11:20 n New Tools to Position the LV Lead at the PointGold M. - Charleston, USA 105/2 of Latest Activation Cantu’ F. - Bergamo, ITA 106/211:40 n EFFORTLESS – The First ResultsBoersma L. - Nieuwegein, NLD 105/3 11:40 n Continuous Automatic Adaptation of the AV and VV Interval12:00 n The Future of ICD Therapy Milasinovic G. - Belgrade, CS 106/3Morgan J. - Southampton, GBR 105/4 12:00 n Care Pathway of HF Patients: Improving n Lunch Efficiency Wright J. - Liverpool, GBR 106/4Session made possible thanks to an educational grant fromCAMERON HEALTH n Lunch Session made possible thanks to an educational grant from MEDTRONIC - 77 - www.cardiostim.com

Thursday June 14Created by Jacques Mugica NON INVASIVE STROKE ELECTROPHYSIOLOGY GERIATRIC CARDIOLOGY THERAPIES FOR ATRIAL FIBRILLATION Organized by ADVANCES AND CONTROVERSIES Win K. Shen - Rochester, USA, Ronald E. Vlietstra - Lakeland, USA IN ATRIAL FIBRILLATION (A.C.A.F) Special Concerns for Your Elderly Patient: A Case-Based Interactive Program Chairmen: G. V. Naccarelli - Hershey, USA, J.J. Blanc - Brest, France, S. Lévy – Marseille, France 11:00-12:30 11:00-12:30 Room 1.3 - Level 1 / Méditerranée Room 1.4 - Level 1 / Méditerranée SESSION 107 SESSION 108 ATRIAL FIBRILLATION II APPROACHES TO ATRIAL FIBRILLATION AND Co-Chair: STROKE PREVENTION: NEW TECHNIQUES, van Gelder I.C. - Groningen, NLD / Capucci A. - Ancona, ITA NEW TECHNOLOGY, NEW ANTICOAGULANTS AND NEW DRUGS FOR THE ELDERLY 11:00 n Dronedarone in 2012: What is New? Le Heuzey J. - Paris , FRA 107/1 Co-Chair: Gaita F. - Asti, ITA / Munger T.T. - Rochester, USA 11:30 n PALLAS: Why Was It Performed? Where Are We? 11:00 n State of the Art Lecture: Hohnloser S. - Frankfurt, DEU 107/2 AF in the Elderly: Drugs, Ablation and Devices Calkins H. - Baltimore, USA 108/1 12:00 Dronedarone and Ranolazine: Is a Combination n Drug a Good Idea? 11:20 n Case 1: 86 yr W, HTN, Diabetic w/ 2 recurrent Antzelevitch C. - Utica, USA 107/3 TIAs in setting of PAF, GI bleeds/fall Friedman P. - Rochester, USA 108/2 n Lunch 11:40 n Case 2: 90 yr M, persistent AF, HTN, CHF, and Unrestricted Educational Support: sanofi aventis COPD Shen W. - Rochester, USA 108/3 12:00 n Case 3: 85 yr retired surgeon runs marathon, sinus bradycardia and symptomatic PAF Hocini M. - Bordeaux, FRA 108/4 n Lunch www.cardiostim.com - 78 -

Thursday June 14 BASIC ELECTROPHYSIOLOGY CRT Organized by M. Sermesant - Sophia Antipolis, FRA from Course Directors: D. Hayes - Rochester, USA/ INRIA (Institut National, de Recherche en Informatique et P. Ritter- Bordeaux, FRA/ D.S. Cannom - Los Angeles, USA/ Automatique) J. Singh - Boston, USA/ F. Abi-Samra - New Orleans, USA 11:00-12:30 11:00-12:30 Thursday June 14 Room 1.5 - Level 1 / Méditerranée Room 1.6 / Iris - Level 1 / MéditerranéeSESSION 109 SESSION 110COMPUTATIONAL ELECTROPHYSIOLOGY: ROLE OF DIFFERENT PROVIDERS TONOVEL TOOLS TO IMPROVE CLINICAL ASSURE CRT SUCCESSUNDERSTANDING Co-Chair:Co-Chair: Labrousse L. - Bordeaux, FRA / Oseroff O. - Buenos Aires, ARGPanfilov A.V. - Utrecht, NLD / Rhode K. - London, GBR 11:00 n What Can Surgeons Add to the Care/Success of11:00 nElectrotonic Modulation of Cardiac CRT Patients?Repolarization in Health and Disease: Insights from a Jansens J. - Brussels, BEL 110/1Combined Computational and Experimental StudyBernus O. - Bordeaux, FRA 109/1 11:20 n What Can EP Specialists Do for CRT Patients? Hayes D. - Rochester, USA 110/211:20 n Electro-Mechanical Interaction – Is ThisSomething the Clinical Electrophysiologist Has to Care 11:40 n What Can Heart Failure Experts Do for CRTabout or Is This only of Interest to the Cellular Researcher? Patients?Bijnens B. - Barcelona, ESP 109/2 Parks K. - Boston, USA 110/311:40 nElectrical and Structural Characteristics of 12:00 n What Can Specialists In Imaging Techniques DoBorder Zone in Infarcted Swine: Insights from 3D MR for CRT Patients? Cochet H. - Bordeaux, FRA 110/4Image-Based Computer Models, Histopathology and EPData n LunchPop M. - Toronto, CAN 109/312:00 n Cardiac Radiofrequency Ablation Planning fromPersonalized Biophysical ModelsDelingette H. - Sophia Antipolis, FRA 109/4 n Lunch - 79 - www.cardiostim.com

Thursday June 14Created by Jacques Mugica MISCELLANEOUS SUDDEN CARDIAC DEATH European Heart Rhythm Association INTERNATIONAL SYMPOSIUM ON HIGH (EHRA) Program RESOLUTION ECG AND NONINVASIVE Organized by EUROPACE Program Committee Chairman: ELECTROPHYSIOLOGY A. Goette - Magdeburg, DEU Organized by El.Sherif N. - Brooklyn, USA & Turitto G. - New York City, USA Sudden Cardiac Death. From Molecular Biology to Clinical Management, an Unfinished Odyssey 11:00-12:30 11:00-12:30 Room 3.1 / Clio - Level 3 / Les Muses Room 3.2 - Level 3 / Les Muses SESSION 111 SESSION 112 HIGHLIGHTS FROM EUROPACE 2011: CASE#3: 29 y/o male collapsed and INTERVENTIONAL EP AND MEDICAL spontaneously recovered during THERAPY/HIGHLIGHTS FROM EUROPACE running NY Marathon, ECG= LVH 2011: DEVICE THERAPY pattern, 2-D echo= suggestive of Co-Chair: hypertrophic cardiomyopathy Auricchio A. - Lugano, CHE / Hindricks G. - Leipzig, DEU Chair: Lévy S. - Marseille, FRA 11:00 n Interventional EP Merino J. - Madrid, ESP 111/1 11:00 n Molecular Biology of Hypertrophic CMP Ackerman M. - Rochester, USA 112/1 11:20 Pharmacotherapyn Camm A.J. - London, GBR 111/2 11:20 n Pathophysiology of SCD in Athletes Thiene G. - Padova, ITA 112/2 11:40 Pacing n Vardas P. - Heraklion, GRC 111/3 11:40 n Risk Stratification of SCD in Athletes Biffi M. - Bologna, ITA 112/3 12:00 Defibrillation and CRT-D n Wolpert C. - Ludwigsburg, DEU 111/4 12:00 n Panel consensus: How to Best Manage This Patient n Lunch n Lunch www.cardiostim.com - 80 -

Thursday June 14 SUDDEN CARDIAC DEATH ICD THERAPY ADVANCES IN NONINVASIVE Course Directors: D. Hayes - Rochester, USA/ ELECTROCARDIOLOGY (ISHNE) P. Ritter- Bordeaux, FRA/ D.S. Cannom - Los Angeles, USA/ J. Singh - Boston, USA/ F. Abi-Samra - New Orleans, USA Chairmen: W. Zareba, USA, S. Dubner, ARG, A.J. Moss, USA 11:00-12:30 11:00-12:30 Thursday June 14 Room 3.3 / Erato - Level 3 / Les Muses Room 3.4 / Uranie - Level 3 / Les MusesSESSION 113 SESSION 114EARLY REPOLARIZATION CHALLENGES OF ICD THERAPY - PART II:Co-Chair: PROGRAMMING THE DEVICETristani-Firouzi M. - Salt Lake City, USA / Stern S. - Jerusalem, Co-Chair:ISR Cannom D.S. - Los Angeles, USA / Lubinski A. - Lodz, POL11:00 n Isoproterenol Effect on Inferolateral Early 11:00 n Young Patient with Normal Heart (Brugada,Repolarization Versus Brugada Type ECG Long QT, Idiopathic VF)Roten L., Derval N., Sacher F., Pascale P., Scherr D., Shah A., Probst V. - Nantes, FRA 114/1Komatsu Y., Ramoul K., Denis A., Hocini M., Jaïs P.,Haïssaguerre M. - Bern, CHE 113/1 11:20 n Ischemic Heart Disease & Primary Prevention Mittal S. - New York City, USA 114/211:15 n Ecg Predictors for Ventricular FibrillationRecurrence in Early Repolarization 11:40 n Young Patient with HypertrophicRoten L., Derval N., Sacher F., Scherr D., Pascale P., Shah A., Cardiomyopathy (Obstructive and Non-Obstructive)Komatsu Y., Ramoul K., Arnaud D., Jaïs P., Haïssaguerre M., Ellenbogen K. - Richmond, USA 114/3Hocini M. - Bern, CHE 113/2 12:00 n Impact of Drugs on ICD Programming (Clinical11:30 The Role of the Tpeak-Tend Interval and Tpeak- n Cases)Tend/QT Ratio in Risk Stratification of Patients with J Wave Lemke B. - Bochum, DEU 114/4SyndromeAhmed Talib A., Nobuyuki Sato N., Takuya Myojo M., Naka n LunchSakamoto N., Yasuko Tanabe Y., Toshiharu Takeuchi T., YuichiroKawamura Y., Naoyuki Hasebe N. - Asahikawa, JPN 113/311:45 n The Relationship between Left Ventricular Scarand Ventricular Repolarisation in Patients with CoronaryArtery Disease: a Late Gadolinium Enhancement MRI StudyScott P., Rosengarten J., Shahed A., Murday D., Yue A.,Roberts P., Peebles C., Harden S., Curzen N., Morgan J. -Southampton, GBR 113/412:00 n The Specific Characteristics of the QTDynamicity and Heart Rate Variability in EarlyRepolarization with or without Ventricular FibrillationTalib A., Sato N., Myojo T., Sakamoto N., Tanabe Y., Takeuchi T.,Kawamura Y., Hasebe N. - Asahikawa, JPN 113/512:15 n Deltat50 - a New Marker for ArrhythmiaLiability during QT Interval ProlongationDuker G., Abrahamsson C., Edvardsson N., Skallefell B.,Carlsson L., Moors J., Philip K., Skinner M., Valentin J. -Mölndal, SWE 113/6 n Lunch - 81 - www.cardiostim.com

Thursday June 14Created by Jacques Mugica INVASIVE ELECTROPHYSIOLOGY & BASIC ELECTROPHYSIOLOGY ABLATION TECHNIQUES Chairman: D. Zipes – Indianapolis, USA WORLD CONGRESS ON CATHETER ABLATION «FORTY YEARS OF GROUND-BREAKING CONCEPTS IN Chairmen: M. Scheinman - San Fransciso, USA, M. O’Neill - CARDIAC ELECTROPHYSIOLOGY» London, GBR - V. Probst- Nantes, FRA - F. Sacher - Bordeaux-Pessac, FRA 11:00-12:30 14:00-15:30 Room 3.5 / Calliope - Level 3 / Les Muses Room 2.1 / Hermes - Level 2 / Rhodes SESSION 115 SESSION 121 PAROXYSMAL SUPRAVENTRICULAR THE INTERCALATED DISC AND TACHYCARDIA ABLATION I ARRHYTHMOGENIC CARDIOMYOPATHY Co-Chair: Co-Chair: Kalman J.M. - Parkville, AUS / Callans D. - Philadelphia, USA Poelzing S. - Salt Lake City, USA / Ehrlich J. - Frankfurt, DEU 11:00 n How to Best Diagnose SVT Mechanisms? 14:00 n Based on Science, What Is the Best Name for Callans D. - Philadelphia, USA 115/1 Arrhythmogenic Right Ventricular Cardiomyopathy? McKenna W. - London, GBR 121/1 11:20 n Ablation of Complex ANVRT Circuits Badhwar N. - San Francisco, USA 115/2 14:20 n Cell-Cell Communication in ARVC Greene K. - Chicago, USA 121/2 11:40 Rapid Arrhythmias Ablation Using 3D Mapping n Electrocardiography 14:40 n Arrhythmia Mechanisms and Therapy Hocini M. - Bordeaux, FRA 115/3 Calkins H. - Baltimore, USA 121/3 12:00 n Localization and Ablation of Atrial Tachycardias 15:00 n What Is Needed for a Cure? Kalman J. - Parkville, AUS 115/4 Thiene G. - Padova, ITA 121/4 n Lunch 15:20 n What Are the Clinical Implications? Marcus F. - Tucson, USA 121/5 n Break / Visit of Exhibits www.cardiostim.com - 82 -

Thursday June 14 CRT FETAL CARDIOLOGY European Heart Rhythm Association Organized by Guirgis M. - Paris, FRA (EHRA) Program Organized by EUROPACE Program Committee Chairman: A. Goette - Magdeburg, DEU 14:00-15:30 14:00-15:30 Thursday June 14 Room 2.3 / Athena - Level 2 / Rhodes Room 2.4 - Level 2 / GallieniSESSION 122 SESSION 123CRT IMPLANTATION AND FOLLOW-UP: FETAL ARRHYTHMIAS - Part IEHRA-HRS CONSENSUS STATEMENT Co-Chair:Co-Chair: Hornberger L.K. - Edmonton, CAN / Jaeggi E. - Toronto, CANDaubert J.C. - Rennes, FRA / Saxon L.A. - Los Angeles, USA 14:00 n Update in Genetics Studies of Fetal Arrhythmias14:00 Pre-Implant Evaluation n Priori S. - Pavia, ITA 123/1Brignole M. - Lavagna, ITA 122/1 14:15 n Diagnosis of Fetal Tachyarrhythmias14:15 n Implantation Procedure Hornberger L. - Edmonton, CAN 123/2Singh J. - Boston, USA 122/2 14:30 n Diagnosis of Fetal Bradycardias14:30 n Post-Discharge Evaluation Jaeggi E. - Toronto, CAN 123/3Leclercq C. - Rennes, FRA 122/3 14:45 n How to Suspect Long QT in a Fetus?14:45 n Device and Heart Failure Follow-Up Cuneo B. - Chicago, USA 123/4Israel C. - Bielefeld, DEU 122/4 15:00 n Fetal heart failure in fetal arrhythmias:15:00 nCRT Response Mechanisms and echocardiographic presentationsGold M. - Charleston, USA 122/5 Silverman N. - USA 123/515:15 n Special Issues n Break / Visit of ExhibitsSaxon L. - Los Angeles,, USA 122/6 n Break / Visit of Exhibits - 83 - www.cardiostim.com

Thursday June 14Created by Jacques Mugica PEDIATRIC CARDIOLOGY MISCELLANEOUS Organized by Thambo J.B. - Bordeaux, FRA, Alice Maltret - Paris, FRA, Paul Khairy - Montreal, CAN, Georgia Brugada - Barcelona, ESP 14:00-15:30 14:00-15:30 Room 2.6 - Level 2 / Gallieni Room 1.2 - Level 1 / Méditerranée SESSION 124 SESSION 125 CHANNELOPATHY IN PEDIATRICS: CASE NEW ADVANCES FOR PATIENTS WITH REPORT, EKG ATRIAL FIBRILLATION Co-Chair: Co-Chair: Brugada P. - Aalst, BEL / Priori S.G. - Pavia, ITA Camm A.J. - London, GBR / Hindricks G. - Leipzig, DEU 14:00 n Brugada Syndrome 14:00 n Impact from Remote Monitoring on Brugada P. - Aalst, BEL 124/1 Anticoagulation Ip J. - Lansing, USA 125/1 14:30 Long QT Syndrome n Wilde A. - Amsterdam Zuidoost, NLD 124/2 14:20 n Ways to Reduce Inappropriate ICD Therapies in AF 15:00 n ICD in Pediatrics Bänsch D. - Rostock, DEU 125/2 Berul C. - Washington, USA 124/3 14:40 n How to Achieve Reliable Cardiac n Break / Visit of Exhibits Resynchronization in AF? Gras D. - Nantes, FRA 125/3 15:00 n Improving the Outcome of AF Ablation Kuck K. - Hamburg, DEU 125/4 n Break / Visit of Exhibits Session made possible thanks to an educational grant from BIOTRONIK www.cardiostim.com - 84 -

Thursday June 14 ABLATION TECHNIQUES NON INVASIVE ELECTROPHYSIOLOGY THERAPIES FOR ATRIAL FIBRILLATION ADVANCES AND CONTROVERSIES IN ATRIAL FIBRILLATION (A.C.A.F) Chairmen: G. V. Naccarelli - Hershey, USA, J.J. Blanc - Brest, France, S. Lévy – Marseille, France 14:00-15:30 14:00-15:30 Thursday June 14 Room 1.2 - Level 1 / Méditerranée Room 1.3 - Level 1 / MéditerranéeSESSION 126 SESSION 127PULMONARY VEIN ISOLATION: THE ATRIAL FIBRILLATION IIICORNERSTONE OF ATRIAL FIBRILLATION Co-Chair:ABLATION Santini M. - Rome, ITA / Breithardt G. - Münster, DEUCo-Chair: 14:00 n Novel Anticoagulants: Where Are We in 2012?Furniss S. - Eastbourne, GRB / Blomstrom-Lundqvist C. - Naccarelli G. - Hershey, USA 127/1Uppsula, SWE 14:30 n Can Newer Anticoagulants Be Used Safely for14:00 nTechniques for Catheter Ablation of Paroxysmal Cardioversion of AF Patients?and Persistent Atrial Fibrillation: A Systematic Review Aliot E. - Nancy, FRA 127/2Verma A. - Newmarket, CAN 126/1 15:00 n Antiarrhythmic/Anticoagulant Drug14:15 n Cryoballoon Ablation of Pulmonary Veins: Interactions: What Do We Know?Global Clinical Experience Tamargo J. - Madrid, ESP 127/3Neumann T. - Bad Nauheim, DEU 126/2 n Break / Visit of Exhibits14:30 n Duty Cycled Phased RF: Global ClinicalExperience and Evolution Unrestricted Educational Support: sanofi aventisGeller C. - Bad Berka, DEU 126/314:45 n Comparing Technologies: What Are the Impactsof Energy Source on Results?Schilling R. - London, GBR 126/415:00 n Early Ablation: Should Cryoballoon Ablation BeProposed as First-Line Therapy?Chierchia J. - Brussels, BEL 126/5 n Break / Visit of ExhibitsSession made possible thanks to an educational grant fromMEDTRONIC - 85 - www.cardiostim.com

Thursday June 14Created by Jacques Mugica PACING & ICD THERAPY BASIC ELECTROPHYSIOLOGY GERIATRIC CARDIOLOGY Organized by Pruvot E. - Lausanne, CHE & Narayan S. - San Diego, USA Organized by Win K. Shen – Rochester, USA, Ronald E. Vlietstra – Lakeland, USA Special Concerns for Your Elderly Patient: A Case-Based Interactive Program 14:00-15:30 14:00-15:30 Room 1.4 - Level 1 / Méditerranée Room 1.5 - Level 1 / Méditerranée SESSION 128 SESSION 129 PACEMAKER AND ICD: WHEN DO WE SAY PART I: REPOLARIZATION ALTERNANS YES AND WHEN DO WE SAY NO? – TRANSLATING FUNDAMENTAL Co-Chair: OBSERVATIONS TO CLINICAL PRACTICE Hammill S.C. - Rochester, USA / Gillis A.M. - Calgary, CAN FOR ATRIAL AND VENTRICULAR ARRHYTHMIAS 14:00 n State of the Art Lecture: Pacemaker and ICD: Implantation, withhold and withdraw Co-Chair: Therapy Pruvot E. - Lausanne, CHE / Narayan S.M. - San Diego, USA Hayes D. - Rochester, USA 128/1 14:00 n From Pulsus to Pulseless: The Saga of Cardiac 14:20 Case 1: 82 yr M, CAD, prior EF 32%, NYHA III, n Repolarization Alternans NSTEMI 3 days ago, SR 34 bpm, EF 30% Rosenbaum D. - Cleveland, USA 129/1 Cha Y. - Rochester, USA 128/2 14:15 n Intermittent Atrial Tachycardia Promotes 14:40 Case 2: 89 yr W, independent, DCM, NYHA II, EF n Repolarization Alternans and Susceptibility to AF in a Free- 25%, not PM dependent, ICD at ERI Behaving Sheep Model Jahangir A. - Scottsdale, USA 128/3 Pruvot E. - Lausanne, CHE 129/2 15:00 n Case 3: 92 yr W, PAF, daytime pauses of 4.2 14:30 n Atrial Repolarization Alternans as a Dynamic seconds, EF 55%, no symptoms Substrate Promoting Wavebreaks in Human Paroxysmal Srivathsan K. - Scottsdale, USA 128/4 and Persistent AF Narayan S.M. - San Diego, USA 129/3 n Break / Visit of Exhibits 14:45 n SERCA2A Overexpression as a Molecular Intervention to Suppress Repolarization Alternans and Susceptibility of Cardiac Fibrillation Cutler M. - Cleveland, USA 129/4 15:00 n Intracardiac Repolarization Alternans/Variability Predicts Imminent Ventricular Tachyarrhythmias in ICD Recipients Swerdlow C. - Los Angeles, USA 129/5 n Break / Visit of Exhibits www.cardiostim.com - 86 -

Thursday June 14 CRT LEAD EXTRACTION Course Directors: D. Hayes - Rochester, USA/ LEAD MANAGEMENT P. Ritter- Bordeaux, FRA/ D.S. Cannom - Los Angeles, USA/ Organized by C. Kennergren – Göteborg, SWE J. Singh - Boston, USA/ F. Abi-Samra - New Orleans, USA 14:00-15:30 14:00-15:30 Thursday June 14 Room 1.6 / Iris - Level 1 / Méditerranée Room 3.1 / Clio - Level 3 / Les MusesSESSION 130 SESSION 131YOUR OPINION - CRT ISSUES - PART I PERFORMING LEAD EXTRACTIONCo-Chair: Co-Chair:Linde C.M. - Stockholm, SWE / Oto A. - Ankara, TUR Klug D. - Lille, FRA / Rozkovec A. - London, GBR14:00 n CRT in Heart Failure Patients with Preexistent or 14:00 n Training and Site RequirementsNew Persistent Atrial Fibrillation - I Ablate the His Bundle Mitkowsky P. - Poznan, POL 131/1Padeletti L. - Florence, ITA 130/1 14:20 n Transvenous Lead Extraction from the Route of14:20 nCRT in Heart Failure Patients with Preexistent or Implantation; available TechniquesNew Persistent Atrial Fibrillation - I Ablate the Atria Rinaldi A. - London, GBR 131/2Sanders P. - Adelaide, AUS 130/2 14:40 n Femoral, Transjugular, Surgical, Hybrid and14:40 Pro - There Is a Role for CRT in Patients with n Other Non Standard Lead Extraction TechniquesNarrow (< 120 ms) QRS Love C. - Columbus, USA 131/3Ruschitzka F. - Zurich, CHE 130/3 15:00 n Treatment of Lead Extraction Complications15:00 n Contra - There Is a Role for CRT in Patients with Kennergren C. - Göteborg, SWE 131/4Narrow (< 120 ms) QRSBeshai J. - Chicago, USA 130/4 n Break / Visit of Exhibits n Break / Visit of Exhibits - 87 - www.cardiostim.com

Thursday June 14Created by Jacques Mugica SUDDEN CARDIAC DEATH NONINVASIVE INTERNATIONAL SYMPOSIUM ON HIGH ELECTROCARDIOLOGY RESOLUTION ECG AND NONINVASIVE ADVANCES IN NONINVASIVE ELECTROPHYSIOLOGY ELECTROCARDIOLOGY (ISHNE) Organized by Chairmen: W. Zareba, USA, S. Dubner, ARG, A.J. Moss, USA El.Sherif N. - Brooklyn, USA & Turitto G. - New York City, USA Sudden Cardiac Death. From Molecular Biology to Clinical Management, an Unfinished Odyssey 14:00-15:30 14:00-15:30 Room 3.2 - Level 3 / Les Muses Room 3.3 / Erato - Level 3 / Les Muses SESSION 132 SESSION 133 CASE#4: 45 y/o male presents with one RISK STRATIFICATION OF SUDDEN AND syncopal episode, normal 2-D echo. TOTAL MORTALITY IN SPECIFIC GROUPS ECG=prominent early repolarization Co-Chair: wave in inferior surface leads Klein H. - Rochester, USA / Goldberger J. - Chicago, USA Chair: 14:00 n Risk Stratification in Post-MI PCI-Treated Breithardt G. - Münster, DEU Patients Exner D. - Calgary, CAN 133/1 14:00 Benign vs Malignant Early Repolarization n Napolitano C. - Pavia, ITA 132/1 14:20 n Risk Stratification in Dilated Cardiomyopathy Hombach V. - Ulm, DEU 133/2 14:20 n Continuous Spectrum between Early Repolarization and Brugada Syndrome 14:40 n Risk Stratification in Diabetes Antzelevitch C. - Utica, USA 132/2 Goldberger J. - Chicago, USA 133/3 14:40 n Panel consensus: How to Best Manage This Case 15:00 n Risk Stratification in Atrial Fibrillation Patients Lombardi F. - Milan, ITA 133/4 15:00 n Epilogue: SCD in 2012 Breithardt G. - Münster, DEU 132/3 n Break / Visit of Exhibits n Break / Visit of Exhibits www.cardiostim.com - 88 -

Thursday June 14 ICD THERAPY INVASIVE ELECTROPHYSIOLOGY & Course Directors: D. Hayes - Rochester, USA ABLATION TECHNIQUES P. Ritter- Bordeaux, FRA/ D.S. Cannom - Los Angeles, USA WORLD CONGRESS ON CATHETER ABLATION J. Singh - Boston, USA/ F. Abi-Samra - New Orleans, USA Chairmen: M. Scheinman - San Fransciso, USA, M. O’Neill - London, GBR - V. Probst- Nantes, FRA, F. Sacher - Bordeaux-Pessac, FRA 14:00-15:30 14:00-15:30 Thursday June 14 Room 3.4 / Uranie - Level 3 / Les Muses Room 3.5 / Calliope - Level 3 / Les MusesSESSION 134 SESSION 135CHALLENGES OF ICD THERAPY - PART III: PAROXYSMAL SUPRAVENTRICULARMANAGEMENT OF ELECTRICAL STORMS TACHYCARDIA ABLATION IIAND INAPPROPRIATE SHOCKS Co-Chair:Co-Chair: Ernst S. - London, GBR / Cheng J. - Houston, USAHayes D. - Rochester, USA / Mabo P. - Rennes, FRA 14:00 n Ablation of the Patient with Atrio-Fascicular14:00 n Drugs for Recurrent VAs in ICD Patients PathwaysGiudici M. - Davenport, USA 134/1 Jackman W. - Oklahoma City, USA 135/114:20 n Catheter Ablation in ICD Patients 14:20 n Ablation of Atrial Tachycardia/AccessoryMaury P. - Toulouse, FRA 134/2 Pathways from the Aortic Sinus Ernst S. - London, GBR 135/214:40 n Decision Making Process for ICD Lead ChangeHauser R. - Minneapolis, USA 134/3 14:40 n Mechanisms and Results of Ablative Therapy for Patients with Focal Junctional Tachycardia15:00 n Broken Lead in a System That Never Recorded Cheng J. - Houston, USA 135/3VAs: Extract, Replace or Remove Everything?Neuzil P. - Prague, CZE 134/4 15:00 n Diagnoses, Therapy and Results of Ablative Therapy for Patients with Manifest or Concealed Nodo- n Break / Visit of Exhibits Fascicular (Ventricular) Pathways Badhwar N. - San Francisco, USA 135/4 n Break / Visit of Exhibits - 89 - www.cardiostim.com

Thursday June 14Created by Jacques Mugica INVASIVE EP & ABLATION Posters must remain on display from 14:00 to 17:30, but during the break your presence is required beside your poster 14:00-17:30 14:00-17:30 Poster Area - Level 3 / Agora 3 Area - Level 3 / Agora 3 Poster SESSION 136P EP 2: INVASIVE EP & ABLATION n Spinal Cord Stimulation Protects against Tachypacing Induced AF Bernstein S., Wong B., Vasquez C., Rosenberg S., Rooke R., n The Risk of LA Thrombus and Mitral Annular Kuznekoff L., Lader J., Mahoney V., Budylin T., Alvstrand M., Rakowski-Anderson T., Bharmi R., Shah R., Fowler S., Holmes D., Velocity in AF Patients Farazi T., Chinitz L., Morley G. - New York, USA 136P/8 Masuda M., Inoue K., Kimura R., Toyoshima Y., Doi A., Sotomi Y., Iwakura K., Fujii K. - Osaka, JPN 136P/1 n Mechanism of Low Energy Multi-Stage Atrial Multiple Co-Morbidities Are Associated with a n Cardioversion Therapy Janardhan A., Li W., Gutbrod S., Lang D., Schuessler R., Prolongation of the Pre-Ablation ECG P-Wave Duration Efimov I. - St. Louis, USA 136P/9 Roux Y., Tenkorang J., Carroz P., Schlaepfer J., Pascale P., Rollin Garderes A., Fromer M., Pruvot E. - Lausanne, CHE 136P/2 n Obstructive Sleep Apnea Induces Atrial Fibrosis Is Post Operative Atrial Fibrillation Associated n in a Chronic Murine Model. Ramos P., Almendros I., Rubies C., Torres M., Batlle M., Farre R., with Atrial Dysfunction? Montserrat J., Mont L. - Barcelona, ESP 136P/10 Law S., Lim E., Ong B., Lai S., Binte Katwadi K., Liang Z., Shanmugam N., Chong D., Tan B., Ching C., Teo W., Ding Z., Chua Y., Liew R. - Singapore, SGP 136P/3 n Rgs 4 Ko Mice Are Predisposed to Atrial Fibrillation (AF) and Show Disrupted Sympathovagal n Atrial Fibrillation and Diabetes. How High Is the Balance, Making Rgs 4 a Potential Therapeutic Target Risk? for AF Burazor I., Pesic M., Burazor Z., Perisic Z., Burazor M., Opel A., Tinker A. - London, GBR 136P/11 Todorovic L., Lazovic M., Stojkovic A., Kostic T., Cvetkovic P. - Nis, SRB 136P/4 n Niferidile, New Class Antiarrhythmic III Agent: Electrophysiologic Effects and Efficacy in Patients with n New Onset of Atrial Fibrillation in Stemi Paroxysmal Supraventricular Tachycardia Patients Six Months after Stem Cell Therapy Mironov N., Golitsyn S., Sokolov S., Yuricheva Y., Maikov E., Celentano E., De Potter T., Geelen P., Peytchev P., Stefan L., Shlevkov N., Rosenstraukh L., Chazov E. - Eisenberger M., Bartunek J. - Aalst, BEL 136P/5 Moscow, RUS 136P/12 n The Contribution of Trigger Activity to the n Is Atrial Fibrillation Associated with Endothelial Persistence of Atrial Fibrillation Dysfunction? Inoue K., Kimura R., Toyoshima Y., Masuda M., Doi A., Sotomi Chan J., Cheung C., Yip W., Shanmugam N., Chong D., Y., Iwakura K., Fujii K. - Osaka, JPN 136P/6 Tan B., Ching C., Teo W., Allen J., Wong T., Liew R. - Singapore, SGP 136P/13 n Intraoperative Epicardial Electrophysiolosic Mapping of Ganglionated Plexi for Concomitant Atrial n Influence of Atrial Heterogeneities on Local Fibrillation with a Temporary Pacemaker Capture during Rapid Pacing of Atrial Fibrillation Kondo Y., Ueda M., Watanabe T., Ishizaka T., Matsumiya G., Virag N., Viso A., Vesin J., Kappenberger L. - Kobayashi Y. - Chiba, JPN 136P/7 Tolochenaz, CHE 136P/14 n Conserved Rotors and Focal Beats Enable Triggers to Initiate Human Atrial Fibrillation Schricker A., Lalani G., Krummen D., Narayan S. - San Diego, USA 136P/15 www.cardiostim.com - 90 -

Thursday June 14 INVASIVE EP & ABLATION Posters must remain on display from 14:00 to 17:30, but during the break your presence is required beside your poster 14:00-17:30 Thursday June 14 Poster Area - Level 3 / Agora 3 n Atrial Firillation Termination Prediction from n Left Atrial Conduction Delay Measured withLeft Atrial Parameters PW-Tissue Doppler Imaging Predicts the Outcome afterWatanabe I., Okumura Y., Sonoda K., Kofune M., Circumferential Pulmonary Vein IsolationNagashima K., Mano H., Ohkubo K., Nakai T., Kasamaki Y., Dinov B., Schoenbauer R., Bode K., Sommer P., Arya A.,Hirayama A. - Tokyo, JPN 136P/16 Bollmann A., Hindricks G., Piorkowski G. - Leipzig, DEU 136P/23 n Additional Linear Lesions Following n Predictors of Pulmonary Vein Reconnection atCircumferential Pulmonary Vein Isolation for Paroxysmal the Time of Repeat Ablation for Atrial FibrillationAtrial Fibrillation Do Not Predict Procedural Success Wichterle D., Aldhoon B., Peichl P., Cihak R., Kautzner J. -Jarman J., Patel P., Lysitsas D., Kontogeorgis A., Richardson J., Prague, CZE 136P/24Wong T., Markides V., Hussain W. - London, GBR 136P/17 n Sphericity Index of Left Atrium Predicts Success n Impact of Baseline Atrial Fibrillation Cycle of Atrial Fibrillation AblationLength on Acute and Long-Term Outcome of Persistent Bisbal F., Guiu E., Calvo N., Borràs R., Arbelo E., Tolosana J.,Atrial Fibrillation Ablation Using a Stepwise Approach Berruezo A., Brugada J., Mont L. - Barcelona, ESP 136P/25Ammar S., Paulik M., Reents T., Fichtner S., Schön P., Pavaci H.,Kathan S., Jilek C., Kolb C., Hessling G., Deisenhofer I. - n Determinants of Recurrence FollowingMunich, DEU 136P/18 Persistent Atrial Fibrillation Ablation Jarman J., Patel P., Lysitsas D., Kontogeorgis A., Richardson J., n Impact of Sex-Related Differences in Outcome Wong T., Markides V., Hussain W. - London, GBR 136P/26of Atrial Fibrillation Ablation.Calvo N., Bisbal F., Nadal M., Andreu D., Guiu E., Borràs R., n Tissue Doppler ECHO Based Atrial FibrillationArbelo E., Tolosana J., Berruezo A., Brugada J., Mont L. - Cycle Length/wall MotionBarcelona, ESP 136P/19 Watanabe I., Okumura Y., Sonoda K., Kofune M., Nagashima K., Mano H., Ohkubo K., Nakai T., Kasamaki Y., Hirayama A. n Ganglionated Plexi Ablation Combined with - Tokyo, JPN 136P/27Pulmonary Vein Isolation Improves Outcome of CatheterAblation in Patients with Longstanding Persistent Atrial n Assessment of Left Atrial MechanicalFibrillation: A Prospective Randomized Comparison Dyssynchrony with Speckle Tracking EchocardiographyRomanov A., Pokushalov E., Artyomenko S., Losik D., Predicts Atrial Fibrillation Recurrence after CatheterShirokova N., Turov A., Karaskov A. - Novosibirsk, RUS 136P/20 Ablation Karimzadeh K., Loghin C., Ananaba I., Mukerji S., Moye L., n Impact of Moderate and Severe Sleep Apnea Memon N., Dougherty A., Kantharia B. - Houston, USA 136P/28Syndrome on Efficacy of First Atrial Fibrillation Ablation(3a Study) n Prediction of Atrial Fibrillation RecurrencesZarqane N., Latcu D., Ricard P., Berthier F., Yaici K., Rinaldi J., after Radiofrequency Pulmonary Vein Isolation Using theDugourd C., Cellario M., Saoudi N. - Monaco, MCO 136P/21 P-Wave Signal Averaged Electrocardiogram Zimmermann M., Blanche C., Tran N., Burri H. - n Prediction of Permanent PV Isolation by Time to Meyrin-Geneva, CHE 136P/29Effect in Cryoballoon AF AblationDorwarth U., Schmidt M., Wankerl M., Krieg J., Straube F., n Conduction Recovery Following Electrical SuperiorHoffmann E. - München, DEU 136P/22 Vena Cava Isolation in the Context of Atrial Fibrillation Ablation: Prevalence and Electrophysiological Properties Miyazaki S., Koura K., Uchiyama T., Takayama K., Kusa S., Taniguchi H., Iesaka Y. - Tsuchiura, JPN 136P/30 - 91 - www.cardiostim.com

Thursday June 14Created by Jacques Mugica INVASIVE EP & ABLATION Posters must remain on display from 14:00 to 17:30, but during the break your presence is required beside your poster 14:00-17:30 Poster Area - Level 3 / Agora 3 n Impact of the Pre-Procedural Frequency of n Development of Body Temperature in Patients Paroxysmal Atrial Fibrillation on the Clinical Outcome after Undergoing Atrial Fibrillation Ablation: Catheter Ablation Berg S., Licher M., Maschke S., Holtgrewe U., Wolff E., Miyazaki S., Kuwahara T., Takahashi A. - Tsuchiura, JPN136P/31 Grove R., Kranig W. - Bad Rothenfelde, DEU 136P/39 n Peri-Mitral Flutter Ablation Depends on Mitral n Efficacy, Safety, and Outcome of Atrial Isthmus Anatomy Fibrillation Ablation in the Elderly Latcu D., Massaad Y., Mahjoub M., Squara F., Saoudi N. - Arbelo E., Guiú E., Berruezo A., Tolosana J., Andreu D., Monaco, MCO 136P/32 Ramos P., Bisbal F., Borras R., Brugada J., Mont L. - Barcelona, ESP 136P/40 n E/e’ as a Marker of Left Ventricular Diastolic Dysfunction Is Useful for the Prediction of the Long-Term n Randomized Comparison of Pulmonary Vein Sinus Rhythm Maintenance after Pulmonary Vein Isolation Isolation Using Robotic and Manual Approach - Interim Fujii F. - Kurashiki, JPN 136P/33 Results and Procedural Characteristics of the Roma Study Bulava A., Hanis J., Sitek D., Novotny A. - n Dabigatran Anticoagulation for Ceske Budejovice, CZE 136P/41 Electrophysiology Procedures Webber M., Gray I., Stiles M. - Hamilton, NZL 136P/34 n Characteristics of Atrial Fibrillation Ablation in Routine Practice: In-Hospital Results of a French Registry of n Electrophysiological Criteria to Guide More than 1000 Procedures Segmental Pulmonary Veins Isolation-Anatomical Anselme F., Cebron J., Pavin D., Halimi F., Defaye P., Gardey K., Implications Boveda S., Albenque J. - Rouen, FRA 136P/42 Andronache M., Abdelaal A., Magnin-Poull I., Muresan L., Jarmouny S., Negru-Ivanica A., Cedano J., Schwartz J., n The Impact of Atrial Fibrillation Ablation on Groben L., Zinzius P., Sellal J., Mandry D., Cismaru G., P Left Ventricular Function Estimated by Cardiac Magnetic auriah M., Brembilla-Perrot B., Aliot E., De Chillou C. - Resonance Nancy, FRA 136P/35 Amraoui S., Cochet H., Nault I., Shah A., Derval N., Montaudon M., Laurent F., Sacher F., Hocini M., Haissaguerre M., Jais P. - n Intracardiac Echocardiography for Thrombus Pessac, FRA 136P/43 Detection in the Left Atrium. Baran J., Stec M.S., Pilichowska-Paszkiet E., Zaborska B., n Determining the Requirement for Extra-Pv Sikora-Frac M., Krynski T., Kuiakowski P. - Warsaw, POL 136P/36 Ablation for Persistent Atrial Fibrillation Shah D., Park C., Burri H., Sunthorn H., Gentil-Baron P. - n First Experience of a New Remote Catheter Geneva, CHE 136P/44 System for AF Ablation Using 3D Mapping Systems Brown P., Yusuf S., Chalil S., Sandilands A., Stafford P., Ng G. - n Different Strategies for Promoting Stable PV Leicester, GBR 136P/37 Isolation Shah D., Park C., Burri H., Sunthorn H., Gentil-Baron P. - n Electrical Connections between Contiguous Geneva, CHE 136P/45 Pulmonary Veins in Patients with Atrial Fibrillation – Implication for Ablation Strategy n Ablation of AV Nodal Reentrant Tachycardia in Kobori A., Koujitani H., Ide Y., Furukawa Y. - Kobe, JPN136P/38 Patients with Paroxysmal Atrial Fibrillation Scheduled for Pulmonary Vein Isolation Karolyi L., Weinmann T., Otto T., Rämmler C., Kadalie C., Spitzer S. - Dresden, DEU 136P/46 www.cardiostim.com - 92 -

Thursday June 14 INVASIVE EP & ABLATION Posters must remain on display from 14:00 to 17:30, but during the break your presence is required beside your poster 14:00-17:30 Thursday June 14 Poster Area - Level 3 / Agora 3 n The Characteristics of Complex Fractionated n How Effective and Safe Is the Catheter AblationAtrial Electrogram and the Pattern of the Changes in Atrial in Patients with Typical Atrial Flutter Using DifferentFibrillation Cycle Length with Catheter Ablation in Patients Catheter Technologies (comparison of Cryoablation Vs.with Long-Lasting Persistent Atrial Fibrillation: Left Atrial Radiofrequency Ablation)Vs. Biatrial Ablation Heiderfazel S., Ewertsen C., Kuck K., Brachmann J., Willems S.,Nagamoto Y., Park J., Tanubudi D., Ko Y., Ban J., Park Y., Hoffmann E., Horack M., Senges J., Andresen D. -Park H., Choi J., Lim H., Park S., Kim Y. - Seoul, KOR 136P/47 Berlin, DEU 136P/54 n Clinical Significance of Cycle Length of Induced n Ganglionated Plexi Ablation Directed by High-Atrial Tachycardia Following Termination of Chronic Atrial Frequency Stimulation and Complex Fractionated AtrialFibrillation after Stepwise Approach Electrograms for Paroxysmal Atrial FibrillationNagamoto Y., Park J., Tanubudi D., Ko Y., Ban J., Park Y., Pokushalov E., Romanov A., Artyomenko S., Shirokova N.,Park H., Choi J., Park S., Kim Y. - Seoul, KOR 136P/48 Turov A., Karaskov A. - Novosibirsk, RUS 136P/55 n Automated Complex Fractionated Atrial n Comparison of a Radiofrequency PoweredElectrogram Mapping Guided Right Atrial Ablation as One Flexible Needle with a Classic Rigid Brockenbrough Needleof Stepwise Approach for Chronic, Long-Lasting Atrial for Transseptal Punctures in Terms of Safety and EfficacyFibrillation Jauvert G., Grimard C., Lozinguez O., Lazarus A., Alonso C. -Nagamoto Y., Park J., Tanubudi D., Ko Y., Ban J., Park Y., Paris, FRA 136P/56Park H., Choi J., Lim H., Park S., Kim Y. - Seoul, KOR 136P/49 n Effect of Adenosine Testing for Dormant nThe Relationship between Low Voltage Zone Pulmonary Vein Reconduction after Cryoballoon Ablationand the Mechanism of Atrial Tachycardia. for Atrial FibrillationNagamoto Y., Tsuchiya T., Yamaguchi T., Miyamoto K., Stuehlinger M., Spuller K., Senn A., Koman C., Pachinger O.,Sadamatsu K., Hayashida K. - Seoul, KOR 136P/50 Hintringer F. - Innsbruck, AUT 136P/57 n The Achieve-Cryoballoon System: Changing the n Electrical Isolation of the Laa Occurs FollowingFuture of Cryoballoon Pvi Epicardial Laa LigationAcou W., Stockman D., De Greef Y., Wijchers S., Schwagten B. - Han F., Bartus K., Bednarek J., Badhwar N., Lee R. -2020, BEL 136P/51 San Francisco, USA 136P/58 n Three-Dimensional Transesophageal n Electrophysiological Properties of the SuperiorEchocardiographic Imaging as a Novel Tool to Guide the Vena Cava and the Venoatrial Junction in Patients withCryoballoon Ablation of Atrial Fibrillation Atrial Fibrillation: Relevance to Catheter AblationBregasi A., Ottaviano L., Antonelli A., Bruno N., Alsheraei A., Fukumoto K., Takatsuki S., Kimura T., Nishiyama N., TanimotoMassa D., Gronda E., Donatelli F., Porrini A., Montenero A. - K., Hagiwara Y., Aizawa Y., Fukuda Y., Miyoshi S., Fukuda K. -Sesto S. Giovanni Milan, ITA 136P/52 Shinjuku City, JPN 136P/59 n Safety and Efficacy of Concomitant Unipolar RF n Interest of a Novel 8-Pole Micro CircularAblation during Cardiac Surgery Mapping Catheter for Cryoablation of Af: A ComparativeGundry S., Ehrman W. - Palm Springs, USA 136P/53 Study. Cassagneau R., Jacon P., Defaye P. - La Tronche, FRA 136P/60 - 93 - www.cardiostim.com

Thursday June 14Created by Jacques Mugica INVASIVE EP & ABLATION Posters must remain on display from 14:00 to 17:30, but during the break your presence is required beside your poster 14:00-17:30 Poster Area - Level 3 / Agora 3 n Atrial Fibrillation Ablation with Cryo-Balloon n Enhanced Efficiency of a Novel Irrigated RF Technology 3 D ECHO Guided Approach. Ablation Technology for Pulmonary Vein Isolation - Ottaviano L., Bregasi A., Bruno N., Antonelli A., Alsheraei A., A Randomized Trial Massa D., Gronda E., Donatelli F., Porrini A., Montenero A. - Schiebeling-Roemer J., Jadidi A., Weber R., Sesto S. Giovanni Milan, ITA 136P/61 Herrera-Siklody C., Allgeier H., Lehrmann H., Park C., Astheimer K., Restle C., Stockinger J., Blum V., Arentz T. - n Linear Lesions Reduce Biatrial Fractionation at Bad Krozingen, DEU 136P/68 Remote Sites in Persistent AF and Heart Failure Jones D., Haldar S., Jarman J., Johar S., Hussain W., n Pulmonary Vein Isolation with a Multipolar Markides V., Wong T. - London, GBR 136P/62 Ablation Catheter (pvac®) Compared to a Navx-Guided Approach n Endocardial and Epicardial Left Atrial Spitzer S., Karolyi L., Weinmann T., Rämmler C., Otto T., Appendage Isolation Kadalie C. - Dresden, DEU 136P/69 Di Biase L., Valderrabano M., Sanchez J., Santangeli P., Bai R., Mohanty P., Pump A., Horton R., Gallinghouse G., Mohanty S., n Catheter Ablation after Minimally Invasive Thomas B., Gilbert G., Beheiry S., Metz T., Elayi C., Lakkireddy D., Surgical Ablation for Atrial Fibrillation Burkhardt J., Natale A. - Austin, USA 136P/63 Wichterle D., Skalsky I., Peichl P., Cihak R., Kautzner J. - Prague, CZE 136P/70 n Significance of Adenosine Triphosphate- Induced Atrial Fibrillation from Non-Pv Foci n The Impact of Steerable Sheath in Extensive Tao S., Yamauchi Y., Okda H., Maeda S., Naito T., Kagiyama N., Encircling Pulmonary Vein Isolation Yamaguchi T., Hara N., Konishi Y., Umemoto T., Miyamoto T., Inaba O., Nitta J., Kanoh M., Iwai S., Asano M., Muramatsu K., Obayashi T. - Tokyo, JPN 136P/64 Yamato T., Satoh A., Matsumura Y., Takei K., Asakawa K. - Saitama, JPN 136P/71 n Ablation of Epicardial Connections between Pulmonary Vein and Left Atrium n Electrophysiological Effects of an Anteroseptal Lyan E., Klukvin A., Gromyko G., Kazakov A., Merkureva A., Line as an Alternative to Mitral Isthmus Ablation during Yashin S. - Saint- Petersburg, RUS 136P/65 Pulmonary Vein Isolation and Left Atrial Substrate Modification n Significant Reduction of Procedure Time and Brunelli M., Große A., Raffa S., Wagner U., Sammut M., Fluroscopy Exposure Using the Achieve Mapping Wire for Roos M., Richter S., Gorki S., Illhardt E., Geller J. - Pulmonary Vein Isolation with the Cryocath Balloon Bad Berka, DEU 136P/72 Hoenig S., Steinwender C., Kypta A., Lambert T., Saleh K., Leisch F. - Linz, AUT 136P/66 n Alternating Atrial Tachycardia after Prior AF Ablation n Closed and Open Irrigated Radiofrequency Jones D., Johar S., Wang J., Markides V., Wong T. - Ablation Catheters Have a Similar Efficiency and Safety London, GBR 136P/73 Profile at Most Ablation Conditions Guerra J., Jorge E., Raga S., Galvez C., Alonso-Martin C., n Robotic Lasso-Catheter Manipulation Rodríguez-Font E., Cinca J., Viñolas X. - Barcelona, ESP 136P/67 Integrated into Remote Magnetic Ablation of Atrial Fibrillation: Is It Superior to Manual Lasso Manipulation? Nölker G., Gutleben K., Heintze J., Muntean B., Vogt J., Horstkotte D. - Bad Oeynhausen, DEU 136P/74 www.cardiostim.com - 94 -

Thursday June 14 INVASIVE EP & ABLATION Posters must remain on display from 14:00 to 17:30, but during the break your presence is required beside your poster 14:00-17:30 Thursday June 14 Poster Area - Level 3 / Agora 3 n Electrophysiologic Markers of Ablation of the n Catheter Contact Is an Important PredictorCoronary Sinus Substrate of Atrial Fibrillation of Microbubble (mb) Formation Seen on IntracardiacShah D., Park C., Burri H., Sunthorn H., Gentil-Baron P. - Echocardiography (ice) during Ablation Using a Multipolar,Geneva, CHE 136P/75 Duty-Cycled (pvac) Ablation Catheter Verma A., Findley G., Giewercer D., Whaley B., Beardsall M., n Surgical Treatment of Atrial Fibrillation by Tsang B., Pantano A., Wulffhart Z., Khaykin Y. -Ultrasounds with Epicor System Newmarket, CAN 136P/82D’Alessandro C., Hidden-Lucet F., Duthoit G., Gandjbakhch E.,Waintraub X., Chaumeil A., Chastre T., Leprince P., Pavie A. - n Determination of the Contact FORCE duringParis, FRA 136P/76 Ablation of Atrial Fibrillation: Inter-Operator Variability Carmo P., Adragão P., Cavaco D., Morgado F., Candeias R., n Feasibility and Reliability of Stand Alone Almeida S., Quaresma R., Mendes M. - Lisboa, PRT 136P/83Mapping Using a Transluminal Circular Mapping Catheterin Cryoballoon Pulmonary Vein Isolation n Respiration Affects Catheter-Tissue ContactSchade A., Groschup G., Krug J., Langbein A., Schumacher B., FORCE and Pulmonary Vein Reconnection during AtrialStahl C., Szöllösi A., Deneke T. - Bad Neustadt, DEU 136P/77 Fibrillation Ablation Kumar S., Morton J., Halloran K., Wong M., Lee J., Kelland N., n Dormant Pulmonary Vein Conduction Is Less Spence S., Kistler P., Kalman J. - Melbourne, AUS 136P/84Common after Isolation by Means of Cryoballoon thanRadiofrequency Ablation n Optimized Touch Techniques in AtrialGoromonzi F., Baker V., Diab I., Duncan E., Sporton S., Fibrillation Ablation: Is the Contact FORCE GuidedSchilling R., Earley M. - London, GBR 136P/78 Approach Superior to Magnetically Directed Ablation Technology? n 3D-Visualization of Cryo Balloon Catheters and Nölker G., Gutleben K., Heintze J., Muntean B., Horstkotte D.,Left Atrium in Biplane Fluoroscopy for Cryo Pulmonary Vogt J. - Bad Oeynhausen, DEU 136P/85Vein IsolationBourier F., Brost A., Vukajlovic D., Hornegger J., Schneider H., n Pulmonary Vein Isolation: Interest of Real-TimeStrobel N., Kurzidim K. - Regensburg, DEU 136P/79 Contact FORCE Sensing during Radiofrequency Catheter Ablation n Intravascular Ultrasound within the Coronary Albenque J., Grand-Larrieu D., Guy-Moyat B., Fazaa S.,Sinus: A Novel Approach to Facilitate Ablation of the Treguer F., Rosa A., Andre J., Combes N., Combes S., Marijon E.,Mitral Isthmus Boveda S. - Toulouse, FRA 136P/86Ginks M., Page S., Lovell M., Hunter R., Kirkby C., Baker V.,Richmond L., Ramsay S., Sporton S., Schilling R. - n Contact FORCE and Force-Time Integral in AtrialLondon, GBR 136P/80 Catheter Ablation Procedures Predict Bipolar Electrogram Criteria of Transmural Lesion n Prospective Study Comparing Duty-Cycled Squara F., Latcu D., Massaad Y., Mahjoub M., Saoudi N. -Bipolar and Unipolar Radiofrequency to Pulmonary Vein Nice, FRA 136P/87Isolation by Point-By-Point Ablation and CryoballoonAblation. n EndMokrani B., Sarrazin J., Champagne J., Nault I., Zannad N.,Barthez O., Blier L., Phillipon F., Molin F., O’Hara G. -Québec, CAN 136P/81 - 95 - www.cardiostim.com

Thursday June 14Created by Jacques Mugica BASIC ELECTROPHYSIOLOGY SUDDEN CARDIAC DEATH Chairman: D. Zipes – Indianapolis, USA European Heart Rhythm Association «FORTY YEARS OF GROUND-BREAKING CONCEPTS (EHRA) Program IN CARDIAC ELECTROPHYSIOLOGY» Organized by EUROPACE Program Committee Chairman: A. Goette - Magdeburg, DEU 16:00-17:30 16:00-17:30 Room 2.1 / Hermes - Level 2 / Rhodes Room 2.3 / Athena - Level 2 / Rhodes SESSION 141 SESSION 142 UNDERSTANDING ATRIAL FIBRILLATION THE CHALLENGES OF THE ASYMPTOMATIC Co-Chair: PATIENT IN HEREDITARY SYNDROMES Hocini M. - Bordeaux, FRA / Probst V. - Nantes, FRA Co-Chair: Priori S.G. - Pavia, ITA / Wolpert C. - Ludwigsburg, DEU 16:00 n Potassium Channel Remodeling Nattel S. - Montreal, CAN 141/1 16:00 n Asymptomatic Patient with Long QT Syndrome Schulze-Bahr E. - Munster, DEU 142/1 16:20 n Remodeling of Calcium Handling Dobrev D. - Heidelberg, DEU 141/2 16:20 n Asymptomatic Patient with Brugada Syndrome Brugada P. - Aalst, BEL 142/2 16:40 n Structural Remodeling Allessie M. - Maastricht, NLD 141/3 16:40 n Asymptomatic Patient with Early Repolarization Syndrome 17:00 n What Are the Clinical Implications? Haïssaguerre M. - Bordeaux, FRA 142/3 Natale A. - Cleveland, USA 141/4 17:00 n Asymptomatic Patient with Catecholaminergic 17:20 n General Discussion Polymorphic VT Wanguemert Perez F. - Las Palmas, USA 142/4 n End n End www.cardiostim.com - 96 -

Thursday June 14 FETAL CARDIOLOGY PEDIATRIC CARDIOLOGY Organized by Guirgis M. - Paris, FRA Organized by Thambo J.B. - Bordeaux, FRA, Alice Maltret - Paris, FRA, Paul Khairy - Montreal, CAN, Georgia Brugada - Barcelona, ESP 16:00-17:30 16:00-17:30 Thursday June 14 Room 2.4 - Level 2 / Gallieni Room 2.6 - Level 2 / GallieniSESSION 143 SESSION 144FETAL ARRHYTHMIAS - Part II VENTRICULAR ARRYHTHMIAS AND SUDDENCo-Chair: DEATH IN CONGENITAL HEART DISEASE:Silverman N. - USA / Cuneo B. - Chicago, USA CHALLENGES AND CREATIVE SOLUTIONS Co-Chair:16:00 n Pitfalls in Fetal Rhythm Diagnosis Berul C. - Washington, / Thambo J.B. - Pessac, FRABlom N. - Leiden, DEU 143/116:15 n Fetal Therapy : Medical and Ethical Basis 16:00 n Risk Stratification for VT and Sudden Death inGuirgis M. - Paris, FRA 143/2 Congenital Heart Disease: When to Worry? Abadir S. - Montreal, CAN 144/116:30 n Treatment Strategies of Fetal TachyarrhythmiasHornberger L. - Edmonton, CAN 143/3 16:30 n Optimizing ICD Programming In Congenital Heart Disease16:45 n Current Management of Auto Immune Av Block Mansour F. - Montreal, CAN 144/2Jaeggi E. - Toronto, CAN 143/4 17:00 n VT Ablation in Congenital Heart Disease:17:00 n The Cardiac Fetus at Risk of Sudden Death Lessons Learned from Acquired Heart DiseaseCuneo B. - Chicago, USA 143/5 Sacher F. - Bordeaux, FRA 144/317:15 n Pratical Interactive Workshop - Live n EndDemonstrations of Echodoppler Technics for Analysis ofFetal RythmJaeggi E. - Toronto, CAN 143/6Hornberger L. - Edmonton, CAN 143/7 n End - 97 - www.cardiostim.com

Thursday June 14Created by Jacques Mugica PACING & ICD THERAPY CRT 16:00-17:30 16:00-17:30 Room 1.1 - Level 1 / Méditerranée Room 1.2 - Level 1 / Méditerranée SESSION 145 SESSION 146 EVERYTHING AND MRI: IS IT FOR ADVANCES IN CRT: AUTOMATIC CRT EVERYBODY? OPTIMIZATION FOR IMPROVED PATIENT Co-Chair: RESPONSE Bordachar P. - Bordeaux, FRA Co-Chair: Dickstein K. - Stavanger, NOR / Padeletti L. - Florence, ITA 16:00 n MRI & Medical Devices: Current Status Götte M.J.W. - Den Haag, NDL 145/1 16:00 n New Evidence on Dynamic Changes Caused by Reverse Remodelling: Implications for On-Going Patient 16:20 n New Pacemaker Generations and MRI – Current Management Status Sadoul N. - Vandoeuvre Les Nancy, FRA 146/1 Martínez J. - Alicante, ESP 145/2 16:20 n CRT Optimization to Improve Clinical Response: 16:40 ICD’s and MRI, Is This Really MRI Conditional? n From CLEAR to CRT RESPOND Trials Pasquié J. - Montpellier, FRA 145/3 Singh J. - Boston, USA 146/2 17:00 n Leadless Pacing – A Glimpse in the Future 16:40 n Case Presentation: Automatic Optimization of Carlson M. - Cleveland, USA 145/4 CRT Timing with SonR Technology Oliveira M. - Lisbon, PRT 146/3 n End 17:00 n Case Presentation: Adapting CRT Settings to Session made possible thanks to an educational grant from Varying Patient Activity: New Strategies ST JUDE MEDICAL Mansourati J. - Brest, FRA 146/4 17:20 n Round Table Discussion n End Session made possible thanks to an educational grant from SORIN GROUP www.cardiostim.com - 98 -

Thursday June 14 NON INVASIVE HEART FAILURE ELECTROPHYSIOLOGY GERIATRIC CARDIOLOGY THERAPIES FOR ATRIAL FIBRILLATION Organized by ADVANCES AND CONTROVERSIES Win K. Shen – Rochester, USA, Ronald E. Vlietstra – Lakeland, USA IN ATRIAL FIBRILLATION (A.C.A.F) Special Concerns for Your Elderly Patient: A Case-Based Interactive Program Chairmen: G. V. Naccarelli - Hershey, USA, J.J. Blanc - Brest, France, S. Lévy – Marseille, France 16:00-17:30 16:00-17:30 Thursday June 14 Room 1.3 - Level 1 / Méditerranée Room 1.4 - Level 1 / MéditerranéeSESSION 147 SESSION 148ATRIAL FIBRILLATION IV HEART FAILURE AND CARDIAC IMAGING:Co-Chair: SPECIAL CONSIDERATIONS AND RELEVANTLévy S. - Marseille, FRA / Vardas P.E. - Heraklion, GRC ISSUES IN THE ELDERLY Co-Chair:16:00 n Asymptomatic AF: Prognostic Implications Vlietstra R.E. - Lakeland, USA / Wilkoff B.L. - Cleveland, USABlanc J.J. - Brest, FRA 147/116:30 n Is Catheter Ablation of AF Prothrombotic or 16:00 n State of the Art Lecture: Heart Failure in the Elderly: Knowledge Gaps in CRTAntithrombotic? Cannom D. - Los Angeles, USA 148/1Packer D. - Rochester, USA 147/217:00 nRole of Novel Anticoagulants During AF 16:20 n Case 1: 83 yr M, prior MI NYHA III CHF, COPD, QRS duration 120 ms, Echo EF 30%Ablation Procedures? Lee H. - Rochester, USA 148/2Cappato R. - San Donato Milanese (MI), ITA 147/3 n End 16:40 n Case 2: 88 yr W, renovascular HTN, PVCs, Sestamibi EF 60%, NYHA III CHF symptomsUnrestricted Educational Support: sanofi aventis Zieman S. - Baltimore, USA 148/3 17:00 n Case 3: 86 yr W, DOE on golf course, EF 48%, dense LMCA/LAD CA++, elevated BNP Behrenbeck T. - Rochester, USA 148/4 n End - 99 - www.cardiostim.com

Thursday June 14Created by Jacques Mugica BASIC ELECTROPHYSIOLOGY CRT Organized by Course Directors: D. Hayes - Rochester, USA/ Pruvot E. - Lausanne, CHE & Narayan S. - San Diego, USA P. Ritter- Bordeaux, FRA/ D.S. Cannom - Los Angeles, USA/ J. Singh - Boston, USA/ F. Abi-Samra - New Orleans, USA 16:00-17:30 16:00-17:30 Room 1.5 - Level 1 / Méditerranée Room 1.6 / Iris - Level 1 / Méditerranée SESSION 149 SESSION 150 MECHANISTICALLY-GUIDED THERAPIES FOR YOUR OPINION - CRT ISSUES - PART II HUMAN CARDIAC FIBRILLATION - PART II - Co-Chair: ATRIAL ARRHYTHMIAS Abi-Samra F.M. - New Orleans, USA / Lewalter T. - Bonn, DEU Co-Chair: 16:40 n Pro - Now, I Apply CRT only in Heart Failure Berenfeld O. - Ann Arbor, USA Patients with QRS ≥ 150ms Kautzner J. - Prague, CZE 150/1 16:00 n Basic Science of Atrial Fibrillatory Sources: The Role of Rotors vs Multiple Wavelets 17:00 n Contra - Now, I Apply CRT only in Heart Failure Jalife J. - Ann Arbor, USA 149/1 Patients with QRS ≥ 150ms Linde C. - Stockholm, SWE 150/2 16:15 n Localized Rotors and Focal Beats in Human Atrial Fibrillation 16:00 n Pro - Some Patients with LBBB Can Be Cured Narayan S.M. - San Diego, USA 149/2 Thanks to the CRT Blanc J. - Brest, FRA 150/3 16:30 n Clinical Application of Noninvasive Electrocardiographic Imaging (ECGI) 16:20 n Contra - Some Patients with LBBB Can Be Cured Cuculich P. - St. Louis, USA 149/3 Thanks to the CRT Jourdain P. - Pontoise, FRA 150/4 16:45 n Electrogram Correlates of Localized Sources During AF n End Mansour M. - Boston, USA 149/4 17:00 n Role of Imaging and Ablating Structural Obstacles to Treat Human AF Marrouche N. - Salt Lake City, USA 149/5 n End www.cardiostim.com - 100 -

Thursday June 14 PACING BASIC ELECTROPHYSIOLOGY European Heart Rhythm Association European Heart Rhythm Association (EHRA) Program (EHRA) Program Organized by EUROPACE Program Committee Chairman: Organized by EUROPACE Program Committee Chairman: A. Goette - Magdeburg, DEU A. Goette - Magdeburg, DEU 16:00-17:30 16:00-17:30 Thursday June 14 Room 3.1 / Clio - Level 3 / Les Muses Room 3.2 - Level 3 / Les MusesSESSION 151 SESSION 152CONTEMPORARY CONSIDERATIONS BASED TRANSLATIONAL APPROACHES IN ATRIALON TECHNOLOGICAL DEVELOPMENTS IN FIBRILLATIONCARDIAC PACING Co-Chair:Co-Chair: Zaza A. - Milan, ITA / Goette A. - Magdeburg, DEUBotto G. - Como, ITA / Sutton R. - Monaco, MCO 16:00 n Genes and Mutations in Patients with Lone16:00 n Should All Permanent Pacemakers Be MRI Atrial Fibrillation: Do They Matter?Compatible? Olesen M. - Copenhagen, DNK 152/1Santini M. - Rome, ITA 151/1 16:20 n Ionic Remodelling: From Bench to Bedside16:20 n Is Telemonitoring a New Necessity? Van Gelder I. - Groningen, NLD 152/2Burri H. - Geneva, CHE 151/2 16:40 n Structural Remodeling: Which Impact for16:40 n Leadless Pacing: A Step Forward? Catheter Ablation?Roberts P. - Southampton, GBR 151/3 Schotten U. - Maastricht, NLD 152/317:00 n Biological Pacemakers: A Futuristic Approach? 17:00 n Atrial and Ventricular Oxidatives Stress duringIsrael C. - Bielefeld, DEU 151/4 Atrial Fibrillation Lendeckel U. - Greifswald, DEU 152/4 n End n End - 101 - www.cardiostim.com

Thursday June 14Created by Jacques Mugica NONINVASIVE ICD THERAPY ELECTROCARDIOLOGY Course Directors: D. Hayes - Rochester, USA/ ADVANCES IN NONINVASIVE P. Ritter- Bordeaux, FRA/ D.S. Cannom - Los Angeles, USA/ J. Singh - Boston, USA/ F. Abi-Samra - New Orleans, USA ELECTROCARDIOLOGY (ISHNE) Chairmen: W. Zareba, USA, S. Dubner, ARG, A.J. Moss, USA 16:00-17:30 16:00-17:30 Room 3.3 / Erato - Level 3 / Les Muses Room 3.4 / Uranie - Level 3 / Les Muses SESSION 153 SESSION 154 CONSENSUS ON REMOTE MONITORING OF CHALLENGES OF ICD THERAPY - PART IV: CARDIAC IMPLANTED DEVICE DIFFICULT DECISIONS Co-Chair: Co-Chair: Dubner S. - Buenos Aires, ARG / Auricchio A. - Lugano, CHE Binner L. - Ulm, DEU / Varma N. - Cleveland, USA 16:00 n Update on Telemedicine Using Implanted 16:00 n ICD for Elderly Patients: What Is the Limit and Devices when Should We Consider ICD Deactivation? Auricchio A. - Lugano, CHE 153/1 Hayes D. - Rochester, USA 154/1 16:20 n Technologies for Remote Monitoring 16:30 n Driving for ICD Recipients: Where Are the Kirchhof P. - Münster, DEU 153/2 International Rules? Albert C. - Boston, USA 154/2 16:40 n Definitions in Remote Monitoring Schuger C. - Detroit, USA 153/3 17:00 n ICD Recipients at Work: Impact of Environment Binner L. - Ulm, DEU 154/3 17:00 n Indications and Benefits of Remote Monitoring Steinberg J. - New York, USA 153/4 n End n End www.cardiostim.com - 102 -

Thursday June 14 INVASIVE ELECTROPHYSIOLOGY & ABLATION TECHNIQUES WORLD CONGRESS ON CATHETER ABLATION Chairmen: M. Scheinman - San Fransciso, USA, M. O’Neill - London, GBR - V. Probst- Nantes, FRA - F. Sacher - Bordeaux-Pessac, FRA 16:00-17:30 Thursday June 14 Thursday June 14 Room 3.5 / Calliope - Level 3 / Les MusesSESSION 155Interactive sessionChair:Scheinman M. - San Francisco, USA16:00 n Presentation of Complex Cases (SVT)Scheinman M. - San Francisco, USA 155/116:00 n Interactive sessionBadhwar N. - San Francisco, USA 155/2Kalman J. - Parkville, AUS 155/3Callans D. - Philadelphia, USA 155/4 n End - 103 - www.cardiostim.com

Scientific Contents Friday June 15 Sessions 161 to 235 page 109 to 151 Friday June 15 Created by Jacques Mugica - 105 - www.cardiostim.com

Friday June 15 Medtronic Room 2.9 Gallieni Level Visit the TechVillage and discuss with experts . The Next Generation Cryo Technology . The Next Generation Phased RF Technology . The Next Generation Cardiac Monitors . Medtronic - Leading in Leads Opening Hours: Wednesday June 13 to Friday June 15 From 9:00 to 17:00 Please contact your Medtronic representative to register in advance or directly at the welcome desk! www.cardiostim.com - 106 -

Wednesday June 13Today, some prepared programs are still running such asthe Basic Electrophysiology in room 2.1, the CRT in room 1.6, the EHRAprogram in rooms 1.4, 3.1 & 3.2, the ISHNE program in room 3.3, andthe Ablation Techniques in room 3.5.A large part of sessions is dedicated to: • Oral abstract presentations in rooms 1.1, 1.2, 1.5, 2.4, 2.6 • Associate symposia: - HRS symposium and session on Palpitations in room 2.3 - The Brugada Syndrome in rooms 1.3 & 1.5 - sia-Pacific symposium, and symposium on Neuro-Cardiogenic Syncope A in room 1.4 - JHRS symposium, and Italian Cardiostim in room 1.3Educative sessions are proposed about: • Complex arrhythmia management in room 2.3 • Challenging ICD EGMs in room 3.3 • ICD EGMs in the STIMUPRAT program, given in French, in room 3.4 Friday June 15Industry symposia will be the followingAt 9:00 am: • pectranetics, room 1.1: Laser Lead Extraction: Moving to the Next Level. S • Medtronic, room 1.2: ICD Therapy Saves Lives: Do You Care? At 11:00 am: • edtronic, room 1.1: New Advances in Treatment of Pacemaker Patient. M • oston Scientific, room 1.2: LAA Closure for Stroke Prevention: What Every B Electrophysiologist Should Know. i Don’t forget to visit the Poster area in Agora 3! Please think about switching off your cell phone. If your phone rings during sessions, it really disturbs the speakers, thank you for them. Preview Room is at level 2, Gallieni level, close to room 2.4. Scientific Secretariat is at level 2, close to room 2.1 Hermès. The exhibition closes tonight. - 107 - www.cardiostim.com

Friday June 15 BASIC ELECTROPHYSIOLOGY ABLATION TECHNIQUES Chairman: D. Zipes – Indianapolis, USA Joint Session HRS/Cardiostim «FORTY YEARS OF GROUND-BREAKING CONCEPTS IN CARDIAC ELECTROPHYSIOLOGY» 09:00-10:30 09:00-10:30 Room 2.1 / Hermes - Level 2 / Rhodes Room 2.3 / Athena - Level 2 / RhodesSESSION 161 SESSION 162ROLE OF CaMKII IN ARRHYTHMIAS THE 2012 HRS / EHRA / ECAS CONSENSUSCo-Chair: DOCUMENT ON CATHETER AND SURGICALMaier L.S. - Goettingen, DEU / Gilmour Jr R. - Ithaca, USA ABLATION OF ATRIAL FIBRILLATION Chair:09:00 n CaMKII Regulation of Ion Channels Calkins H. - Baltimore, USAPitt G. - Durham, USA 161/1 Friday June 1509:20 n CaMKII Regulation of RyR Receptors and Ca 09:00 n Introduction and Overview of the RecommendationsCycling Calkins H. - Baltimore, USA 162/1Wehrens X. - Houston, USA 161/209:40 n Role of CaMKII in Cardiac Arrhythmias 09:20 n Strategies for Anticoagulation: What Does theMohler P. - Columbus, USA 161/3 Consensus Document Tell Us? Lyndsay B. - Cleveland, USA 162/210:00 n CaMKII as a Potential Antiarrhythmic TargetMaier L. - Goettingen, DEU 161/4 09:40 n Implications for the Design of Clinical Trials of AF Ablation10:20 n What Are the Clinical Implications? Packer D. - Rochester, USA 162/3Mohler P. - Columbus, USA 161/5 10:00 n AF Guidelines from Around the World: How Do n Break / Visit of Exhibits They Compare? Gillis A. - Calgary, CAN 162/4 n Break / Visit of Exhibits nnn INNOVATION AWARD CEREMONY ON JUNE 15 The Innovation Ceremony will be held nnn on Friday June 15 from 12:30 to 13:15 INNOVATION AWARD CEREMONY ON JUNE 15 in room 3.5 / Calliope - Level 3, Les Muses The Innovation Ceremony will be held on Friday June 15 from 12:30 to 13:15 in room 3.5 / Calliope - Level 3, Les Muses - 109 - www.cardiostim.com

Friday June 15Created by Jacques Mugica ABLATION 09:00-10:30 Room 2.4 - Level 2 / Gallieni SESSION 163 EPICARDIAL OR ENDOCARDIAL APPROACH 10:15 n Ventricular Scar at MRI Correlate to Critical Isthmus of Ventricular Tachycardia Circuits and Sites of TO THE TREATMENT OF VT Slow Conduction during Sinus Rhythm Co-Chair: Jadidi A., Cochet H., Komat Y., Scherr D., Kim S., Sacher F., Zeppenfeld K. - Leiden, NLD / Mont L. - Barcelona, ESP Shah A., Derval N., Pascale P., Roten L., Marrouche N., Semersant M., Arentz T., Hocini M., Haissaguerre M., Jais P. 09:00 n A Randomized Trial Comparing Encircling - Bad Krozingen, DEU 163/6 Endocardial versus Endocardial-Epicardial Cryoablation to Prevent VT after LV Reconstruction n Break / Visit of Exhibits Van Huls Van Taxis C., Klein P., Wijnmaalen A., Piers S., Braun J., Versteegh M., Verwey H., Schalij M., Klautz R., Zeppenfeld K. - Leiden, NLD 163/1 nnn 09:15 n Encircling Endocardial Cryoablation during LV INNOVATION AWARD CEREMONY ON JUNE 15 Reconstruction for Primary Prevention of VT The Innovation Ceremony will be held Van Huls Van Taxis C., Klein P., Piers S., Wijnmaalen A., on Friday June 15 from 12:30 to 13:15 Braun J., Versteegh M., Verwey H., Schalij M., Klautz R., in room 3.5 / Calliope - Level 3, Les Muses Zeppenfeld K. - Leiden, NLD 163/2 09:30 n Homogeneization of the Scar (endo/epi) versus Limited Substrate Ablation in Patients with Ischemic Cardiomyopathy and Electrical Storm: Outcomes and Recurrences Mode Di Biase L., Santangeli P., Burkhardt J., Bai R., Mohanty P., Carbucicchio C., Dello Russo A., Casella M., Mohanty S., Pump A., Gilbert G., Metz T., Beheiry S., Pelargonio G., Zucchetti M., Sanchez J., Elayi C., Lakkireddy D., Tondo C., Natale A. - Austin, USA 163/3 09:45 n Differentiation between Scar, Viable Myocardium and Epicardial Fat during Electroanatomical Mapping for Ventricular Tachycardia Ablation: Validation by Integration of Multi-Detector CT and MRI Piers S., Van Huls Van Taxis C., Tao Q., Van Der Geest R., Siebelink H., Schalij M., Zeppenfeld K. - Leiden, NLD 163/4 10:00 n Discrepancies between Unipolar and Bipolar Voltage Mapping for Scar Assessment in the RV: Insights from High Resolution MRI Sacher F., Cochet H., Jalal Z., Relan J., De Guillebon M., Derval N., Pascale P., Roten L., Scherr D., Iriart X., Denis A., Ambri W., Hocini M., Sermesant M., Montaudon M., Ayache N., Haissaguerre M., Laurent F., Thambo J., Jais P. - Bordeaux, FRA 163/5 www.cardiostim.com - 110 -

Friday June 15 LEADs LEAD EXTRACTION 09:00-10:30 09:00-10:30 Room 2.6 - Level 2 / Gallieni Room 1.1 - Level 1 / MéditerranéeSESSION 164 SESSION 165LEAD EXTRACTION: STATE OF THE ART LASER LEAD EXTRACTION: MOVING TO THECo-Chair: NEXT LEVELBongiorni M.G. - Pisa, ITA / Defaye P. - Grenoble, FRA Co-Chair: Klug D. - Lille, FRA / Boveda S. - Toulouse, FRA09:00 n Results of the Lead Extraction Device Evaluationand Results (leader) Database 09:00 n New Technologies in Laser Assisted LeadLove C., Kutalek S., Starck C., Bowse E., Norlander B. - Friday June 15 ExtractionColumbus, USA 164/1 Curnis A. - Brescia, ITA 165/109:15 n Percutaneous Extraction of an Implantable Left 09:20 n Simulated Extraction TrainingAtrial Pressure Monitor Kennergren C. - Göteborg, SWE 165/2Pretorius V., Birgersdotter-Green U., Heywood J., HafelfingerW., Gutfinger D., Eigler N., Love C., Abraham W. - 09:40 n Lead Implantation in Patients with OccludedSan Diego, USA 164/2 Veins Blum T. - Bad Krozingen, DEU 165/309:30 n Canadian Lead Extraction Risk ScoreBashir J., Karim S., Danter M., Cowan S., Tyers G. - 10:00 n Results of Extraction of Non- Infected LeadsVancouver, CAN 164/3 Rinaldi A. - London, GBR 165/409:45 n A Novel Therapy for Salvage of Infected n Break / Visit of ExhibitsPacemakers and Implantable Cardioverter-DefibrilatorsTopaz M., Kazatsker M., Oron Y., Silberman A., Carmel N., Session made possible thanks to an educational grant fromKeren G., Shotan A. - Hadera, ISR 164/4 SPECTRANECTICS10:00 n Infected Device in Dependent Patients: SingleCombined Procedure of Epicardial Pacemaker Implantation nnnFollowed by ExtractionAmraoui S., Barandon L., Whinnett Z., Ploux S., Denis A., INNOVATION AWARD CEREMONY ON JUNE 15Ritter P., Haissaguerre M., Bordachar P. - Pessac, FRA 164/5 The Innovation Ceremony will be held on Friday June 15 from 12:30 to 13:1510:15 n Coronary Sinus Lead Extraction – Single CentreExperience of 145 Procedures and 153 CS Located Ingrown in room 3.5 / Calliope - Level 3, Les MusesLeadsKutarski A., Malecka B., Zabek A., Czajkowski M. -Lublin, POL 164/6 n Break / Visit of Exhibits nnn INNOVATION AWARD CEREMONY ON JUNE 15 The Innovation Ceremony will be held on Friday June 15 from 12:30 to 13:15 in room 3.5 / Calliope - Level 3, Les Muses - 111 - www.cardiostim.com

Friday June 15Created by Jacques Mugica ICD THERAPY SUDDEN CARDIAC DEATH Organized by Sacher F. - Bordeaux-Pessac, FRA 09:00-10:30 09:00-10:30 Room 1.2 - Level 1 / Méditerranée Room 1.3 - Level 1 / Méditerranée SESSION 166 SESSION 167 ICD THERAPY SAVES LIVES: DO YOU CARE? THERAPEUTIC OPTIONS IN BRUGADA Co-Chair: SYNDROME van Gelder I.C. - Groningen, NLD / Kacet S. - Lille, FRA Co-Chair: Veltman C. - Hannover, DEU / Nogami A. - Yokohama, JPN 09:00 n Why Should We Care Implanting ICDs? Auricchio A. - Lugano, CHE 166/1 09:00 n Risk Stratification in Brugada Syndrome Delise P. - Conegliano (TV), ITA 167/1 09:15 n Economics of ICD Therapy: Limitations of Cost Efficacy 09:30 n Outcome after ICD Implantation Braunschweig F. - Stockholm, SWE 166/2 Sacher F. - Bordeaux, FRA 167/2 09:30 n Role of Discrimination Algorithms to Prevent 10:00 n VF Ablation in Brugada Syndrome Inappropriate Shocks Nademanee K. - Los Angeles, USA 167/3 Gold M. - Charleston, USA 166/3 n Break / Visit of Exhibits 09:45 n New Solutions to Increase Benefits and Reduce Risks Gasparini M. - Rozzano (MI), ITA 166/4 nnn 10:00 n Innovative Tools to Improve Patient’s and INNOVATION AWARD CEREMONY ON JUNE 15 Physician’s Lives The Innovation Ceremony will be held Mason M. - Harefield, DEU 166/5 on Friday June 15 from 12:30 to 13:15 n Break / Visit of Exhibits in room 3.5 / Calliope - Level 3, Les Muses Session made possible thanks to an educational grant from MEDTRONIC nnn INNOVATION AWARD CEREMONY ON JUNE 15 The Innovation Ceremony will be held on Friday June 15 from 12:30 to 13:15 in room 3.5 / Calliope - Level 3, Les Muses www.cardiostim.com - 112 -

Friday June 15 ABLATION TECHNIQUES BASIC ELECTROPHYSIOLOGYASIA PACIFIC CARDIOSTIM SYMPOSIUM Under Organized by the Auspices of the Asia Pacific Society Pruvot E. - Lausanne, CHE & Narayan S. - San Diego, USA of Cardiology Organized by K. Sethi – New Delhi, IND/ J. Vohra – Melbourne, AUS/ G. Sloman - Richmond, AUS 09:00-10:30 09:00-10:30 Room 1.4 - Level 1 / Méditerranée Room 1.5 - Level 1 / MéditerranéeSESSION 168 SESSION 169MANAGEMENT OF ARRHYTHMIAS IN THE MECHANISTICALLY-GUIDED APPROACHESELDERLY IN THE ASIAN PACIFIC REGION TO HUMAN CARDIAC FIBRILLATION -PART IIICo-Chair: – VENTRICULAR ARRHYTHMIASSloman G. - Richmond, AUS / Vohra J.K. - Melbourne, AUS Chair: Shivkumar K. - Los Angeles, USA09:00 n Non-Ischaemic Ventricular Tachycardia in Asia Friday June 15Pacific : Regional variation 09:00 n Trigger Mechanisms for Human VentricularSethi K. - New Delhi, IND 168/1 Fibrillation Knecht S. - Bruxelles, BEL 169/109:20 n Catheter Ablation of Ventricular Tachycardia inHypertrophic Cardiomyopathy and Sarcoidosis 09:15 n Recent Developments in Defibrillation and inSoejima K. - Kawasaki, JPN 168/2 Understanding Ventricular Fibrillation Ideker R. - Birmingham, USA 169/209:40 n Catheter Ablation of unusual outflowVentricular Tachycardia 09:30 n What Is the Optimal Mapping Approach toKantharia B. - Columbus,, USA 168/3 Guide Ablation of Human Ventricular Tachyarrhythmias? Shivkumar K. - Los Angeles, USA 169/310:00 n Surgical Ablation of non-ischemic VentricularTacycardia 09:45 n Signal Processing Approaches to Guide ComplexNitta T. - Tokyo, JPN 168/4 Ablation Lin Y. - Taipei, TWN 169/4 n Break / Visit of Exhibits 10:00 n Signal Processing Insights Into the Mechanisms of Human Ventricular Arrhythmias nnn Krummen D. - San Diego, USA 169/5 INNOVATION AWARD CEREMONY ON JUNE 15 n Break / Visit of Exhibits The Innovation Ceremony will be held on Friday June 15 from 12:30 to 13:15 in room 3.5 / Calliope - Level 3, Les Muses nnn INNOVATION AWARD CEREMONY ON JUNE 15 The Innovation Ceremony will be held on Friday June 15 from 12:30 to 13:15 in room 3.5 / Calliope - Level 3, Les Muses - 113 - www.cardiostim.com

Friday June 15Created by Jacques Mugica CRT PACING Course Directors: D. Hayes - Rochester, USA/ European Heart Rhythm Association P. Ritter- Bordeaux, FRA/ D.S. Cannom - Los Angeles, USA/ (EHRA) Program J. Singh - Boston, USA/ F. Abi-Samra - New Orleans, USA Organized by EUROPACE Program Committee Chairman: A. Goette - Magdeburg, DEU 09:00-10:30 09:00-10:30 Room 1.6 / Iris - Level 1 / Méditerranée Room 3.1 / Clio - Level 3 / Les Muses SESSION 170 SESSION 171 YOUR OPINION - CRT ISSUES - Part III THE COMPLEX PACEMAKER IMPLANTATION Co-Chair: Co-Chair: Biffi M. - Bologna, ITA / Prinzen F.W. - Maastricht, NLD Zaza A. - Milan, ITA / Davy J.M. - Montpellier, FRA Endocardial LV Pacing Is Better than Epicardial LV Pacing 09:00 n Device Implant in Case of Subclavian Vein 09:00 Pro n Occlusion Singh J. - Boston, USA 170/1 Bracke F. - Eindhoven, NLD 171/1 09:20 Contra n 09:20 n Implantation of a Pacing System in GUCH Derval N. - Bordeaux, FRA 170/2 Patients Morgan J. - Southampton, GBR 171/2 CCM Is an Efficient Therapy for Heart Failure 09:40 n Pro 09:40 n Pacing Considerations in Pediatric Patients Ricci R. - Rome, ITA 170/3 Cantu’ F. - Bergamo, ITA 171/3 10:00 n Contra 10:00 n Pacemaker Therapy after TAVI Procedure Butter C. - Bernau, DEU 170/4 Wissner E. - Hamburg, DEU 171/4 n Break / Visit of Exhibits n Break / Visit of Exhibits nnn nnn INNOVATION AWARD CEREMONY ON JUNE 15 INNOVATION AWARD CEREMONY ON JUNE 15 The Innovation Ceremony will be held The Innovation Ceremony will be held on Friday June 15 from 12:30 to 13:15 on Friday June 15 from 12:30 to 13:15 in room 3.5 / Calliope - Level 3, Les Muses in room 3.5 / Calliope - Level 3, Les Muses www.cardiostim.com - 114 -

Friday June 15 ABLATION TECHNIQUES SUDDEN CARDIAC DEATH European Heart Rhythm Association ADVANCES IN NONINVASIVE (EHRA) Program ELECTROCARDIOLOGY (ISHNE) Organized by EUROPACE Program Committee Chairman: Chairmen: W. Zareba, USA, S. Dubner, ARG, A.J. Moss, USA A. Goette - Magdeburg, DEU 09:00-10:30 09:00-10:30 Room 3.2 - Level 3 / Les Muses Room 3.3 / Erato - Level 3 / Les MusesSESSION 172 SESSION 173IMPROVING OUTCOMES IN THE CATHETER QT VARIABILITY AND DYNAMICSABLATION OF ATRIAL FIBRILLATION Co-Chair:Co-Chair: Verrier R.L. - Boston, USA / La Rovere M.T. - Pavia, ITAKautzner J. - Prague, CZE / Kuck K.H. - Hamburg, DEU 09:00 n QT Variability09:00 nDenervation of the Heart. The Role of gP Haigney M. - Bethesda, USA 173/1 Friday June 15Ablation in Atrial Fibrillation TreatmentPokushalov E. - Novosibirsk, RUS 172/1 09:20 n QT Dynamics Predicting VT Trayanova N. - Baltimore, USA 173/209:20 n Early Ablation of Atrial Fibrillation. Would WeHave Better Long-Term Results in the Future? 09:40 n QRS-T AngleKirchhof P. - Münster, DEU 172/2 Huikuri H. - Oulu, FIN 173/309:40 n Catheter Ablation of the Long-Standing 10:00 n QT/RR Slope Locati E. - Milano, ITA 173/4Persistent Atrial Fibrillation. Where We Are Now?Willems S. - Hamburg, DEU 172/3 n Break / Visit of Exhibits10:00 n Current Standard of Care in Atrial FibrillationAblationJaïs P. - Bordeaux, FRA 172/4 nnn INNOVATION AWARD CEREMONY ON JUNE 15 n Break / Visit of Exhibits The Innovation Ceremony will be held on Friday June 15 from 12:30 to 13:15 nnn in room 3.5 / Calliope - Level 3, Les Muses INNOVATION AWARD CEREMONY ON JUNE 15 The Innovation Ceremony will be held on Friday June 15 from 12:30 to 13:15 in room 3.5 / Calliope - Level 3, Les Muses - 115 - www.cardiostim.com

Friday June 15Created by Jacques Mugica ICD THERAPY INVASIVE ELECTROPHYSIOLOGY & Course Directors: D. Hayes - Rochester, USA/ ABLATION TECHNIQUES P. Ritter- Bordeaux, FRA/ D.S. Cannom - Los Angeles, USA/ WORLD CONGRESS ON CATHETER ABLATION J. Singh - Boston, USA/ F. Abi-Samra - New Orleans, USA Chairmen: M. Scheinman - San Fransciso, USA, M. O’Neill - London, GBR - V. Probst- Nantes, FRA - F. Sacher - Bordeaux-Pessac, FRA 09:00-10:30 09:00-10:30 Room 3.4 / Uranie - Level 3 / Les Muses Room 3.5 / Calliope - Level 3 / Les Muses SESSION 174 SESSION 175 SUBCUTANEOUS ICDs: A PATH TO A VENTRICULAR TACHYCARDIA ABLATION I TECHNOLOGICAL REVOLUTION Co-Chair: Co-Chair: Bogun F. - Ann Arbor, USA / Callans D. - Philadelphia, USA Borggrefe M. - Mannheim, DEU / Murgatroyd F.D. - Cambridge, GBR 09:00 n Role of Identifying and Ablating Late Potentials Jaïs P. - Bordeaux, FRA 175/1 09:00 n Tolerance of the Material and Efficacy of Arrhythmia Detection 09:20 n Recognition and Ablation of Intraseptal VT Bardy G. - Seattle, USA 174/1 Bogun F. - Ann Arbor, USA 175/2 09:30 n Data Based on Clinical Studies 09:40 n Does Cardiac MRI Identify the Critical VT Exner D. - Calgary, CAN 174/2 Isthmus? Dickfeld T. - Baltimore, USA 175/3 10:00 A Specific Population for SQ ICDs? n Jordaens L. - Rotterdam, NLD 174/3 10:00 n The Role of Endocardial Unipolar Recordings for VT Ablation n Break / Visit of Exhibits Callans D. - Philadelphia, USA 175/4 n Break / Visit of Exhibits nnn INNOVATION AWARD CEREMONY ON JUNE 15 nnn The Innovation Ceremony will be held INNOVATION AWARD CEREMONY ON JUNE 15 on Friday June 15 from 12:30 to 13:15 The Innovation Ceremony will be held in room 3.5 / Calliope - Level 3, Les Muses on Friday June 15 from 12:30 to 13:15 in room 3.5 / Calliope - Level 3, Les Muses www.cardiostim.com - 116 -

Friday June 15 CRT Posters must remain on display from 9:00 to 12:30, but during the break your presence is required beside your poster 09:00-12:30 Poster Area - Level 3 / Agora 3SESSION 176PCRT n A Novel Single-Lead ECG Algorithm for Diagnosing Intermittent Loss of Ventricular Capture in n Optimization Methods after Implantation of Cardiac Resynchronization TherapyCardiac Resynchronization Devices Ganière V., Domenichini G., Niculescu V., Cassagneau R.,Matía R., Hernández-Madrid A., Castilla L., Moro C. - Defaye P., Burri H. - Genève, CHE 176P/8Madrid, ESP 176P/1 n Non Invasive Cardiac Output with Co2 Rebreathing Method for CRT Patients. Friday June 15 nTreatment Options in Non-Responder toCardiac Resynchronization Therapy. Occhetta E., Devecchi C., Devecchi P., Cavallino C., Facchini E.,Matía R., Hernández-Madrid M., Castilla L., Moro C. - Barbieri L., Plebani L., Marino P. - Novara, ITA 176P/9Madrid, ESP 176P/2 n Atrium-Ventricular Delay Optimization by n A Reduction in Total Isovolumic Time with Doppler Echocardiography Reduce Atrial FibrillationCardiac Resynchronisation Therapy Is a Predictor of Clinical Burden in Patients with Cardiac Resynchronization TherapyOutcomes DevicesGuha K., Mantizari L., Mcdonagh T., Sharma R., Gibson D., Cipolletta L., Luzi M., Zuliani L., Capucci A. -Duncan A. - London, GBR 176P/3 Ancona, ITA 176P/10 n A Chronic Heart Failure Model for Experimental n Can Left Atrial Longitudinal Peak DiastolicOptimization in Cardiac Resynchronization Therapy (crt) Strain Predict Cardiac Resynchronization TherapyBecher J., Schmid D., Lippert M., Vollkron M., Petersen S., Response?Czygan G., Maier S. - Würzburg, DEU 176P/4 Soares F., Moreira N., Teixeira R., António N., Elvas L., Martins R., Barbosa A., Gonçalves L., Providência L. - n Experimental Mitral Regurgitation and Left Coimbra, PRT 176P/11Bundle Branch Block; a New Model for DyssynchronousHeart Failure n Patient Selection for ICD and CRT ImplantationVan Middendorp L., Strik M., Houthuizen P., Van Hunnik A., and Device Optimization with Myocardial QuantitativeKuiper M., Prinzen F. - Maastricht, NLD 176P/5 Gated Spect Hovhannesyan A., Hapetyan I. - Yerevan, AM 176P/12 n Reproducibility of Optimal Avd Proposed bySonr Algorithm for Cardiac Resynchronization Therapy n Stimulus Intensity in Left Ventricular Leads andOptimization during Follow Up Response to Cardiac Resynchronization (silver-Crt)Delnoy P., Mansourati J., Leclercq C., Vinolas X., Ritter P., Bavikati V., Langberg J., Williams Iii B., Kella D., Lloyd M. -Anselmi F., Nagele H. - Zwolle, NLD 176P/6 Atlanta, USA 176P/13 n Using Impedance Cardiography for Non- n A New Method Based on QRS for OptimizationInvasive Hemodynamic Optimization of Av-/vv-Delay of the AV and VV Intervals for Cardiac Resynchronizationin CRT Patients: Is It a Feasible Method for Iterative Arbelo E., Borras R., Trucco E., Tolosana J., Penela D.,Measurements? Doltra A., Andreu M., Aceña M., Matas M., Brugada J., Mont L.Puetz V., Dorszewski A. - Essen, DEU 176P/7 - Barcelona, ESP 176P/14 - 117 - www.cardiostim.com

Friday June 15Created by Jacques Mugica CRT Posters must remain on display from 9:00 to 12:30, but during the break your presence is required beside your poster 09:00-12:30 Poster Area - Level 3 / Agora 3 n Optimal Biventricular Pacing Delay and n The Inter- and Intra-Vein Range of Cardiac Electrical Interventricular Conduction Delay in Cardiac Outputs at CRT Implantation, Measured Non-Invasively Resynchronization Therapy with Nicom Heinke M., Ismer B., Kuehnert H., Hoppe H., Solbrig O., Jones M., Khiani R., Foley P., Rajappan K., Bashir Y., Betts T. - Heinke T., Querengaesser J., Surber R., Prochnau D., Figulla H. - Oxford, GBR 176P/22 Jena, DEU 176P/15 n Success in CRT with a New Quadripolar LV Lead Quad-Polar Lead Provides Reliable LV Mid and n Electrical Options Basal Pacing Alzueta Rodriguez J., Olagüe Ros J., Fernández-Lozano I., Prevot S., Anselme F., Philippon F., Molin F., Hong Fung W., García Guerrero J., Fernández De La Concha J., Hernández- Delnoy P., Crijns H., Morillo C., Maru F., Krahn A., Delumeau J., Madrid A., Tolosana Viu J., Barrera Cordero A., Liu L., Gutleben K. - Marseille, FRA 176P/16 Osca Asensi J., Moñivas Palomero V., Santamaría Rebollo P., Simon M., Cabrera-Bueno F. - Malaga, ESP 176P/23 n Long Term Clinical Performance of the Quartet Left Ventricular Lead n Safety and Hemodynamic Impact of a Novel Tomassoni G., Baker J., Corbisiero R., Love C., Martin D., Multi-Point Pacing System - Results from a 1-Month Follow- Niazi I., Sheppard R., Worley S. - Lexington, USA 176P/17 Up Study Gutleben K., Kranig W., Barr C., Morgenstern M., Simon M., n Use of a Quadripolar Left Ventricular Lead Lee K. - Bad Oeynhausen, DEU 176P/24 in Patients with Phrenic Nerve Stimulation and/or High Pacing Thresholds at Cardiac Resynchronisation Therapy n Improvement in Hemodynamic Response Using with Conventional Bipolar LV Leads a New Quadripolar LV Lead Ohlow M., Buchter B., Farah A., Dar Alammouri Y., Cabrera-Bueno F., Olagüe Ros J., Fernández-Lozano I., Fuhrmann J., Von Korn H., Brunelli M., Schreiber M., Geller J., García Guerrero J., Fernández De La Concha J., Hernández- Lauer B - Bad Berka, DEU 176P/18 Madrid A., Tolosana Viu J., Barrera Cordero A., Osca Asensi J., Moñinas Palomero V., Ruiz Jurado A., Llorente Hernangómez E., n Changes in Electromechanical Parameters Alzueta Rodriguez J. - Malaga, ESP 176P/25 during Different Pacing Configurations with a Quadripolar Left Ventricular Lead n A Novel Quad-Polar LV Lead Providing Two Valzania C., Eriksson M., Biffi M., Boriani G., Gadler F. - Zone Pacing Stockholm, SWE 176P/19 Philippon F., Molin F., Fung W., Deharo J., Anselme F., Delnoy P., Crijns H., Morillo C., Maru F., Krahn A., Delumeau J., n Using a Quadripolar Lead in Cardiac Liu L., Gutleben K. - Quebec, CAN 176P/26 Resynchronization: Is There a Hemodynamic Impact of Different Stimulation Vectors? n Trend of Pacing Thresholds in 6 Left Ventricular Puetz V., Dorszewski A. - Essen, DEU 176P/20 Pacing Vectors Giudici M., Ellenbogen K., Shibaji S., Mccabe A., Doshi R., n New Onset of Phrenic Nerve Stimulation by Left Bedi M., Gold M., Kalahasty G. - Davenport, USA 176P/27 Ventricular Pacing at Mid-Term Follow up Zanon F., Pastore G., Baracca E., Fraccaro C., Aggio S., n Practicality of Deliberate Anodal Pacing in Boaretto G., Roncon L., Mazza A., Barold S. - Rovigo, ITA 176P/21 Cardiac Resynchronization Therapy Niazi I., Ryu K., Dahme R., Choudhuri I., Jahangir A., Akhtar M., Sra J. - Milwaukee, USA 176P/28 www.cardiostim.com - 118 -

Friday June 15 CRT Posters must remain on display from 9:00 to 12:30, but during the break your presence is required beside your poster 09:00-12:30 Poster Area - Level 3 / Agora 3 n Effectiveness of Cardiac Resynchronization n Kidney and Right Ventricular Function in HeartTherapy in Elderly Patients: The Same Benefits for an Failure PatientsIncreasing Population? Pieragnoli P., Ricciardi G., Sticchi E., Ristalli F., Ricceri I.,Barbarossa A., Urbinati A., Brambatti M., Matassini M., Checchi L., Nesti M., Pontecorboli G., Fatini C., Romagnuolo I.,Guerra F., Cipolletta L., Capucci A. - Ancona, ITA 176P/29 Porciani M., Padeletti L., Abbate R., Michelucci A. - Florence, ITA 176P/37 n Super Responders to Cardiac ResynchronizationTherapy Have Decreased Risk of Hospitalization or Death n Cystatin C and Response to Cardiac Friday June 15Phan H., Hewitt C., Gill J., Abraham W., Gras D., Resynchronization TherapyBirgersdotter-Green U. - San Diego, USA 176P/30 Ricciardi G., Pieragnoli P., Sticchi E., Ristalli F., Xhaferi B., Ricceri I., Pontecorboli G., Fatini C., Romagnuolo I., Porciani M., n How Many Patients in Functional Class II Are Padeletti L., Abbate R., Michelucci A. - Florence, ITA 176P/38Being Treated with Resynchronization in the Real World?.Matía R., Hernández-Madrid A., Castilla L., Moro C. - n Left Ventricular Function and Quality of LifeMadrid, ESP 176P/31 after Cardiac Resynchronization Therapy (crt) Based on Electrocardiographic and Echocardiographic Changes; Our n Treatment Options in Patients in Atrial Center ExperienceFibrilation during Cardiac Resynchronization Devices Singhal R., Jaswal A., Saxena A. - Delhi, IND 176P/39ImplantationMatía R., Hernández-Madrid A., Castilla L., Moro C. - n Resumption of Sinus Rhythm in Patients withMadrid, ESP 176P/32 Chronic Atrial Fibrillation and Dilated Cardiomyopaty with CRT Implant n Development of Indication for Cardiac Turco P., D’Onofrio A., Stabile G., Solimene F., La Rocca V.,Resynchronization Therapy Cavallaro C., Iuliano A., Donnici G., Vecchione F., De Vivo S.,Ståhlberg M., Kowalski J., Braunschweig F., Linde C., Edner M., De Simone A. - Napoli, ITA 176P/40Dahlström U., Lund L. - Stockholm, SWE 176P/33 n Have Fragmented QRS Complexes Any nRehabilitation Is Better than CRT in Patients Prognostic Value in CRT Patients?with NYHA III and Low Ejection Fraction. Cipolletta L., Oliva M., Brambatti M., Matassini M., Guerra F.,Chwyczko T., Smolis-BAk E., DAbrowski R., SterliNski M., Luzi M., Capucci A. - Ancona, ITA 176P/41MaciAg A., Borowiec A., Kowalik I., Pytkowski M., Szwed H. -Warsaw, POL 176P/34 n Myocardial Perfusion as an Indicator for CRT Response n The Role of Dobutamine Stress Testing as a Svendsen M., Prinzen F., Das M., Berwick Z., Tune J.,Predictor of Left Ventricular Ejection Fraction Improvement Combs W., Berbari E., Kassab G. - Indianapolis, USA 176P/42after Cardiac Resynchronization TherapyNikcevic G., Djordjevic Dikic A., Raspopovic S., Djordjevic S., n Baseline ECG Morphology and Outcome inJovanovic V., Kircanski B., Radovanovic N., Zivkovic M., Patients Treated with Cardiac Resynchronization TherapyPavlovic S., Milasinovic G. - Belgrade, SRB 176P/35 Goldenberg G., Nevzorov R., Eisen A., Kuzniec J., Golovchiner G., Porter A., Strasberg B., Haim M. - n Impact of Right Ventricular Function on Petach Tickva, ISR 176P/43Outcome of Cardiac Resynchronization TherapyHassan A., Farah A., Geller J. - Alexandria, EGY 176P/36 - 119 - www.cardiostim.com

Friday June 15Created by Jacques Mugica CRT Posters must remain on display from 9:00 to 12:30, but during the break your presence is required beside your poster 09:00-12:30 Poster Area - Level 3 / Agora 3 n Reverse Electrical Remodeling by Cardiac n Preservation LV Function with CRT and Ablate Resynchronization Therapy: Prevalence and Clinical Impact and Pace Therapy Sebag F., Martins R., Defaye P., Hidden-Lucet F., Mabo P., Gupta N., Doshi N., Casillas C., Doshi R. - Laguna Hills, USA Daubert J., Leclercq C. - Rennes, FRA 176P/44 176P/51 n Cardiac Resynchronisation Therapy’s Impact n Toward Better Ventricular Pacing in Patients Upon Clinical Outcomes within an Octogenarian with Systemic Right Ventricle Population Van Geldorp I., Bordachar P., Lumens J., De Guillebon M., Guha K., Modi B., Khalique Z., Chandrasekaran B., Whinnett Z., Prinzen F., Haissaguerre M., Delhaas T., Thambo J. - Mcdonagh T., Sharma R. - London, GBR 176P/45 Maastricht, NLD 176P/52 n Electrical and Mechanical Delay in Cardiac n Position of the Left Ventricular Lead and Resynchronization Therapy Outcome of Cardiac Resynchronization Therapy: Role of Kristiansen H., Vollan G., Hovstad T., Keilegavlen H., Echocardiographic Deformation Imaging Faerestrand S. - Bergen, NOR 176P/46 Karimzadeh K., Loghin C., Mukerji S., Memon N., Dougherty A., Kantharia B. - Houston, USA 176P/53 n Prediction of Left Ventricular Ejection Fraction Improvement after CRT by Magnetic Resonance Imaging: n Changes of Interleukin 6 and NT-ProBNP in the Myocardial Scar, Electrical and Mechanical Synchrony Response to Cardiac Resynchronization Therapy Amraoui S., Cochet H., Denis A., Derval N., Ploux S., Minarik T., Brecka D., Vrkocova K., Taborsky M. - Lumens J., Laurent F., Montaudon M., Haissaguerre M., Jais P., Olomouc, CZE 176P/54 Ritter P., Bordachar P. - Pessac, FRA 176P/47 n Right Ventricle Diameters Changes during Preoperative Electrical Interatrial and n Cardiac Resynchronization Therapy Interventricular Conduction Delay by Transesophageal Rinkuniene D., Bucyte S., Zabiela V., Kazakevicius T., Sileikis V., Electrocardiogram Recording in Cardiac Resynchronization Jurkevicius R., Puodziukynas A. - Kaunas, LTU 176P/55 Therapy Heinke M., Ismer B., Kuehnert H., Otte A., Surber R., Jansen D., n Impact of Viability on Ventricular Arrhythmias Prochnau D., Figulla H. - Jena, DEU 176P/48 in Resynchronization Therapy Cvijic M., Zizek D., Lezaic L., Jan M., Zupan I. - n Atrioventricular Junction Ablation Is Not a Ljubljana, SVN 176P/56 Predictor of Mortality in Patients with Atrial Fibrillation Treated with Cardiac Resynchronization Therapy. n Impact of Cardiac Resynchronization Therapy Trucco M., Tolosana J., Castel M., Borrás R., Sitges M., on Left Atrial Geometry: a Prospective Study Calvo N., Arbelo E., Berruezo A., Mont L., Brugada J. - Moreira N., Soares F., Teixeira R., António N., Elvas L., Barcelona, ESP 176P/49 Martins R., Barbosa A., Ferreira M., Providência L. - Coimbra, PRT 176P/57 n Long-Term Outcomes after Cardiac Resynchronization Therapy Are Worse in Patients Who n Female Sex, Arterial Hypertension and Need Junction Ablation for Atrial Fibrillation than in Those Permanent Atrial Fibrillation Support Baseline Age-Related with Sinus Rhythm. Survival in CRT Patients in Long-Term Observational Study. Jedrzejczyk-Patej E., Pruszkowska P., Lenarczyk R., Kowalski O., Kowalik I., Sterlinski M., Maciag A., Lewandowski M., Mazurek M., Boidol J., Pluta S., Sokal A., Kukulski T., Kalarus Z. Ciszewski J., Kraska A., Szwed H. - Warsaw, POL 176P/58 - Zabrze, POL 176P/50 www.cardiostim.com - 120 -

Friday June 15 CRT Posters must remain on display from 9:00 to 12:30, but during the break your presence is required beside your poster 09:00-12:30 Poster Area - Level 3 / Agora 3 n Safety and Long-Term Efficacy of Cardiac n Effect of Left Ventricular Lead Inter-ElectrodeResynchronization Therapy in the Eldery Spacing on Phrenic Nerve and Cardiac Pacing Thresholds:Hoke U., Thijssen J., Van Bommel R., Delgado V., Schalij M., an Acute Canine StudyBax J., Ajmone Marsan N. - Leiden, NLD 176P/59 Biffi M., Foerster L., Breithaupt A., Eastman B., Eggen M., Grenz N., Sommer J., De Santo T., Yang P. - Bologna, ITA 176P/67 n Outcome of Cardiopulmonary Exercise TestingParameters and Left Ventricular Ejection Fraction One Year n Short Term Performance of Right Atrial Leadafter Left Ventricular Pacing Alone in Heart Failure and Sensor Based Optimization Friday June 15Left Ventricular Asynchrony Mont L., Anselme F., Klug D., Binner L., Oswald H., Anselmi F.,Abalea J., Fatémi M., Etienne Y., Castellant P., Valls-Berthault V., Abdennour K., Delnoy P. - Barcelona, ESP 176P/68Novak E., Mialon P., Mansourati J. - Brest, FRA 176P/60 n Incidence and Predictors of Upgrade to n First-Degree Atrioventricular Block Is Associated Resynchronization Therapy: The Raft Upgrade Substudywith Less Benefit from Cardiac Resynchronization Essebag V., Birnie D., Sterns L., Phillipon F., Yee R., Crystal E.,Lee Y., Wu J., Asirvatham S., Del Carpio Munoz F., Friedman P., Kus T., Rinne C., Healey J., Sami M., Thibeault B., Exner D.,Cha Y. - Taipei City, TWN 176P/61 Coutu B., Simpson C., Wulffhart Z., Wells T., Tang A. - Montreal, CAN 176P/69 n Transvenous Left Ventricular Pacing ViaCoronary Sinus in Patients with Tricuspid Valve Disease and n Optimal Pacing Site for CardiacProthesis Resynchronization Therapy in Patients with Systemic RightFan K., Yip G. - Hong Kong, HKG 176P/62 Ventricle Miyazaki A., Sakaguchi H., Ohuchi H., Kagisaki K., Komori A., n Use of St. Jude Medical Ex3100 Pacing System Matsuoka M., Yamamoto T., Yamada O. - Suita, JPN 176P/70Analyzer to Facilitate Left Ventricular Epicardial LeadPlacement in CRT. n Comparison of Thresholds in 6 Left VentricularSchaerf R., Develle R. - Burbank, USA 176P/63 Pacing Vectors Shome S., Kalahasty G., Hessen S., Doshi R., Giudici M., n Hemodynamic Effects of Single and Dual Site Gallagher P., Bedi M., Brisben A., Gold M., Ellenbogen K. - St.Left Ventricular Pacing from a Dual Cathodal Coronary Paul, USA 176P/71Sinus LeadVan Gelder B., Houthuizen P., Bracke F. - Eindhoven, NLD n Use of Imaging Techniques Prior to the 176P/64 Implantation of Cardiac Resynchronization Devices Matía R., Hernández-Madrid A., Castilla L., Moro C. - n Dynamic 3D Model of Coronary Sinus Anatomy Madrid, ESP 176P/72Utilizing 3D Cardiovascular Navigation SystemGreenberg S., Heist K., Costandi P., More R., Ryu K., n Interest of a Simple Method for CoronaryValderrabano M. - Rosyln, USA 176P/65 Sinus Lead Tunneling from Controlateral to Homolateral Subclavian Vein in Upgrading Indications n Evaluation of Electrode Spacing Effect on Taieb J., Garcia E., Quennelle F., Verhaeghe M., Morice R.,Phrenic Nerve Stimulation: the Ping-Ep Study Bouet M., Barnay C. - Aix en Provence, FRA 176P/73Biffi M., Zanon F., Bertaglia E., Padeletti L., Ziacchi M.,Baracca E., Yang P., Varbaro A., De Santo T., De Seta F., n Impact of Left Ventricular Lead Position on theBoriani G. - Bologna, ITA 176P/66 Outcome of Cardiac Resynchronization Therapy Hassan A., Buchter B., Raffa S., Geller J. - Alexandria, EGY 176P/74 - 121 - www.cardiostim.com

Friday June 15Created by Jacques Mugica CRT Posters must remain on display from 9:00 to 12:30, but during the break your presence is required beside your poster 09:00-12:30 Poster Area - Level 3 / Agora 3 n Left Ventricular Lead Position in Cardiac n Electroanatomic Mapping of Coronary Sinus Resynchronization Therapy Using an Insulated Guide Wire Helps LV Lead Fixation Site Kristiansen H., Vollan G., Hovstad T., Keilegavlen H., Choice during CRT Device Implantation. Faerestrand S. - Bergen, NOR 176P/75 Del Greco M., Marini M., Bonmassari R. - Trento, ITA 176P/82 n Resynchronization Device Implantation n Left Ventricular Electrical Activation during Procedure in Real Life. The French Electra Survey Cardiac Resynchronization: Insights from Endocardial Taieb J., Guenoun M., Lazarus A., Fossati F., Cebron J., Contact Mapping. Mansourati J. - Aix en Provence, FRA 176P/76 Pascale P., Derval N., Denis A., Whinnett Z., Ramoul K., Roten L., Shah A., Scherr D., Komatsu Y., Sacher F., n Electrical Activation in Cardiac Knecht S., Bordachar P., Ritter P., Hocini M., Jaïs P., Resynchonization Therapy (CRT): Validation of Noninvasive Haïssaguerre M. - Bordeaux, FRA 176P/83 Activation Mapping with Invasive Electroanatomic Mapping n Pre-Implantation Distress Is Associated with Derval N., Pascale P., Sacher F., Denis A., Ploux S., Roten L., Poorer Health Status in CRT-D Patients Bokan R., Shah A., Ramoul K., Strom M., Ritter P., Versteeg H., Van ‘T Sant J., Meine M., Zwetsloot P., Cramer M., Ramanathan C., Bordachar P., Hocini M., Jaïs P., Doevendans P., Denollet J., Pedersen S. - Tilburg, NLD 176P/84 Haïssaguerre M. - Bordeaux, FRA 176P/77 n Comparison of Benefits from Cardiac Measurement of Left Ventricular Epicardial n Resynchronization Therapy between Ischemic and Non Contraction Timing Using Intraprocedural Fluoroscopy Ischemic Patients Rahman M., Belohlavek M., Whitman T., Hare J., Krum D., Vaccari D., Orazi S., Szwed H., Zupan I., Scheffer M., Choudhuri I., Costa A., Zarkh M., Rapoport A., Khandheria B., Martino M., Ritter P. - Montebelluna, ITA 176P/85 Sra J. - Milwaukee, USA 176P/78 n Intra-Operative Differences between Bipolar and Unipolar Pacing Thresholds in n Ischemic and Non-Ischemic Cardiomyopathy during CRT Multipolar Left Ventricular Leads Implantation Niazi I., Tomassoni G., Baker J., Corbisiero R., Love L., Hassan A., Ohlow M., Buchter B., Geller J. - Martin D., Sheppard R., Worley S., Harbert N. - Alexandria, EGY 176P/86 Milwaukee, USA 176P/79 n Crt Implantation and Factors Affecting Use of Coronary Venous Stents for Left n Radiation Exposure: Results of the Land-It Registry Ventricular Lead Implants Heist E., Toluie K., Mazer S., Lee K. - Sylmar, USA 176P/87 Niazi I., Dhala A., Cooley R., Choudhuri I., Bhatia A., Blanck Z., Sra J. - Milwaukee, USA 176P/80 n Using LV Dp/dt to Assess Acute Hemodynamic Effect of Pacing: a Protocol to Minimize Measurement n Lv/rv Lead Reversal in the Device Header at Variability CRT Upgrade or Generator Change in Order to Mitigate Thibault B., Dubuc M., Guerra P., Karst E., Ryu K., Paiement P., the Risk of Re-Operation in Patients with a Pre-Existing Farazi T. - Montréal, CAN 176P/88 Sprint Fidelis Lead Sivakumaran S., Houlden L., Irwin M., Kimber S. - n Lunch Edmonton, CAN 176P/81 www.cardiostim.com - 122 -

Friday June 15 NONINVASIVE BASIC ELECTROPHYSIOLOGY ELECTROCARDIOLOGY Chairman: D. Zipes – Indianapolis, USA ADVANCES IN NONINVASIVE «FORTY YEARS OF GROUND-BREAKING CONCEPTS IN ELECTROCARDIOLOGY (ISHNE) CARDIAC ELECTROPHYSIOLOGY» Chairmen: W. Zareba, USA, S. Dubner, ARG, A.J. Moss, USA The author’s presence is required to present their poster from 10:30 to 11:00. Posters must remain on display from 9:30 to 12:00 10:30-11:00 11:00-12:30Room Poster Area Les Muses - Level 3 / Les Muses Poster Area Les Muses - Level 3 / Les Muses Room 2.1 / Hermes - Level 2 / RhodesSESSION 177PW SESSION 181CARDIAC ARRHYTHMIAS, HOLTER ROLE OF THE AUTONOMIC NERVOUSCo-Chair: SYSTEM IN ARRHYTHMOGENESISExner D. - Calgary, CAN / Piotrowicz R. - Warsaw, POL Co-Chair: Yamada K. - St.Louis, USA / Franz M.R. - Washington, USA10:30 n Terminal Intra-Qrs Electrical Transients:Markers of Poor Outcome in Subjects with Cardiomyopathy 11:00 n Sympathetic-Vagal Interactions in ConsciousBenchimol Barbosa P., Bomfim A., Barbosa E., Boghossian S., Friday June 15 DogsDa Rocha P., Ginefra P. - Rio De Janeiro, BRA 177PW/1 Lin S. - Indianapolis, USA 181/110:30 n A Vertical Sternal Electrode Pair Provides 11:20 n Vagal Modulation of Atrial ArrhythmiasSuperior Diagnostics for Holter Monitors Po S. - Oklahoma City, USA 181/2Bardy G., Trobaugh G., Trobaugh A., Smith W., Burke M.,Crozier I., Melton I., Inglis J., Anderson J., Johnson G., Gleva M., 11:40 n Vagal Modulation of InflammationPoole J. - Bellevue, USA 177PW/2 Sabbah H. - Detroit, USA 181/310:30 n New HRT Categories and Mortality after 12:00 n What Are the Clinical Implications?Myocardial Infarction Goldberger J. - Chicago, USA 181/4Cebula S., Sredniawa B., Kowalczyk J., Musialik-Lydka A.,Krawczynska A., Swiatkowski A., Kalarus Z. - Zabrze, POL 12:20 n General discussion 177PW/3 Lunch10:30 n Use of Seismocardiography in Cardiac nResynchronization TherapyBurrows M., Jahns G., Houlton G., Van Gelder B.,Marcus F. - Vancouver, CAN 177PW/4 nnn INNOVATION AWARD CEREMONY ON JUNE 1510:30 n Handheld, Thumbs Activated Web Based EventRecording in Children: Use of a Einthoven Lead I Event The Innovation Ceremony will be heldRecorder [er] (zenicor Ekg-2 Tm) on Friday June 15 from 12:30 to 13:15Will J., Usadel L., Opgen-Rhein B., Weiss K., Schmitz L., in room 3.5 / Calliope - Level 3, Les MusesBerger F. - Berlin, DEU 177PW/510:30 n Qrs Fragmentation in Patients withArrhythmogenic Right Ventricular Dysplasia/cardiomyopathy and Complete Right Bundle Branch Block.Peters S. - Gronau, DEU 177PW/6 n Break / Visit of Exhibits nnn INNOVATION AWARD CEREMONY ON JUNE 15 The Innovation Ceremony will be held on Friday June 15 from 12:30 to 13:15 in room 3.5 / Calliope - Level 3, Les Muses - 123 - www.cardiostim.com

Friday June 15Created by Jacques Mugica MISCELLANEOUS ABLATION Stimuprat FORMATION SessionS DE 11:00-12:30 11:00-12:30 Room 2.3 / Athena - Level 2 / Rhodes Room 2.4 - Level 2 / Gallieni SESSION 182 SESSION 183 LES THERAPIES HYBRIDES : PROTHESE ATRIAL IMAGING TECHNIQUES TO GUIDE AF IMPLANTABLE + ABLATION + MEDICAMENTS THERAPY AND ABLATION + … DU CABINET A LA SALLE Co-Chair: D’ELECTROPHYSIOLOGIE Marrouche N. - Salt Lake City, USA / Dickfeld T. - Baltimore, USA Modérateurs : 11:00 n Detailed Analysis of PV Anatomy Can Help Selecting Appropriate Ablation Strategy Frédéric Sacher - Bordeaux - FRA Schwagten B., De Greef Yves Y., Stockman Dirk D., Van Etienne Aliot - Nancy, FRA Langenhove Glenn G. - Antwerp, BEL 183/1 Vincent Probst - Nantes, FRA 11:00 n Analyse de dossiers d’électrophysiologie 11:15 n Acute Physiology of Atrial Resynchronization Via 3D Speckle Tracking Echocardiography complexe, du cabinet à la salle d’exploration invasive Choudhuri I., Ammar K., Niazi I., Sra J., Khandheria B. - Milwaukee, USA 183/2 n Lunch 11:30 n Predictive Value of Delayed Enhancement-MRI in Atrial Fibrillation Ablation Using a Patient-Tailored nnn Protocol INNOVATION AWARD CEREMONY ON JUNE 15 Seitz J., Horvilleur J., Salerno F., Monchi M., Moynagh A., The Innovation Ceremony will be held Mylotte D., O H-Ici D., Mouhoub Y., Curel L., Garot J. - Marseille, FRA 183/3 on Friday June 15 from 12:30 to 13:15 in room 3.5 / Calliope - Level 3, Les Muses 11:45 n Late Gadolinium Enhancement Magnetic Resonance Imaging Prediction of Gaps in Atrial Ablation Lesions Harrison J., Linton N., Karim R., Williams S., Nagahara D., Gill J., Cooklin M., Rinaldi A., Wright M., Rhode K., Schaeffter T., Razavi R., O’Neill M. - London, GBR 183/4 12:00 n Late Gadolinium Enhancement Magnetic Resonance Imaging Correlates with Histology of Acute Atrial Ablation Lesions Harrison J., Linton N., Bloch L., Grøndal A., Fjord S., Bentzon J., Chirbiri A., Kolbitsch C., Karim R., Williams S., Nagahara D., Rhode K., Kim W., Jensen H., Wright M., Cooklin M., Gill J., Razavi R., Schaeffter T., O’Neill M. - London, GBR 183/5 12:15 n MRI Determined Residual Tissue Fibrosis Predicts Recurrent Arrhythmia Following Catheter Ablation of Atrial Fibrillation Akoum N., Morris A., Perry D., Cates J., Burgon N., Macleod R., Marrouche N. - Salt Lake City, USA 183/6 n Lunch www.cardiostim.com - 124 -

Friday June 15 DEVICES PACING 11:00-12:30 11:00-12:30 Room 2.6 - Level 2 / Gallieni Room 1.1 - Level 1 / MéditerranéeSESSION 184 SESSION 185REMOTE MONITORING - MAGNETIC NEW ADVANCES IN TREATMENT OFRESONANCE IMAGING PACEMAKER PATIENTSCo-Chair: Co-Chair:Clémenty J. - Bordeaux-Pessac, FRA / Varma N. - Cleveland, USA Sperzel J. - Bad Nauheim, DEU / Sutton R. - Monaco, MCO11:00 n Remote Monitoring Reduces the Risk of 11:00 n Pacemaker Therapy in Vasovagal Syncope: Friday June 15Delayed Adverse Event Detection in CRT-D Patients ISSUE III Study ResultsDe Ruvo E., Pisanò E., Quaglione R., Sciarra L., Rebecchi M., Brignole M. - Lavagna, ITA 185/1Stirpe F., De Luca L., Zuccaro L., Sebastiani F., Iulianella R.,Magliari F., Iannucci L., Gargaro A., Calò L. - Rome, ITA 184/1 11:15 n Experience with MRI Safe Devices Weishaupt D. - Zurich, CHE 185/211:15 nScheduled ICD Patient Follow-Up May Be “inPerson or Remote”- but Are These Techniques Equivalent? 11:30 n The Importance of Device Detected AtrialResults from the Trust Remote Monitoring Trial FibrillationVarma N., Michalski J., Trust Investigators - Santini M. - Rome, ITA 185/3Cleveland, USA 184/2 11:45 n The Role of New Technology in Device Follow-11:30 nRedundancy of Alert Notifications during ICD UpRemote Monitoring- Friend or Foe? Results from the Trust Morgan J. - Southampton, GBR 185/4Remote Monitoring TrialVarma N., Michalski J., Trust Investigators - 12:00 n The Future of Bradycardia Pacing: LeadlessCleveland, USA 184/3 Pacemakers Ritter P. - Bordeaux, FRA 185/511:45 n Impact of Remote Monitoring Follow-UpStrategy of Implantable Cardioverter Defibrillators n LunchCompared with Conventional Follow-UpDe Ruvo E., Gargaro A., Sciarra L., Rebecchi M., Guarracini F., Session made possible thanks to an educational grant fromStirpe F., Fagagnini A., Sforza M., Palozzi G., Sangiovanni L., MEDTRONICSebastinani F., Iulianella R., Chirico A., Lioy E.,Calò L. - Rome, ITA 184/4 nnn12:00 nSuccessful Use of Magnetic Resonance Imagingin Patients with Implanted Cardioverter Defibrillators INNOVATION AWARD CEREMONY ON JUNE 15Schaerf R., Develle R. - Burbank, USA 184/5 The Innovation Ceremony will be held on Friday June 15 from 12:30 to 13:1512:15 n Magnetic Resonance Imaging in Patients with in room 3.5 / Calliope - Level 3, Les MusesImplantable Cardiac DevicesLupo P., De Ambroggi G., Secchi F., Pittalis M., Foresti S., Ali H.,Infusino T., Sorgente A., Postorino C., Sardanelli F., Cappato R. -San Donato Milanese (MI), ITA 184/6 n Lunch - 125 - www.cardiostim.com

Friday June 15Created by Jacques Mugica STROKE MISCELLANEOUS Cardiostim/Japanese Heart Rhythm Society (JHRS) Joint Symposium 11:00-12:30 11:00-12:30 Room 1.2 - Level 1 / Méditerranée Room 1.3 - Level 1 / Méditerranée SESSION 186 SESSION 187 LAA* CLOSURE FOR STROKE PREVENTION: CURRENT CONCERNS IN JAPAN WHAT EVERY ELECTROPHYSIOLOGIST Co-Chair: SHOULD KNOW Nakazato Y. - Tokyo, JPN / Cazeau S. - Paris, FRA Co-Chair: 11:00 n Physiology of the Failing Heart Camm A.J. - London, GBR / Schumacher B. - Bad Neustadt/ Gronda E. - Milan, ITA 187/1 saale, DEU 11:20 n Narrow QRS Patients: Is the Story Over? 11:00 Is There a Room for a Device Alternative to Oral n Anselme F. - Rouen, FRA 187/2 Anticoagulants? Camm A.J. - London, GBR 186/1 11:40 n Ablation of the Begnin VT? Uno K. - Tsuchiura, JPN 187/3 11:15 n LAAC with WATCHMANTM Device: Latest Clinical Evidences 12:00 n Brugada Syndrome Management - The Reddy V. - New York, USA 186/2 Japanese Position Takagi M. - Osaka, JPN 187/4 11:30 Patient Selection: Finding the Right Patient in n the Right Place n Lunch Schumacher B. - Bad Neustadt/saale, DEU 186/3 Session made possible thanks to an educational grant from 11:45 n LAAC Implant: Practicing Our Knowledge on SORIN GROUP Real Cases Reddy V. - New York, USA 186/4 Debate: LAAC & AFIB Ablation. Should We Perform Both nnn Simultaneously? INNOVATION AWARD CEREMONY ON JUNE 15 nDebate: Pro: The Innovation Ceremony will be held 12:00 Boersma L. - Nieuwegein, NLD 186/5 on Friday June 15 from 12:30 to 13:15 nDebate: Contra: in room 3.5 / Calliope - Level 3, Les Muses 12:10 Schmidt B. - Hamburg, DEU 186/6 n Lunch Session made possible thanks to an educational grant from BOSTON SCIENTIFIC nnn INNOVATION AWARD CEREMONY ON JUNE 15 The Innovation Ceremony will be held on Friday June 15 from 12:30 to 13:15 in room 3.5 / Calliope - Level 3, Les Muses www.cardiostim.com - 126 -

Friday June 15 SYNCOPE SUDDEN CARDIAC DEATH Organized by Daniel Flammang - Lyon, FRA Organized by Sacher F. - Bordeaux-Pessac, FRA 11:00-12:30 11:00-12:30 Room 1.4 - Level 1 / Méditerranée Room 1.5 - Level 1 / MéditerranéeSESSION 188 SESSION 189UNDERSTANDING SYNCOPE UNSOLVED ISSUES IN BRUGADA SYNDROMECo-Chair: Co-Chair:Kenny R.A. - Dublin, IRL / Blanc J.J. - Brest, FRA Lambiase P. - London, GBR / Antzelevitch C. - Utica, USA11:00 n Syncope and Channellopathies 11:00 n SCN5A: Which Role in Brugada SyndromeAbi Samra F. - New Orleans, USA 188/1 Probst V. - Nantes, FRA 189/1 Friday June 1511:15 n Neurophysiology of TLOC: Syncope and Non- 11:30 n Brugada Syndrome Mechanism: Depolarization/Syncope Repolarization or Different Entities with a Same ECGRyvlin P. - Lyon, FRA 188/2 Pattern Postema P. - Amsterdam, NLD 189/211:30 n Physiopathology of CSMParry S. - Newcastle Upon Tyne, GBR 188/3 12:00 n Value of Electrophysiological Study for Risk Stratification: The PRELUDE Study11:45 n New Research Pathways in Syncope Priori S. - Pavia, ITA 189/3Benditt D. - Minneapolis, USA 188/4 n Lunch12:00 n ATP Test in the Management of Syncope: BasicAspects of Data InterpretationPelleg A. - Philadelphia, USA 188/5 nnn n Lunch INNOVATION AWARD CEREMONY ON JUNE 15 The Innovation Ceremony will be held on Friday June 15 from 12:30 to 13:15 nnn in room 3.5 / Calliope - Level 3, Les Muses INNOVATION AWARD CEREMONY ON JUNE 15 The Innovation Ceremony will be held on Friday June 15 from 12:30 to 13:15 in room 3.5 / Calliope - Level 3, Les Muses - 127 - www.cardiostim.com

Friday June 15Created by Jacques Mugica CRT ABLATION TECHNIQUES Course Directors: D. Hayes - Rochester, USA/ European Heart Rhythm Association P. Ritter- Bordeaux, FRA/ D.S. Cannom - Los Angeles, USA/ (EHRA) Program J. Singh - Boston, USA/ F. Abi-Samra - New Orleans, USA Organized by EUROPACE Program Committee Chairman: A. Goette - Magdeburg, DEU 11:00-12:30 11:00-12:30 Room 1.6 / Iris - Level 1 / Méditerranée Room 3.1 / Clio - Level 3 / Les Muses SESSION 190 SESSION 191 CRT ISSUES, PART IV: OPINIONS CONTINUOUS MONITORING IN ATRIAL REGARDING TECHNIQUES FOR LV LEAD FIBRILLATION MANAGEMENT. NEW SCIENCE PLACEMENT OR NEW TRUTH? Co-Chair: Co-Chair: Israel C.W. - Bielefeld, DEU / Gras D. - Nantes, FRA Lewalter T. - Bonn, DEU / Zupan I. - Ljubljana, SVN 11:00 n I Choose That Sheath in That Case 11:00 n Symptomatic/Asymptomatic Events after AF Morgan J. - Southampton, GBR 190/1 Ablation Hindricks G. - Leipzig, DEU 191/1 11:20 n I Choose That Lead in That Patient Gras D. - Nantes, FRA 190/2 11:20 n Anticoagulation/Antiarrhythmic Management after AF Ablation 11:40 n I Decide to Stop or Continue the Procedure in Kirchhof P. - Münster, DEU 191/2 That Case (Reference to Complications and Duration of Procedure) 11:40 n AF Burden in Assessment of Long-Term Success Worley S. - Lancaster, USA 190/3 after AF Ablation Puererfellner H. - Linz, AUT 191/3 n Lunch 12:00 n Management of Early Post-Operative Period. Who Will Need Early Reablation? nnn Pokushalov E. - Novosibirsk, RUS 191/4 INNOVATION AWARD CEREMONY ON JUNE 15 n Lunch The Innovation Ceremony will be held on Friday June 15 from 12:30 to 13:15 in room 3.5 / Calliope - Level 3, Les Muses nnn INNOVATION AWARD CEREMONY ON JUNE 15 The Innovation Ceremony will be held on Friday June 15 from 12:30 to 13:15 in room 3.5 / Calliope - Level 3, Les Muses www.cardiostim.com - 128 -

Friday June 15 ABLATION TECHNIQUES SUDDEN CARDIAC DEATH European Heart Rhythm Association ADVANCES IN NONINVASIVE (EHRA) Program ELECTROCARDIOLOGY (ISHNE) Organized by EUROPACE Program Committee Chairman: Chairmen: W. Zareba, USA, S. Dubner, ARG, A.J. Moss, USA A. Goette - Magdeburg, DEU 11:00-12:30 11:00-12:30 Room 3.2 - Level 3 / Les Muses Room 3.3 / Erato - Level 3 / Les MusesSESSION 192 SESSION 193COMPLICATIONS RELATED TO ATRIAL EARLY REPOLARIZATION: BENIGN VERSUSFIBRILLATION CATHETER ABLATION DANGEROUS?Co-Chair: Co-Chair:Gaita F. - Asti, ITA / Hatala R. - Bratislava, SVK Huikuri H. - Oulu, FIN / Turitto G. - Brooklyn, USA11:00 n Prevalence and Predictors of Complications of 11:00 n Electrophysiology of Early Repolarization El-Sherif N. - Brooklyn, USA Friday June 15Radiofrequency Catheter Ablation for Atrial Fibrillation 193/1Kautzner J. - Prague, CZE 192/1 11:20 n Early Repolarization and SCD11:20 n Catheter Ablation on Uninterrupted Warfarin: Haïssaguerre M. - Bordeaux, FRA 193/2Is It Safe?Schilling R. - London, GBR 192/2 11:40 n Early Repolarization in Athletes Corrado D. - Padova, ITA 193/311:40 nIncidence of Silent Cerebral ThromboembolicLesions after Atrial Fibrillation Ablation: Predictive Factors? 12:00 n Current State of the Early RepolarizationScaglione M. - Asti, ITA 192/3 Clinical Research Stern S. - Jerusalem, ISR 193/412:00 n Long-Term Rates of Death, Stroke, andDementia Following Atrial Fibrillation Ablation n LunchDay J. - Salt Lake City, USA 192/4 n Lunch nnn INNOVATION AWARD CEREMONY ON JUNE 15 nnn The Innovation Ceremony will be held on Friday June 15 from 12:30 to 13:15 INNOVATION AWARD CEREMONY ON JUNE 15 in room 3.5 / Calliope - Level 3, Les Muses The Innovation Ceremony will be held on Friday June 15 from 12:30 to 13:15 in room 3.5 / Calliope - Level 3, Les Muses - 129 - www.cardiostim.com

Friday June 15Created by Jacques Mugica PACING & ICD THERAPY INVASIVE ELECTROPHYSIOLOGY & Course Directors: D. Hayes - Rochester, USA/ ABLATION TECHNIQUES P. Ritter- Bordeaux, FRA/ D.S. Cannom - Los Angeles, USA/ WORLD CONGRESS ON CATHETER ABLATION J. Singh - Boston, USA/ F. Abi-Samra - New Orleans, USA Chairmen: M. Scheinman - San Fransciso, USA, M. O’Neill - London, GBR - V. Probst- Nantes, FRA - F. Sacher - Bordeaux-Pessac, FRA 11:00-12:30 11:00-12:30 Room 3.4 / Uranie - Level 3 / Les Muses Room 3.5 / Calliope - Level 3 / Les Muses SESSION 194 SESSION 195 YOUR OPINION VENTRICULAR TACHYCARDIA ABLATION II Co-Chair: Co-Chair: Ritter P. - Bordeaux, FRA / Reynolds D.W. - Oklahoma City, USA Kay N. - Birmingham, USA / Hocini M. - Bordeaux, FRA 11:00 n Leadless ICD and Leadless Pacemaker 11:00 n Ablation of the Patient with Ischemic VT Wilkoff B. - Cleveland, USA 194/1 Soejima K. - Kawasaki, JPN 195/1 11:20 n Leadless ICD and Leadless Pacemaker 11:20 n Catheter Ablation of VT from Papillary Muscles Brachman J. - Coburg, DEU 194/2 Kay N. - Birmingham, USA 195/2 11:40 n Implantation of ICDs for Primary Prevention in 11:40 n VF Ablation in Post MI Patients Patients Older than 80 Years Snumowski L. - Warsaw, POL 195/3 Murgatroyd F. - Cambridge, GBR 194/3 12:00 n Long-Term Outcome after VF Ablation 12:00 Implantation of ICDs for Primary Prevention in n Hocini M. - Bordeaux, FRA 195/4 Patients Older than 80 Years Klein H. - Rochester, USA 194/4 n Lunch n Lunch nnn nnn INNOVATION AWARD CEREMONY ON JUNE 15 The Innovation Ceremony will be held INNOVATION AWARD CEREMONY ON JUNE 15 on Friday June 15 from 12:30 to 13:15 The Innovation Ceremony will be held in room 3.5 / Calliope - Level 3, Les Muses on Friday June 15 from 12:30 to 13:15 in room 3.5 / Calliope - Level 3, Les Muses www.cardiostim.com - 130 -

Friday June 15 BASIC ELECTROPHYSIOLOGY PALPITATIONS Chairman: D. Zipes – Indianapolis, USA Organized by Raviele A. - Venice, ITA «FORTY YEARS OF GROUND-BREAKING CONCEPTS IN CARDIAC ELECTROPHYSIOLOGY» 14:00-15:30 14:00-15:30 Room 2.1 / Hermes - Level 2 / Rhodes Room 2.3 / Athena - Level 2 / RhodesSESSION 201 SESSION 202SMALL CONDUCTANCE CALCIUM- MANAGEMENT OF PATIENTS WITHACTIVATED POTASSIUM CHANNELS (SK) PALPITATIONSAND CARDIAC ARRHYTHMIAS Co-Chair:Co-Chair: Raviele A. - Venice, ITA / Scheinman M.M. - San Francisco, USALakatta E. - Baltimore, USA / Opthof T. - Amsterdam, NLD 14:00 n Definition, Causes and Classifications Steinbeck G. - Munich, DEU Friday June 1514:00 What Are SK Channels? n 202/1Chiamvimonvat N. - Chicago, USA 201/1 14:15 n Diagnosis Strategy and Clinical Evaluation14:20 n SK Channels and Ventricular Arrhythmias in Blanc J.J. - Brest, FRA 202/2Heart FailureChen P. - Indianapolis, USA 201/2 14:30 n Ambulatory Electrocardiographic Monitoring Giada F. - Noale, ITA 202/314:40 n SK Channels Modulate CardiogenesisLiebau S. - Ulm, DEU 201/3 14:45 n Electrophysiologic Study and Other Instrumental Investigations15:00 n SK Channels and Genetic Basis of Atrial Callans D. - Philadelphia, USA 202/4FibrillationEllinor P. - Boston, USA 201/4 15:00 n How to Treat and When to Hospitalize Viskin S. - Tel Aviv, ISR 202/515:20 What Are the Clinical Implications? nMyerburg R. - Miami, USA 201/5 n Break / Visit of Exhibits n Break / Visit of Exhibits nnn INNOVATION AWARD CEREMONY ON JUNE 15 nnn The Innovation Ceremony will be held INNOVATION AWARD CEREMONY ON JUNE 15 on Friday June 15 from 12:30 to 13:15 The Innovation Ceremony will be held in room 3.5 / Calliope - Level 3, Les Muses on Friday June 15 from 12:30 to 13:15 in room 3.5 / Calliope - Level 3, Les Muses - 131 - www.cardiostim.com

Friday June 15Created by Jacques Mugica ABLATION ABLATION 14:00-15:30 14:00-15:30 Room 2.4 - Level 2 / Gallieni Room 2.6 - Level 2 / Gallieni SESSION 203 SESSION 204 ALTERNATE TECHNIQUES FOR AF ABLATION CONTACT FORCE AND OUTCOME OF AF Chair: ABLATION Sanders P. - Adelaïde, USA Co-Chair: Shah D. - Geneva, CHE / O’Neill M. - London, GBR 14:00 n Impact of AF-Induced Tachycardiomyopathy on Outcome of Atrial Fibrillation Ablation 14:00 n Evolution of Ablation Technique during PVI Calvo N., Bisbal F., Guiu E., Ramos P., Tolosana J., Arbelo E., Using Contact FORCE Berruezo A., Sitges M., Brugada J., Mont L. - Neuzil P., Michaud G., Saliba W., Albenque J., Mangrum J., Barcelona, ESP 203/1 Kuck K., Mansour M., Harari D., Lambert H., Reddy V. - Prague, CZE 204/1 14:15 n Characterization of Radiofrequency Redo Procedures after Cryoballoon Pulmonary Vein Isolation 14:15 n Contact FORCE Instability Caused by Respiration Godin B., Gardey K., Savoure A., Anselme F. - during RFA for PVI Rouen, FRA 203/2 Albenque J., Mansour M., Natale A., Michaud G., Kuck K., Kalbfleisch S., Shah D., D’Avila A., Ben Chikh A., Yulzari A., 14:30 n Analysis of Efficacy of Pulmonary Vein Isolation Reddy V. - Toulouse, FRA 204/2 with Cryoballoon and Irrigated Tip Catheter Using Propensity Score Matching 14:30 n Anatomical Variations in Contact FORCE Berkowitsch A., Zaltsberg S., Greiss H., Pajitnev D., Akkaya E., Mitigated by Deflectable Sheath Lehinant S., Erkapic D., Schmitt J., Hamm C., Kuniss M., Shah D., Mansour M., Neuzil P., Kuck K., Packer D., Jordaens L., Neumann T. - Bad Nauheim, DEU 203/3 D’Avila A., Yulzari A., Harari D., Reddy V. - Geneva, CHE 204/3 14:45 n To Isolate or Not to Isolate: A Prospective 14:45 n Lesion Size Index for Prediction of Reconnection Randomized Study Comparing Standard Pulmonary Vein Following PVI Isolation vs. Arrhythmogenic Vein Isolation in Paroxysmal Kuck K., Nakagawa H., Shah D., Neuzil P., Kautzner J., Atrial Fibrillation Fremont O., Yulzari A., Lambert H. - Hamburg, DEU 204/4 Fichtner S., Estner H., Büchner M., Jilek C., Ammar S., Reents T., Kathan S., Hessling G., Deisenhofer I. - Munich, DEU 203/4 15:00 n Efficas 2 Results: Contact Force, FTI, Lesion Continuity Roles at PVI 15:00 n Results of Linear Block at the Left Atrial Roof in Neuzil P., Wissner E., Kautzner J., Cihak R., Peichl P., Paroxysmal Atrial Fibrillation: A Prospective Randomized Wichterle D., Petru J., Skoda J., Lambert H., Yulzari A., Kuck K. - Study Prague, CZE 204/5 Arbelo E., Guiú E., Berruezo A., Tolosana J., Andreu D., Ramos P., Bisbal F., Borras R., Brugada J., Mont L. - 15:15 n Adenosin-Mediated Acute Pulmonary Vein Barcelona, ESP 203/5 Reconnection Occurs at Regions of Low Contact Force-Time Integral - A Randomized Trial 15:15 n Renal Denervation and Pulmonary Vein Jadidi A., Park C., Weber R., Lehrmann H., Schiebeling-Roemer Isolation in Patients with Drug Resistant Hypertension and J., Allgeier J., Herrera-Sidloky C., Astheimer K., Restle C., Symptomatic Atrial Fibrillation Stockinger J., Blum T., Arentz T. - Bad Krozingen, DEU 204/6 Pokushalov E., Romanov A., Artyomenko S., Turov A., Shirokova N., Karaskov A. - Novosibirsk, RUS 203/6 n Break / Visit of Exhibits n Break / Visit of Exhibits www.cardiostim.com - 132 -

Friday June 15 INVASIVE EP CRT 14:00-15:30 14:00-15:30 Room 1.1 - Level 1 / Méditerranée Room 1.2 - Level 1 / MéditerranéeSESSION 205 SESSION 206MAPPING OF COMPLEX ARRHYTHMIAS: A IMMEDIATE AND LONG-TERM OPTIMIZATIONNEW LOOK AT OLD DISEASES OF CRTCo-Chair: Co-Chair:Jalife J. - Ann Arbor, USA / Ibeker R.E. - Birmingham, USA Cazeau S. - Paris, FRA / Francis D. - London, GBR14:00 n Lack of Correlations between Electrical and 14:00 n Is There a Role for Intraoperative Measurement Friday June 15Anatomical-Mechanical Left Atrial Remodeling in Patients of DP/DT in Severe Heart Failure and Narrow QRSwith Atrial Fibrillation Luedorff G., Grove G., Wolff E., Kranig W. -Maury P., Thomson E., Combes N., Duparc A., Mondoly P., Guetersloh, DEU 206/1Berry M., Cognet T., Lairez O., Gauthier M., Massabuau P.,Arnaudis B., Delay M., Albenque J. - Toulouse, FRA 205/1 14:15 n Optimizing Cardiac Resynchronization Therapy: Revival of Vectorcardiography14:15 n Rotors and Focal Beats Explain how Triggers Strik M., Houthuizen P., Van Middendorp L., Ploux S.,Initiate Human Atrial Fibrillation Van Hunnik A., Kuiper M., Prinzen F. - Maastricht, NLD 206/2Schricker A., Lalani G., Krummen D., Narayan S. -San Diego, USA 205/2 14:30 n Haemodynamic Response to AV Delay Optimisation Depends on Heart Rate: Patient Data14:30 n Rotors and Focal Beats that Sustain Analysed with Model SimulationsAtrial Fibrillation Correlate Poorly with Fractionated Lumens J., Whinnett Z., Van Geldorp I., Ploux S.,Electrograms Haïssaguerre M., Ritter P., Bordachar P. - Maastricht, NLD 206/3Schricker A.A., Lalami G., Krummen D.E.,Narayan S. - San Diego, USA 205/3 14:45 n Impact of Electrical Dyssynchrony on the Benefit of Electrogram Based AV Optimization: Findings14:45 n Impact of Atrial Fibrosis on Wave Propagation from the Smart-AV Trialin Human Atrial Fibrillation - Evidence for Regional Gold M., Singh J., Birgersdotter-Green U., Yu Y., Meyer T.,Channel / Pivot / Slow Conduction at Delayed Enhanced Seth M., Ellenbogen K. - Charleston, USA 206/4SitesJadidi A., Cochet H., Kim S., Miyazaki S., Scherr D., 15:00 n AV Optimization in the Presence of LV ElectricalShah A., Derval N., Sacher F., Pascale P., Roten L., Marrouche N., Delay: Findings from the Smart-AV TrialSemersant M., Arentz T., Hocini M., Haissaguerre M., Gold M., Singh J., Yu Y., Meyer T., Seth M., Ellenbogen K. -Jais P. - Bad Krozingen, DEU 205/4 Charleston, USA 206/515:00 n Percutaneous Detection of Human Ventricular 15:15 n Early Positive Response to CRT in PatientsFibrillation Rotors Optimized by SonR: Results from the Clear StudyKrummen D., Morris D., Mulpuru S., Ho J., Smetak M., Ho G., Lunati M., Beauverger Y., Mabo P., Galley D., Schumacher B.,Briggs C., Narayan S. - San Diego, USA 205/5 Martino M., Padeletti L. - Milan, ITA 206/615:15 n Surface ECG Phase Correlation Predicts Human n Break / Visit of ExhibitsVentricular Fibrillation RotorsKrummen D., Morris D., Mulpuru S., Smetak M., Ho J., Ho G.,Briggs C., Narayan S. - San Diego, USA 205/6 n Break / Visit of Exhibits - 133 - www.cardiostim.com

Friday June 15Created by Jacques Mugica PACING & ICD THERAPY SYNCOPE Organized by Santomauro M. - Naples, ITA Organized by Daniel Flammang - Lyon, FRA 14:00-15:30 14:00-15:30 Room 1.3 - Level 1 / Méditerranée Room 1.4 - Level 1 / Méditerranée SESSION 207 SESSION 208 SPORT PRACTICE IN PACEMAKER AND ICD CLINICAL CASES SESSION PATIENTS Co-Chair: Co-Chair: Parry S.W. - Newcastle Upon Tyne, GBR / Flammang D. - Lyon, FRA Botto G. - Como, ITA / Brignole M. - Lavagna, ITA 14:00 n CLINICAL CASES SESSION: Presentation and 14:00 Elegibility to Sport Practice of Patients with PM n Interpretation of Chimical Cases on Syncope and/or ICD: Current Guidelines Parry S. - Newcastle Upon Tyne, GBR 208/1 Delise P. - Conegliano (TV), ITA 207/1 Benditt D. - Minneapolis, USA 208/2 Pruvot E. - Lausanne, CHE 208/3 14:15 n Management of Inappropriate ICD Therapies in Flammang D. - Lyon, FRA 208/4 Athletes Deharo J. - Marseille, FRA 208/5 Padeletti L. - Florence, ITA 207/2 n Break / Visit of Exhibits 14:30 n Commotio Cordis in Young Athletes: How to Prevent It? Calo’ L. - Rome, ITA 207/3 14:45 n Sudden Death in Athletes: The Role of the PM and the ICD Lunati M. - Milan, ITA 207/4 15:00 n Management of the Syncope in Athletes with Implantable Devices Inama G. - Crema, ITA 207/5 n Break / Visit of Exhibits www.cardiostim.com - 134 -

Friday June 15 MISCELLANEOUS CRT Course Directors: D. Hayes - Rochester, USA/ P. Ritter- Bordeaux, FRA/ D.S. Cannom - Los Angeles, USA/ EPIC ALLIANCE Scientific Session@CARDIOSTIM J. Singh - Boston, USA/ F. Abi-Samra - New Orleans, USA 14:00-15:30 14:00-15:30 Room 1.5 - Level 1 / Méditerranée Room 1.6 / Iris - Level 1 / MéditerranéeSESSION 209 SESSION 210EP: WHAT’S HOT, WHAT’S NOT, WHAT’S FOLLOW-UP OF CRT PATIENTSTOUGH Co-Chair:Co-Chair: Ricci R. - Rome, ITA / Taborski M. - Olomovc, CZEPoole J.E. - Seattle, USA / Hoffmann E. - Munich, DEU 14:00 n Management of Non-Respondersn AF Ablation: Beyond Pulmonary Vein Isolation – Case Parks K.A. - Boston, USA 210/1 Friday June 15studies14:00 Ernst S. - London, GBR 209/1 14:20 n Management of Super Responders Stellbrink C.- Bielefeld, DEU 210/214:10 Eisenberg S. - Walnut Creek, USA 209/2n Controversies in Lead Extractions for Non-Infectious 14:40 n Management of AFIndications Leyva F. - Sutton Coldfield, GBR 210/314:20 Birgersdotter-Green U. - San Diego, USA 209/314:30 Bongiorni M. - Pisa, ITA 209/4 15:00 n Management of VAs (from PVCs to Sustained VT) Mittal S. - New York City, USA 210/4n Complex VT Ablation: When the Going Gets Tough14:40 Chung M. - Cleveland, USA 209/5 n Break / Visit of Exhibits14:50 Blomström-Lundqvist C. - Uppsula, SWE 209/615:00 n Panel Discussion / Q&A n Break / Visit of Exhibits - 135 - www.cardiostim.com

Friday June 15Created by Jacques Mugica ICD THERAPY ABLATION TECHNIQUES European Heart Rhythm Association European Heart Rhythm Association (EHRA) Program (EHRA) Program Organized by EUROPACE Program Committee Chairman: Organized by EUROPACE Program Committee Chairman: A. Goette - Magdeburg, DEU A. Goette - Magdeburg, DEU 14:00-15:30 14:00-15:30 Room 3.1 / Clio - Level 3 / Les Muses Room 3.2 - Level 3 / Les Muses SESSION 211 SESSION 212 MANAGEMENT OF PATIENTS WITH ADVANCES IN ROBOTIC AND 3D MAPPING DEFIBRILLATOR SHOCKS: STATE-OF-THE ART TECHNOLOGIES FOR ATRIAL FIBRILLATION Co-Chair: ABLATION Boriani G. - Bologna, ITA / Morgan J.M. - Southampton, GBR Co-Chair: Kautzner J. - Prague, CZE / Santini M. - Rome, ITA 14:00 n Incidence, Predictors and Impact on Mortality van Rees J.B. - Den Haag, NLD 211/1 14:00 n Remote Magnetic Catheter Navigation: Is It the «Gold Standard»? 14:20 n ICD Configuration and Programming to Ernst S. - London, GBR 212/1 Optimise Shock Treatment Katz A. - Beer, ISR 211/2 14:20 n Methods, Efficacy, and Safety of Robotic Catheter Ablation for Atrial Fibrillation 14:40 n Results of Catheter Ablation in Patients with Pisapia A. - Marseille, FRA 212/2 Shocks Arenal Maiz A. - Madrid, UK 211/3 14:40 n Three-Dimensional Rotational Angiography: A New Online Imaging Tool 15:00 n How to Manage Patient Anxiety Noelker G. - Coburg, DEU 212/3 Ladwig K. - Munich, DEU 211/4 15:00 n Catheter Ablation of Atrial Fibrillation Using a n Break / Visit of Exhibits New Non-Fluoroscopic Sensor-Guided 3D Navigation Tool Hindricks G. - Leipzig, DEU 212/4 n Break / Visit of Exhibits www.cardiostim.com - 136 -

Friday June 15 SUDDEN CARDIAC DEATH ICD THERAPY ADVANCES IN NONINVASIVE ELECTROCARDIOLOGY (ISHNE) Chairmen: W. Zareba, USA, S. Dubner, ARG, A.J. Moss, USA Stimuprat FORMATION SessionS DE 14:00-15:30 14:00-15:30 Room 3.3 / Erato - Level 3 / Les Muses Room 3.4 / Uranie - Level 3 / Les MusesSESSION 213 SESSION 214UPDATE ON INHERITED ARRHYTHMIA LA CONSULTATION EN LIVE :DISORDERS: DON’T MISS THE DIAGNOSIS FONCTIONNEMENT DES DEFIBRILLATEURS(case-based presentation) AUTOMATIQUES IMPLANTABLES A PARTIRCo-Chair: DES PROGRAMMATEURS (D’UNE MARQUEZareba W. - Rochester, USA / Locati E. - Milano, ITA A L’AUTRE) Modérateurs: Friday June 1514:00 Long QT Syndrome n Pierre Bordachar - Bordeaux - FRAMoss A. - Rochester, USA 213/1 Stéphane Garrigue - Bordeaux - FRA Sylvain Reuter - Bordeaux - FRA14:20 n ARVC Philippe Ritter - Bordeaux - FRAMarcus F. - Tucson, USA 213/2 Frédéric Anselme - Rouen, FRA Serge Boveda - Toulouse, FRA14:40 n Brugada Syndrome Pascal Defaye - Grenoble, FRABrugada P. - Aalst, BEL 213/3 Nicolas Sadoul - Nancy, FRA15:00 n Anderson-Tawil Syndrome n Break / Visit of ExhibitsTristani-Firouzi M. - Salt Lake City, USA 213/4 n Break / Visit of Exhibits - 137 - www.cardiostim.com

Friday June 15Created by Jacques Mugica INVASIVE ELECTROPHYSIOLOGY & INVASIVE EP & ABLATION ABLATION TECHNIQUES WORLD CONGRESS ON CATHETER ABLATION Posters must remain on display from 14:00 to 17:30, Chairmen: M. Scheinman - San Fransciso, USA, but during the break your presence is required M. O’Neill - London, GBR - V. Probst- Nantes, FRA - beside your poster F. Sacher - Bordeaux-Pessac, FRA 14:00-15:30 14:00-17:30 14:00-17:30 Room 3.5 / CalliopeLevel 3 /3Agora Muses Poster Area - - Level / Les 3 Poster Area - Level 3 / Agora 3 SESSION 215 SESSION 216P VENTRICULAR TACHYCARDIA ABLATION III - EP 1: INVASIVE EP & ABLATION FOR ATRIAL Debates FIBRILLATION Co-Chair: n Novel Robotic Catheter Manipulation System Badhwar N. - San Francisco, USA Integrated with Remote Magnetic Navigation for Fully Remote Ablation of Atrial Tachyarrhythmias: a Multi- Patients with 1st Appropriate ICD Shock Should be Treated Center Evaluation with Ablation: Akca F., Nölker G., Gutleben K., Muntean B., Vogt J., Horstkotte D., 14:00 n PRO Dabiri Abkenari L., Szili-Torok T. - Rotterdam, NLD 216P/1 de Chillou C. - Nancy, FRA 215/1 n Rotational Angiography of Left Atrium for 14:20 CON n Pulmonary Vein Isolation. Comparison with Mri Soejima K. - Kawasaki, JPN 215/2 Baszko A., Lanocha M., Kaimucki P., Michalski M., Dankowski R., Jerzykowska O., Pyda M., Elikowski W., Ablation of AF : First Line Therapy in Electrical Storms: Siminiak T., Szyszka A. - Poznan, POL 216P/2 14:40 n PRO n A Systematic Comparison of Left Atrial Boyle N. - Los Angeles, USA 215/3 Endocardial Voltage and Late Gadolinium Enhancement 15:00 n CON Magnetic Resonance Imaging (lge Mri) Coromilas J. - New York, USA 215/4 Harrison J., Linton N., Karim R., Williams S., Nagahara D., Gill J., Cooklin M., Rinaldi A., Wright M., Rhode K., Schaeffter T., n Break / Visit of Exhibits Razavi R., O’Neill M. - London, GBR 216P/3 n Mediguide Magnetic Positioning Technology Accurately Tracks Catheter Location Sih H., Hegrenes J., Rollmann T., Jensen J. - St. Paul, USA216P/4 n Spatial Accuracy of 3D Electro-Anatomical Systems during Pulmonary Vein Isolation Allgeier J., Jadidi A., Schiebeling-Roemer J., Weber R., Lehrmann H., Herrera-Siklody C., Astheimer K., Restle C., Blum T., Stockinger J., Park C., Arentz T. - Bad Krozingen, DEU 216P/5 n Volume-Based Mapping Is More Accurate than Electroanatomical Surface Mapping of the Left Atrium Latcu D., Mahjoub M., Zarqane N., Popescu I., Massaad Y., Rijo N., Saoudi N. - Monaco, MCO 216P/6 n Simulation of the Effect of Sodium and Potassium Blockers on the Ecg Zemzemi N., Rodriguez Blanca - Talence, FRA 216P/7 www.cardiostim.com - 138 -

Friday June 15 INVASIVE EP & ABLATION Posters must remain on display from 14:00 to 17:30, but during the break your presence is required beside your poster 14:00-17:30 Poster Area - Level 3 / Agora 3 n Complex Fractionated Electrogram Influenced n Long Term Results of Catheter Ablation ofby Antiarrhythmogenic Agents and Modified Atrial Ventricular Tachycardia in Patients with ArrhythmogenicSubstrate Right Ventricular Cardiomyopathy/Dysplasia and ElectricalKaitani K., Okishige K., Hanazawa K., Aoyagi H., Azegami K., StormNakagawa Y. - Tenri, JPN 216P/8 Müssigbrodt A., Dinov B., Richter S., Fiedler L., Schönbauer R., Eitel C., Sommer P., Piorkowski C., Hindricks G., Arya A. n Persistent Atrial Fibrillation Dominant - Leipzig, DEU 216P/16Frequency on Standard ECG Predicts Catheter Ablation Friday June 15Outcome n Are Radiofrequency Energy Applications withinGaribaldi M., Zarzoso V., Latcu D., Meo M., Meste O., the Aortic Sinus Cusp for Curing Ventricular ArrhythmiasPopescu I., Saoudi N. - Sophia Antipolis, FRA 216P/9 Really Effective and Safe in the Long Run? Nakano E., Tada H., Sekiguchi Y., Yoshida K., Aonuma K., n Ecg Spatiotemporal Complexity Predicts Harada T., Miyake F. - Kawasaki, JPN 216P/17Catheter Ablation Outcome in Persistent AfibMeo M., Latcu D., Zarzoso V., Meste O., Garibaldi M., n Long Term Follow up of Catheter Ablation ofPopescu I., Saoudi N. - Sophia Antipolis Cedex, FRA 216P/10 Ventricular Tachycardias in Patients after Correction of Complex Congenital Heart Disease n Transvalvular Impedance Signal as a Peichl P., Janousek J., Gebauer R., Kubus P., Kautzner J. -Reliable Indicator of Acute Changes in Left Ventricular Prague, CZE 216P/18Performance: Validation Study with Pressure-Volume LoopAnalysis in a Swine Model n Electrogram Characteristics of SuccessfulLionetti V., Bianchi G., Romano S., Bernini F., Mascia G., Nesti M., Ablation in Fascicular VTDi Gregorio F., Barbetta A., Padeletti L. - Pisa, ITA 216P/11 Thachil A., Premkumar K., Masilamani L., Chennapragada S., Rao H., Kalavakolanu S., Narasimhan C. - Hyderabad, IND n Using an Adaptive Autoregressive Model for 216P/19the Early Detection of Action Potential Duration AlternansPrudat Y., Borgstrom N., Olcese R., De Lange E., Kucera J. - n Successful Epicardial Ablation of IncessantBern, CHE 216P/12 Papillary Muscle Ventricular Tachycardia Using a 40mm Intra-Pericardial Balloon to Prevent Phrenic Nerve Injury n Differences in Characteristics of Ventricular Sun A., Darden W., Kanter R., Hranitzky P. - Durham, USAEpicardium between a Patient with and without Early 216P/20Repolarization on 12-Lead ElectrocardiogramMiki Y., Naito S., Nishiuchi S., Matsuhashi N., Tsukada N., Sasaki T., n Characterization of Endocardial and EpicardialHayano M., Nakamura K., Fuke E., Sakamoto T., Nakamura K., Vetricular Arrhythmogenic Substrate in IschemicKaseno K., Kumagai K., Oshima S. - Maebashi, JPN 216P/13 Cardiomyopathy Vergara P., Bellini B., Petracca F., Trevisi N., Sala S., Radinovic A., n Cardiac Involvement in Patients with Steinert Mazzone P., Maccabelli G., Della Bella P. - Milano, ITA 216P/21Muscular DystrophyPistone E., Golzio P., Mongini T., Morello M., Grosso Marra W., n Novel Magnetic Positioning Technology in LeftGaita F. - Torino, ITA 216P/14 Ventricle 3D Anatomic Model Creation Sih H., Rollmann T., Hegrenes J., Jensen J. - St. Paul, USA n J Point Elevation in Children at Risk and 216P/22Survivors of Near-Miss Sudden Cardiac Death in ChildhoodOsman A., Seager M., Stuart G., Harrison M. - Bristol, GBR 216P/15 - 139 - www.cardiostim.com

Friday June 15Created by Jacques Mugica INVASIVE EP & ABLATION Posters must remain on display from 14:00 to 17:30, but during the break your presence is required beside your poster 14:00-17:30 Poster Area - Level 3 / Agora 3 n Late Potentials Show Higher Spectral Frequency n Epicardial Ventricular Tachycardia Ablation and Rate-Dependant Exaggeration at Sites of Successful Using a Steerable Epicardial Sheath: an Initial Clinical Ventricular Tachycardia Ablation Experience Lalani G., Narayan S., Scherr D., Komatsu Y., Jadidi A., Sacher F., Dinov B., Schoenbauer R., Romano V., Sommer P., Bollmann A., Hocini M., Haissaguerre M., Jais P. - San Diego, USA 216P/23 Gaspar T., Husser-Bollmann D., Piorkowski C., Hindricks G., Arya A. - Leipzig, DEU 216P/30 n Programmed Ventricular Stimulation in Asymptomatic Patients with Arrhythmogenic Right n Increasing Incidence of 24h Isolated Pvcs Ventricular Cardiomyopathy Is Related to Growing Complexity and Incidence of Maupain C., Gandjbakhch E., Duthoit G., Amet D., Arrhythmia in Chagasic Subjects with Preserved Left Hidden-Lucet F., Komajda M. - Paris, FRA 216P/24 Ventricular and Autonomic Functions Benchimol Barbosa P., Tura B., Barbosa E., Barbosa-Filho J., n The Use of Waveform Capnography for Kantharia B. - Rio De Janeiro, BRA 216P/31 Procedural Sedation during Electrophisyological Studies and Cardiac Ablations n Automated Matching Technique in Patients Morandi F., Pecora D., Predolini S., Stamera C., Cipressa A., Ablated Due to Outflow Tract Ventricular Arrhythmias Cuccia C. - Brescia, ITA 216P/25 Kuteszko R., Pytkowski M., Farkowski M., Maciag A., Jankowska A., Kowalik I., Kraska A., Zajac D., Chwyczko T., n Long Term Outcome of Catheter Ablation Szwed H. - Warsaw, POL 216P/32 of Electrical Storm Due to Monomorphic Ventricular Tachycardia in a Large Cohort of Patients with Nonischemic n Conscious Sedation with Sufentanil for Cardiomyopathy Epicardial VT Ablation. Fiedler L., Dinov B., Schönbauer R., Bollmann A., Sommer P., Ramoul K., Tafer N., Derval N., Knecht S., Remi J., Roten Gaspar T., Husser-Bollmann D., Piorkowski C., Hindricks G., L., Pascale P., Hocini M., Jais P., Haissaguerre M., Sacher F. - Arya A. - Leipzig, DEU 216P/26 Bordeaux, FRA 216P/33 n Focal Idiopathic Ventricular Tachycardias. Origin n Relation between Myocardial Wall Thinning and Catheter Ablation. and Arrhythmogenic Substrate Underlying Postinfarction Robles F., Galizio N., Gonzalez J., Albano F., Palazzo A., Ventricular Tachycardia Carnero G., Gargano A., Martinenghi N., Vallejos X. - Komatsu Y., Hubert Cochet H., Daniel Scherr D., Amir S. Ciudad Autonoma De Buenos Aires, ARG 216P/27 Jadidi A., Frederic Sacher F., Nicolas Derval N., Ashok Shah A., Laurent Roten L., Patrizio Pascale P., Shinsuke Miyazaki S., n Changes in NT-ProBNP Level after Successful Maxime Sermesant M., Jatin Relan J., Michel Montaudon M., Pvc Ablation in Patiens without Structural Heart Disease: François Laurent F., Steven J.Kim S., Mélèze Hocini M., Michel Evendince for Pvc-Induced Chronis Wall Stress Haïssaguerre M., Pierre Jaïs P. - Bordeaux, FRA 216P/34 Van Huls Van Taxis C., Leong D., Piers S., Wijnmaalen A., Dyrda K., Delgado V., Van Der Laarse A., Pijnappels D., Schalij M., n Sudden Cardiac Death: First Non-Ischaemic Zeppenfeld K. - Leiden, NLD 216P/28 Application of a Novel Risk Marker Smith M., Nicolson W., Brown P., Tuan J., Sandilands A., n Three-Dimensional Scar Distribution in Stafford P., Schlindwein F., Mccann G., Ng G. - Leicester, GBR Idiopathic Dilated Cardiomyopathy and Ventricular 216P/35 Arrhythmias. Evertz R., Berruezo A., Fernández-Armenta J., Andreu D., Borràs R., Mont L., Brugada J. - Barcelona, ESP 216P/29 www.cardiostim.com - 140 -

Friday June 15 INVASIVE EP & ABLATION Posters must remain on display from 14:00 to 17:30, but during the break your presence is required beside your poster 14:00-17:30 Poster Area - Level 3 / Agora 3 n New Onset Effect on Ventricular Arrhythmias in n Ablation of Paroxysmal AF. Two Year Results inStemi Patients Six Months after Stem Cell Therapy a Large Patient Cohort.Celentano E., Geelen P., De Potter T., Peytchev P., Stefan L., Maglia G., Nardi S., Argenziano L., De Martino G.,Eisenberger M., Bartunek J. - Aalst, BEL 216P/36 Scaglione M., Esposito C., Borrello F., Marullo F., Schiavone V. - Catanzaro, ITA 216P/44 n Catheter Ablation Improves Hemodynamics,Functional Status, and Quality of Life in Patients with n Long Term Follow-Up after Cryoablation ofLong-Standing Persistent Atrial Fibrillation and Low Left Atrial Fibrillation Friday June 15Ventricular Ejection Fraction Cassagneau R., Jacon P., Defaye P. - La Tronche, FRA 216P/45Fiala M., Wichterle D., Sknouril L., Bulková V., Nevralová R.,Toman O., Chovancík J., Dorda M., Pindor J., Januska J., n The Impact of Catheter Ablation for AtrialSpinar J. - Trinec, CZE 216P/37 Fibrillation on Right Atrial Reverse Remodeling Doi A., Inoue K., Sotomi Y., Masuda M., Toyoshima Y., n Surgical AF Ablation. Results of Kimura R., Koyama Y., Iwakura K., Fujii K. - Osaka, JPN 216P/46Electrophysiological Study at 6 Months.Sacher F., Labrousse L., Barandon L., Roten L., Derval N., n Does AF Burden Measured by Implantable LoopPascale P., Hocini M., Scherr D., Haissaguerre M., Roques X., Recorder during Post-Ablation Blanking Period PredictJais P. - Bordeaux, FRA 216P/38 Response at 12 Month Follow-Up? Pokushalov E., Romanov A., Losik D., Corbucci G., n Surgical Treatment of Atrial Fibrilation – Long- Artyomenko S., Turov A., Shirokova N., Karaskov A., Mittal S.,Term Experience Steinberg J. - Novosibirsk, RUS 216P/47Krausová R., Kautzner J., Pirk J., Skalsky I. - Prague, CZE 216P/39 n Long-Term Incidence of Atrial Fibrilation after n Mechanisms of Very Late Recurrence after Lone Persistent Atrial Flutter Radiofrequency AblationAtrial Fibrillation Ablation Fernando Scazzuso F., Gomez L., Alberto Giniger A.,Sotomi Y., Inoue K., Kimura R., Toyoshima Y., Masuda M., Santiago Rivera S., Gaston Albina G., Ruben Laiño R. -Doi A., Iwakura K., Fujii K. - Osaka, JPN 216P/40 Buenos Aires, ARG 216P/48 n Length of Hospital Stay and Results of n Prediction of Sinus Node Dysfunction afterCatheterablation - 1yr-Follow-Up-Data from the German Ablation for Persistent AFAblation Register Masuda M., Inoue K., Kimura R., Toyoshima Y., Doi A.,Spitzer S., Brachmann J., Kuck K., Andresen D., Willems S., Sotomi Y., Iwakura K., Fujii K. - Osaka, JPN 216/49Hoffmann E., Tebbenjohanns J., Schumacher B., Becker R.,Heinroth K., Senges J. - Dresden, DEU 216P/41 n Report on the Nationwide Survey of Catheter Ablation in Japan n AF Ablation in Persistent AF. Two Year Results Murakawa Y., Nogami A., Hirao K., Shoda M., Aizawa Y.,in a Large Patient Cohort. Nitta T., Mitamura H., Okumura K. - Kawasaki, JPN 216P/50Nardi S., Argenziano L., De Martino G., Scaglione M.,Esposito C., Borrello F., Marullo F., Schiavone V., Maglia G. - n Efficacy of Radiofrequency Catheter Ablation inCastel Volturno, ITA 216P/42 Patients of Atrial Fibrillation with Structural Heart Disease: Results from a Single Center Experience in 250 Patients n Improvement in Kidney Function Following Kanamori N., Saeki T., Mukai Y., Hanaoka R., Takatori O.,Catheter Ablation of Atrial Fibrillation Omi W., Nagai H., Sakagami S. - Kanazawa, JPN 216P/51Akoum N., Windfelder J., Barakat M., Burgon N., Kanamu L.,Marrouche N. - Salt Lake City, USA 216P/43 - 141 - www.cardiostim.com

Friday June 15Created by Jacques Mugica INVASIVE EP & ABLATION Posters must remain on display from 14:00 to 17:30, but during the break your presence is required beside your poster 14:00-17:30 Poster Area - Level 3 / Agora 3 n Irrigated Gold-Tip Catheter Ablation of n Significant Pulmonary Vein Remodeling after Persistent Atrial Fibrillation – Safety, Feasibility and Duty-Cycled Bipolar/unipolar Radiofrequency Ablation for Outcome of a Magnetically Guided Technique Atrial Fibrillation Nölker G., Gutleben K., Heintze J., Vogt J., Muntean B., Compier M., Leong D., Ajmone Marsan N., Delgado V., Horstkotte D. - Bad Oeynhausen, DEU 216P/52 Zeppenfeld K., Schalij M., Trines S. - Leiden, NLD 216P/58 n Transcatheter Atrial Fibrillation Ablation in a n Safety and Efficacy of Dabigatran in Patients Single High Volume Center : Symptomatic Complications Undergoing Left Atrial Ablation Procedures: a Case- and Silent Cerebral Ischemia Matched Analysis Corleto A., Battaglia A., Sardi D., Pianelli M., Blandino A., Pavaci H., Reents T., Fichtner S., Ammar S., Schön P., Zhu P., Ferraris F., Di Donna P., Caponi D., Scaglione M., Gaita F. - Wu J., Kathan S., Jilek C., Hessling G., Kolb C., Deisenhofer I. - Torino, ITA 216P/53 München, DEU 216P/59 n Cardiac Perforation during Radiofrequency n Transseptal Access to the Left Atrium Using Ablation of Atrial Fibrillation in Medium Size Centers: a Novel Radiofrequency Needle - an Efficient Tool for Incidence and Mechanisms of Perforation Difficult Cases Mahjoub M., Latcu D., Massaad Y., Boulé S., Maury P., Schiebeling-Roemer J., Lehrmann H., Jadidi A., Weber R., Traulé S., Anselme F., Extramiana F., Zimmerman M., Deharo J., Herrera-Siklody C., Allgeier H., Park C., Astheimer K., Restle C., Saoudi N. - Monaco, MCO 216P/54 Stockinger J., Blum V., Arentz T. - Bad Krozingen, DEU 216P/60 n Recurrent Spontaneous Clinical Peri-Mitral n Pulmonary Vein Isolation Has No Short-Term Atrial Tachycardia Following Atrial Fibrillation Ablation: Effect on Cognitive Function: a Comparison of 3 Different Clinical Characteristics and Outcome Ablation Techniques Miyazaki S., Shah A., Scherr D., Jadidi A., Roten L., Pascale P., Nagy Balo E., Kiss A., Clemens M., Kovacs K., Csiba L., Edes I., Pedersen M., Derval N., Sacher F., Hocini M., Jais P., Csanadi Z. - Debrecen, HUN 216P/61 Haissaguerre M. - Tsuchiura, JPN 216P/55 n Left Atrial Area and Atrial Fibrillation Incidence n Qtc Prolongation Following Atrial Fibrillation in Patients Who Underwent Typical Atrial Flutter Ablation Ablation Gomez G., Scazzuso Fernando S., Giniger Alberto G., Albina Mokrani B., Garnier F., Roten L., Sarrazin J., Kneicht S., Gaston A., Rivera Santiago R., Laiño Ruben R. - Champagne J., O’Hara G., Haissaguerre M., Zannad N., Buenos Aires, ARG 216P/62 Phillipon F., Blier L., Molin F., Barthez O., Nault I. - Québec, CAN 216P/56 n Response to Atrial Entrainment Is Highly Accurate in Identifying Mechanism of Wide Complex n Incidence and Management of Potentially Tachycardia Fatal Peri-Procedural Tamponade in Patients Undergoing Abdelwahab A., Abdelghani M., Baghdadi Y., Noman A., Pulmonary Vein Isolation for Atrial Fibrillation Sapp J. - Cairo, EGY 216P/63 Allgeier J., Jadidi A., Weber R., Schiebeling-Roemer J., Herrera-Siklody C., Lehrmann H., Park C., Astheimer K., Restle n The Superior Vena Caval Route to Mapping C., Stockinger J., Blum T., Hocini M., Haissaguerre M., Jais P., and Ablating Right Anterior, Anteroseptal and Parahis Arentz T. - Bad Krozingen, DEU 216P/57 Accessory Pathways - a Safe, Stable Alternative to the Femoral Venous Route. Okreglicki A. - Cape Town, ZAF 216P/64 www.cardiostim.com - 142 -

Friday June 15 INVASIVE EP & ABLATION Posters must remain on display from 14:00 to 17:30, but during the break your presence is required beside your poster 14:00-17:30 Poster Area - Level 3 / Agora 3 n Atrial Preexcitation and a Fixed S-A Interval n Morphology of Slow Pathway Potential andin Relation to the Fusion Zone Are Superior to Ppi-Tcl in Its Relation to Junctional Rhythm and Ablation Success inIdentifying SVT Mechanism Pediatric Population with AvnrtAbdelwahab A., Abdelhamid M., Abdelhady Y., Shafiq M. - Baszko A., Czyz K., Surmacz R., Zuchowski B., Bobkowski W.,Cairo, EGY 216P/65 Siwinska A., Szyszka A. - Poznan, POL 216P/73 n Ablation of Atrial Arrhythmias Occurred after n Prospective Validation of Automated RightSurgical Closure of Atrial Septal Defect Ventricular Pacing from Right Inflow and Outflow Tract for Friday June 15Ebrille E., Scaglione M., Raimondo C., Caponi D., Di Donna P., Differential Diagnosis of Supraventricular Tachycardia.Alciati M., Delcrè S., Corsinovi L., Blandino A., Gaita F. - Stec S., Romanek J., Chlebus M., Sledz J., Klank-Szafran M.,Asti, ITA 216P/66 Mazij M., Szafarz P., Sztembis R., Ludwik B., Ras M., Labus M., Banasik M., Bzymek M., Chrabaszcz M. - Warsaw, POL 216P/74 n Radiofrequency Ablation of Atrial Arrhythmiasin Patients with Transposition of the Great Arteries n The Maximal Negative Slope in UnipolarHaththotuwa H., Abozguia K., Thorne S., Clift P., Hudsmith L., Electrograms: a Novel Two-Step Algorithm to Assess LocalMarshall H., Lencioni M., Girffith M., De Bono J. - Activation Time in Atrial and Ventricular TachycardiaBirmingham, GBR 216P/67 El Haddad M., Houben R., Stroobandt R., Van Heuverswyn F., De Meyer G., Tavernier R., Duytschaever M. - n Is Maintenance of Oral Anticoagulant Therapy Ghent, BEL 216P/75for Catheter Ablation of Typical Atrial Flutter Associatedwith Less Bleeding and Thromboembolic Complications? n Left Atrial Mapping and Catheter Ablation ofFatemi M., Dider R., Le Gal G., Etienne Y., Jobic Y., Supraventricular Tachycardia in Complex Congenital HeartMansourati J. - Brest, FRA 216P/68 Disease by Retroaortic Approach Using Remote Magnetic Navigation Is Safe and Effective n Atrial Tachycardias – Gender Differences in Derval N., Sacher F., Pedersen M., De Guillebon M., Scherr D.,Mechanism, Localisation, and Ablation Success in 326 Pascale P., Roten L., Denis A., Knecht S., Iriart X., Shah A.,Consecutive Patients. Hocini M., Jaïs P., Thambo J., Haïssaguerre M. -Insulander P., Bastani H., Braunschweig F., Drca N., Bordeaux, FRA 216P/76Gudmundsson K., Kennebäck G., Sadigh B., Schwieler J.,Tapanainen J., Jensen-Urstad M. - Stockholm, SWE 216P/69 n Adverse LV Mechanics as a Result of Preexcitation and Atrioventricular RV Pacing in the Young n Characterization of Typical and Atypical Atrial Tejman-Yarden S., Bachner Hinenzon N., Khamis H., Rzasa C.,Flutter from the Analysis of Atrial Vectorcardiographic Printz B., Adam D., Perry J. - San Diego, USA 216/77LoopsCastells F., Meste O., Guillem M., Climent A., Mihi N., n Fluoroscopic and Nonfluoroscopic AblationLorenzo L., Millet J., Quesada A. - Valencia, ESP 216P/70 with Ensite NavX in Children. Baszko A., Czyz K., Surmacz R., Gasiewski A., Bobkowski W., n Late Cavo-Tricuspid Isthmus (cti) Conduction Siwinska A., Szyszka A. - Poznan, POL 216P/78Recovery after Bidirectional Conduction BlockPark C., Ehret G., Sunthorn H., Burri H., Zimmermann M., n Role of Catheter Ablation among theGentil P., Shah D. - Bad Krozingen, DEU 216P/71 Comprehensive Therapy in the Patients with Congenital Heart Disease. n Ablation of the Cavotricuspid Isthmus - Very Sakaguchi H., Miyazaki A., Ohuchi H., Kagisaki K., Komori A.,Easy, or Very Difficult? Matsuoka M., Ebishima H., Yamamoto T., Yamada O.,Jones M., Wong K., Qureshi N., Betts T. - Oxford, GBR 216P/72 Shiraishi I. - Suita, Osaka, JPN 216P/79 - 143 - www.cardiostim.com

Friday June 15Created by Jacques Mugica INVASIVE EP & ABLATION BASIC ELECTROPHYSIOLOGY Chairman: D. Zipes – Indianapolis, USA Posters must remain on display from 14:00 to 17:30, but during «FORTY YEARS OF GROUND-BREAKING CONCEPTS IN the break your presence is required beside your poster CARDIAC ELECTROPHYSIOLOGY» 14:00-17:30 16:00-17:30 Poster Area - Level 3 / Agora 3 Room 2.1 / Hermes - Level 2 / Rhodes SESSION 221 One Patient with Two Transplanted Hearts and n ROLE OF miRNAs IN ARRHYTHMIA One Common Arrhythmia Okreglicki A. - Cape Town, ZAF 216/P80 SYNDROMES Co-Chair: Heterogeneity of APD Adaptation to Changes n Grunnet M. - Ballerup, DNK / Boyden P.A. - New York, USA in Heart Rate as a Component of Arrhythmogenesis Bueno-Orovio A., Hanson B., Gill J., Taggart P., Rodriguez B. - 16:00 n Why All the Interest in miRNAs? Oxford, GBR 216/P81 Pinto Y. - Amsterdam, NLD 221/1 n QT Interval Modulation by Local Temperature 16:20 n Hypertrophic Cardiomyopathy Changes in Isolated Heart Models Ackerman M. - Rochester, USA 221/2 Guill A., Millet J., Tormos A., Roses E., Trapero I., Such-Miquel L., Chorro F. - Valencia, ESP 216/P82 16:40 n Long QT Syndrome Ackerman M. - Rochester, USA 221/3 n End 17:00 n Dilated Cardiomyopathy Engelhardt S. - Munich, DEU 221/4 17:20 n What Are the Clinical Implications? Roden D. - Nashville, USA 221/5 n End www.cardiostim.com - 144 -

Friday June 15 ABLATION INVASIVE EP 16:00-17:30 16:00-17:30 Room 2.4 - Level 2 / Gallieni Room 2.6 - Level 2 / GallieniSESSION 223 SESSION 224MONITORING AND OUTCOME AFTER AF ABLATION BASIC MECHANISMS OF ARRHYTHMIASCo-chair: Co-chair:Scherr D. - Graz, AUT / Merino J.L. - Madrid, ESP Lendeckel U. - Greifswald, DEU / Gaïta F. - Asti, ITA16:00 n Early AF-Ablation Success Rate Assessed withContinuous Monitoring 16:00 n What Is the Role of Tumour Necrosis FactorPürerfellner H., Pokushalov E., Mrochak A., Block M., Beiras J., Alpha in the Pathogenesis of Atrial Fibrosis?Rieger G., West T., Geller J., Bucx J., Kuznetsov V., Lebedev D., Liew R., Katwadi N., Gu Y., Tee N., Moe W., Nay L., Nin Y., Friday June 15Bokeria O., Knaut M., Schlüter S., Rybak K., Ungar A., Faber T., Moe K. - Singapore, SGP 224/1Pezawas T., Lewalter T. - Linz, AUT 223/1 16:10 n Atrial Conduction Slowing Is the Predominant16:15 n Ablation of Paroxysmal and Persistent Atrial Mechanism of Action when Omega-3 Is Available in FreeFibrillation: Long-Term Recurrence Rates Via Continuous Fatty Acid Form in the Human CirculationSubcutaneous Monitoring Kumar S., Sutherland F., Wong M., Williams M., Watt S.,Romanov A., Pokushalov E., Corbucci G., Artyomenko S., Turov A., Cirjak A., Robinson T., Heck P., Sparks P. - Melbourne, AUS 224/2Shirokova N., Karaskov A., Mittal S., Steinberg J. - Novosibirsk, RUS 223/2 16:20 n Action Potential Alternans as Harbinger of16:30 nNew Score for Pre-Ablative Evaluation of the Sudden Death. Translational Study of Kcnh2-R835qEfficacy of Catheter Ablation of Atrial Ablation Mutation in Lqts-2Berkowitsch A., Zaltsberg S., Greiss H., Pajitnev D., Akkaya E.,Lehinant S., Erkapic D., Schmitt J., Hamm C., Kuniss M., Biliczki P., Schweigmann U., Ramirez R., Marschall C., Kotzot D.,Neumann T. - Bad Nauheim, DEU 223/3 Girmatsion Z., Hohnloser S., Ehrlich J. - Frankfurt, DEU 224/316:45 n Five Years Follow up of Patients Undergoing 16:30 n Paralogous Annotation of Disease-CausingCatheter Ablation of Persistent Atrial Fibrillation Using the Variants in Long QT Syndrome GenesStepwise Approach: Bloc-AF Study Ware J., Walsh R., Cunningham F., Birney E., Cook S. -Scherr D., Miyazaki S., Aurillac-Lavignolle V., Pascale P., Roten L., London, GBR 224/4Komatsu Y., Ramoul K., Shah A., Jadidi A., Wilton S., Pedersen M.,Linton N., Knecht S., Cochet H., Denis A., Sacher F., Derval N., 16:40 n Estradiol Shortens QT in Long QT Syndrome -Hocini M., Jaïs P., Haïssaguerre M. - Bordeaux, FRA 223/4 Clincial Evidence and Cellular Mechanism Anneken L., Baumann S., Biliczki P., Wewer C., Zumhagen S.,17:00 n Length of Mitral Isthmus but Not Anatomical Girmatsion Z., Takac I., Brandes R., Kissler S., Wiegratz I.,Location of Ablation Line Predicts Bidirectional Mitral Stallmeyer B., Nattel S., Hohnloser S., Klingenheben T.,Isthmus Block in Patients Undergoing Catheter Ablation of Schulze-Bahr E., Ehrlich J. - Erlangen, DEU 224/5Persistent Atrial Fibrillation: Randomized Controlled TrialScherr D., Derval N., Pascale P., Jadidi A., Komatsu Y., Roten L.,Ramoul K., Wilton S., Pedersen M., Miyazaki S., Linton N., 16:50 n Neuronal Type Sodium Channels Contribute toShah A., Denis A., Sacher F., Hocini M., Jaïs P., Haïssaguerre M., Ventricular Repolarization during IschemiaKnecht S. - Bordeaux, FRA 223/5 Biet M., Ton A., Delabre J., Morin N., Dumaine R. - Sherbrooke, CAN 224/617:15 n Symptoms, Quality of Life, Hospitalizations, andWorking Incapacity after Ablation of Paroxysmal Versus Long- 17:00 n Nicotine Delays the Development of CardiacStanding Persistent Atrial Fibrillation – Results of Bi-Centric Study Conduction System: Potential Cause for ArrhythmiasBulkova V., Fiala M., Simek J., Chovancík J., Havránek _., Sknouril Leading to Sudden Infant Death SyndromeL., Neuwirth R., Pindor J., Gorzolka J., Kociánová L., Fikar M., Vavrík Ton A., Delabre J., Biet M., Morin N., Dumaine R. -D., Krawiec _., Januska J., Wichterle D. - Prague, CZE 223/6 Sherbrooke, CAN 224/7 n End n End - 145 - www.cardiostim.com

Friday June 15Created by Jacques Mugica ABLATION CRT 16:00-17:30 16:00-17:30 Room 1.1 - Level 1 / Méditerranée Room 1.2 - Level 1 / Méditerranée SESSION 225 SESSION 226 NEW SIGNAL PROCESSING IN ALATION OF RESPONSE TO CRT ATRIAL FIBRILLATION Co-Chair: Co-Chair: Curnis A. - Brescia, ITA / Chauvin M. - Strasbourg, FRA Saoudi N. - Monaco, MCO / Pruvot E. - Lausanne, CHE 16:00 n Electrocardiographic Imaging to Predict Clinical 16:00 Rapid Acute Termination of Atrial Fibrillation n CRT Response. by Focal Impulse and Rotor Modulation Ploux S., Denis A., Lumens J., Strom M., Ramanathan C., Narayan S., Sehra R., Hopper K., Moyeda A., Hildreth J., Derval N., Jia P., Zemmoura A., De Guillebon M., Haissaguerre M., Jaynes S., Krummen D. - San Diego, USA 225/1 Bordachar P. - Bordeaux - Pessac, FRA 226/1 16:15 n The Onset of Bipolar Electrograms: a Novel 16:15 n Delayed Intrinsicoid Deflection Onset in Algorithm to Assess Local Activation Time in Atrial and Lateral ECG Leads Predicts Response after Cardiac Ventricular Tachycardia Resynchronization Therapy. El Haddad M., Houben R., Stroobandt R., Van Heuverswyn F., Del-Carpio Munoz F., Powell B., Cha Y., Wiste H., Redfield M., De Meyer G., Tavernier R., Duytschaever M. - Ghent, BEL 225/2 Friedman P., Asirvatham S. - La Crosse, USA 226/2 16:30 Termination of Atrial Fibrillation by Catheter n 16:30 n Effects of Tricuspid Valve Regurgitation on Ablation Can Be Successfully Predicted from Baseline Ecg Outcome and Clinical Response among Patients with Buttu A., Van Zaen J., Viso A., Forclaz A., Pascale P., Narayan S., Cardiac Resynchronization Therapy Vesin J., Pruvot E. - Lausanne, CHE 225/3 Grupper A., Killu A., Abu Sham’A R., Buber J., Friedman P., Powell B., Feinberg M., Asirvatham S., Espinosa R., Luria D., 16:45 n Results of Complex Fragmented Atrial Webster T., Brooke K., Hodge D., Wiste H., Cha Y., Glikson M. - Electrograms Ablation in Persistent Atrial Fibrillation: a Tel Hashomer, ISR 226/3 Prospective Randomized Study Arbelo E., Guiú E., Berruezo A., Tolosana J., Andreu D., Ramos P., 16:45 n Are ICD Still Necessary for Patients with Lvef Bisbal F., Borras R., Brugada J., Mont L. - Barcelona, ESP 225/4 More than 35% after Crt? Insights from Cubic Registry Ando K., Shizuta S., Fujii S., Inoue K., Kaitani K., Arita T., 17:00 n Additional Complex Fractionated Atrial Soga Y., Kimura T., Isshiki T., Nobuyoshi M., Cubic Investigators Electrogram (cfae) Ablation Does Not Improve Single - Kitakyushu, JPN 226/4 Procedural Success in the Treatment of Persistent Atrial 17:00 n Mortality Risk Prediction of Seattle Heart Fibrillation Failure Model in CRT Patients Wong K., Paisey J., Qureshi N., Jones M., Hayes C., Regoli F., Scopigni F., Leyva F., Landolina M., Tritto M., Muthumala A., Bala R., Sopher M., Rajappan K., Bashir Y., Calo’ L., Acena M., Klersy C., Moccetti T., Auricchio A. - Betts T. - Oxford, GBR 225/5 Lugano, CHE 226/5 17:15 n Correlation between Epicardial Fat and High 17:15 n Abnormal Repolarization in Cardiac Dominant Frequency Sites Resynchronization Therapy Watanabe I., Okumura Y., Nagashima K., Kofune M., Mano H., Wecke L., Van Deursen C., Bergfeldt L., Prinzen F. - Sonoda K., Ohkubo K., Nakai T., Kasamaki Y., Hirayama A. Stockholm, SWE 226/6 - Tokyo, JPN 225/6 n End n End www.cardiostim.com - 146 -

Friday June 15 SUDDEN CARDIAC DEATH SYNCOPE Organized by Santomauro M. - Naples, ITA European Heart Rhythm Association (EHRA) Program Organized by EUROPACE Program Committee Chairman: A. Goette - Magdeburg, DEU 16:00-17:30 16:00-17:30 Room 1.3 - Level 1 / Méditerranée Room 1.4 - Level 1 / MéditerranéeSESSION 227 SESSION 228SUDDEN DEATH IN HOSPITAL AND OUT-OF- DIAGNOSTIC EVALUATION OF SYNCOPE INHOSPITAL: NEWS AUTOMATIC EXTERNAL SPECIAL PATIENT GROUPSDEFIBRILLATION ON-LINE Co-Chair:Co-Chair: Kenny R.A. - Dublin, IRL / Glikson M. - Ramat Gan, ISRGulizia G. - Catania, ITA / Santomauro M. - Napoli, ITA 16:00 n Patients with Bundle Branch Block Moya A. - Barcelona, ESP Friday June 1516:00 nThe Network of AED in Hospital 228/1Ammirati F. - Rome, ITA 227/1 16:20 n Syncope in Athletes16:15 n AED in Hospital: The Impact of the 2010 ILCOR Flevari P. - Halandri, GRC 228/2GuidelinesMontenero A. - Milan, ITA 227/2 16:40 n Syncope in the Elderly: Particularities Kenny R. - Dublin, IRL 228/316:30 n Applicabilty of New AEDs On-Line during SportsEvents 17:00 n Syncope Unit: A New Necessity?Giada F. - Noale, ITA 227/3 Brignole M. - Lavagna, ITA 228/416:45 nCost/Effectiveness of AEDs on Public Use n EndCapucci A. - Ancona, ITA 227/417:00 n PAD Projects with the News AEDs On-LineRicci R. - Rome, ITA 227/517:15 n Legal Issue on Public Use of AEDs with RemoteMonitoringRiganti C. - Naples, ITA 227/6 n End - 147 - www.cardiostim.com

Friday June 15Created by Jacques Mugica ABLATION PACING AND ICD Course Directors: D. Hayes - Rochester, USA/ P. Ritter- Bordeaux, FRA/ D.S. Cannom - Los Angeles, USA/ J. Singh - Boston, USA/ F. Abi-Samra - New Orleans, USA 16:00-17:30 16:00-17:30 Room 1.5 - Level 1 / Méditerranée Room 1.6 / Iris - Level 1 / Méditerranée SESSION 229 SESSION 230 COMPLICATIONS OF CATHETER ABLATION HOW TO IDENTIFY RESPONDERS/ Co-Chair: NONRESPONDERS TO CRT? Deisenhofer I. - München, DEU / Cappato R. - San Donato Co-Chair: Milanese (MI), ITA Blanc J.J. - Brest, FRA / Ovsyshcher E. - Beersheva, ISR 16:00 n Influence of Steroid Therapy on Pericarditis 16:00 n Should a Universal Definition of a CRT- and Atrial Fibrillation Following Percutaneous Epicardial Responder Be Agreed Upon? Mapping and Ablation for Ventricular Tachycardia Padeletti L. - Florence, ITA 230/1 Dyrda K., Piers S., Van Huls Van Taxis C., Schalij M., Zeppenfeld K. - Leiden, NLD 229/1 16:20 n How to Assess Responders in NYHA I-II Heart Failure Patients? 16:15 n Investigation into Causes of Dw-Mri Findings Linde C. - Stockholm, SWE 230/2 Following Pvac Duty-Cycled, Phased RF Ablation of AF Wieczorek M., Hoeltgen R., Lukat M., Lawrenz W., Hilje T., 16:40 n How to Assess CRT Response in Non-Compliant Missler U. - Bocholt, DEU 229/2 Patients? Gold M. - Charleston, USA 230/3 16:30 n Mri Following Phased RF Ablation of AF: Low Cerebral Lesion Rate 17:00 n Are There Specific Criteria to Identify Super Nardi S., Argenziano L., De Martino G., Scaglione M., Responders before and during Implantation? Esposito C., Borrello F., Marullo F., Schiavone V., Maglia G. - Reynolds D. - Oklahoma City, USA 230/4 Castel Volturno, ITA 229/3 n End 16:45 Oesophageal Hematoma after Atrial Fibrillation n Ablation: Incidence, Clinical Features and Sequelae of Esophageal Injury of a Different Sort Kumar S., Ling L., Halloran K., Morton J., Spence S., Joseph S., Kistler P., Sparks P., Kalman J. - Melbourne, AUS 229/4 17:00 n Dual-Source Cardiac Computed Tomography for the Detection of Left Atrial Appendage Thrombus Prior to Left Atrial Ablation: Improved Specificity and Reduced Radiation Dose by Optimized Contrast- and Scanning- Protocol. Jilek C., Loibl S., Meyer T., Ammar S., Reents T., Fichtner S., Hendrich E., Will A., Martinoff S., Hausleiter J., Kolb C., Hessling G., Deisenhofer I. - München, DEU 229/5 17:15 n Dabigatran in Patients Post Atrial Fibrillation Ablation Eitel C., Hindricks G., Sommer P., Arya A., Bollmann A., Piorkowski C. - Leipzig, DEU 229/6 n End www.cardiostim.com - 148 -

Friday June 15 MISCELLANEOUS ABLATION TECHNIQUES European Heart Rhythm Association European Heart Rhythm Association (EHRA) Program (EHRA) Program Organized by EUROPACE Program Committee Chairman: Organized by EUROPACE Program Committee Chairman: A. Goette - Magdeburg, DEU A. Goette - Magdeburg, DEU 16:00-17:30 16:00-17:30 Room 3.1 / Clio - Level 3 / Les Muses Room 3.2 - Level 3 / Les MusesSESSION 231 SESSION 232ARRHYTHMIAS IN WOMEN: STATE OF THE NEW ENERGIES AND TECHNOLOGIES TOEVIDENCE TREAT ATRIAL FIBRILLATIONCo-Chair: Co-Chair:Borggrefe M. - Mannheim, DEU / Heidbüchel H.J. - Leuven, BEL Davies W. - London, GBR / Kuck K.H. - Hamburg, DEU16:00 n Managing Arrhythmias in Pregnancy: What’s in 16:00 n Mapping and Pulmonary Vein Isolation Using Friday June 15the Guidelines? the PVACBlomstrom-Lundqvist C. - Uppsula, SWE 231/1 Duytschaever M. - Brugges, BEL 232/116:20 n Gender Differences in Atrial Fibrillation 16:20 n Cryoballoon Pulmonary Vein Isolation GuidedMont L. - Barcelona, ESP 231/2 by Real-Time PV Potential Recording Hoffmann E. - Munich, DEU 232/216:40 n Outcomes in Women UndergoingElectrophysiological Procedures 16:40 n Low-Level Vagosympathetic Nerve Stimulation:Santangeli P. - Austin, USA 231/3 A New Target for Atrial Fibrillation Suppression? Jackman W. - Oklahoma City, USA 232/317:00 n Implantable Cardioverter Defibrillators inWomen 17:00 n Minimally Invasive Surgical Techniques: ForZupan I. - Ljubljana, SVN 231/4 Which Patients? La Meir M. - Maastricht, NLD 232/4 n End n End - 149 - www.cardiostim.com

Friday June 15Created by Jacques Mugica ICD THERAPY ICD THERAPY ADVANCES IN NONINVASIVE Symposium STIMUPRAT ELECTROCARDIOLOGY (ISHNE) Organisé par Pierre Bordachar, Stéphane Garrigue, Sylvain Reuter, Chairmen: W. Zareba, USA, S. Dubner, ARG, A.J. Moss, USA Philippe Ritter, Frédéric Sacher - Bordeaux - FRA Stimuprat FORMATION SessionS DE 16:00-17:30 16:00-17:30 Room 3.3 / Erato - Level 3 / Les Muses Room 3.4 / Uranie - Level 3 / Les Muses SESSION 233 SESSION 234 APPROPRIATE OR INAPPROPRIATE ICD LA CONSULTATION EN LIVE : THERAPY (Interactive Session) FONCTIONNEMENT DES DEFIBRILLATEURS Co-Chair: AUTOMATIQUES IMPLANTABLES A PARTIR Turitto G. - Brooklyn, USA / Exner D. - Calgary, CAN DES PROGRAMMATEURS (D’UNE MARQUE A L’AUTRE) 16:00 n Challenging EGMs: Appropriate or Inappropriate ICD Therapy Moderators: Turitto G. - Brooklyn, USA 233/1 Anselme F. - Rouen, FRA 234/5 Exner D. - Calgary, CAN 233/2 Boveda S. - Toulouse, FRA 234/6 Ritter P. - Bordeaux, FRA 233/3 Defaye P. - Grenoble, FRA 234/7 Sadoul N. - Vandoeuvre Les Nancy, FRA 234/8 n End n End www.cardiostim.com - 150 -

Friday June 15 INVASIVE ELECTROPHYSIOLOGY & ABLATION TECHNIQUES WORLD CONGRESS ON CATHETER ABLATION Chairmen: M. Scheinman - San Fransciso, USA, M. O’Neill - London, GBR - V. Probst- Nantes, FRA - F. Sacher - Bordeaux-Pessac, FRA 16:00-17:30 Room 3.5 / Calliope - Level 3 / Les MusesSESSION 235VENTRICULAR TACHYCARDIA ABLATION IVCo-Chair:Reddy V.Y. - New York, USA / Nogami A. - Yokohama, JPN16:00 n Catheter Ablation of Patients withArrhythmogenic Right Ventricular Dysplasia (ARVD)Reddy V. - New York, USA 235/1 Friday June 1516:00 n Catheter Ablation of Patients with VT andSystemic Disease (Sarcoid/Amyloid/Iron Overload/MyotonicDystrophy)Arruda M. - Case Western, USA 235/216:00 n Catheter Ablation of Fascicular Tachycardia inPracticeNogami A. - Yokohama, JPN 235/316:00 n Bipolar Voltage Map vs. MR for Detection ofMyocardial ScarCallans D. - Philadelphia, USA 235/4 n End - 151 - www.cardiostim.com

Scientific Contents Saturday June 16 Sessions 251 to 275 page 155 to 159 Saturday June 16 Created by Jacques Mugica - 153 - www.cardiostim.com

Saturday June 16Today, five rooms are still running on level 3, dedicated to education,with high standard programs: • eorge Klein proposes two sessions for interpretation of complex EP recordings. G These sessions should be very attractive! • HRA has two programs running: E - wo sessions with debates between experts in room 3.1. Interaction with T the audience is welcome! - In room 3.2, two sessions are organized, one about certification and exams, the other one for Allied Professionals. • he RETAC group has two sessions to discuss clinical cases of patients implanted T with devices. • he STIMUPRAT program, given in French, deals with ECGs and EGMs of paced T patients. i Don’t forget to visit the Poster area in Agora 3! Please think about switching off your cell phone. If your phone rings during sessions, it really disturbs the speakers, thank you for them. Preview Room is now at level 3. Scientific Secretariat is now at level 3. www.cardiostim.com - 154 -

Saturday June 16 NON INVASIVE MISCELLANEOUS ELECTROPHYSIOLOGY European Heart Rhythm Association European Heart Rhythm Association (EHRA) Program (EHRA) Program Organized by EUROPACE Program Committee Chairman: A. Goette - Magdeburg, DEU Organized by EUROPACE Program Committee Chairman: A. Goette - Magdeburg, DEU 09:00-10:30 09:00-10:30 Room 3.1 / Clio - Level 3 / Les Muses Room 3.2 - Level 3 / Les MusesSESSION 251 SESSION 252DEBATES AND CONTROVERSIES IN THE CERTIFICATION: FIGHTING AGAINSTANTITHROMBOTIC MANAGEMENT OF ATRIAL INEQUALITY IN HEALTH CARE ACROSSFIBRILLATION BORDERSCo-Chair: Co-Chair:Savelieva I. - London, GBR Auricchio A. - Lugano, CHE / Nielsen J.C. - Aarhus, DNKLow Risk Patients with Atrial Fibrillation Can Be Treated 09:00 n A Powerful Tool for Improvement in Healthwith No Antithrombotic Therapy: Care09:00 n FOR Zeppenfeld K. - Leiden, NLD 252/1Fauchier L. - Tours, FRA 251/1 09:20 n Models to Be Listened: UK09:20 AGAINST n Linker N.- Middlesbourg, GBR 252/2Rasmussen L. - Aalborg, DNK 251/2 09:40 n Certification of Allied ProfessionalsAntiplatelet Therapy Should Be Added to Anticoagulant Nolan P. - Galway, IRL 252/3Therapy in Patients with Atrial Fibrillation and VascularDisease: 10:00 n Certification in Europe: Differences with and Saturday June 1609:40 nFOR Lessons from USARubboli A. - Bologna, ITA 251/3 Arribas Ynsaurriaga F. - Madrid, UK 252/410:00 n AGAINSTMarin F. - Murcia, ESP 251/4 n Break / Visit of Exhibits n Break / Visit of Exhibits - 155 - www.cardiostim.com

Saturday June 16Created by Jacques Mugica ICD THERAPY & ABLATION PACING TECHNIQUES Symposium STIMUPRAT Didactic course based on tracings Organisé par and clinical experience by the Pierre Bordachar, Stéphane Garrigue, Sylvain Reuter, Philippe Ritter, Frédéric Sacher - Bordeaux - FRA RETAC Group – Reunion of European countries for the Treatment of ArrHythmias in Cardiology/Réseau Stimuprat Européen pour le Traitement des FORMATION Arythmies CardiaqueS SessionS DE 09:00-10:30 09:00-10:30 Room 3.3 / Erato - Level 3 / Les Muses Room 3.4 / Uranie - Level 3 / Les Muses SESSION 253 SESSION 254 TROUBLESHOOTINGS LA CONSULTATION EN LIVE : FONCTIONNEMENT Co-Chair: DES STIMULATEURS CARDIAQUES ET TOUT CE Boveda S. - Toulouse, FRA / Defaye P. - Grenoble, FRA QUE VOUS AVEZ OUBLIE ! 09:00 n Surface ECGs Part 1 Moderators: Zimmermann M. - Meyrin-Geneva, CHE 253/1 Bordachar P. - Bordeaux, FRA 254/1 Garrigue S. - Bordeaux, FRA 254/2 09:15 n Congenital Heart Disease Patients Reuter S. - Bordeaux, FRA 254/3 Combes N. - Toulouse, FRA 253/2 Ritter P. - Bordeaux, FRA 254/4 Anselme F. - Rouen, FRA 254/5 09:30 n EGMs from Pacemakers Boveda S. - Toulouse, FRA 254/6 Boveda S. - Toulouse, FRA 253/3 Defaye P. - Grenoble, FRA 254/7 Gras D. - Nantes, FRA 254/8 09:45 n EGMs from ICDs Defaye P. - Grenoble, FRA 253/4 n Break / Visit of Exhibits 10:00 n Surface ECGs Part 2 De Roy L. - Yvoir, BEL 253/5 n Break / Visit of Exhibits www.cardiostim.com - 156 -

Saturday June 16 INVASIVE ELECTROPHYSIOLOGY & NON INVASIVE ABLATION TECHNIQUES ELECTROPHYSIOLOGY Organized by G.J. Klein – London, CAN, European Heart Rhythm Association Sacher F. - Bordeaux-Pessac, FRA, O’Neill M. - London, GBR (EHRA) Program Organized by EUROPACE Program Committee Chairman: A. Goette - Magdeburg, DEU 09:00-10:30 11:00-12:30 Room 3.5 / Calliope - Level 3 / Les Muses Room 3.1 / Clio - Level 3 / Les MusesSESSION 255 SESSION 271THE CHALLENGING CASE - PART I ANTIARRHYTHMIC DRUGS FOR ATRIALCo-Chair: FIBRILLATIONKlein G.J. - London, CAN / Callans D. - Philadelphia, USA Co-Chair: Capucci A. - Ancona, ITA / van Gelder I.C. - Groningen, NLD09:00 n The Challenging Case - Part ICallans D. - Philadelphia, USA 255/1 11:00 n Basics of Ion Channel Antiarrhythmic Drugs forO’Neill M. - London, GBR 255/2 Prevention of Atrial FibrillationKlein G. - London, CAN 255/3 Dobrev D. - Heidelberg, DEU 271/1Skanes A. - London, CAN 255/4 11:20 n Basics of Upstream Therapies for Prevention of n Break / Visit of Exhibits Atrial Fibrillation Goette A. - Magdeburg, DEU 271/2 11:40 n Ion Channel Antiarrhythmic Drugs for Prevention of Atrial Fibrillation Crijns H. - Maastricht, NLD 271/3 Saturday June 16 12:00 n Upstream Therapies for Prevention of Atrial Fibrillation Savelieva I. - London, GBR 271/4 n End - 157 - www.cardiostim.com

Saturday June 16Created by Jacques Mugica MISCELLANEOUS ICD THERAPY & ABLATION European Heart Rhythm Association TECHNIQUES (EHRA) Program Didactic course based on tracings Organized by EUROPACE Program Committee Chairman: and clinical experience by the A. Goette - Magdeburg, DEU RETAC Group – Reunion of European countries for the Treatment of ArrHythmias in Cardiology/Réseau Européen pour le Traitement des Arythmies CardiaqueS 11:00-12:30 11:00-12:30 Room 3.2 - Level 3 / Les Muses Room 3.3 / Erato - Level 3 / Les Muses SESSION 272 SESSION 273 NURSE-LED INTERVENTIONS FOR PATIENTS NIGHTMARES WITH ARRHYTHMIAS Co-Chair: Co-Chair: Boveda S. - Toulouse, FRA / Defaye P. - Grenoble, FRA Linker N.J. - Middlesbrough, GRB / Zeppenfeld K. - Leiden, NLD 11:00 n Difficult LV Leads 11:00 COPE -ICD Trial: Comprehensive Rehabilitation n Guerra J. - Barcelona, ESP 273/1 for Patients with Implantable Defibrillators Kikkenborg Berg S. - Copenhagen, DNK 272/1 11:15 n CRT Non-Responders Defaye P. - Grenoble, FRA 273/2 11:20 Reducing Psychological Distress for Patients n with Implantable Defibrillators 11:30 n Acute Cardiac Tamponade Management Dunbar S. - Atlanta, USA 272/2 Arentz T. - Bad Krozingen, DEU 273/3 11:40 n Implementing a Nurse-Led Atrial Fibrillation 11:45 n Electrical Storm Halimi F. - Le Chesnay, FRA 273/4 Clinic Hendriks J. - Maastricht, NLD 272/3 12:00 n Challenging Lead Extractions Defaye P. - Grenoble, FRA 273/5 12:00 n Palpitations: Effectiveness of A Nurse-Led Clinic Smallwood A. - Wolverhampton, UK 272/4 12:15 n Challenging Lead Extractions Boveda S. - Toulouse, FRA 273/6 n End n End www.cardiostim.com - 158 -

Saturday June 16 PACING INVASIVE ELECTROPHYSIOLOGY & Symposium STIMUPRAT ABLATION TECHNIQUES Organisé par Organized by G.J. Klein – London, CAN, Pierre Bordachar, Stéphane Garrigue, Sylvain Reuter, Sacher F. - Bordeaux-Pessac, FRA, O’Neill M. - London, GBR Philippe Ritter, Frédéric Sacher - Bordeaux - FRA Stimuprat FORMATION SessionS DE 11:00-12:30 11:00-12:30 Room 3.4 / Uranie - Level 3 / Les Muses Room 3.5 / Calliope - Level 3 / Les MusesSESSION 274 SESSION 275LA CONSULTATION EN LIVE : DEMARCHE THE CHALLENGING CASE - PART IIDIAGNOSTIQUE ET THERAPEUTIQUE CHEZ Co-Chair:LE PATIENT STIMULE ET SYMPTOMATIQUE Klein G.J. - London, CAN / Callans D. - Philadelphia, USA(DOULEUR THORACIQUE, DYSPNEE, 11:00 n The Challenging Case - Part IIPALPITATIONS, MALAISE, SYNCOPE) Klein G. - London, CAN 275/1 Callans D. - Philadelphia, USA 275/2Moderators: O’Neill M. - London, GBR 275/3Bordachar P. - Bordeaux, FRA 274/1 Skanes A. - London, CAN 275/4Garrigue S. - Bordeaux, FRA 274/2Reuter S. - Bordeaux, FRA 274/3 n EndRitter P. - Bordeaux, FRA 274/4Anselme F. - Rouen, FRA 274/5Boveda S. - Toulouse, FRA 274/6Defaye P. - Grenoble, FRA 274/7Gras D. - Nantes, FRA 274/8 End Saturday June 16 n - 159 - www.cardiostim.com

Chairman & Author IndexChairman or Author. . ...... Session numberA Almendros I. ..............................................136P/10 Alonso C. ................................. 96P/82, 136P/56 Argenziano L. ....... 216/44, 216/42, 229/3 Arguello J. ......................................................56P/50Abadir S. ..............................................................144/1 Alonso J. ........................ 56P/49, 44/3, 96P/62 Arita T. ...................................................................226/4Abalea J. ........................................................176P/60 Alonso-Martin C. ..................................136P/67 Arkolaki E. ......................................................56P/18Abbate R. .............................. 176P/38, 176P/37 Alsheikh-Ali A. ................................................. 66/1 Armbruster R. .............................................96P/64Abdelaal A. .................................................136P/35 Alsheraei A. ........................ 136P/61, 136P/52 Arnaud D. ...........................................................113/2Abdelghani M. .......................................... 216/63 Altavilla T. .......................................................96P/36 Arnaudis B. .......................................................205/1Abdelhady Y. .............................................. 216/65 Alvstrand M. ................................................136P/8 Arnsbo P. ..................................... 56P/46, 96P/58Abdelhamid M. ......................................... 216/65 Alzueta Rodriguez J. ..... 176P/25, 176P/23 Arora V. ..............................................................96P/44Abdelwahab A. ....................216/65, 216/63 Amara W. .................................... 56P/25, 96P/71 Arribas Ynsaurriaga F. ...........................252/4Abdennour K. ..........................................176P/68 Ambarus V. .....................................................96P/15 Arruda M. ............................................ 74/2, 235/2Abe H. .................................................................56P/31 Ambri W. .............................................................163/5 Arsenescu Georgescu C. ..................96P/15Abe T. ...................................................................96P/38 Amet D. ............................................................ 216/24 Arsenos P. ......................................... 44/2, 96P/39Abed N. .............................................................56P/44 Amiel A. ............................................................56P/28 Artyomenko S. .............. 136P/55, 136P/20,Abi-Samra F. M. ............................. 49/7, 188/1 Amine M. .........................................................96P/66 216/47, 203/6, 223/2Abi-Samra F. M. ............................................... 150 Amir S. Jadidi A. ...................................... 216/34 Arya A. ................ 136P/23, 216/30, 216/26,Abozguia K. ................................................. 216/67 Ammar K. ...........................................................183/2 216/16, 229/6Abraham P. .....................................................96P/55 Ammar S. ............................... 56P/15, 136P/18, Asakawa K. .................................................136P/71Abraham W. ............................. 176P/30, 164/2 216/59, 203/4, 229/5 Asano M. .......................................................136P/71Abrahamsson C. ..........................................113/6 Ammirati A. ......................................................102/3 Asbach S. ............................................................... 68/7Abriel H. .................................................................. 61/1 Ammirati F. ...................................... 102/3, 227/1 Ashok Shah A. ........................................... 216/34Abu Sham’A R. ..............................................226/3 Amraoui S. ........ 136P/43, 176P/47, 164/5 Asirvatham S. ...........................75/3, 176P/61,Acena M. ..................................... 226/5, 176P/14 An Y. .....................................................................56P/73 226/2, 226/3Ackerman M. ............. 112/1, 221/2 , 221/3 Ananaba I. ...................................................136P/28 Aslan O. ................................................................... 66/4Acou W. ..........................................................136P/51 Andersen H. ........................................................ 64/1 Asopa S. .................................................................. 24/1Adam D. ........................................................... 216/77 Anderson J. .............................................. 177PW/2 Astheimer K. ...................... 136P/68, 216/60,Adragao P. ......................27/3, 136P/83, 27/3 Andersson E. ................................................... 96P/4 216/5, 216/57, 204/6Aggio S. ........................................... 68/4, 176P/21 Ando K. ................................................................226/4 Atia I. ...................................................................56P/44Ahmed Talib A. .............................................113/3 Andou K. ..........................................................56P/73 Atie J. .......................................................... 71/1, 91/4Aime E. .......................................... 56P/28, 96P/80 Andre J. ..........................................................136P/86 Auger D. ...........................................................56P/37Aizawa Y. .................................136P/59, 216/50 Andresen D. ..........................136P/54, 216/41 Auricchio A. .......................... 2/1, 68/8, 153/1,Ajmone Marsan N. ....... 56P/37, 176P/59, Andreu D. ...................... 63/4, 63/5, 136P/19, 166/1, 226/5 216/58 136P/40, 216/29, 203/5, 225/4 Auricchio A. ...................... 111, 153, 22, 252Akca F. ..................................................... 63/2, 216/1 Andreu M. ....................................................176P/14 Aurillac-Lavignolle V. ......... 96P/35, 223/4Akhtar M. .....................................................176P/28 Andrikopoulos G. .......................................... 68/7 Aversa E. ........................................ 56P/13, 96P/9Aki S. Havulinna ......................................96P/18 Andronache M. .......................................136P/35 Ayache N. ...........................................................163/5Akkaya E. .......................................... 203/3, 223/3 Anneken L. ........................................................224/5 Azab A. ..............................................................56P/44Ako J. ...................................................................56P/45 Anselme F. ...... 96P/80, 136P/42, 176P/68, Azegami K. ........................................................216/8Akoum N. ...................................... 183/6, 216/43 176P/26, 176P/16, 187/2, 216/54, Azzolini P. .............................................................. 64/6Al Fayyad M. .......................................................... 48 203/2, 234/5, 254/5, 274/5Al-Fagih A. ............................................................... 66Albano F. ........................................... 44/4, 216/27 Anselmi F. ................................ 176P/68, 176P/6 Anselmino M. ................................................. 56P/7 BAlbenque J. ....................... 136P/86, 136P/42, Antonelli A. ........................ 136P/61, 136P/52 Babka D. ...........................................................56P/75 204/1, 205/1, 204/2 António N. ........................... 176P/11, 176P/57 Babuty D. ....................... 33/1, 96P/5, 97PW/1Albert C. ..............................................................154/2 Antti Jula .........................................................96P/18 Bachner Hinenzon N. .......................... 216/77 Chairman & AuthorAlberto Giniger A. ................................. 216/48 Antzelevitch C. ......12/3, 81/1, 107/3, 132/2 Badhwar N. ............115/2, 136P/58, 135/4,Albina Gaston A. .................................... 216/62 Antzelevitch C. ................................................ 189 155/2Alboni P. .................................................................. 102 Aonuma K. .................................................... 216/17 Badhwar N. .......................................................... 215Albornoz M. ..................................................56P/13 Aoyagi H. ............................................................216/8 Badran H. .........................................................56P/15Alciati M. ......................................................... 216/66 Araujo C. ..........................................................56P/21 Baduena L. ................................ 56P/42, 56P/41Aldhoon B. ..................................................136P/24 Arbelo E. ................ 63/4, 136P/19, 136P/40, Baghdadi Y. .................................................. 216/63Ali H. ........................................................................184/6 136P/25, 176P/14, 176P/49, 203/1, Bahl V. ........................ 56P/40, 56P/39, 56P/36Alings M. ..........................................................96P/51 203/5, 225/4 Bai R. ............... 23/6, 56P/7, 136P/63, 163/3Aliot E. ........................................... 136P/35, 127/2 Arbouin C. ......................................................56P/61 Baker J. ................................... 176P/17, 176P/79Allen J. .............................................................136P/13 Archontakis S. ................ 44/2, 63/6, 96P/39 Baker V. ................................... 136P/78, 136P/80Allessie M. ............................ 15/2, 87/2, 141/3 Ardissino D. ...................................................96P/36 Bakhtadze N. .......................... 56P/58, 96P/30Allgeier J. ....................216/5, 216/57, 204/6, Arenal Maiz A. ..............................................211/3 Bala R. ....................................................................225/5 136P/68, 216/60 Arentz T. ................136P/68, 163/6, 216/60, Balk A. ................................................................96P/55Almeida S. ...................................................136P/83 216/5, 216/57, 205/4, 204/6, 273/3 Balke A. .............................................................96P/72 - 161 - www.cardiostim.com

Chairman & Author IndexChairman or Author. . ...... Session numberBan J. ................. 136P/48, 136P/49, 136P/47 Ben Chikh A. ....................................................204/2 Bisleri G. ................................................................. 23/1Banasik M. ..................................................... 216/74 Ben Youssef I. ..............................................56P/25 Bittlinsky A. ...................................................96P/86Bänsch D. ............................................. 62/1, 125/2 Benchimol Barbosa P. ...... 177PW/1, 216/31 Bizeau 0. ...........................................................96P/88Baracca E. .............. 68/4, 176P/21, 176P/66 Benditt D. G. ................ 102/1, 188/4, 208/2 Bizeau O. ..................................... 96P/78, 96P/71Barakat M. ..................................................... 216/43 Benditt D. G. ........................................................... 88 Blanc J. J. ..................... 96P/88, 102/2, 147/1,Baran J. ...........................................................136P/36 Benkemoun H. ............................................56P/28 150/3, 202/2Baranchuk A. ........................ 17PW/2, 96P/47 Bennadji A. .......................................................... 23/2 Blanc J. J. .................................................... 188, 230Barandon L. ................................. 164/5, 216/38 Bentzon J. ..........................................................183/5 Blanche C. ....................................................136P/29Baranowski B. .............................................96P/84 Berbari E. ......................................................176P/42 Blanck Z. ........................................................176P/80Baratto F. ................................................................ 63/3 Berenfeld O. ....................................................... 149 Bland J. ..............................................................96P/54Barauskiene V. ............................................... 56P/4 Berg S. .............................................................136P/39 Blandino A. ...............................216/66, 216/53Barbarossa A. ...........................................176P/29 Berger F. ...................................................... 177PW/5 Blier L. .................... 56P/71, 136P/81, 216/56Barbetta A. ................................ 56P/33, 216/11 Bergfeldt L. ..................................... 96P/4, 226/6 Bloch L. .................................................................183/5Barbieri L. ........................................................176P/9 Berkowitsch A. ............................ 203/3, 223/3 Block M. ...............................................................223/1Barbosa A. ........................... 176P/11, 176P/57 Berman L. ........................................................96P/59 Blom N. ............................................... 103/1, 143/1Barbosa E. .............................177PW/1, 216/31 Berne P. .................................................................... 33/4 Blomstrom-Lundqvist C. ........................ 126Barbosa-Filho J. ........................................ 216/31 Berngardt E. ..................................................96P/34 Blomström-Lundqvist C. ... 209/6, 231/1Bardy G. .....................................174/1, 177PW/2 Bernini F. .......................................................... 216/11 Blum T. ... 90/2, 165/3, 216/5, 216/57, 204/6Barnay C. ......................................................176P/73 Bernstein S. ...................................................136P/8 Blum V. .......................................136P/68, 216/60Barnett C. ................................... 56P/24, 56P/23 Bernus O. ............................................................109/1 Boaretto G. .................................................176P/21Barold S. ........................................................176P/21 Berruezo A. ........................... 13/3, 63/4, 63/5, Bobkowski W. ........................216/78, 216/73Barr C. ............................................... 24/6, 176P/24 136P/25, 136P/40, 136P/19, 176P/49, Bochoeyer A. ...............................................56P/50Barrera Cordero A. ...... 176P/25, 176P/23 203/1, 216/29, 203/5, 225/4 Bodden C. ............................................................. 24/3Bartez O. ..........................................................56P/71 Berry M. ...............................................................205/1 Bode F. ................................................................56P/30Barthez O. ...............................136P/81, 216/56 Bersohn M. .....................................................96P/42 Bode K. ...........................................................136P/23Bartunek J. ................................ 136P/5, 216/36 Bertaglia E. ..................................................176P/66 Bodky J. .............................................................56P/35Bartus K. ........................................................136P/58 Berthier F. .....................................................136P/21 Boem A. .................... 56P/69, 56P/76, 96P/61Bashir J. ................................................................164/3 Berul C. .................................................................124/3 Boersma L. .........................24/6, 105/3, 186/5Bashir Y. ....................................... 176P/22, 225/5 Berul C. .................................................................... 144 Bogers A. ............................................................ 56P/5Basso C. ................................................................... 81/2 Berwick Z. ....................................................176P/42 Boghossian S. ........................................ 177PW/1Bastani H. ....................................................... 216/69 Beshai J. F. ..........................................................130/4 Bogossian H. ................................................96P/69Bastiaenen R. .............................................97PW/4 Betts T. ........................ 56P/22, 43/5, 176P/22, Bogun F. ...............................................................175/2Baszko A. .................. 216/78, 216/73, 216/2 216/72, 225/5 Bogun F. .................................................................. 175Batlle M. ........................................................136P/10 Beuscart R. .....................................................96P/76 Boidol J. ..........................................................176P/50Battaglia A. ................................................... 216/53 Bhardwaj R. ...................................................56P/10 Bokan R. .........................................................176P/77Bauer W. ...........................................................96P/53 Bharmi R. .........................................................136P/8 Bokeria O. ..........................................................223/1Bauernfeind T. .................................................. 63/2 Bhatia A. ........................................................176P/80 Bokhari F. .........................................................96P/50Baumann G. ........................................................ 64/5 Bianchi G. ....................................................... 216/11 Bolanos O. ................................. 56P/49, 96P/62Baumann S. ......................................................224/5 Bianchi S. ............................ 56P/47, 65/4, 64/6 Bollinger C. .......................................................... 24/3Bavikati V. ....................................................176P/13 Bieganowska K. ........................................56P/66 Bollmann A. ........................ 136P/23, 216/30,Bax J. ............................................ 56P/37, 176P/59 Biet M. ................................................. 224/6, 224/7 216/26, 229/6Baxter W. ............................................................... 47/5 Biffi M. .................112/3, 176P/19, 176P/67, Bolloré G. ........................................................96P/78Beardsall M. ...............................................136P/82 176P/66 Bomfim A. ................................................. 177PW/1Beau S. ..................................................................... 24/1 Biffi M. ..................................................................... 170 Bonaventura K. .......................................17PW/3Beaufort C. ....................................................96P/17 Bijnens B. ............................................................109/2 Bonet J. ..............................................................56P/61Beauverger Y. .................................................206/6 Biliczki P. ............................................ 224/3, 224/5 Bongard V. ........ 33/2, 33/3, 33/5, 97PW/3Becher J. ............................................................176P/4 Binah O. ..................................................................... 1/2 Bongiorni M. G. ...................56P/70, 56P/69,Becker R. .......................................................... 216/41 Binner L. .........................47/4, 154/3, 176P/68 56P/76, 67/5, 96P/61, 86/1, 209/4Bedi M. .................................... 176P/71, 176P/27 Binner L. .................................................................. 154 Bongiorni M. G. ...................................... 90, 164Bednarek J. .................................................136P/58 Binte Katwadi K. ......................................136P/3 Bonmassari R. ..........................................176P/82Beheiry S. ................................... 136P/63, 163/3 Birbach M. ......................................................56P/66 Bonnes J. ..........................................................96P/83Behr E. ..............................................................97PW/4 Birgersdotter-Green U. .......................... 52/4, Bonny A. ...........................................................56P/25Behrenbeck T. .................................................148/4 176P/30, 164/2, 209/3, 206/4 Bontempi L. ......................................................... 23/1Beiras J. ................................................................223/1 Birkenhauer F. ................................................... 24/3 Book W. .............................................................96P/85Bellini B. .........................56P/68, 63/3, 216/21 Birney E. ..............................................................224/4 Bordachar P. ........... 13/5, 43/5, 70/4, 94/1,Bellisario A. ......................................................... 64/6 Birnie D. .........................................................176P/69 96P/35, 104/2, 176P/47, 176P/77,Belohlavek M. ..........................................176P/78 Bisbal F. ..........136P/19, 136P/40, 136P/25, 176P/52, 176P/83, 164/5, 206/3,Belott P. H. ................................................................ 70 203/1, 203/5, 225/4 226/1, 254/1, 274/1, 273/2Belvito C. .................................... 56P/58, 96P/30 Bisceglia C. ........................................................... 63/3 Bordachar P. .................................. 43, 104, 145 www.cardiostim.com - 162 -

Chairman & Author IndexChairman or Author. . ...... Session numberBordier P. ................................................................ 46/4 Brugada P. .................................................... 33, 124 Cannom D. S. ..................................................... 114Borggrefe M. ......................... 21/4, 51/2, 65/3 Brugada R. ............................................................ 33/4 Cantu’ F. ............................................. 106/2, 171/3Borggrefe M. ................................ 65, 174, 231 Brunelli M. ........ 56P/17, 96P/87, 136P/72, Capelli F. ............................................................96P/30Borgstrom N. ............................................... 216/12 176P/18 Caponi D. ....................................216/66, 216/53Boriani G. ................ 26/2, 56P/47, 176P/19, Bruno N. ................................. 136P/61, 136P/52 Cappato R. ..................... 105/1, 147/3, 184/6 176P/66 Brusich S. ............................................................... 24/4 Cappato R. ............................................................ 229Boriani G. .............................................. 2, 87, 211 Brzezinska-Paszke M. ..........................56P/66 Capucci A. ......... 96P/21, 96P/27, 176P/29,Borleffs C. .................................. 96P/49, 96P/48 Brzozowski W. ....................... 56P/63, 56P/64 176P/10, 176P/41, 227/4Borowiec A. ................................................176P/34 Buber J. .................................................................226/3 Capucci A. ................................................. 107, 271Borras R. .............136P/40, 176P/14, 203/5, Büchner M. ........................................................203/4 Carboni A. .......................................................96P/36 225/4, 63/5, 136P/25, 136P/19, Buchter B. .............................. 96P/87, 176P/18, Carbucicchio C. .............................................163/3 176P/49, 216/29 176P/86, 176P/74 Cardin C. ...... 23/2, 33/2, 33/3, 33/5, 43/3Borrello F. .................. 216/44, 216/42, 229/3 Bucx J. ....................................................................223/1 Cardinal R. ............................................................ 15/1Bortnik M. .................................. 56P/42, 56P/41 Bucyte S. ........................................................176P/55 Carlson M. D. ................................... 24/5, 145/4Bosnjakovic P. ..............................................56P/16 Budylin T. .........................................................136P/8 Carlsson L. .........................................................113/6Botto G. ................................................................... 10/5 Bueno S. ............................................................56P/52 Carmel N. ............................................................164/4Botto G. ....................................................... 151, 207 Bueno-Orovio A. ..................................... 216/81 Carmo P. .........................................................136P/83Boudou N. .......................................................56P/12 Bulava A. .................................. 56P/35, 136P/41 Carnero G. ....................................... 44/4, 216/27Bouet M. ........................................................176P/73 Bulkova V. ..................................... 223/6, 216/37 Carraro M. ............................................................. 68/4Boulé S. ............................................................ 216/54 Burazor I. .................................... 56P/16, 136P/4 Carrault G. ......................................................96P/81Bourier F. .......................................................136P/79 Burazor M. ................................ 56P/16, 136P/4 Carrie D. ..................................... 56P/12, 97PW/3Bouzelmat H. ...............................................56P/59 Burazor Z. ........................................................136P/4 Carroz P. ............................................................136P/2Boveda S. ............................ 136P/86, 136P/42, Burban M. .................... 56P/14, 64/2, 96P/81 Casella M. ...........................................................163/3 234/6, 254/6, 253/3, 274/6, 273/6 Burger H. ................................................................ 90/2 Casillas C. .....................................................176P/51Boveda S. ...................................... 165, 253, 273 Burgon N. ...................................... 183/6, 216/43 Cassagneau R. ................... 96P/70, 136P/60,Bowse E. ..............................................................164/1 Burgun A. ........................................................96P/76 176P/8, 216/45Boyden P. A. ........................................................ 221 Burke M. ..................................................... 177PW/2 Castel M. .......................................................176P/49Boyle N. ................................................................215/3 Burkhardt J. .............56P/7, 136P/63, 163/3 Castellant P. ................................................176P/60Brachman J. ......................................................194/2 Burri H. .................... 22/3, 136P/29, 136P/45, Castells F. ........................................................ 216/70Brachmann J. ........ 24/5, 136P/54, 216/41 136P/44, 136P/75, 151/2, 176P/8, Castilla L. ............ 176P/2, 176P/1, 176P/72,Bracke F. ............56P/74, 43/6, 90/1, 171/1, 216/71 176P/32, 176P/31 176P/64 Burrows M. .............................................. 177PW/4 Cates J. ..................................................................183/6Brambatti M. ..........................96P/21, 96P/27, Butter C. ................7/3, 56P/30, 52/3, 170/4 Cavaco D. ......................................................136P/83 176P/29, 176P/41 Butter C. ..................................................................... 30 Cavallaro C. ................................................176P/40Brand F. ............................................................17PW/3 Buttu A. ................................................................225/3 Cavallino C. .............................. 56P/42, 176P/9Brandes R. ..........................................................224/5 Butz T. .................................................................96P/86 Cazeau S. ................................................... 187, 206Braun J. .................................23/3, 163/1, 163/2 Byeon K. .................................... 17PW/5, 96P/29 Cebron J. .................. 56P/14, 64/2, 136P/42,Braunschweig F. ...... 32/4, 51/3, 176P/33, Bzymek M. .................................................... 216/74 176P/76 166/2, 216/69 Cebula S. ................................... 96P/8, 177PW/3Brecka D. .......................................................176P/54Bregasi A. ............................. 136P/61, 136P/52 C Cedano J. ......................................................136P/35 Celentano E. ............................ 136P/5, 216/36Breithardt G. .................................... 14/1, 132/4 Cabrera-Bueno F. ........... 176P/25, 176P/23 Cellario M. ...................................................136P/21Breithardt G. .......................................... 127, 132 Caliskan K. ......................................................96P/55 Cepeda S. .........................................................56P/13Breithaupt A. ............................................176P/67 Calkins H. ........................ 108/1, 121/3, 162/1 Cernelc P. ................................................................ 44/5Brembilla-Perrot B. ..............................136P/35 Calkins H. ............................................................... 162 Cesarani F. .......................................................... 56P/7 Chairman & AuthorBriggs C. ............................................ 205/5, 205/6 Callahan T. ......................................................96P/84 Cha Y. M. ..................... 70/1, 128/2, 176P/61,Brignole M. .......102/4, 122/1, 185/1, 228/4 Callans D. ....................... 115/1, 155/4, 175/4, 226/2, 226/3Brignole M. .......................................................... 207 202/4, 235/4, 255/2, 275/2 Chaib A. .............................................................56P/59Brisben A. .....................................................176P/71 Callans D. ......................... 115, 175, 255, 275 Chalil S. ...........................................................136P/37Brooke K. ............................................................226/3 Calò L. ............................ 96P/74, 184/1, 184/4, Chammams E. ................................................... 48/1Brost A. ...........................................................136P/79 207/3, 226/5 Champagne J. ................... 56P/71, 136P/81,Brouwer M. ...................................................96P/83 Calvi V. ................................................................56P/33 216/56Brown B. ................................................................. 65/7 Calvo N. .................. 13/3, 136P/19, 136P/25, Chan J. .............................................................136P/13Brown P. .................. 96P/1, 136P/37, 216/35 176P/49, 203/1 Chandrasekaran B. ..............................176P/45Bru P. ............................................... 56P/25, 96P/81 Camm A. ..............................45/1, 111/2, 186/1 Chastre T. ......................................................136P/76Brugada J. ................ 13/3, 33/4, 63/4, 63/5, Camm A. J. ............................ 34, 82, 125, 186 Chatzizisis I. ..................................................96P/10 136P/40, 136P/19, 136P/25, 176P/14, Camous J. ......................................................97PW/6 Chatzizisis Y. .................................................96P/19 176P/49, 203/1, 216/29, 203/5, 225/4 Candeias R. .................................................136P/83 Chaumeil A. ................................................136P/76Brugada P. ..... 101/2, 124/1, 142/2, 213/3 Cannom D. S. ................................... 94/3, 148/1 Chauvin M. ........................................................... 226 - 163 - www.cardiostim.com

Chairman & Author IndexChairman or Author. . ...... Session numberChawla M. ......................................................56P/20 Climent A. ........................................ 33/4, 216/70 Curnis A. ............................................... 23/1, 165/1Chazov E. ....................................... 13/4, 136P/12 Cochet H. ...........110/4, 136P/43, 176P/47, Curnis A. ........................................... 66, 106, 226Checchi L. ......................................................176P/37 163/5, 163/6, 205/4, 223/4 Curzen N. ............................................................113/4Cheggour S. ..................................................56P/25 Cognet T. .............................................................205/1 Cutler M. .............................................................129/4Chen J. ........................................... 56P/60, 56P/57 Cohen I. S. .................................................................... 1 Cvetkovic P. .............................. 56P/16, 136P/4Chen P. ...................................................................201/2 Coll-Vinent B. .................................................... 13/3 Cvijic M. ........................................... 13/6, 176P/56Cheng J. ................................................................135/3 Combes N. ............... 136P/86, 205/1, 253/2 Cygankiewicz I. ............................................ 56P/6Cheng J. ................................................................... 135 Combes S. ....................................................136P/86 Czajkowski M. .......................... 56P/72, 164/6 Combs W. .....................................................176P/42 Czygan G. ........................................................176P/4Chennapragada S. ................................. 216/19 Compier M. ..................................... 23/3, 216/58 Czyz K. ...........................................216/78, 216/73Chernyavskiy A. .............................................. 23/4 Conejeros W. ................................................56P/50Cheung C. ....................................................136P/13Chevalier M. ...............................................97PW/5 Connolly S. ...................................................17PW/6 DChevalier P. ................................... 33/1, 97PW/1 Conte G. ............................................................96P/36 D’Alessandro C. ...................... 68/9, 136P/76 Conte L. ................................................................... 68/4 D’Avila A. .......................................... 204/2, 204/3Chiamvimonvat N. ....................................201/1 Conti J. ..................................................................... 68/2 D’Onofrio A. ..............................................176P/40Chierchia J. ........................................................126/5 Cook S. ..................................................................224/4 Da Rocha P. .............................................. 177PW/1Chin A. ..............................................................17PW/6 Cooke D. ................................................................. 47/1 Dabiri Abkenari L. ....................... 63/2, 216/1Ching C. .................................... 136P/3, 136P/13 Cooklin M. ..................... 183/4, 183/5, 216/3 Dabiri-Abkenari L. ..................................96P/59Chinitz L. ..........................................................136P/8 Cooley R. .......................................................176P/80 DAbrowski R. ............................................176P/34Chirbiri A. ...........................................................183/5 Copie X. .............................................................96P/78 Dahlström U. .............................................176P/33Chirico A. ............................................................184/4 Corbisiero R. .... 96P/64, 176P/17, 176P/79 Dahme R. ......................................................176P/28Chirife R. ................................................64/4, 96P/9 Corbucci G. ................................... 216/47, 223/2 Daida H. ............................................................56P/34Chirife R. ........................................................... 29, 49 Corleto A. ....................................................... 216/53 Dakos G. ...................................... 96P/10, 96P/19Chlebus M. .................................................... 216/74 Coromilas J. ......................................................215/4 Damiano R. .......................................................149/3Choi J. ................. 96P/29, 136P/48, 136P/49, Coronel R. ............................................................. 61/4 Danchin N. ................................................................ 83 136P/47 Corrado D. .......................................... 92/1, 193/3 Daniel Scherr D. ....................................... 216/34Chong D. .................................. 136P/3, 136P/13 Corsinovi L. ................................................... 216/66 Dankowski R. .................................................216/2Chorro F. .......................................................... 216/82 Cortinovis A. ................................................96P/30 Danter M. ...........................................................164/3Choudhuri I. ..................... 176P/80, 176P/28, Costa A. ..........................................................176P/78 Dar Alammouri Y. ........... 96P/87, 176P/18 176P/78, 183/2 Costa R. .............................................................56P/52 Darden W. ...................................................... 216/20Chouvarda I. ............................ 96P/10, 96P/19 Costandi P. .............................. 56P/56, 176P/65 Das M. ..............................................................176P/42Chovancík J. ................................ 216/37, 223/6 Costeas C. .......................................................56P/48 Daszkowska-York J. ..............................56P/66Chrabaszcz M. ............................................ 216/74 Cotter P. ................................................................... 26/3 Daubert J. ......................... 56P/14, 50/1, 54/3,Christiaens L. ...............................................96P/17 Couderc J. .............................................................. 44/6 64/2, 176P/44Christopher J. O’donnell ..................96P/18 Couderc P. ........................................................96P/71 Daubert J. C. ........................................ 50/1, 54/3Christopher Newton-Cheh ............96P/18 Cousins L. ........................................................56P/75 Daubert J. C. .............................................. 32, 122Christophle-Boulard S. .......................96P/17 Coutu B. .........................................................176P/69 Davies W. ............................................................... 25/4Chrysostomakis S. ..................................56P/18 Cowan S. .............................................................164/3 Davies W. ............................................................... 232Chua Y. ...............................................................136P/3 Cowie M. ................................................................ 32/2 Davy J. M. .................... 7/2, 33/1, 33/2, 33/3,Chudzik M. ................................... 56P/32, 56P/6 Cramer M. ............56P/9, 97PW/2, 176P/84 33/5, 56P/29, 97PW/1Chugh S. S. ........................................................101/4 Cranke G. ............................................................... 68/6 Davy J. M. .............................................................. 171 Crevellari E. ...................................................56P/52 Day J. ......................................................................192/4Chung M. ....................................... 96P/84, 209/5 Crijns H. J. ...................... 68/5, 87/1, 176P/26, De Ambroggi G. ...........................................184/6Chwyczko T. ..........................176P/34, 216/32 176P/16, 271/3 De Bie M. .........................................................96P/48Ciconte G. .......................................................56P/68 Crijns H. J. .................................................................. 11 De Bono J. ...................................................... 216/67Cihak R. ................ 136P/24, 136P/70, 204/5 Cron C. ..................................................................... 23/2 De Caterina R. ................................................... 82/1Cinca J. ............................................................136P/67 Crowley A. ......................................................56P/75 De Chillou C. ........................... 136P/35, 251/1Cipolletta L. ..... 96P/21, 96P/27, 176P/29, Crozier I. ..................................................... 177PW/2 De Chillou C. .......................................................... 71 176P/10, 176P/41 Crystal E. .......................................................176P/69 De Greef Y. ................................ 136P/51, 183/1Cipressa A. ..................................................... 216/25 Csanadi Z. ....................................................... 216/61 De Groot N. ................... 56P/5, 63/2, 96P/59Cirjak A. ................................................................224/2 Csiba L. .............................................................. 216/61 De Guillebon M. .......................13/5, 96P/35,Cismaru G. ...................................................136P/35 Cubic Investigators ..................................226/4 176P/52, 163/5, 216/76, 226/1Ciszewski J. .................................................176P/58 Cubranic Z. ........................................................... 24/4 De Lange E. ................................................... 216/12Clemens M. ................................................... 216/61 Cuccia C. .......................................................... 216/25 De Luca L. ...................................... 96P/74, 184/1Clémenty J. ..................................... 96P/35, 13/5 Cuculich. P. .........................................................149/3 De Luca S. ........................................................96P/27Clémenty J. ................................................. 24, 184 Cuneo B. ......... 103/2, 103/3, 123/4, 143/5 De Lucia R. ................................56P/70, 56P/69,Clemmensen P. M. ......................................... 28/4 Cuneo B. ................................................................. 143 56P/76, 96P/61Clemmensen P. M. ............................................. 28 Cunningham F. ..............................................224/4 De Martino G. ...... 216/44, 216/42, 229/3Clift P. .................................................................. 216/67 Curel L. ..................................................................183/3 De Meyer G. ............................... 216/75, 225/2 www.cardiostim.com - 164 -

Chairman & Author IndexChairman or Author. . ...... Session numberDe Paulis R. .......................................................... 64/6 Develle R. ................................... 176P/63, 184/5 Dumonteil N. ...............................................56P/12De Potter T. ............................... 136P/5, 216/36 Dhala A. .........................................................176P/80 Dunbar S. ............................................................272/2De Roy L. .............................................................253/5 Di Biase L. .............................23/6, 56P/7, 89/2, Duncan A. .......................................................176P/3De Ruvo E. ...................96P/74, 184/1, 184/4 136P/63, 163/3 Duncan E. .....................................................136P/78De Santo T. .......................... 176P/67, 176P/66 Di Cori A. ............... 56P/70, 56P/69, 56P/76, Duparc A. .................. 23/2, 33/2, 33/3, 33/5,De Seta F. ......................................................176P/66 96P/61 56P/12, 43/3, 65/6, 97PW/3, 205/1De Simone A. ............................................176P/40 Di Donna P. ...............................216/66, 216/53 Dupuis J. ... 56P/14, 56P/29, 64/2, 96P/88De Vivo S. .....................................................176P/40 Di Gregorio F. .......................... 56P/33, 216/11 Duthoit G. .. 23/5, 68/9, 136P/76, 216/24Defaye P. ........ 33/1, 46/3, 96P/70, 96P/88, Di Ruocco V. ..................................................56P/42 Duytschaever M. .. 216/75, 232/1, 225/2 90/4, 97PW/1, 136P/42, 136P/60, Di Toro D. .........................................................96P/47 Dyrda K. .......................................... 216/28, 229/1 176P/8, 176P/44, 216/45, 234/7, Diab I. ...............................................................136P/78 Diallo A. ..........................................................97PW/5 254/7, 253/4, 274/7, 273/5Defaye P. .............................. 30, 164, 253, 273 Dianaty A. .................................56P/55, 56P/56, EDegand B. .................................. 96P/78, 96P/17 56P/54, 56P/53 Earley M. .......................................................136P/78Deharo J. ......................... 33/1, 52/1, 97PW/1, Dickfeld T. ..........................................................175/3 Eastman B. ..................................................176P/67 176P/26, 216/54, 208/5 Dickfeld T. .............................................................. 183 Ebishima H. ................................................... 216/79Deisenhofer I. ................... 56P/15, 136P/18, Dickstein K. ...............................................2/2, 22/4 Ebrille E. ........................................................... 216/66 216/59, 203/4, 229/5 Dickstein K. .......................................................... 146 Edes I. ................................................................. 216/61Deisenhofer I. ................................................... 229 Dider R. ............................................................. 216/68 Edner M. ........................................................176P/33Dekker L. ..........................................................56P/74 Diener H. C. ............................................................. 45 Edvardsson N. ................................................113/6Del Carpio Munoz F. ..........................176P/61 Dietrich J. .............. 56P/55, 56P/56, 56P/57, Efimov I. ............................................................136P/9Del Greco M. .............................................176P/82 56P/53 Eggen M. .......................................................176P/67Del-Carpio Munoz F. ................................226/2 Dijkman B. .................................. 56P/9, 97PW/2 Ehara N. .............................................................96P/22Delabre J. .......................................... 224/6, 224/7 Dilaveris P. ......................... 44/2, 63/6, 96P/39 Ehret G. ............................................................ 216/71Delacretaz E. ................................................... 56P/5 Ding Z. ................................................................136P/3 Ehrlich J. ...............................31/1, 224/3, 224/5Delannoy E. .................................................97PW/6 Dinov B. .............. 136P/23, 216/30, 216/26, Ehrlich J. .................................................................. 121Delarche N. ............................... 96P/88, 96P/71 216/16 Ehrman W. .............................. 96P/31, 136P/53Delay M. .................... 23/2, 33/2, 33/3, 33/5, Djordjevic S. ...............................................176P/35 Eigler N. ................................................................164/2 56P/12, 43/3, 97PW/3, 205/1 Djordjevic Dikic A. ...............................176P/35 Eisen A. ...........................................................176P/43Delcrè S. ........................................................... 216/66 Dobrev D. ......................................... 141/2, 271/1 Eisenberg S. .....................................................209/2Delgado V. ....................... 23/3, 56P/37, 63/1, Doevendans P. .........................................176P/84 Eisenberger M. ...................... 136P/5, 216/36 176P/59, 216/28, 216/58 Doi A. ........................ 96P/12, 136P/1, 136P/6, Eitel C. .............................................. 216/16, 229/6Delhaas T. .....................................................176P/52 216/49, 216/40, 216/46 Ejima E. ......................................... 96P/67, 96P/45Delingette H. ..................................................109/4 Doltra A. ........................................................176P/14 Eklund J. ................................................................. 64/3Delise P. .............................................. 167/1, 207/1 Domanovic D. ................................................... 44/5 El Allaf D. .........................................................56P/29Della Bella P. .................. 56P/68, 71/2, 63/3, Domenichini G. ..........................................176P/8 El Haddad M. ............................. 216/75, 225/2 216/21 Donatelli F. .......................... 136P/61, 136P/52 El-Sherif N. ......................................... 72/1, 193/1Dello Russo A. ................................................163/3 Donnici G. ....................................................176P/40 El-Sherif N. ............................................................... 72Delmar M. ............................................................. 61/2 Dorda M. ......................................................... 216/37 Elayda M. .......................................................17PW/4Delnoy P. ................................. 176P/68, 176P/6, Doria G. .............................................................56P/33 Elayi C. .......................................... 136P/63, 163/3 176P/26, 176P/16 Dorian P. ................................................................. 87/3 Eldar M. ................................................................... 24/2Delnoy P. P. ............................................................... 94 Dorszewski A. ..................... 176P/20, 176P/7 Elikowski W. ....................................................216/2Delumeau J. ....................... 176P/26, 176P/16 Dorwarth U. ...............................................136P/22 Ellenbogen K. .................. 75/1, 94/2, 114/3,Deneke T. ......................................................136P/77 Doshi N. ..........................................................176P/51 176P/71, 176P/27, 206/4, 206/5Denis A. .....13/5, 96P/5, 96P/35, 97PW/5, Chairman & Author Doshi R. .................. 23/6, 176P/71, 176P/27, Ellenbogen K. .............................................. 50, 75 113/1, 176P/83, 176P/47, 176P/77, 176P/51 Ellinor P. ...............................................................201/4 164/5, 163/5, 216/76, 226/1, Douard H. ......................................................97PW/5 Ellis C. ....................................................................... 24/1 223/4, 223/5 Dougherty A. .................... 136P/28, 176P/53 Elvas L. .................................... 176P/11, 176P/57Denjoy I. .........................................................97PW/6Denollet J. ............................... 96P/51, 176P/84 Drca N. ............................................................... 216/69 Emkanjoo Z. ..................................................... 96P/6Derval N. .... 13/5, 96P/5, 96P/35, 96P/77, Dresing T. .........................................................96P/84 Engelhardt S. ..................................................221/4 84/3, 97PW/5, 113/1, 113/2, 136P/43, Dubner S. ............................................................... 73/1 Enjoji Y. ......................................... 96P/67, 96P/45 176P/47, 176P/83, 176P/77, 170/2, Dubner S. ............................................ 33, 73, 153 Epstein J. ..........................................................96P/31 163/5, 163/6, 216/76, 216/55, 216/33, Dubuc M. ......................................................176P/88 Epstein L. ................................................................... 90 216/38, 205/4, 226/1, 223/4, 223/5 Duchemin L. ............................. 96P/76, 96P/81 Erdman R. ......................................... 44/1, 96P/52Derval N. .................................................................... 84 Duffy H. ................................................................... 41/4 Eriksson M. .................................................176P/19Desai M. .................................................................. 89/1 Dugourd C. .................................................136P/21 Erkapic D. ......................................... 203/3, 223/3Devecchi C. ....................................................176P/9 Duker G. ..............................................................113/6 Ernst S. ................ 84/1, 135/2, 209/1, 212/1Devecchi P. ......................................................176P/9 Dumaine R. ..................................... 224/6, 224/7 Ernst S. ..................................................................... 135 - 165 - www.cardiostim.com

Chairman & Author IndexChairman or Author. . ...... Session numberEscudero J. ......................................................96P/47Espinosa R. ........................................................226/3 Filippoli E. .......................................................56P/58 Findley G. .....................................................136P/82 GEsposito C. .............. 216/44, 216/42, 229/3 Fiorelli M. ........................................................56P/52 Gadler F. .........................................................176P/19Essebag V. ....................................................176P/69 Fischer A. ...................... 96P/79, 96P/44, 90/3 Gaita F. ....................... 56P/67, 56P/7, 216/53,Estner H. ..............................................................203/4 Fischer W. .................................................................. 64 216/66, 216/14Etienne Y. ................................176P/60, 216/68 Fishman G. I. ........................................................... 61 Gaita F. ............................................ 108, 192, 224Euzen M. ..................................... 96P/82, 96P/80 Fister M. ............................................................96P/23 Galizia C. ..........................................................96P/36Evain S. ..............................................................56P/14 Fitzpatrick M. ............................................17PW/2 Galizio N. .......................................... 44/4, 216/27Evertz R. ............................................. 63/4, 216/29 Fjord S. ..................................................................183/5 Galje M. ................................................................145/1Ewertsen C. ................................................136P/54 Flammang D. ...................................................208/4 Gallagher P. ................................................176P/71Exner D. .....133/1, 176P/69, 174/2, 233/2 Flammang D. ...................................................... 208 Galley D. ..............................................................206/6Exner D. ....................................................... 177, 233 Flevari P. ...............................................................228/2 Gallinghouse G. ..... 23/6, 56P/7, 136P/63Extramiana F. .............................................. 216/54 Flori M. ...............................................................96P/21 Galvez C. .......................................................136P/67 Floria M. ............................................................96P/15 Gandjbakhch E. .. 23/5, 136P/76, 216/24F Foerster L. ....................................................176P/67 Foley P. ............................................................176P/22 Ganière V. ........................................................176P/8Faber T. .................................................................223/1 Fonseca-Guzman A. .................................... 33/4 Garcia E. .........................................................176P/73Facchini E. .......................................................176P/9 For The Triple-Site Versus Standard García Guerrero J. ........ 176P/25, 176P/23Faerestrand S. .......................96P/68, 96P/75, Resynchronizat ................................................ 43/2 Garcia M R. .....................................................56P/21 176P/75, 176P/46 Forclaz A. ............................................................225/3 Gardey K. .................................... 136P/42, 203/2Fagagnini A. ............................... 96P/74, 184/4 Foreman B. .....................................................56P/75 Gargano A. ...................................... 44/4, 216/27Fan K. ................................................................176P/62 Foresti S. ..............................................................184/6 Gargaro A. ...................96P/74, 184/1, 184/4Fanelli A. ..........................................................56P/67 Fortin D. ............................................................56P/75 Garibaldi M. ................................ 216/10, 216/9Farah A. ............. 96P/87, 176P/18, 176P/36 Fossati F. ........................................................176P/76 Garnier F. ......................................................... 216/56Farazi T. ........ 24/5, 43/5, 136P/8, 176P/88 Fouchard S. ................................... 33/1, 97PW/1 Garot J. ..................................................................183/3Farkowski M. .............................................. 216/32 Fowler S. ..........................................................136P/8 Garrigue S. ..................96P/71, 254/2, 274/2Farre R. ............................................................136P/10 Fraccaro C. ...................................................176P/21 Garrigue S. ..................................................... 46, 62Fast V. ............................................................................... 1 Francalacci G. ......................... 56P/42, 56P/41 Gasiewski A. ................................................ 216/78Fatemi M. ................................216/68, 176P/60 Francis D. ...................................................... 50, 206 Gaspar T. ......................................216/30, 216/26Fatini C. .................................. 176P/38, 176P/37 François Laurent F. ................................. 216/34 Gasparini M. .................30/3, 56P/47, 166/4Fauchier L. .........................................................251/1 Frank R. ................................................................... 23/5 Gaston Albina G. .................................... 216/48Faulknier B. ............................... 56P/24, 56P/23 Franz M. R. ........................................................... 181Fazaa S. ..........................................................136P/86 Gatzoulis K. ...................... 44/2, 63/6, 96P/39 Frederic Sacher F. .................................... 216/34Fazal I. ............................................ 56P/10, 96P/63 Freedman R. ..................................................96P/57 Gauthier M. ......................................................205/1Fedorov V. ................................................................. 61 Fremont O. ........................................................204/4 Gayet E. ................................................................... 64/4Feinberg M. ......................................................226/3 Fressonnet R. ...............................................56P/61 Gebauer R. .................................................... 216/18Feld G. ................................................................56P/62 Friedman P. A. ...................... 108/2, 176P/61, Geelen P. ...................................... 136P/5, 216/36Feldman S. ............................................................ 24/2 226/2, 226/3 Geller C. ...............................24/5, 126/3, 126/3Feliciano Z. .....................................................96P/42 Fromer M. .......................................................136P/2 Geller J. ................ 56P/17, 96P/87, 136P/72,Felis S. .................................................................56P/33 Fruhwald F. .......................................................... 32/3 176P/18, 176P/36, 176P/86, 176P/74,Feng K. ...............................................................56P/57 Frutuoso C. ....................................................56P/21 223/1Ferek-Petric B. ................................................... 24/4 Fuhrmann J. .......................... 96P/87, 176P/18 Gentil P. ............................................................ 216/71Fernandez F. ........................................................ 23/5 Fujii F. ................................................................136P/33 Gentil-Baron P. ............... 136P/45, 136P/44,Fernández De La Concha J. ...... 176P/25, Fujii K. ...................... 96P/12, 136P/1, 136P/6, 136P/75 176P/23 216/49, 216/40, 216/46 Gerdes J. ...........................................................56P/38Fernández-Armenta J. .............. 63/4, 63/5, Fujii S. .....................................................................226/4 Giada F. ............................................... 202/3, 227/3 216/29 Fujimoto M. ...................................................... 56P/3 Gialernios T. ......................................... 44/2, 63/6Fernández-Lozano I. .........176P/25, 176P/23 Fujita M. ............................................................96P/28 Gibson D. .......................................... 23/6, 176P/3Fernando Scazzuso F. ......................... 216/48 Fukamizu S. ...................................................96P/38 Giewercer D. .............................................136P/82Ferraris F. ......................................................... 216/53 Fuke E. ............................................................... 216/13 Gilbert G. .................................... 136P/63, 163/3Ferreira M. ...................................................176P/57 Fukuda K. .....................................................136P/59 Gili S. ....................................................................... 56P/7Ferrieres J. .....................................................97PW/3 Fukuda Y. ......................................................136P/59Fiala M. ............................................ 216/37, 223/6 Fukumoto K. ..............................................136P/59 Gill J. ........... 24/5, 96P/77, 176P/30, 183/4,Fichtner S. .........56P/15, 136P/18, 216/59, Fukunami M. ................................................96P/46 183/5, 216/3, 216/81 203/4, 229/5 Funatsu A. ................................. 96P/67, 96P/45 Gillis A. M. .......................................... 10/1, 162/4Fiedler L. ......................................216/16, 216/26 Fung W. ..........................................................176P/26 Gillis A. M. ............................................................ 128Figulla H. ............................... 176P/48, 176P/15 Furber A. ............................................................. 96P/5 Gilmour Jr R. ....................................................... 161Fikar M. ................................................................223/6 Furniss S. ................................................................ 126 Gina Peloso ...................................................96P/18Filipecki A. ......................................................96P/41 Furukawa Y. ......96P/46, 96P/22, 136P/38 Ginefra P. .................................................... 177PW/1 www.cardiostim.com - 166 -

Chairman & Author IndexChairman or Author. . ...... Session numberGiniger Alberto G. ................................. 216/62 Grond M. ................................................................ 82/3 Haïssaguerre M. ............... 13/5, 33/2, 33/3,Ginks M. .........................................................136P/80 Gronda E. ............ 136P/61, 136P/52, 187/1 33/5, 44/6, 96P/5, 96P/35, 97PW/5,Girffith M. ...................................................... 216/67 Grøndal A. .........................................................183/5 113/1, 113/2, 142/3, 176P/83, 216/76,Girmatsion Z. ................................ 224/3, 224/5 Groschup G. ...............................................136P/77 206/3, 136P/43, 176P/47, 176P/77,Giudici M. ................... 56P/75, 56P/20, 68/2, Große A. ........................................................136P/72 176P/52, 163/5, 164/5, 163/6, 216/57, 134/1, 176P/71, 176P/27 Grosso Marra W. ..................................... 216/14 216/55, 216/56, 216/33, 216/38,Gleva M. ................................. 96P/60, 177PW/2 Grove G. ..............................................................206/1 216/23, 205/4, 226/1, 223/4, 223/5,Glikson M............................................................... 228 Grove R. ....... 56P/26, 43/4, 68/3, 136P/39 216/34Glikson M. .......................................... 24/2, 226/3 Grunnet M. .......................................................... 221 Haïssaguerre M. ........................................ 85, 91Glock Y. .................................................................... 23/2 Grupper A. ........................................................226/3 Haitsma D. ...................... 56P/5, 63/2, 96P/59Godin B. ...............................................................203/2 Gu Y. ........................................................................224/1 Haldar S. ........................................................136P/62Goette A. ............................................................271/2 Guardian S. ....................................................96P/21 Halimi F. ........................................ 136P/42, 273/4Goette A. ............................................................... 152 Guarracini F. .....................................................184/4 Halloran K. ................................ 136P/84, 229/4Gold M. .................49/1, 49/4, 105/2, 122/5, Guberman S. ...................................................... 44/6 Halperin H. ........................................................... 21/3 176P/71, 176P/27, 166/3, 206/4, Gudmundsson K. .................................... 216/69 Hamati F. ..................................... 56P/49, 96P/62 206/5, 230/3 Guedon Moreau L. .................................96P/81 Hamm C. .............................24/5, 203/3, 223/3Goldberger J. ................................ 133/3, 181/4 Guenon C. ......................................................56P/28 Hammami M. ...............................................96P/32Goldberger J. ............................................ 97, 133 Guenoun M. ...............................................176P/76 Hammill S. C. ..................................................... 128Goldenberg G. .........................................176P/43 Guerra F. ........... 96P/27, 176P/29, 176P/41 Han F. ................................................................136P/58Golitsyn S. .................................... 13/4, 136P/12 Guerra J. ...................................... 136P/67, 273/1 Han J. ...................................................................96P/42Golovchiner G. ........................................176P/43 Hanaoka R. ................................ 56P/27, 216/51 Guerra P. ........................................................176P/88Golzio P. ....................................... 56P/67, 216/14 Hanazawa K. ...................................................216/8 Guha K. ...................................... 176P/45, 176P/3Gomez G. ........................................................ 216/62 Hanis J. ............................................................136P/41 Guill A. .............................................................. 216/82Gomez L. ......................................................... 216/48 Hanna I. ................................................................... 44/3 Guillem M. ....................................... 33/4, 216/70Gonçalves L. ...............................................176P/11 Hanson B. ....................................................... 216/81 Guiraudon G. M. ............................................ 15/3Gonzalez J. ...................................... 44/4, 216/27 Hapetyan I. .................................................176P/12 Guiraudon G. M. ...................................... 15, 23González Villegas E. .............................56P/77 Hara N. ............................................................136P/64 Guirgis M. ..........................................................143/2Gonzi G. ............................................................96P/36 Harada T. ..................................... 96P/13, 216/17 Guirgis M. ............................................................. 103 Harari D. ............................................ 204/1, 204/3Gorenek B. ............................................................ 28/2 Guiú E. ............136P/19, 136P/25, 136P/40, Harbert N. ....................................................176P/79Gorenek B. ................................................................ 28 203/1, 203/5, 225/4 Harden S. ............................................................113/4Gorki S. ...........................................................136P/72 Gula L. .................................................................96P/16 Hare J. ..............................................................176P/78Goromonzi F. .............................................136P/78 Gulati S. .............................................................96P/20 Hariharan R. ..................................................96P/66Gorzolka J. ........................................................223/6 Gulizia G. ............................................................... 227 Harrison J. ...................... 183/4, 183/5, 216/3Gotti E. ...............................................................56P/58 Gulletta S. .......................................................56P/68 Harrison M. .................................................. 216/15Gouraud J. ..............33/2, 33/3, 33/5, 96P/5 Gully C. ..............................................................56P/25 Haruna T. ..........................................................96P/28Gourraud J. ..................................... 56P/14, 64/2 Gundry S. ................................. 96P/31, 136P/53 Hasebe N. ...........................................................113/5Goya M. .............................................................56P/73 Gupta N. ........................................................176P/51 Hasenfuss G. ...................................................... 44/6Grancelli H. ....................................................... 96P/9 Gustafsson J. ................................................56P/24 Hassan A. ........ 96P/87, 176P/36, 176P/86,Grand-Larrieu D. ...................................136P/86 Gutbrod S. ......................................................136P/9 176P/74Grantham T. ..................................................56P/20 Gutfinger D. .....................................................164/2 Hatala R. ...........................................................56P/30Gras D. ................56P/14, 64/2, 86/3, 125/3, Gutleben K. J. ..................... 10/4, 43/5, 86/2, Hatala R. ........................................................ 23, 192 176P/30, 190/2, 254/8, 274/8 Hatani T. ............................................................96P/22 136P/85, 136P/74, 176P/26, 176P/24,Gras D. ................................................ 70, 106, 190 Haththotuwa H. ...................................... 216/67 176P/16, 216/1, 216/52 Chairman & AuthorGray I. ...............................................................136P/34 Hauser R. .............................................................134/3 Guy-Moyat B. ...........................................136P/86Greco O. ............................................................96P/47 Hausleiter J. .....................................................229/5 Guyomar Y. ....................................................96P/71Green A. ..........................................................97PW/4 Havránek ............................................................223/6Green B. ............................................................56P/62Greenberg S. ....56P/49, 96P/62, 176P/65 H Hayano M. ..................................................... 216/13 Hayashi F. ................................... 96P/67, 96P/45Greene K. ............................................................121/2 Ha K. .....................................................................96P/65 Hayashi H. ......................................................56P/34Greer S. .................................................................... 24/1 Haarbo J. ..........................................................96P/58 Hayashi T. ........................................................96P/38Greiss H. ............................................. 203/3, 223/3 Habibi H. ..........................................................56P/56 Hayashida K. .............................................136P/50Grenz N. .........................................................176P/67 Haddad F. ...................... 44/5, 96P/23, 96P/24 Hayes C. ...............................................................225/5Grieco D. ...........................................................96P/43 Hafelfinger W. ...............................................164/2 Hayes D. ....... 96P/57, 110/2, 128/1, 154/1Grimard C. ...................................................136P/56 Hagiwara Y. ................................................136P/59 Hayes D. ......................................................... 46, 134Grippo M. ........................................................56P/50 Haigney M. .......................................................173/1 Heacock A. .....................................................56P/75Groben L. ......................................................136P/35 Haigney M. .................................................... 17, 53 Healey J. ................................. 17PW/2, 176P/69Gromyko G. ................................................136P/65 Haim M. ..........................................................176P/43 Hebe J. ...................................................................... 84/2 - 167 - www.cardiostim.com

Chairman & Author IndexChairman or Author. . ...... Session numberHeck P. ....................................................................224/2 Hoberman K. ................................................56P/53 Huikuri H. .............................................................. 193Hegrenes J. .................................. 216/4, 216/22 Hochadel M. .................................................96P/40 Hunter R. .......................................................136P/80Hegwood E. ..................................................56P/48 Hocini M. ................ 33/2, 33/3, 33/5, 96P/5, Hussain W. ........136P/62, 136P/26, 136P/17Heidbüchel H. .......................................... 51, 231 96P/35, 97PW/5, 113/1, 113/2, 115/3, Hussein K. .......................................................56P/44Heiderfazel S. ...........................................136P/54 108/4, 136P/43, 176P/83, 176P/77, Husser-Bollmann D. .........216/30, 216/26Heinke M. ............................. 176P/48, 176P/15 163/5, 163/6, 195/4, 216/38, 216/23,Heinke T. ........................................................176P/15 216/76, 216/55, 216/33, 216/57, 205/4, 223/4, 223/5, 216/34 IHeinroth K. ................................................... 216/41Heintze J. ......... 136P/85, 136P/74, 216/52 Hocini M. .................................................... 141, 195 Iannucci L. ..........................................................184/1Heinzel F. ................................................................ 26/4 Hodge D. .............................................................226/3 Ide Y. ............................................ 96P/22, 136P/38Heist E. ............................................................176P/87 Hoeltgen R. .......................................................229/2 Ideker R. E. ........................................................169/2Heist K. ...........................................................176P/65 Hoenen S. ........................................................56P/35 Ideker R. E. ........................................................... 205Helland J. R. ......................................................... 47/3 Hoenig S. ......................................................136P/66 Iesaka Y. .........................................................136P/30 Hoey M. .............................................................96P/44 Iida J. ....................................................................96P/28Helland J. R. ............................................................. 67 Hoffmann A. ................................................... 96P/2 Ikeda K. .............................................................56P/27Hemayat S. .....................................................56P/43 Hoffmann E. ....................... 56P/29, 136P/22, Ikeda T. .................................................................. 56P/3Hendrich E. ........................................................229/5 136P/54, 216/41, 232/2 Ilic D. .....................................................................56P/16Hendriks J. M. L. ...........................................272/3 Hoffmann E. ....................................................... 209 Illhardt E. ......................................................136P/72Hendrikx T. ................................. 17PW/1, 96P/7 Hohnloser S. .. 14/3, 107/2, 224/3, 224/5 Imani R. .............................................................56P/55Henry C. ............................................................96P/76 Hohnloser S. ........................................................... 26 Imnadze G. ........................ 56P/26, 43/4, 68/3Herczku C. ............................................................ 63/5 Hojo R. ................................................................96P/38 Inaba O. ..........................................................136P/71Hermida J. .................. 33/1, 96P/78, 96P/71, Hoke U. ..................56P/37, 96P/49, 176P/59 Inama G. ..............................................................207/5 96P/5, 97PW/1 Holcomb R. .....................................................96P/60 Infusino T. ..........................................................184/6Hernández-Madrid A. ....................... 176P/1, Holman E. ........................................................56P/37 Inglis J. ......................................................... 177PW/2 176P/72, 176P/32, 176P/31, 176P/25, Holmeister J. ...................................................... 10/2 Ino Y. ............................................... 96P/67, 96P/45 176P/23 Holmes D. ........................................................136P/8 Inoko M. ...........................................................96P/28Hernández-Madrid M. ........................176P/2 Holtgrewe U. ............................................136P/39 Inoue K. .................. 96P/12, 136P/1, 136P/6,Herpin D. ..........................................................96P/17 Hombach V. ......................................................133/2 216/49, 216/46, 216/40, 226/4Herrera-Sidloky C. .....................................204/6 Hombach V. ............................................................. 93 Insulander P. ................................................ 216/69Herrera-Siklody C. ........ 136P/68, 216/60, Honda S. ...........................................................96P/22 Ip J. ............................................................................125/1 216/5, 216/57 Hong Fung W. ..........................................176P/16 Iriart X. ............................................. 163/5, 216/76Hessen S. .................................. 96P/66, 176P/71 Hoogwegt M. ..............................................96P/52 Irwin M. ..........................................................176P/81Hessling G. .......56P/15, 136P/18, 216/59, Hopman W. ..................................................17PW/2 Ishikawa Y. .....................................................96P/13 203/4, 229/5 Hoppe H. .......................................................176P/15 Ishimura T. ......................................................96P/28Hevia S. ................................................................... 13/3 Hopper K. ...........................................................225/1 Ishizaka T. ........................................................136P/7Hewitt C. ......................................................176P/30 Horack M. .....................................................136P/54 Ismer B. ................................... 176P/48, 176P/15Heywood J. .......................................................164/2 Hornberger L. K. .... 123/2, 143/3, 143/7 Israel C. ...................... 7/1, 29/4,122/4, 151/4Hidden Lucet F. .............................................104/3 Hornberger L. K. ........................................... 123 Hornegger J. ..............................................136P/79 Israel C. W. .................................................. 94, 190Hidden-Lucet F. ........ 23/5, 68/9, 136P/76, Hörnsten R. ...................................................... 96P/7 Isshiki T. ................................................................226/4 176P/44, 216/24 Horstkotte D. .................. 136P/85, 136P/74, Iulianella R. ..................................... 184/1, 184/4Hildreth J. ...........................................................225/1 216/1, 216/52 Iuliano A. ......................................................176P/40Hilje T. ....................................................................229/2 Horton R. .................................... 56P/7, 136P/63 Iwai S. ..............................................................136P/71Hill M. ........................................................................ 45/5 Iwakura K. ........... 96P/12, 136P/1, 136P/6, Horvilleur J. ......................................................183/3Himbert C. ............................................................ 68/9 216/49, 216/40, 216/46 Hoskins M. .....................................................96P/85Himmrich E. ...................................................56P/28 Iwasaki Y. ........................................................96P/46 Houben R. ..................................... 216/75, 225/2Hindricks G. .............. 55/3, 136P/23, 191/1, Izumi T. ...............................................................96P/28 Houlden L. ...................................................176P/81 216/16, 216/30, 216/26, 212/4, 229/6 Houlton G. ............................................... 177PW/4Hindricks G. ................................... 55, 111, 125Hintringer F. ...............................................136P/57 Houthuizen P. ...........................43/6, 176P/64, J 176P/5, 206/2Hirahara T. ......................................................56P/45 Hovhannesyan A. .................................176P/12 Jacobsen P. .....................................................96P/16Hirao K. ............................................................ 216/50 Hovstad T. ............................ 176P/75, 176P/46 Jacon P. .................. 96P/70, 136P/60, 216/45Hiraoka M. .....................................................96P/38 Hranitzky P. .................................... 23/6, 216/20 Jacques J. .........................................................96P/76Hirayama A. ..... 136P/27, 136P/16, 225/6 Hsia H. ................................................................96P/24 Jacquot C. .......................................................56P/61Hirose S. ............................................................96P/28 Huber K. .................................................................. 45/3 Jadidi A. .................136P/68, 163/6, 216/23,Ho G. ..................................................... 205/5, 205/6 Hubert Cochet H. .................................... 216/34 216/60, 216/5, 216/57, 216/55, 205/4,Ho J. ....................................................... 205/5, 205/6 Hudsmith L. .................................................. 216/67 204/6, 223/4, 223/5Ho S. Y. ..................................................................... 51/4 Huh J. ............................................ 17PW/5, 96P/29 Jaeggi E. ........................... 123/3, 143/4, 143/6Ho_ková L. .....................................................96P/43 Huikuri H. ...........................................................173/3 Jaeggi E. .................................................................. 123 www.cardiostim.com - 168 -

Chairman & Author IndexChairman or Author. . ...... Session numberJagia P. ................................................................56P/40 Juneja R. ...................................... 56P/39, 56P/36 Kawamura Y. ..................................................113/5Jahangir A. ................................ 128/3, 176P/28 Jurkevicius R. ............................................176P/55 Kawasaki M. .................................................96P/46Jahns G. ....................................................... 177PW/4 Jurkuvenas P. ...............................................96P/43 Kawashima A. .............................................56P/27Jaïs P. ...............33/2, 33/3, 33/5, 67/2, 74/3, Kawata H. .......................................................56P/62 96P/5, 96P/35, 97PW/5, 113/1, 113/2, 176P/83, 175/1, 172/4, 216/76, 43/7, K Kay N. .....................................................................195/2 Kay N. ........................................................................ 195 136P/43, 176P/47, 176P/77, 163/5, Kaab S. ......................................................................... 12 Kazakevicius T. ........................................176P/55 163/6, 216/38, 216/55, 216/33, 216/57, Kacet S. .................................................................... 43/5 Kazakov A. ..................................................136P/65 216/23, 205/4, 223/4, 223/5 Kacet S. .................................................................... 166 Kazatsker M. ...................................................164/4Jalal Z. ....................................................................163/5 Kadalie C. ............................. 136P/69, 136P/46 Keel A. ...................................................................... 43/5Jalife J. ...................................... 41/3, 61/3, 149/1 Kagisaki K. .............................176P/70, 216/79 Keeney J. ....................... 24/1, 56P/49, 96P/62Jalife J. ............................................................. 12, 205 Kagiyama N. ..............................................136P/64 Keilegavlen H. ................. 176P/75, 176P/46Jamart J. ............................................................96P/15 Kaimucki P. ........................................................216/2 Kella D. ...................................... 96P/85, 176P/13Jan M. ...............................................................176P/56 Kaitani K. .......................................... 216/8, 226/4 Kelland N. ....................................................136P/84Janardhan A. ................................................136P/9 Kaji S. ...................................................................96P/22 Kennebäck G. ............................................. 216/69Jankowska A. ............................................. 216/32 Kalahasty G. ...................... 176P/71, 176P/27 Kennergren C. ............................. 131/4, 165/2Janou_ek J. .................................................... 216/18 Kalarus Z. .................... 43/2, 96P/8, 176P/50, Kennergren C. ......................................... 67, 165Jansen D. .......................................................176P/48 177PW/3 Kenny R. A. .......................................................228/3Jansens J. L. ......................................................110/1 Kalavakolanu S. ....................................... 216/19 Kenny R. A. .......................................................... 188Janu_ka J. ...................................... 216/37, 223/6 Kalbfleisch S. ...............68/6, 96P/57, 204/2 Keren G. ...............................................................164/4January C. T. .......................................................... 1/3 Kallikazaros I. ................. 44/2, 63/6, 96P/39 Khaled Nagi H. ...........................................56P/44Jarman J. ....... 136P/62, 136P/26, 136P/17 Kalman J. M. ............ 115/4, 95/4, 136P/84, Khalili M. ............................................................. 96P/6Jarmouny S. ...............................................136P/35 155/3, 229/4 Khalique Z. ..................................................176P/45Jarverud K. .....................................................56P/24 Kalman J. M. .............................................. 21, 115 Khamis H. ....................................................... 216/77Jaspers Focks J. ..........................................96P/83 Kamperidis V. ...............................................96P/19 Khan A. .................................................................... 44/3Jaswal A. ..................................... 56P/8, 176P/39 Kanagaratnam P. ............................. 23/6, 85/1 Khandheria B. ........................ 176P/78, 183/2Jatin Relan J. ............................................... 216/34 Kanamori N. ................................................. 216/51 Khare V. ................................................................... 64/3Jauvert G. ............56P/29, 56P/30, 136P/56 Kanamu L. ...................................................... 216/43 Khaykin Y. ....................................................136P/82Jaynes S. ..............................................................225/1 Kanj M. ..............................................................96P/84 Kheyi J. ..............................................................56P/59Jazra C. .................................................................... 48/4 Kanoh M. ......................................................136P/71 Khiani R. ........................................................176P/22Jazra C. ........................................................................ 66 Kanter R. ......................................................... 216/20 Khoury M. .............................................. 66/2, 66/2Jean S. .................................................................56P/61 Kantharia B. ........................ 96P/25, 136P/28, Khoury M. ................................................................. 48Jedrzejczyk-Patej E. ............. 43/2, 176P/50 176P/53, 168/3, 216/31 Kida H. ................................................................96P/46Jeffery S. ........................................................97PW/4 Kappenberger L. ...................................136P/14 Kikkenborg Berg S. ..................................272/1Jensen H. ........................................ 56P/38, 183/5 Karaskov A. ........ 23/4, 136P/55, 136P/20, Killu A. ...................................................................226/3Jensen J. .......................................... 216/4, 216/22 216/47, 203/6, 223/2 Kim E. ................................................................17PW/5Jensen M. ........................................................96P/73 Kardos A. .........................................................96P/55 Kim J. ............................................... 17PW/5, 96P/3Jensen-Urstad M. .................................... 216/69 Karim R. ............................ 183/4, 183/5, 216/3 Kim K. ..................................................................96P/22Jeon E. ................................................................96P/29 Karim S. ................................................................164/3 Kim S. ................................................... 163/6, 205/4Jerzykowska O. ............................................216/2 Karimzadeh K. ................. 136P/28, 176P/53 Kim S.J. .............................................................. 216/34Jia P. ..........................................................................226/1 Karlsson A. .....................................................56P/23 Kim W. ...................................................................183/5Jilek C. ..................56P/15, 136P/18, 216/59, Karolyi L. ............................... 136P/69, 136P/46 Kim Y. ............... 136P/48, 136P/49, 136P/47 203/4, 229/5 Karst E. ............................................................176P/88 Kimber S. ......................................................176P/81Jobic Y. .............................................................. 216/68 Kartsagoulis E. ...........................................96P/39 Kimmo Kontula .........................................96P/18Joergensen O. .............................................96P/58 Karvounis H. .................................................96P/19 Kimmo Porthan .........................................96P/18 Chairman & AuthorJohansen J. .................. 24/6, 56P/46, 96P/58 Karystinos G. ...................................... 44/2, 63/6 Kimura M. .......................................................96P/28Johar S. ................................... 136P/73, 136P/62 Kasamaki Y. ...... 136P/27, 136P/16, 225/6 Kimura R. .............. 96P/12, 136P/1, 136P/6,Johnson G. ............................................... 177PW/2 Kasashima S. ................................................56P/27 216/49, 216/40, 216/46Jokhadar M. ..................................................96P/85 Kaseno K. ....................................................... 216/13 Kimura T. ..................................... 136P/59, 226/4Jones D. .................................. 136P/73, 136P/62 Kassab G. ......................................................176P/42 Kinoshita M. .................................................96P/22Jones M. ..............56P/22, 176P/22, 216/72, Kaszuba A. .....................................................56P/66 Kircanski B. .................................................176P/35 225/5 Kathan S. ............... 136P/18, 216/59, 203/4 Kirchhof P. ........................... 13/1, 82/4, 153/2,Jordaens L. ..... 44/1, 56P/5, 63/2, 96P/55, Katoh T. .............................................................96P/28 172/2, 191/2 96P/59, 96P/52, 89/5, 174/3, 204/3 Katwadi N. ........................................................224/1 Kirchhof P. ....................................................... 22, 45Jorge E. ...........................................................136P/67 Katz A. ...................................................................211/2 Kirkby C. .......................................................136P/80Joseph S. .............................................................229/4 Kautzner J. ...................... 25/1, 23/6, 96P/43, Kirkfeldt R. ...................................... 56P/46, 64/1Jourdain P. .........................................................150/4 136P/24, 136P/70, 150/1, 192/1, Kiss A. ................................................................ 216/61Jovanovic V. ...............................................176P/35 216/18, 216/39, 204/4, 204/5 Kissler S. ..............................................................224/5Jumrussirikul P. ..........................................96P/65 Kautzner J. ............................................... 172, 212 Kistler P. ....................................... 136P/84, 229/4 - 169 - www.cardiostim.com

Chairman & Author IndexChairman or Author. . ...... Session numberKitai T. .................................................................96P/22 Korabathina R. ................................................. 33/6 Kuwahara T. ...............................................136P/31Kiyama M. ......................................................... 56P/3 Kostic T. ........................................ 56P/16, 136P/4 Kuznekoff L. .................................................136P/8Klank-Szafran M. .................................... 216/74 Kottkamp H. ....................................................... 71/4 Kuznetsov V. ...................................................223/1Klautz R. ..............................23/3, 163/1, 163/2 Kottkamp H. ........................................................... 10 Kuzniec J. ......................................................176P/43Kleber A. .................................................................... 41 Kotzot D. .............................................................224/3 Kwasniewski W. .......................................96P/41Kleemann T. ................................... 24/5, 96P/40 Koujitani H. ................................................136P/38 Kypta A. .........................................................136P/66Klehn R. .............................................................96P/56 Koura K. .........................................................136P/30Klein G. J. .................. 96P/16, 255/11, 275/1 Kouraki K. .......................................................96P/40 LKlein G. J. ......................................... 15, 255, 275 Kovacs K. ........................................................ 216/61 Kowalczyk J. .......................... 96P/8, 177PW/3 La Meir M. .........................................................232/4Klein H. .................................... 53/2, 92/3, 194/4 Kowalik I. ........ 176P/58, 176P/34, 216/32 La Rocca V. ...................................................176P/40Klein H. ........................................................ 105, 133 Kowalski J. ..................................................176P/33 La Rovere M. T. .................................. 72/2, 93/4Klein N. .................................................................... 68/7 Kowalski M. ........................................................ 43/4 La Rovere M. T. ................................................. 173Klein P. ................................................. 163/1, 163/2 Labrousse L. ................................................. 216/38Klersy C. ..............................................................226/5 Kowalski O. ................ 43/2, 96P/8, 176P/50 Labrousse L. ........................................................ 110Klimczak A. .................................. 56P/32, 56P/6 Koyama Y. ...................................................... 216/46 Labus M. .......................................................... 216/74Klingenheben T. ............................ 93/3, 224/5 Kraaier K. .........................................................96P/37 Lader J. ...............................................................136P/8Klionsky L. ......................................................56P/53 Krahn A. ............ 96P/16, 176P/26, 176P/16 Ladwig K. H. ....................................................211/4Kloppe A. .........................................................96P/69 Kranig W. ............ 56P/26, 43/4, 43/5, 68/3, Lagrange P. ....................................................56P/28Klug D. .........................33/1, 96P/80, 96P/5, 9 136P/39, 176P/24, 206/1 Lai S. .....................................................................136P/3 7PW/1, 176P/68 Kraska A. ..................................176P/58, 216/32 Laiño Ruben R. .......................................... 216/62 Krausová R. .................................................. 216/39Klug D. ......................................................... 131, 165 Lairez O. ...............................................................205/1 Krawczynska A. .................................. 177PW/3 Lakatta E. ............................................................... 201Klukvin A. ....................................................136P/65 Krawiec ................................................................223/6 Lakkireddy D. ......................... 136P/63, 163/3Knaut M. .............................................................223/1 Krieg J. ............................................................136P/22 Lalani G. ..... 136P/15, 216/23, 205/2, 205/3Knecht S. .......31/4, 95/2, 169/1, 176P/83, Krieger D. .................................................................. 26 Lamaison D. ..................................................... 96P/5 216/33, 216/76, 223/4, 223/5 Krinski V. ................................................................ 44/6 Lambert H. .................... 204/1, 204/4, 204/5Knecht S. .................................................................... 95 Kristiansen H. ........................96P/68, 96P/75, Lambert T. ....................................................136P/66Kneicht S. ....................................................... 216/56 176P/75, 176P/46 Lambiase P. .......................................................... 24/6Knops R. .................................................................. 24/6 Kronborg M. .................................................56P/38 Lambiase P. .......................................................... 189Ko Y. .................. 136P/48, 136P/49, 136P/47 Krug J. ..............................................................136P/77 Lande G. ............................................ 56P/14, 64/2Kobayashi K. ................................................96P/12 Krum D. ..........................................................176P/78 Landolina M. .............................. 56P/47, 226/5Kobayashi T. ............................ 96P/67, 96P/45 Krummen D. E. .................... 136P/15, 169/5, Lang D. ...............................................................136P/9Kobayashi Y. .................................................136P/7 205/2, 205/3, 205/5, 205/6, 225/1 Langbein A. ................................................136P/77Kobo B. .................................................................... 24/2 Langberg J. ............................ 96P/85, 176P/13 Krupa R. .................................................................. 68/2Kobori A. .................................. 96P/22, 136P/38 Lanocha M. .......................................................216/2 Krynski T. ......................................................136P/36Kociánová L. ....................................................223/6 Lasse O................................................................96P/18 Kubu_ P. ........................................................... 216/18Koenig M. .......................................................96P/25 Latcu D. .........136P/32, 136P/87, 136P/21, Kucera J. .......................................................... 216/12Kofune M. .......... 136P/27, 136P/16, 225/6 Kuck K. H. ................... 74/1, 136P/54, 125/4, 216/6, 216/10, 216/54, 216/9Kohjitani H. ...................................................96P/22 216/41, 204/1, 204/2, 204/3, Lauer B. .................56P/17, 96P/87, 176P/18Kohl P. ....................................................................... 41/1 204/4, 204/5 Laurent F. ............ 136P/43, 176P/47, 163/5Kohno R. ...........................................................56P/31 Laurent G. ..................................... 96P/71, 96P/5 Kuck K. H. .................................. 2, 31, 172, 232Kolasa J. ............................................................... 96P/2 Laurent Roten L. ...................................... 216/34 Kuehnert H. ........................ 176P/48, 176P/15Kolb C. ....................... 56P/15, 68/7, 136P/18, Lauter J. .............................................................96P/72 Kuiakowski P. ...........................................136P/36 216/59, 229/5 Law S. ..................................................................136P/3 Kuiper M. ............ 43/1, 68/5, 68/8, 176P/5,Kolbitsch C. ......................................................183/5 Lawrenz W. .......................................................229/2 206/2 Lazarus A. .................. 27/4, 96P/81, 96P/88,Komajda M. .................................... 68/9, 216/24 Kukulski T. ...................................................176P/50 136P/56, 176P/76Koman C. ......................................................136P/57 Kumagai K. ................................................... 216/13 Lazarus A. ................................................................. 68Komat Y. ..............................................................163/6 Kumar S. .....56P/2, 136P/84, 224/2, 229/4 Lazovic M. .................................. 56P/16, 136P/4Komatsu K. ....................................................56P/34 Kuniss M. .......................................... 203/3, 223/3 Lazzara R. .................................................................. 81Komatsu Y. .............113/1, 113/2, 176P/83, Kurzidim K. .................................................136P/79 Le Bloa M. .......................................................... 96P/5 216/34, 216/23, 223/4, 223/5 Kus T. .................................................................176P/69 Le Gal G. .......................................................... 216/68Komiyama K. ...............................................96P/38 Kusa S. .............................................................136P/30 Le Heuzey J. Y. ...............................................107/1Komori A. ................................176P/70, 216/79 Kusumoto F. ............................................................ 89 Le Marec H. ...............33/1, 96P/77, 97PW/1Kondo Y. ...........................................................136P/7 Kutalek S. ...................................... 96P/57, 164/1 Lebedev D. ........................................................223/1Konishi Y. ......................................................136P/64 Kutarski A. .......... 56P/72, 56P/66, 56P/63, Leclercq C. ...... 56P/14, 43/5, 64/2, 96P/5,Kontaraki I. ....................................................56P/18 56P/64, 164/6 106/1, 122/3, 176P/44, 176P/6Kontogeorgis A. ............ 136P/26, 136P/17 Kuteszko R. ................................................... 216/32 Leclercq C. ................................................................ 86 www.cardiostim.com - 170 -

Chairman & Author IndexChairman or Author. . ...... Session numberLeclercq J. F. ............................................................. 31 Linker N. J. ............................................................ 272 Maciag A. ........ 176P/58, 176P/34, 216/32Lee H. C. ...............................................................148/2 Linton N. ....... 183/4, 183/5, 216/3, 223/4, Maciel M. .........................................................56P/21Lee J. ..................................................................136P/84 223/5 MacLeod R. .......................................................183/6Lee K. ........................................ 176P/87, 176P/24 Lionetti V. ....................................................... 216/11 Maeda S. .......................................................136P/64Lee R. ................................................. 55/1, 136P/58 Lioy E. .....................................................................184/4 Maffei S. ...........................................................96P/27Lee S. ............................................. 17PW/5, 96P/29 Lip G. Y. .................................................... 42/2, 82/2 Maglaveras N. ........................ 96P/10, 96P/19Lee V. ..................................................................17PW/4 Lipinski W. ......................................................56P/66 Maglia G. .................. 216/44, 216/42, 229/3 Lippert M. .......................................................176P/4 Magliari F. ..........................................................184/1Lee Y. ................................................................176P/61 Lisi F. .....................................................................56P/33 Magnani A. ............................... 56P/42, 56P/41Leenhardt A. ............................... 33/1, 97PW/1 Lisi M. ..................................................................56P/33 Magnin-Poull I. .......................................136P/35Lehinant S. ...................................... 203/3, 223/3 Liu C. F. ..................................................................... 89/4 Mahjoub M. ....136P/32, 136P/87, 216/6,Lehrmann H. ....................... 136P/68, 216/60, Liu L. .......................................... 176P/26, 176P/16 216/54 216/5, 216/57, 204/6 Liu Y. ................................................ 56P/60, 56P/57 Mahmood I. ...................................................56P/23Leisch F. ...........................................................136P/66 Mahoney V. ...................................................136P/8Lejeune N. .......................................................56P/61 Llorente Hernangómez E. ............176P/25 Maier L. S. ..........................................................161/4 Lloyd M. .................................... 96P/85, 176P/13Lembcke A. .......................................................... 64/5 Maier L. S. ............................................................. 161 Locati E. ................................................................173/4Lemke B. ...........................68/7, 96P/69, 114/4 Maier S. .............................................................176P/4 Locati E. ................................................................... 213Lemke B. ..................................................................... 24 Maikov E. ......................................................136P/12 Loghin C. .............................. 136P/28, 176P/53Lenarczyk R. ............... 43/2, 96P/8, 176P/50 Mairesse G. ....................................................56P/28 Loibl S. ...................................................................229/5Lenarczyk R. ............................................................ 68 Makdissi A. ....................................................96P/81 Loizeau C. .......................................................96P/35Lencioni M. ................................................... 216/67 Makihara Y. ...................................................56P/73 Lombardi F. .......................................................133/4Lendeckel U. ....................................................152/4 Malan A. ...........................................................96P/47 Lonlas E. ............................................................96P/17Lendeckel U. ....................................................... 224 Malecka B. .........................................................164/6 Lorenz T. ...........................................................56P/75Lennerz C. ....................................... 56P/15, 68/7 Málek I. ..............................................................96P/43 Lorenzo L. ....................................................... 216/70Leong D. ...................... 56P/37, 63/1, 216/28, Maloney J. ......................................................96P/47 Lorgat F. .................................................................. 23/6 216/58 Maltret A. .................................................................. 84 Losik D. ......................................136P/20, 216/47Leong-Sit P. ....................................................96P/16 Mamontov O. ..............................................96P/34 Love C. J. ...... 131/3, 176P/17, 164/1, 164/2 Mandry D. ....................................................136P/35Leprince P. ....................................................136P/76 Love L. .............................................................176P/79 Manisty C. ............................................................ 46/1Lequeux B. .....................................................96P/17 Lovell M. ........................................................136P/80 Mangrum J. ......................................................204/1Leroux L. ................................................................. 27/1 Low P. ........................................................................ 88/1 Mano H. ............... 136P/27, 136P/16, 225/6Lettino M. ............................................................. 28/1 Lozinguez O. .............................................136P/56 Manolis A. S. ...................................................... 28/3Levitan J. ................................................................ 24/2 Lubinski A. ........................................................... 114 Mansour F. .........................................................144/2Levorato D. ........... 56P/69, 56P/76, 96P/61 Lucca E. ......................................... 56P/58, 96P/30 Mansour M. ................. 149/4, 204/1, 204/2,Lévy S. .......................................................... 112, 147 Ludwik B. ........................................................ 216/74 204/3Lewalter T. .........................................................223/1 Luedorff G. .......................................................206/1 Mansourati J. .......... 33/1, 96P/71, 96P/80,Lewalter T. ................................................ 150, 191 Lukat M. ...............................................................229/2 96P/5, 97PW/1, 97PW/6, 146/4,Lewandowski M. ..................................176P/58 Lumens J. ....................... 13/5, 29/3, 176P/52, 176P/76, 176P/6, 176P/60, 216/68Lewek J. .......................................... 56P/32, 56P/6 176P/47, 206/3, 226/1 Mantizari L. ...................................................176P/3Leyva F. ............................................... 210/3, 226/5 Lunati M. ..........56P/47, 49/2, 49/5, 207/4, Mantziari L. .............................. 96P/10, 96P/19Lezaic L. ........................................... 44/5, 176P/56 206/6 Marcheix B. ..................................... 23/2, 56P/12Lhermusier T. ...............................................56P/12 Lunati M. .................................................................... 44 Marchesini M. ........................ 96P/21, 96P/27Li W. ......................................................................136P/9 Lund L. .............................................................176P/33 Marcus F. ................. 121/5, 213/2, 177PW/4Liang Z. ..............................................................136P/3 Lundahl G. ......................................................... 96P/4 Marijon E. .....................................................136P/86Licher M. ........................................................136P/39 Lunde T. ........................................ 96P/68, 96P/75 Marin F. .................................................................251/4 Lupo P. ...................................................................184/6 Marini M. ......................................................176P/82 Chairman & AuthorLiebau S. ..............................................................201/3 Luria D. .................................................. 24/2, 226/3 Marino P. ................. 56P/42, 56P/41, 176P/9Liew R. ...................... 136P/3, 136P/13, 224/1 Luther S. ................................................................. 44/6 Marjamaa ........................................................96P/18Lim E. ...................................................................136P/3 Luzi M. ................ 96P/21, 176P/10, 176P/41 Markides V. ....................... 136P/73, 136P/62,Lim H. ....................................... 136P/49, 136P/47 Lyan E. .............................................................136P/65 136P/26, 136P/17Lin S. ........................................................................181/1 Lysitsas D. ............................ 136P/26, 136P/17 Markku S. Nieminen ............................96P/18Lin S. F. ...................................................................181/1 Markus Perola ............................................96P/18Lin Y. ........................................................................169/4Linde C. M. ................ 22/1, 150/2, 176P/33, M Maron B. ..............................................................101/3 Marrakchi S. ........................................................ 23/5 230/2 Maat A. ..............................................................96P/55 Marrouche N. F. .............................35/3, 149/5,Linde C. M. ........................................................... 130 Mabo P. ..... 56P/14, 64/2, 96P/76, 96P/82, 163/6, 183/6, 216/43, 205/4Lindovská M. ...............................................56P/35 96P/77, 96P/5, 97PW/6, 176P/44, Marrouche N. F. ....................................... 35, 183Lindsay B. D. .................96P/84, 85/4, 162/2 206/6 Marschall C. .....................................................224/3Ling L. .....................................................................229/4 Mabo P. ........................................................... 10, 134 Marshall H. .................................................... 216/67Linker N. J. .........................................................252/2 Maccabelli G. ................................ 63/3, 216/21 Marshall M. ......................................................... 47/2 - 171 - www.cardiostim.com

Chairman & Author IndexChairman or Author. . ...... Session numberMartin D. .......... 96P/84, 176P/17, 176P/79 Medkour F. .....................................................96P/77 Miyoshi S. ....................................................136P/59Martinelli M. ................................................56P/52 Mehri S. .............................................................96P/32 Mizobuchi M. ......................... 96P/67, 96P/45Martinenghi N. ........................... 44/4, 216/27 Meierbachtol C. .............................................. 68/2 Mlcochova H. ..................................................... 23/6Martínez J. G. .................................................145/2 Meine M. .......................................................176P/84 Mlynarska A. ........ 56P/1, 56P/19, 56P/65,Martinkute E. ................................................. 56P/4 Mela T. ...................................................................... 30/1 56P/51Martino M. ................................ 176P/85, 206/6 Melao F. .............................................................56P/21 Mlynarski R. .......... 56P/1, 56P/19, 56P/65,Martinoff S. ......................................................229/5 Meldrum N. ...................................................56P/22 56P/51Martins R. ..... 176P/44, 176P/11, 176P/57 Melton I. ..................................................... 177PW/2 Moccetti T. .........................................................226/5Maru F. .................................... 176P/26, 176P/16 Melzer C. ............................................................... 64/5 Modi B. ...........................................................176P/45Marullo F. .................. 216/44, 216/42, 229/3 Memon N. ....... 96P/25, 136P/28, 176P/53 Modi S. ...............................................................96P/16Marzi A. .............................................................56P/68 Memon S. ........................................................96P/25 Moe K. ...................................................................224/1Maschke S. ..................................................136P/39 Mendes M. ..................................................136P/83 Moe W. ..................................................................224/1Mascia G. ........................................................ 216/11 Menendez C. ...............................................56P/13 Moen D. .................................................................. 64/3Mascioli G. ................................ 56P/58, 96P/30 Meo M. ............................................ 216/10, 216/9 Mohammadi Z. .............................................. 96P/6Maselli D. ............................................................... 64/6 Merati F. ............................................................56P/58 Mohanty P. ................ 23/6, 56P/7, 136P/63,Masilamani L. ............................................. 216/19 Merino J. L. ......................................... 91/2, 111/1 163/3Maslow A. ......................................................96P/20 Merino J. L. ............................................................ 223 Mohanty S. ..............56P/7, 136P/63, 163/3Mason M. J. ......................................................166/5 Merkely B. ............................................................ 42/3 Mohler P. J. ...................................... 161/3, 161/5Massa D. ................................ 136P/61, 136P/52 Merkureva A. ............................................136P/65 Moini C. ............................................................96P/71Massaad Y. .......136P/32, 136P/87, 216/6, Mesa García J. .............................................56P/77 Mokrani B. ......... 56P/71, 136P/81, 216/56 216/54 Meste O. .................... 216/10, 216/9, 216/70 Molin F. ............. 56P/71, 136P/81, 176P/26,Massabuau P. ..................................................205/1 Metz T. ........................................... 136P/63, 163/3 176P/16, 216/56Massumi A. ..................................................17PW/4 Meyer T. ........................... 206/4, 206/5, 229/5 Molini S. ............................................................96P/21Masuda M. .......... 96P/12, 136P/1, 136P/6, Meyerfeldt U. .................................................... 23/6 Mollazadeh R. ................................................ 96P/6 216/49, 216/40, 216/46 Meyers D. ........................................................96P/25 Moller M. .................................... 56P/46, 96P/58Matas M. ........................................ 63/4, 176P/14 Mialon P. ........................................................176P/60 Molon G. ..........................................................56P/29Matassini M. ...........................96P/21, 96P/27, Michalski J. ...................................... 184/2, 184/3 Momomura S. .............................................56P/45 176P/29, 176P/41 Michalski M. ....................................................216/2 Monari G. .............................................................. 64/6Matía R. ............... 176P/2, 176P/1, 176P/72, Michaud G. F. ..................55/2, 204/1, 204/2 Monchi M. .........................................................183/3 176P/32, 176P/31 Michaud G. F. ......................................................... 55 Mondoly P. .............. 23/2, 33/2, 33/3, 33/5,Matsuda H. ....................................................96P/13 Michelotti F. ............................. 56P/58, 96P/30 56P/12, 43/3, 97PW/3, 205/1Matsuhashi N. ............................................ 216/13 Michelucci A. ..................... 176P/38, 176P/37 Mongini T. ...................................................... 216/14Matsumiya G. .............................................136P/7 Mihi N. ............................................................... 216/70 Moñivas Palomero V. .... 176P/23, 176P/25Matsumura K. ........................ 96P/67, 96P/45 Mijic D. ...............................................................96P/69 Mont L. ..............13/3, 63/4, 63/5, 136P/25,Matsumura Y. ...........................................136P/71 Miki Y. ................................................................ 216/13 136P/40, 136P/19, 136P/10, 176P/49,Matsuoka M. ........................176P/70, 216/79 Mikuz U. ...........................................................96P/24 176P/68, 176P/14, 203/1, 216/29,Matsushita N. ..............................................96P/38 Milasinovic G. ........................ 106/3, 176P/35 203/5, 231/2, 225/4Matthews I. ...................................................96P/54 Milhem A. .......................................................56P/25 Mont L. ........................................................... 91, 163Matti Viitasalo ...........................................96P/18 Millet J. .......................... 33/4, 216/70, 216/82 Montaudon M. ................. 216/34, 136P/43,Maupain C. ................................................... 216/24 Milpied P. .................................... 96P/82, 96P/80 176P/47, 163/5Maury P. ..................... 33/1, 23/2, 33/2, 33/3, Min X. ..................................................................56P/57 Montenero A. S. ........... 136P/61, 136P/52, 33/5, 56P/12, 43/3, 96P/5, 97PW/3, Minamono E. ...............................................96P/28 227/2 97PW/1, 134/2, 205/1, 216/54 Minarik T. ......................................................176P/54 Montserrat J. ............................................136P/10Maykov E. ............................................................. 13/4 Miniati M. .......................................................96P/74 Moors J. ................................................................113/6Mazer S. .........................................................176P/87 Mironov N. ................................... 13/4, 136P/12 Morandi F. ...................................................... 216/25Mazgalev T. N. ...................................................... 21 Mirro M. ............................................................96P/65 More R. ..................56P/55, 56P/54, 176P/65Mazij M. ........................................................... 216/74 Missler U. ............................................................229/2 Moreira N. ............................ 176P/11, 176P/57Mazurek M. ................................. 43/2, 176P/50 Miszczak-Knecht M. ..............................56P/66 Morello M. ..................................................... 216/14Mazza A. .......................................................176P/21 Mitamura H. ................................................ 216/50 Moreno J. ........................................................56P/30Mazzetti H. ....................... 56P/13, 68/1, 64/4 Mitchell K. ......................................................96P/60 Morgado F. ..................................................136P/83Mazzone P. ..................56P/68, 63/3, 216/21 Mitkowsky P. ...................................................131/1 Morgan J. M. .............. 113/4, 105/4, 171/2,Mc Leod C. ........................................................... 88/4 Mittal S. ........114/2, 216/47, 210/4, 223/2 190/1, 185/4McCabe A. ...................................................176P/27 Miyake F. ..................................... 96P/13, 216/17 Morgan J. M. ............................................. 51, 211McCann G. .................................... 96P/1, 216/35 Miyamoto K. .............................................136P/50 Morgenstern M. ....................................176P/24McCarthy D. ..................................................96P/16 Miyamoto S. .................................................96P/28 Morice R. .......................................................176P/73McComb J. ............. 56P/10, 96P/63, 96P/54 Miyamoto T. ...............................................136P/64 Morillo C. ............................. 176P/26, 176P/16McDonagh T. ........................ 176P/45, 176P/3 Miyazaki A. ............................176P/70, 216/79 Morin N. ............................................. 224/6, 224/7McKenna W. ....................................................121/1 Miyazaki S. ........ 136P/31, 136P/30, 216/55, Morita T. ...........................................................96P/46McVenes R. ............................................................... 47 205/4, 223/4, 223/5, 216/34 Morita Y. ...........................................................96P/28 www.cardiostim.com - 172 -

Chairman & Author IndexChairman or Author. . ...... Session numberMorley G. ........................................................136P/8 Nagy Balo E. ................................................ 216/61 Nin Y. ......................................................................224/1Moro C. ............... 176P/2, 176P/1, 176P/72, Naik N. ........................................... 56P/39, 56P/36 Nishino T. .........................................................96P/22 176P/32, 176P/31 Nair M. ...............................................................96P/44 Nishio S. ............................................................96P/13Morris A. .............................................................183/6 Naito S. ............................................................. 216/13 Nishiuchi S. ................................................... 216/13Morris D. ........................................... 205/5, 205/6 Naito T. ............................................................136P/64 Nishiyama N. .............................................136P/59Mortensen P. ................................................56P/38 Naka Sakamoto N. ....................................113/3 Nishizaki M. ..................................................96P/38Morton J. .................................... 136P/84, 229/4 Nakagawa H. ..................................................204/4 Nitta J. .............................................................136P/71Moss A. J. ............................................. 81/4, 213/1 Nakagawa Y. ...................................................216/8 Nitta T. .............................................. 168/4, 216/50Moss A. J. ................................................................... 53 Nakai T. ................. 136P/27, 136P/16, 225/6 Noblemaire R. ................................................... 43/3Mouchawar G. ...................... 56P/56, 56P/57 Nakajima J. .....................................................56P/45 Nobuyoshi M. ........................... 56P/73, 226/4Mouhoub Y. ...................................... 23/5, 183/3 Nakajima M. .................................................96P/13 Nobuyuki Sato N. .......................................113/3Mounsey J. P. ...................................................... 95/1 Nakamura K. ...........................216/13, 216/13 Noelker G. .........................................................212/3Mounsey J. P. .......................................................... 95 Nakamura S. ............................ 96P/67, 96P/45 Nogami A. ..................................... 216/50, 235/3Moustaghfir A. ..........................................56P/59 Nakane E. ........................................................96P/28 Nogami A. .............................................................. 235Mouton E. .......................................................96P/88 Nakano E. ................................... 96P/13, 216/17 Nohara R. .........................................................96P/28Moya A. ................................................................228/1 Nakazato Y. ...................................................56P/34 Noheria A. ......................................................96P/42Moye L. ...........................................................136P/28 Nakazato Y. ......................................................... 187 Nohr E. ...............................................................56P/46Moyeda A. .........................................................225/1 Naoyuki Hasebe N. ...................................113/3 Nolan P. .................................................................252/3 Napolitano C. .................................. 81/3, 132/1 Nölker G. ............... 24/5, 136P/85, 136P/74,Moynagh A. .....................................................183/3 Nappo R. ...........................................................56P/42 216/1, 216/52Mrochak A. .......................................................223/1 Naqvi T. .................................................................... 43/5 Noman A. ....................................................... 216/63Muggenthaler M. ..................................97PW/4 Narasimhan C. ........................................... 216/19 Norlander B. ....................................................164/1Mukai Y. ........................................................... 216/51 Narayan S. ................. 35/2, 136P/15, 129/3, Noseworthy P. ............................................96P/18Mukerji S. ........ 96P/25, 136P/28, 176P/53 149/2, 216/23, 205/2, 205/3, 205/5, Noskova M. ...................................................96P/11Mulpuru S. ..................56P/62, 205/5, 205/6 205/6, 225/1, 225/3 Novak E. .........................................................176P/60Muneretto C. ..................................................... 23/1 Narayan S. M. ........................................... 35, 129 Novotny A. ..................................................136P/41Munger T. T. ......................................................... 108 Nardella S. ............................................................ 64/6 Nowak S. ............................................................. 96P/2Muñoz T. .........................................................17PW/2 Nardi S. ....................... 216/44, 216/42, 229/3 Nyenhuis J. .....................................................56P/57Muntean B. ......136P/85, 136P/74, 216/1, Nasir N. ..............................................................96P/66 Nyktari E. .........................................................56P/18 216/52 Natale A. ..................... 23/6, 56P/7, 136P/63,Murakawa Y. ............................................... 216/50Muramatsu K. ..........................................136P/71 141/4, 163/3, 204/2 Nattel S. ...............................35/1, 141/1, 224/5 OMuratore C. ................ 56P/13, 64/4, 96P/9, O H-Ici D. .............................................................183/3 Nault I. ............... 56P/71, 136P/81, 136P/43, 96P/47 216/56 O_mera O. ......................................................56P/35Murday D. ..........................................................113/4 Nay L. ......................................................................224/1 O’Hara G. ............ 56P/71, 136P/81, 216/56Muresan L. ...................................................136P/35 Nazeri A. .........................................................17PW/4 O’Neill M. ....... 75/2, 183/4, 183/5, 216/3,Murgatroyd F. D. .......................... 24/6, 194/3 Neason C. .............................................................. 44/3 255/3, 275/3Murgatroyd F. D. ............................................ 174 Negru-Ivanica A. ...................................136P/35 O’Neill M. ........................... 75, 204, 255, 275Musialik-Lydka A. ............ 96P/8, 177PW/3 Nesti M. .....................................176P/37, 216/11 O’Rourke B. ......................................................... 11/3Müssigbrodt A. ......................................... 216/16 Neumann T. ......... 85/2, 126/2, 203/3, 223/3 Obayashi T. .................................................136P/64Muthumala A. ................................................225/5 Neuwirth R. ......................................................223/6 Occhetta E. ............ 56P/42, 56P/41, 176P/9Myerburg R. J. ................................................201/5 Neuzil P. ............ 24/6, 134/4, 204/1, 204/3, Oginosawa Y. ..............................................56P/31Mylotte D. .........................................................183/3 204/4, 204/5 Ohkubo K. ......... 136P/27, 136P/16, 225/6Myojo T. ...............................................................113/5 Neuzil P. ....................................................................... 52 Ohlow M. .......... 56P/17, 96P/87, 176P/18, Nevralová R. ................................................ 216/37 176P/86 Chairman & AuthorN Nevzorov R. ................................................176P/43 Ohuchi H. .................................176P/70, 216/79 Ng G. .......................... 96P/1, 136P/37, 216/35 Okda H. ..........................................................136P/64Naccarelli G. V. ...............................................127/1 Ng J. ....................................................................17PW/6 Okeie K. ................................................................ 56P/3Naccarelli G. V. ...................................................... 87 Niazi I. .............176P/17, 176P/80, 176P/79, Okishige K. ........................................................216/8Nadal M. ........................................................136P/19 176P/28, 183/2 Okreglicki A. ............................216/64, 216/80Nademanee K. ...............................................167/3 Nicolas Derval N. .................................... 216/34 Okumura K. .................................................. 216/50Nagahara D. ................. 183/4, 183/5, 216/3 Nicolson W. .................................. 96P/1, 216/35 Okumura Y. ...... 136P/27, 136P/16, 225/6Nagai H. ........................................................... 216/51 Niculescu V. ....................................................176P/8 Olagüe Ros J. .................... 176P/25, 176P/23Nagamoto Y. ................... 136P/48, 136P/49, Niebauer M. ..................................................96P/65 Olcese R. .......................................................... 216/12 136P/50, 136P/47 Nielsen J. C. ........................7/4, 27/2, 56P/46, Olesen M. ...........................................................152/1Nagashima K. ................. 136P/27, 136P/16, 56P/38, 64/1, 96P/58 Oliva M. ..........................................................176P/41 225/6 Nielsen J. C. ......................................................... 252 Oliveira M. ........................................................146/3Nagashima M. .............................................56P/73 Nikcevic G. ..................................................176P/35 Omi W. .......................................... 56P/27, 216/51Nagele H. .................................... 96P/82, 176P/6 Nilsson J. ............................................................. 96P/4 On Y. .............................17PW/5, 96P/3, 96P/29 - 173 - www.cardiostim.com

Chairman & Author IndexChairman or Author. . ...... Session numberOn Behalf of the Danpace Park J. ............... 136P/48, 136P/49, 136P/47 Phan H. ...........................................................176P/30Investigators ...................................................... 64/1 Park S. ...... 17PW/5, 96P/3, 96P/3, 96P/29, Phan P. ................................................................56P/62Ong B. .................................................................136P/3 136P/47, 136P/48, 136P/49 Philip K. ................................................................113/6Opel A. ............................................................136P/11 Park Y. .............. 136P/48, 136P/49, 136P/47 Philippon F. ......................... 176P/26, 176P/16Opgen-Rhein B. ................................... 177PW/5 Parks K. A. ........................................ 110/3, 210/1 Phillipon F. ..... 56P/71, 136P/81, 176P/69,Opthof T. ................................................................ 201 Parmon E. ........................................................96P/34 216/56Oraii S. ................................................................56P/43 Parry S. W. ........................88/3, 188/3, 208/1 Pianelli M. ...................................................... 216/53Orazi S. ...........................................................176P/85 Parry S. W. ........................................................... 208 Piccirillo G. ........................................................... 64/6Oron Y. ..................................................................164/4 Pascale P. ..................... 113/1, 113/2, 136P/2, Pieragnoli P. ........................ 176P/38, 176P/37Orszulak W. ...................................................96P/41 176P/83, 176P/77, 163/5, 163/6, Pierre Jaïs P. .................................................. 216/34Ortiz J. ...................................................................... 63/5 216/38, 216/76, 216/55, 216/33, Piers S. ............... 63/1, 163/1, 163/2, 163/4,Osca Asensi J. ................... 176P/25, 176P/23 205/4, 225/3, 223/4, 223/5, 216/34 216/28, 229/1Oseroff O. ............................................................. 110 Pasquié J. ....... 33/2, 33/3, 33/5, 96P/5, 145/3 Pietura R. .........................................................56P/72Oshima S. ....................................................... 216/13 Pasquié J. L. ......................................................145/3 Pijnappels D. ............................................... 216/28Osman A. ........................................................ 216/15 Pastore G. ..................................... 68/4, 176P/21 Pilat E. ............................................... 56P/1, 56P/65Oswald H. ....................................................176P/68 Patel C. ......................................... 56P/39, 56P/36 Pilichowska-Paszkiet E. ..................136P/36Oto A. ......................................................... 48/2, 93/1 Patel J. ................................................................56P/62 Pimentel R. ........................................................... 68/6Oto A. ............................................................... 93, 130 Patel P. ..................................... 136P/26, 136P/17 Pindor J. .......................................... 216/37, 223/6Otsuji Y. .............................................................56P/31 Patrianakos A. ............................................56P/18 Pinho P. ..............................................................56P/21Ottaviano L. ....................... 136P/61, 136P/52 Paul D. ............................. 56P/75, 56P/20, 68/2 Pinto Y. ................................................ 221/1, 221/1Otte A. .............................................................176P/48 Paulik M. .......................................................136P/18 Piorkowski C. ............... 25/2, 71/3, 216/16,Otto T. ...................................... 136P/69, 136P/46 Pauriah M. ...................................................136P/35 216/30, 216/26, 229/6Ouarda F. ..........................................................96P/32 Pavaci H. .................... 64/6, 136P/18, 216/59 Piorkowski G. ...........................................136P/23Ouyang F. .............................................................. 23/6 Pavie A. .............................23/5, 68/9, 136P/76 Piot O. .................................................................96P/78Ovsyshcher E. .................................................... 230 Pavin D. ..........................................................136P/42 Piotrowicz R. ...................................................... 73/3Oyarzun R. .................................................................. 7 Pavlovic S. ....................................................176P/35 Piotrowicz R. ................................... 13, 73, 177Oza A. ....................................................................... 68/6 Payaslian M. .................................................56P/13 Pirk J. ................................................................... 216/39 Pecora D. ......................................................... 216/25 Pisanò E. ..............................................................184/1P Pedersen M. .... 97PW/5, 216/76, 216/55, 223/4, 223/5 Pisapia A. ............................................. 23/6, 212/2 Pistelli P. ............................................................56P/41Pachinger O. ..............................................136P/57 Pedersen S. ............... 44/1, 96P/52, 96P/51, Pistone E. ........................................................ 216/14Pachon J. ..........................................................96P/47 176P/84 Pitt G. .....................................................................161/1Packer D. L. .................... 147/2, 162/3, 204/3 Pedrazzini T. ........................................................... 1/1 Pittalis M. ...........................................................184/6Padeletti L. .......... 56P/47, 130/1, 176P/38, Peebles C. ..........................................................113/4 Pizzimenti G. ................................................56P/33 176P/37, 176P/66, 216/11, 207/2, Peichl P. ............ 136P/24, 136P/70, 216/18, Plebani L. ................ 56P/42, 56P/41, 176P/9 206/6, 230/1 204/5 Plehn G. .............................................................96P/86Padeletti L. ........................................................... 146 Pelargonio G. .................................. 52/2, 163/3 Ploux S. ........13/5, 43/1, 96P/35, 176P/47,Page R. L. .................................................................... 74 Pelegrino A. ........................................................ 64/4 176P/77, 164/5, 206/2, 206/3, 226/1Page S. .............................................................136P/80 Pelissero E. .....................................................56P/67 Plummer C. ............................... 56P/10, 96P/63Paglino G. .......................................................56P/68 Pelleg A. ...............................................................188/5 Pluta S. ............................................................176P/50Paiement P. .................................................176P/88 Pellet N. .............................................................96P/70 Po S. .........................................................................181/2Paisey J. ................................................................225/5 Peltonen L. .....................................................96P/18 Pochet H. ..........................................................56P/61Pajitnev D. ....................................... 203/3, 223/3 Penela D. .......................................................176P/14 Poelzing S. ............................................................ 121Palazzo A. ........................................ 44/4, 216/27 Pennesi M. ......................................................96P/30 Poglajen G. ..................................... 44/5, 96P/24Palozzi G. ............................................................184/4 Penot J. ..............................................................56P/61 Pokushalov E. ...........................23/4, 136P/55,Pambrun T. .....................................................96P/17 Penot M. ...........................................................56P/61 136P/20, 172/1, 191/4, 216/47, 203/6,Panfilov A. V. ...................................................... 109 Perings C. ........................................................96P/72 223/1, 223/2Pantano A. ..................................................136P/82 Perisic Z. ....................................... 56P/16, 136P/4 Ponikowski P. ........................................................ 2/4Paperini L. ............ 56P/70, 56P/69, 56P/76, Perry D. .................................................................183/6 Ponikowski P. ............................................ 32, 171 96P/61 Perry J. ............................................................... 216/77 Pontecorboli G. .............. 176P/38, 176P/37Papi E. ....................................................................... 64/6 Pesic M. .............................................................136P/4 Poole J. ..................................... 96P/60, 177PW/2Pappone C. .......................................................... 25/3 Peters S. ...................................................... 177PW/6 Poole J. E. ............................................................... 209Pappone C. .............................................................. 25 Petersen H. .....................................................96P/73 Pop M. ...................................................................109/3Paraskevaidis S. ................... 96P/10, 96P/19 Petersen S. .....................................................176P/4 Popescu E. .......................................................96P/71Parikh N. ................................................................. 64/3 Peterson B. .....................................................96P/44 Popescu I. .................... 216/6, 216/10, 216/9Park C. ............136P/68, 136P/45, 136P/44, Petracca F. ....................56P/68, 63/3, 216/21 Porcelli D. .............................................................. 64/6 136P/75, 216/60, 216/5, 216/71, Petru J. ..................................................................204/5 Porciani M. .......................... 176P/38, 176P/37 216/57, 204/6 Peytchev P. ................................ 136P/5, 216/36 Porrini A. ............................... 136P/61, 136P/52Park H. ............. 136P/48, 136P/49, 136P/47 Pezawas T. .........................................................223/1 Porter A. ........................................................176P/43 www.cardiostim.com - 174 -

Chairman & Author IndexChairman or Author. . ...... Session numberPostema P. G. ..................................................189/2 Radovanovic Z. ..........................................56P/16 Ricci A. ...................................................................... 64/6Postorino C. .....................................................184/6 Raffa S. .................................... 136P/72, 176P/74 Ricci R. .................................................. 170/3, 227/5Poulsen S. ........................................................56P/38 Raga S. ............................................................136P/67 Ricci R. .............................................................. 47, 210Powell B. ........................................... 226/2, 226/3 Rahbari S. ................................... 56P/56, 56P/54 Ricciardi G. .......................... 176P/38, 176P/37Prades E. ...........................................................56P/29 Rahman M. ..................................................176P/78 Richards M. ............................... 56P/24, 56P/23Prakash A. ........................................ 56P/28, 64/3 Raimondo C. ............................................... 216/66 Richardson J. ..................... 136P/26, 136P/17Pratt C. M. ................................................................ 54 Rajappan K. .............................. 176P/22, 225/5 Richmond L. ...............................................136P/80Predolini S. .................................................... 216/25 Raju H. ..............................................................97PW/4 Richter S. ..................................136P/72, 216/16Premkumar K. ............................................ 216/19 Raju P. ........................................................................ 33/6 Rieger G. .............................................................223/1Pretorius V. ................................... 56P/62, 164/2 Rakowski-Anderson T. .......................136P/8 Riemenscheider M. ..............................17PW/3Prevot S. ........................................................176P/16 Ramanathan C. .......13/5, 176P/77, 226/1 Riganti C. ............................................................227/6Price S. ...................................................................... 83/1 Ramdjan T. ......................................................... 56P/5 Rijo N. .....................................................................216/6Printz B. ............................................................ 216/77 Ramirez R. ..........................................................224/3 Rinaldi A. .......................... 50/2, 131/2, 165/4,Prinzen F. ............. 43/1, 68/5, 68/8, 176P/5, Ramirez Valdiris U. .................................56P/77 183/4, 216/3 176P/52, 176P/42, 206/2, 226/6 Rämmler C. ......................... 136P/69, 136P/46 Rinaldi C. ............................................................... 43/5Prinzen F. W. ............................................ 104, 170 Ramos P. ................. 13/3, 136P/40, 136P/10, Rinaldi J. ........................................................136P/21Priori S. G. ............. 12/1, 42/4, 65/2, 123/1, 203/1, 203/5, 225/4 Rinkuniene D. ..........................................176P/55 189/3 Ramos R. ................................................................. 33/4 Rinne C. ..........................................................176P/69Priori S. G. .......................... 65, 101, 124, 142 Ramoul K. .............. 96P/35, 97PW/5, 113/1, Ripatti S. ...........................................................96P/18Probst V. ..................... 33/1, 33/2, 33/3, 33/5, 113/2, 176P/83, 176P/77, 216/33, Ristalli F. ................................. 176P/38, 176P/37 56P/14, 64/2, 96P/77, 96P/5, 97PW/6, 223/4, 223/5 Ritter O. .............................................................96P/53 97PW/1, 114/1, 189/1 Ramsay S. .....................................................136P/80 Ritter P. .................. 13/5, 43/3, 49/6, 96P/35,Probst V. .................................................................. 141 Rao H. ................................................... 33/6, 216/19 96P/82, 85/3, 176P/6, 176P/47,Prochnau D. ........................ 176P/48, 176P/15 Rapoport A. ................................................176P/78 176P/77, 176P/85, 176P/83, 164/5,Providência L. ................... 176P/11, 176P/57 Ras M. ................................................................ 216/74 185/5, 206/3, 233/3, 254/4, 274/4Prudat Y. .......................................................... 216/12 Rasmussen L. H. ...........................................251/2 Ritter P. ......................................................... 194, 233Prull M. ..............................................................96P/86 Rasmussen L. H. .................................................. 82 Rivarola M. .....................................................56P/50Pruszkowska P. ........................................176P/50 Raspopovic S. ...........................................176P/35 Rivera Santiago R. ................................. 216/62Pruszkowska-Skrzep P. ............................ 43/2 Raviele A. .............................................................. 42/1 Roberts J. .........................................................96P/66Pruvot E. ...... 136P/2, 129/2, 208/3, 225/3 Raviele A. ........................................... 42, 88, 202 Roberts P. .......................................... 113/4, 151/3Pruvot E. ..................................................... 129, 225 Razavi M. .......................................................17PW/4 Robinson T. .......................................................224/2Prystowsky E. N. ................................................. 65 Razavi R. .......................... 183/4, 183/5, 216/3 Robles F. ............................................. 44/4, 216/27Puererfellner H. ............................................191/3 Razzo O. ............................................................56P/77 Robotis D. ............................................................. 44/3Puetz V. ...................................... 176P/20, 176P/7 Rebecchi M. ................96P/74, 184/1, 184/4 Roden D. M. .....................................................221/5Pump A. .......................56P/7, 136P/63, 163/3 Reddy V. Y. .................... 186/2, 186/4, 204/1, Rodriguez B. ............................... 216/81, 216/7Puodziukynas A. ...................................176P/55 204/2, 204/3, 235/1 Rodriguez J. ..................................................56P/30Pupita G. ..........................................................96P/27 Reddy V. Y. .......................................................... 235 Rodríguez-Font E. ................................136P/67Pürerfellner H. ...............................................223/1 Redfield M. .......................................................226/2 Roelke M. ........................................................56P/48Pyda M. ................................................................216/2 Reents T. .............56P/15, 136P/18, 216/59, Rohr S. ...................................................................... 41/2Pytkowski M. .......................176P/34, 216/32 203/4, 229/5 Rolando M. ....................................................56P/30 Regoli F. ................................................................226/5 Rolin A. .................................................................... 43/3Q Reiter T. .............................................................96P/53 Rekawek J. .....................................................56P/66 Rollin A. ...................... 23/2, 33/2, 33/3, 33/5, 56P/12, 97PW/3Quaglione R. .................................... 64/6, 184/1 Relan J. ..................................................................163/5 Rollin Garderes A. ...................................136P/2Quaresma R. ..............................................136P/83 Remi J. ............................................................... 216/33 Rollmann T. .................................. 216/4, 216/22 Chairman & AuthorQuennelle F. ...............................................176P/73 Rendu E. ............................................................56P/14 Romagnuolo I. ................. 176P/38, 176P/37Querengaesser J. ..................................176P/15 Restle C. .................136P/68, 216/60, 216/5, Romanek J. .................................................... 216/74Quesada A. ................................................... 216/70 216/57, 204/6 Romano S. ..................................................... 216/11Quirino G. .......................................................56P/41 Reuter S. ............................................ 254/3, 274/3 Romano V. ...................................................... 216/30Qureshi N. ..................................... 216/72, 225/5 Reynolds D. W. ..............................................230/4 Romanov A. ....... 23/4, 136P/55, 136P/20, Reynolds D. W. ................................................. 194 216/47, 203/6, 223/2R Rezaei M. ............................................................... 43/3 Rhode K. .......................... 183/4, 183/5, 216/3 Ronaszéki A. ....................................................... 29/1

2012 Final Program

by Reed Expositions France on Jun 07, 2012

Accessibility

Upload Details

Usage Rights

1 Embed 2

Statistics

2012 Final Program Document Transcript